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Abstract 
Background:  The last few decades have seen a growing emphasis on evidence-
based decision making in health care.  Systematic reviews synthesising and 
evaluating research have been a key component of this movement.  However, 
there is concern that such syntheses do not have the expected impact on policy 
and practice and more work is needed to enable us to maximise their potential.  
The aim of this study was to increase understanding of the likely impacts of 
systematic reviews on policy and identify factors that might facilitate their 
influence. 
Methods:  My own previously published work is integral to this study.  I took ten 
systematic reviews on which I am an author and used established methods for 
the evaluation of research impact, including, bibliometrics and documentary 
review, to examine whether these reviews had influenced policy development.  
Data from these analyses were combined with an overview of the literature to 
identify factors that might increase impact. 
Results:  The reviews had influenced the development of national and 
international policy, although much of the impact was at a ‘micro’ level in the 
form of practice guidelines.  There was considerable variation in the impact of 
the reviews.  Reviews evaluating fluid resuscitation and road safety interventions 
showed the greatest evidence of impact and a review of qualitative studies on 
barriers to fall prevention the least.  Differences might be explained by time 
since publication, type of question, importance to policy makers, the nature and 
strength of the evidence, the purpose of the review and the networks and 
strategies used for dissemination.   
Conclusions:  Systematic reviewers should consider the desired impacts of their 
work and include appropriate strategies for increasing impact, these should be 
detailed in the review protocol.  This might include specifying methods to 
address applicability to particular contexts, and devising active strategies for 
dissemination. 
ii 
 
Acknowledgements 
I would like to thank my supervisors, Dr Geraldine Byrne and Professor Robyn 
Martin, for their valuable advice, support and encouragement; and Professor 
Sally Kendall, for her continuing support.  This study is based on a number of 
publications and I would like to acknowledge the contribution of all my co-
authors, in particular I would like to thank Professor Ian Roberts and my 
colleagues at the Cochrane Injuries Group.  Finally I would like to thank my 
husband, Paul Kayley, for his tireless support. 
  
iii 
 
 
Contents 
Abstract ................................................................................................................................ i 
Acknowledgements ............................................................................................................. ii 
List of tables and figures .....................................................................................................vi 
Abbreviations ..................................................................................................................... vii 
Chapter 1: Introduction ...................................................................................................... 1 
Introduction .................................................................................................................... 1 
The evolution of evidence based policy .......................................................................... 3 
Barriers to the development of evidence based policy ................................................ 11 
Explanatory frameworks and theories of the policy development process ................. 13 
Conclusion ..................................................................................................................... 20 
Aims & objectives.......................................................................................................... 21 
Organisation of the submission .................................................................................... 21 
Chapter 2: Promoting the impact of research .................................................................. 25 
Introduction .................................................................................................................. 25 
Defining research impact .............................................................................................. 25 
Promoting the impact of research on health care policy ............................................. 26 
Promoting the impact of systematic reviews on health care policy ............................. 28 
Facilitators for promoting the influence of research on health care policy ................. 31 
Collaborative approaches ......................................................................................... 31 
Collaborative approaches and systematic reviews ................................................... 34 
Barriers to collaborative approaches ........................................................................ 35 
The role of dissemination in enhancing research use .............................................. 36 
Dissemination strategies and systematic reviews .................................................... 38 
Initiatives to increase the usefulness of systematic reviews ........................................ 40 
Conclusion ..................................................................................................................... 43 
Chapter 3: Methods .......................................................................................................... 51 
Introduction .................................................................................................................. 51 
The role of my own research ........................................................................................ 51 
Methods for determining impact ................................................................................. 54 
Evaluation frameworks ................................................................................................. 64 
Selected framework .................................................................................................. 72 
iv 
 
Other methodological considerations .......................................................................... 73 
Conclusion ..................................................................................................................... 74 
Chapter 4: Strategies for fluid resuscitation: systematic reviews of RCTs ....................... 75 
Introduction .................................................................................................................. 75 
Drivers behind review question/s ................................................................................. 76 
Systematic review methods .......................................................................................... 77 
Results of impact analysis ............................................................................................. 85 
Conclusion ..................................................................................................................... 96 
Chapter 5: The prevention of traffic related injuries: systematic reviews of road safety 
interventions ................................................................................................................... 104 
Introduction ................................................................................................................ 104 
Drivers behind review question/s ............................................................................... 104 
Review methods ......................................................................................................... 106 
Results of impact analysis ........................................................................................... 110 
Barriers to evidence-based road safety ...................................................................... 119 
Conclusion ................................................................................................................... 124 
Chapter 6: Identifying barriers and facilitators to fall prevention interventions: 
systematic review of qualitative research ...................................................................... 126 
Introduction ................................................................................................................ 126 
Drivers behind review question .................................................................................. 126 
The role of qualitative research in systematic reviews .............................................. 127 
Conceptual approaches/methodologies ..................................................................... 129 
Review methods ......................................................................................................... 132 
Results of impact analysis ........................................................................................... 140 
Conclusion ................................................................................................................... 145 
Chapter 7: Systematic review to inform the development of NICE public health guidance
 ........................................................................................................................................ 151 
Introduction ................................................................................................................ 151 
Drivers behind review question .................................................................................. 151 
Rationale for guidelines .............................................................................................. 154 
Potential problems with clinical guidelines ................................................................ 156 
The development of NICE Guidelines ......................................................................... 160 
Methods for NICE reviews .......................................................................................... 161 
The use of guidelines by practitioners ........................................................................ 164 
Results of impact analysis ........................................................................................... 167 
v 
 
Conclusion ................................................................................................................... 172 
Chapter 8: Evaluating the safety and efficacy of telephone consultation: a systematic 
review to inform service delivery & organization ........................................................... 173 
Introduction ................................................................................................................ 173 
Drivers behind review question .................................................................................. 173 
Review methods ......................................................................................................... 174 
Results of impact analysis ........................................................................................... 178 
Research impact and the social construction of policy .............................................. 183 
Conclusion ................................................................................................................... 185 
Chapter 9: Discussion & Conclusions .............................................................................. 187 
Introduction ................................................................................................................ 187 
Overview of the impact analysis ................................................................................. 188 
Factors that play a role in the extent to which systematic reviews can influence policy
 .................................................................................................................................... 197 
Barriers & facilitators to research impact ................................................................... 201 
Meeting the needs of policy makers whilst maintaining methodological rigour ....... 204 
Methodological approach and limitations of the study ............................................. 205 
Implications of the findings......................................................................................... 210 
Implications for future research ................................................................................. 214 
Conclusion ................................................................................................................... 215 
References ...................................................................................................................... 217 
Appendix 1: Full list of authors publications ................................................................... 244 
Appendix 2: Published papers included in submission ................................................... 249 
 
  
vi 
 
List of tables and figures 
 
Tables  
Table 2.1  Mechanisms to drive research impact 27 
Table 2.2  Studies promoting the use of systematic reviews  46 
Table 3.1  Published systematic reviews included in submission  52 
Table 3.2  Search Strategies for identification of evidence of impact Chapters 4-8 62 
Table 4.1  Downloads for Cochrane fluid resuscitation reviews in 2008 and 2009 89 
Table 4.2  Evidence of fluid reviews’ influence on guideline development 97 
Table 5.1  Evidence of road safety reviews’ influence on policy development 115 
Table 6.1  Methods for systematically reviewing qualitative studies 147 
Table 7.1  Results of internet searches to identify organisations citing the 
guidelines 
170 
Table 8.1  Secondary outputs from telephone triage review 181 
Table 9.1  Summary of citations in policy documents: all reviews 190 
Table 9.2  Number of downloads for Cochrane reviews 
 
194 
Figures  
Figure 4.1  Results of citation analysis: fluid therapy reviews 87 
Figure 5.1  Results of citation analysis: road safety reviews 112 
Figure 8.1  Results of original and revised citation analyses: telephone consultation 
review 
179 
Figure 8.2  Policy analysis triangle  183 
 
  
vii 
 
Abbreviations 
 
BMA British Medical Association 
BMJ British Medical Journal 
CBA Controlled before after study 
CIG Cochrane Injuries Group 
CDSR Cochrane Database of Systematic Reviews 
DoH Department of Health 
EPOC Effective Practice and Organisation of Care 
HTA Health technology assessment 
ITS Interrupted time series 
KTE Knowledge transfer and exchange  
NICE National Institute of Health and Clinical Excellence 
NHS National Health Service 
NRS Non randomised studies 
RCT Randomised controlled trial 
SIGN Scottish Intercollegiate Guidelines Network 
STI Sexually transmitted infection 
WHO World Health Organisation 
WoS Web of Science 
 
1 
 
Chapter 1: Introduction 
Introduction 
Over the last few decades there has been a growing emphasis on the use of 
evidence to inform decision making in health care (Dawes et al., 2005, Sackett et 
al., 1996).  Whilst initially much of the focus was on the use of research evidence 
in medicine, and on which clinical interventions were most effective for patients, 
the movement has now expanded to include other aspects of health care 
practice including nursing and public health (Chalmers, 2003, Dawes et al., 2005, 
French, 1999, Kitson et al., 2008, Schuerman, 2002).  There are a number of 
definitions of evidence-based practice but they commonly include an emphasis 
on using evidence that is the best available and that is up to date, valid and 
relevant (Dawes et al., 2005, Sackett et al., 1996).  
One of the key aspects of evidence based practice has been the development of 
methods for the synthesis and integration of primary research.  There are a 
number of terms for such syntheses but the most widely used and understood is 
‘systematic review’.  A systematic review has been defined as ‘ a summary of the 
best available evidence that addresses a sharply defined question’ (Sackett et al., 
1996) which is ‘prepared using a systematic approach to minimising biases and 
random errors and in which there is clear documentation of the process in a 
materials and methods section’ (Chalmers, 1995).  Systematic reviews have 
several advantages over other types of research that have led to them being 
regarded as particularly important tools for decision makers.  For example, they 
are considered to be scientifically rigorous and can generally be conducted more 
rapidly than new primary research which may make them particularly useful for 
policy makers who may be called on to respond quickly to policy issues (Pawson, 
2002).  In addition, it inherently makes sense for decisions to be based on the 
totality of evidence rather than a single study (Sheldon, 2005).   
However, despite this sound and scientific rationale for using systematic reviews 
for decision making, it has been pointed out that ‘the policy and management 
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community in health care in general has been slow to use them for informing 
their decisions’ (Sheldon, 2005).  Indeed the usefulness of systematic reviews for 
aiding policy makers in the decision making process has come into question with 
authors suggesting a number of factors that might reduce their utility.  These 
include a lack of good quality primary research for synthesis, a tendency for 
reviewers to focus on randomised controlled trials and controlled evaluations at 
the expense of other types of research, and inadequate evaluation of complex 
interventions with little recognition of the importance of contextual factors 
(Greenhalgh et al., 2003, Oliver, 2001, Pawson, 2002).  Furthermore, it has been 
argued that researchers may view the relationship between policy and research 
in a simplistic linear fashion, whereby thinking proceeds sequentially through 
stages which are guided by rational analysis, without due consideration of the 
social, cultural, political, economic and ideological factors that contribute to the 
development of health policy.  The factors which influence change are complex 
and further work is needed on the issues involved in ensuring systematic reviews 
make the appropriate contribution to the development of policy and practice. 
In addition, recent years have seen a growing interest in the way in which 
research is used with researchers increasingly expected to consider the wider 
impacts of their work (HEFC, 2009).  This may include the contributions research 
makes to society, culture, the economy, quality of life and public policy.  The 
focus of this study is on systematic reviews and the impact they have on the 
development of health care policy in England.  The study is based around ten 
systematic reviews (14 papers) (Alderson et al., 2000, Bunn et al., 2006a, Bunn et 
al., 2004a, Bunn et al., 2005, Bunn et al., 2003a, Bunn et al., 2003b, Bunn et al., 
2008a, Bunn et al., 2004b, Bunn et al., 2008b, CIG Albumin Reviewers, 1998, 
Duperrex et al., 2002a, Duperrex et al., 2002b, Kwan et al., 2003, The Albumin 
Reviewers et al., 2004), on which I have made a contribution either as first 
author or co-author.  The purpose of the study is to examine whether these 
reviews had influenced policy development and to identify mechanisms 
researchers can use to promote the use of systematic reviews in policy 
development.   
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Before I go further it is important to outline the definition of policy I have 
adopted for this study.  Policy making can be viewed as involving the 
‘authoritative allocation of values’ (Easton, 1953) and when interpreted broadly 
can include people making the policy as government ministers and officials, as 
local health service managers, or as representatives of a professional body.  The 
results may take many forms ranging from national health policies made by the 
Government to clinical guidelines determined by professional bodies (Hanney et 
al., 2003).   
In this chapter I set the context for the study by documenting the evolution of 
evidence based policy, exploring the development of systematic reviews, looking 
at barriers to the development of evidence based policy and examining some of 
the key frameworks and theories for explaining the relationship between 
research and policy.  Finally I present the aims and objectives of the study and 
outline the organisation and contents of the submission in a chapter plan. 
The evolution of evidence based policy 
Evidence based practice 
Although research has long been a factor in the development of health care the 
evidence based practice movement as we know it today is a relatively new 
phenomenon originating in the 1980s when the term evidence-based medicine 
emerged.  A leading proponent of evidence based medicine described the 
process as “the conscientious, explicit and judicious use of current best evidence 
in making decisions about the care of individual patients.  It means integrating 
individual clinical expertise with the best available external clinical evidence from 
systematic research” (Sackett et al., 1996).  The development of the evidence 
based medicine movement saw a shift from the paradigm of medicine as an ‘art’ 
to conceptualising it in more rational scientific terms.  A lengthy medical 
education, personal experience and the guidance of colleagues was no longer 
seen as a sound basis for making decisions about health care.  Instead 
proponents advocated that treatment decisions be based upon research 
evidence (Sackett et al., 1996).  There were a number of drivers behind the 
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movement but key was the realisation that wide variation existed in the practice 
of individual clinicians (Wennberg, 1973), and that many were using treatments 
that colleagues considered inappropriate (Chassin et al., 1987).  Indeed, there 
has been an accumulation of evidence that some ineffective, or possibly harmful, 
treatments have been overused whilst others shown to be effective were under-
utilised (Chalmers, 2003, Hanney et al., 2005, Lau et al., 1992, Ottesen et al., 
2001, Roberts and Bunn, 2002, Wennberg, 2002). 
However, the ethical imperative to do no harm is only one of a number of factors 
involved in the development and growth of the evidence based practice 
movement.  Other drivers which have been identified include: a better informed 
public, an increasing distrust of experts, the huge growth in information 
available, developments in information technology, a growth in the capacity and 
skills of the research community and increased emphasis on cost effectiveness, 
productivity and accountability (Davies, 2000b, Traynor, 2002).  This agenda, and 
the calls for using the best available evidence have influenced all areas of health 
care and the term evidence based practice is now used to encompass the work 
of all health care professionals and not just doctors (Dawes et al., 2005).  Whilst 
definitions and interpretations of the evidence-based movements in different 
professions reflect the differences in the contexts in which they operate they still 
appear to share key ‘ingredients and tenets’ (Traynor, 2002).   
Key to any discussion of evidence based practice and policy is: what constitutes 
evidence?  The Oxford English Dictionary describes evidence as ‘the available 
body of facts or information indicating whether a belief or proposition is true or 
valid’ (OED, 1998).  In reality ideas of what constitutes evidence vary between 
research disciplines and between researchers and policy makers.  Traditionally 
evidence based medicine has tended to take a narrow view of evidence with an 
elevation of quantitative research, in particular randomised controlled trials and 
meta-analyses, over other forms of evidence (Rycroft-Malone, 2006).  Although 
ideas about what constitutes evidence have widened to encompass other types 
of research, such as uncontrolled studies and qualitative research, other forms of 
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non research based evidence such as experience, expert judgement, anecdote or 
theory are still largely discounted by researchers (Lomas, 2005).  
Some critics have objected to the elevation of research evidence over other 
forms of knowledge and argued that advocates of evidence-based policy have 
failed to recognise the fallibility of scientific evidence, that reliable evidence can 
derive from other sources beside research (Hammersley, 2005, Rycroft-Malone, 
2006) and that evidence is socially constructed and means different things to 
different people (Dopson et al., 2002, Dopson, 1999).  In addition, the concept of 
a solid ‘evidence-base’ has been brought into question.  In a recent paper on 
evidence-based policy Annette Boaz argued that the term evidence-base implies 
the existence of a solid foundation that policy or practice can build on whereas, 
in reality, the reliability and relevance of evidence changes over time and, 
therefore, a concept of an ‘evidence pool’ more accurately captures the 
dynamism and fluidity of evidence (Boaz, 2008b).   
Systematic Reviews 
One of the potential barriers to the widespread use of evidence in practice was 
the vast and unmanageable amount of information practitioners were faced with 
(Mulrow, 1994).  As Iain Chalmers points out, clinicians had long recognised the 
challenge they faced in keeping up to date with relevant information (Chalmers 
and Trohler, 2000).  He cites the Army surgeon John Rollo who in 1801 wrote ‘life 
is too short for a conscientious physician to acquire –even with the most suitable 
education, unremitting observation, accurate investigation and unvaried reading- 
satisfactory confidence in the unreserved treatment of the sick committed to his 
charge’ (Rollo, 1801).  In addition, critics began to question the way researchers 
and practitioners failed to learn from, and build on, past research efforts.  Archie 
Cochrane, a UK epidemiologist, encapsulated the idea that medical research 
should be catalogued and evaluated when he wrote ‘it is surely a great criticism 
of our profession that we have not organised a critical summary, by specialty or 
subspecialty, adapted periodically, of all relevant randomised controlled trials’ 
(Cochrane, 1979). 
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In response to this need for strategies for the management and evaluation of the 
evidence base researchers developed methodologies for synthesising primary 
studies.  Central to this has been the development of statistical techniques for 
combining data from different studies.  This work originated with the statistician 
Karl Pearson who in 1904 reported the use of formal statistical techniques to 
combine data from different medical studies.  His rationale for combining data, 
that “many of the groups are far too small to allow of any definite opinion being 
formed at all, having regard to the size of the probable error involved” (Pearson, 
1904), remains as one of the primary justifications for pooling studies today.  
Work on synthesis was carried on in the social sciences, rather than medicine, 
and it was the psychologist Glass who first used the term meta-analysis (Glass, 
1976). 
Systematic reviewing, however, developed as more than just a statistical method 
for pooling the results of different studies.  It was a process which placed an 
emphasis on a scientific and systematic approach to reviewing research which 
was in stark contrast to the “subjective, scientifically unsound and inefficient 
reviews” often previously found in the medical literature (Light, 1984).  As 
methods for synthesis developed commentators highlighted the difference 
between the poor scientific qualities of many non systematic reviews with the 
rigour of those produced using systematic review methodology.  In a critique of 
review articles, published in four major medical journals between 1985 and 
1986, Cynthia Mulrow concluded that ‘current medical reviews do not routinely 
use scientific methods to identify, assess, and synthesize information’.  She goes 
on to say that the reviews evaluated tended to lack a clearly defined question, 
search methods were not defined, standardised criteria for assessing study 
quality were not used and synthesis tended to rely on informal qualitative 
descriptions rather than quantitative methods (Mulrow 1987).  In contrast it was 
claimed that systematic reviews could integrate existing information; provide 
data for rational decision making; establish the consistency and generalisability 
of findings; and, if meta-analysis was used, increase the power and precision of 
treatment effects (Egger, 2001b).  Crucially, the emphasis on a sound scientific 
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process reduces the risk of bias and, therefore, allows for more accurate and 
reliable conclusions to be drawn (Chalmers, 1995, Egger, 2001a, Mulrow, 1994).  
These perceived strengths mean that well conducted systematic reviews have 
come to be considered as one of the most important type of research in 
hierarchies of evidence for evaluating the effectiveness of interventions (Philips, 
2001). 
Evidence based policy 
Despite some criticism of the evidence-based practice movement the concepts 
underlying evidence based practice, and the importance of systematic reviews, 
have gained widespread credence across all disciplines in health (Nutley, 2003b).  
Rycroft-Malone writes that the ideology of evidence based practice ‘has 
penetrated the consciousness, discourse and working practices of professionals’ 
(Rycroft-Malone, 2006).  This widespread recognition of the need for 
practitioners to be aware of the importance of incorporating evidence into 
practice has, unsurprisingly, led to calls for managers and policy makers to 
consider the evidence when making policy decisions.  One commentator 
declared ‘if doctors are expected to base their decisions on the findings of 
research surely politicians should do the same … the case for evidence-based 
policy making is difficult to refute’ (Ham et al., 1995).   
Many proponents of evidence-based policy have appeared to conceptualise it in 
terms that are very comparable to those used to describe evidence based 
practice.  For example, Davies defines evidence based policy as “the integration 
of experience, judgement and expertise with the best available external evidence 
from systematic research” (Davies, 1999); a definition very like Sackett’s 
description of evidence based practice (Sackett et al., 1996).  However, it has 
been argued that policy making is fundamentally different from decisions in 
clinical practice and that evidence-based policy cannot be viewed as simply an 
extension of evidence-based medicine (Black, 2001).  More recently terms such 
as ‘evidence-influenced’, ‘evidence-informed’ or ‘evidence-aware’ have begun to 
be used in place of the more traditional evidence-based to describe the 
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relationship between research and policy (Boaz, 2008b, Chalmers, 2005, Davies, 
2000a).  This change in language appears to represents a shift in thinking about, 
and expectations of, the contribution of evidence to policy.   
At the same time as this growing interest among health care professionals in the 
use of evidence to make decisions, there were a number of political and 
organisational changes that created an environment which was particularly 
receptive to the burgeoning idea of incorporating evidence into the policy 
process.  Throughout  the  20th century there had been an increase in the 
number of organisations, such as pressure groups, researchers, think-tanks, 
professional bodies and statutory organisations, attempting to influence 
government actions often through the use of some form of evidence (Davies, 
2000b).  Although Governments in the UK had become increasingly responsive to 
the use of evidence, this was particularly marked when Labour were elected to 
power in 1997 with a philosophy of ‘what matters is what works’.  Their avowed 
rejection of political ideology in favour of a more pragmatic approach set a 
platform for the development of a more evidence-informed policy process 
(Davies, 2000b).  This emphasis on the importance of knowing what works was 
further established in a number of government documents including the 1999 
white paper on Modernising Government which called for policy makers to show 
a greater willingness to question inherited ways of doing things and to make 
‘better use of evidence and research in policy making’ (Cabinet Office, 1999a) 
and the Cabinet Office report entitled ‘Professional Policy Making for the 21st  
Century (Cabinet Office, 1999b) which stipulated using evidence as a core 
competency for good policy making.  In addition, the 1991 national strategy 
‘Research for Health’ (DOH 1991, 1993) led to a substantial increase in funding 
for health care research.  This was accompanied by a shift in the way in which 
the research agenda was driven so that policy makers, and not just researchers 
or scientists, were involved in setting research priorities (Davies, 2000c).   
Systematic reviews were central to this drive for creating an evidence base to 
inform policy.  The Government initiatives described above involved the 
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development of an infrastructure to evaluate the effectiveness of health and 
public health interventions (Solesbury., 2001).  This included the establishment 
of the National Institute for Health and Clinical Excellence and the NHS Centre for 
Reviews and Dissemination, and the provision of core funding support to the 
Cochrane Collaboration, an international organisation involved in preparing, 
maintaining and disseminating systematic reviews evaluating the effects of 
health care interventions.  All of these bodies use systematic review 
methodology to evaluate evidence and to provide information on effectiveness. 
So why are systematic reviews seen as so integral to decision making in health 
care and why have they received so much government support in England?  This 
preference for systematic reviews is partly pragmatic in that systematic 
reviewers are thought to be able to respond more quickly, and more cheaply, to 
the demands of policy makers than researchers conducting primary studies 
(Pawson, 2002).  Another key factor behind this emphasis on systematic reviews 
is an acceptance of one of the core tenets of evidence based practice, which is 
that it is vital to look at the totality of available evidence rather than at a single 
study in isolation.  Indeed some commentators have claimed that ‘generally the 
results of a single study are not worth disseminating’ (Black, 2001) whereas, in 
contrast, systematic reviews can establish whether findings are consistent and 
generalisable across different populations and settings (Mulrow, 1994).  
Systematic reviews can also, where appropriate,  incorporate statistical 
techniques for pooling data across studies which enhance the precision of 
treatment effects (Egger and Smith, 1997, Egger et al., 1997).  A classic example 
of the advantage of pooling studies is incorporated into the Cochrane 
Collaboration logo which depicts the results of seven trials that evaluated the 
effects of a short course of corticosteroids given to women expected to give birth 
prematurely.  Only two trials had clear cut, statistically significant effects, but 
when data from all of the studies were pooled, the power increased.  This 
yielded a significant combined effect estimate which strongly indicated that the 
treatment reduced the risk of babies dying (Mulrow, 1995).   
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A more cynical interpretation of the prominence given to systematic reviews is 
that government and policy makers view systematic reviews as useful tools for 
rationing health care (Gingrich, 2009).  Until recently decisions about the 
allocation of health care resources in England and Wales have been made by the 
National Institute of Health and Clinical Excellence (NICE).  Their judgements, 
which often provoke a great deal of controversy, are based on evidence of 
effectiveness and cost-effectiveness which comes from systematic reviews.  
These issues are explored more fully in Chapter 7.  
So where and how is it possible to envisage systematic reviews informing policy 
development?  One well known public policy framework is the stages heuristic 
(Brewer and DeLeon, 1983, Lasswell, 1956) which divides the public policy 
process into four stages: agenda setting, policy formulation, the implementation 
of policy, and finally evaluation where the impact of policies is assessed.  This 
framework has subsequently been criticised for being overly simplistic (Sabatier, 
2007) but it does still provide a useful way for thinking about the policy process 
(Walt et al., 2008).  Although it is possible to think that systematic reviews might 
impact on any stage of the process it is most likely that they could influence the 
first or last stages, agenda setting and evaluation.  By bringing together all 
available research on a given topic systematic reviews can be used to develop an 
understanding of a problem, provide potential solutions, highlight gaps in the 
evidence and identify future research questions which may in turn be influential 
in determining the research agenda.   
Indeed, systematic reviews can be used to help answer various types of 
questions.  This is illustrated here using a variety of reviews which I have been 
involved in.  Traditionally systematic reviews were used to answer clearly 
focused questions about the effectiveness of health care interventions, for 
example meta-analyses to evaluate the best type of fluid replacement for injured 
patients (Bunn et al., 2000b, Bunn et al., 2002, Bunn et al., 2008b), drug therapy 
for preventing infections in patients undergoing surgery for breast cancer (Bunn 
et al., 2006b), nutrition for head injured patients (Perel et al., 2006), pelvic floor 
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exercises for post natal continence problems (Wagg and Bunn, 2007) and care 
for patients with spinal injuries (Kwan and Bunn, 2005).  Increasingly reviews are 
evaluating more complex community based interventions many of which focus 
on prevention.  For example, the safety and efficacy of telephone triage (Bunn et 
al., 2005), strategies for preventing sexually transmitted infections and teenage 
pregnancies (Bunn et al., 2006a), the prevention of drugs and alcohol misuse in 
children (Petrie et al., 2007a) and the prevention of road related injuries (Bunn et 
al., 2003a, Duperrex et al., 2002a, Ker et al., 2005).  In addition, systematic 
review methods are being used to synthesise qualitative research to explore 
questions about intervention development, delivery and acceptability rather 
than just effectiveness.  For example, the potential barriers and facilitators to 
older people participating in falls prevention programmes (Bunn et al., 2008a), or 
the way parental perceptions of health behaviours may affect obesity prevention 
interventions for young children (Pocock et al., 2009).  Reviews may also inform 
the development of guidelines at a national or local level (Bunn et al., 2006a). 
Barriers to the development of evidence based policy 
Despite the apparent rationale, and support, for using evidence, and in particular 
systematic reviews, to develop policy a number of commentators have argued 
that research has, in reality, had a minimal impact on government policy (Black, 
2001, Feldman, 1999, Lomas, 2000b).  This perceived inefficacy has been 
attributed to naivety on behalf of researchers about the policy process and, in 
the case of systematic reviews, to limitations in their methods that may restrict 
their usefulness to policy makers.  Both of these ideas will be explored further; 
beginning with an examination of potential problems with systematic reviews 
and then moving on to issues and theories relating to policy development. 
Limitations of systematic reviews as policy tools 
As discussed earlier one of the distinguishing features of systematic reviews was 
the development of rigorous scientific methodologies to reduce the risk of bias.  
As randomised controlled trials (RCTs) are considered to be the ‘gold standard’ 
for evaluating the effectiveness of interventions much of the original 
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methodological endeavour focused on ways to synthesise them.  For example, 
the Cochrane Collaboration, which has been highly influential in developing and 
promoting systematic review methods, has, to date, largely concentrated on the 
synthesis of RCTs.  Many have argued, however, that this strict focus on RCTs has 
limited the utility and generalisability of systematic reviews and that other types 
of studies, such as less rigorous evaluations and qualitative studies, are needed 
to evaluate complex interventions and to give information about process, 
context, and the perspectives of users (Dixon-Woods et al., 2005, Harden et al., 
2004, Oliver, 2005a, Speller et al., 1997).  There is an increasing realisation that it 
is not enough to focus solely on ‘what works’ as policy makers have more 
complex questions and need to know ‘what works for whom and in what 
circumstances’ (Solesbury., 2001).   
In the light of these criticisms researchers have developed new methods for 
synthesising non randomised  (Reeves, 2008) and qualitative studies (Dixon-
Woods et al., 2006b, Popay et al., 1998), for incorporating quantitative and 
qualitative studies together in the same review (Dixon-Woods et al., 2005, 
Harden et al., 2004, Harden and Thomas, 2005, Oliver et al., 2007) and for 
analysing the effects of complex social interventions in relation to context and 
settings  (Pawson, 2002, Pawson et al., 2005).  Most of these techniques are 
largely rooted in the same conceptual ideologies as conventional evidence based 
practice, incorporating or adapting many of the same systematic review 
methods, although some, such as Pawson’s ‘realist synthesis’, use more radical 
methods and reject much of the orthodoxy of the systematic review movement 
(Pawson, 2002, Pawson et al., 2005).  Although these methods may offer 
promising ways to make systematic reviews more relevant to policy, questions 
remain as to whether some approaches, such as realist synthesis, have the 
necessary methodological rigour and transparency which is central to systematic 
reviewing.  The author’s systematic reviews being considered in this study largely 
employ conventional systematic review methods for synthesising quantitative 
studies, in accordance with methods specified in the Cochrane handbook 
(Higgins, 2008).  However, they also include examples of reviews incorporating 
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non randomized and qualitative studies.  The methodological issues associated 
with different approaches are explored further in later chapters. 
It has also been suggested that systematic reviews have not had the anticipated 
impact on policy because of a dearth of good quality primary research to review.  
Many interventions likely to be the subject of policy decisions have not been 
properly evaluated and this lack of good quality research affects the usefulness 
and applicability of systematic reviews (Juni et al., 2001).  However, it can also be 
argued that the inherent emphasis on critical appraisal in evidence based 
practice and systematic reviews has highlighted many of the shortcomings of 
primary research and been instrumental in improving the conduct and reporting 
of studies.   
Explanatory frameworks and theories of the policy development 
process  
Although much credence has been given in recent years to the concept of 
evidence-based or informed policy it is generally accepted that the relationship 
between policy and research is complex, with government policies driven by 
many factors including ‘ideology, value judgments, financial stringency, 
economic theory, political expediency, and intellectual fashion’ (Davis and 
Howden-Chapman, 1996).  Policy makers may be subject to many different 
influences including political imperatives and the media (Campbell, 2007) and 
non research evidence such as personal experience, local information and the 
opinions of eminent colleagues (Black, 2001, Campbell, 2007). 
This idea that policy is influenced by many factors and is not a ‘discrete’ act or 
event but rather an “ethereal, diffuse, haphazard and somewhat volatile” 
process (Lomas, 2000a) is reflected in a number of policy theories.  In the 
garbage can model of policy making the policy process is seen as dynamic, 
unpredictable, chaotic and often fundamentally irrational.  Policy problems and 
solutions get ‘dumped’ together in a metaphorical garbage can and only become 
joined together when opportunities arise (Cohen et al., 1972).  In the 
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enlightenment model (Weiss, 1976, Weiss, 1977) Weiss argues that policy 
makers dislike disruptions to the status quo and may ignore research that does 
not support their own values and beliefs.  Although policy makers may 
sometimes be receptive to research findings, for example for large issues and at 
times of crisis, in general the effect of research is cumulative and indirect, rather 
than immediate, with concepts and ideas from research gradually filtering down 
into the policy process.  Research is seen as only one of a number of knowledge 
sources and is ‘considered less as problem solving than as a process of argument 
or debate to create concern and set the agenda’(Black, 2001).  The nature of this 
process means that problems are not always recognized immediately and it may 
take considerable time for research to impact on policy (Buse, 2005).  For 
example, as Buse points out, it took many years for the government to take the 
evidence on smoking and lung cancer seriously and even longer before any 
legislation was introduced (Buse, 2005).  Weiss also argues that policy makers 
may have different values and goals from those of researchers.  She sees 
researchers and policy makers as two distinct communities, with different 
conceptual frameworks, values and motivations, who often fail to understand 
each other’s positions and language (Weiss, 1976). 
One framework for understanding the way different factors influence policy is 
Walt and Gilson’s health policy triangle (Walt and Gilson, 1994).  This looks at the 
interaction between the policy context, the policy process, and the various 
actors, such as individuals, groups and organisations, involved in the formulation 
of policy.  There are many actors and agencies beside the government and the 
research community who influence the policy agenda.  This includes lobby 
groups, powerful ‘producer groups’ (such as the BMA), charities, the business 
community and of course the mass media.  Buse argues that the media are able 
to ‘raise, shape and determine issues and public opinion’ which, in turn, 
influences the government to respond (Buse, 2005).  This influence may be 
positive, for example the media raising awareness of important but neglected 
issues, or more negative such as giving topics levels of news coverage unrelated 
to their severity and the risks they pose to public health.  This focus on particular 
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issues, because they are seen as dramatic or newsworthy, is a contributory factor 
in shaping individuals’ perceptions of personal risk.  For example, after a paper in 
the Lancet suggested a link between the combined measles, mumps and rubella 
(MMR) vaccine and autism (Wakefield et al., 1998) media coverage greatly 
increased levels of public anxiety and led to a decrease in vaccination.  Although 
the Lancet paper has subsequently been heavily criticised, and further work has 
shown no evidence of a link between the MMR vaccine and autism, levels of 
vaccination remain lower than they were prior to the media furore (Health 
Protection Agency, 2009).  The role of the media in the policy process is 
considered further in Chapter 4. 
Researchers, and in particular proponents of evidence based policy, have been 
criticised for oversimplifying the relationship between research evidence and 
policy by assuming that there is a direct link between the two with policy makers 
identifying a problem which is then ‘solved’ by researchers (Harrison, 2001).  
Buse describes this as the Engineering or problem solving model which is based 
on the premise of a linear relationship between research and policy (Buse, 2005).  
Critics have argued that the underlying assumptions behind evidence based 
policy are naïve and flawed and that systematic reviews, and research in general, 
have failed to influence service policies because of an over-reliance on this 
simplistic model (Black, 2001, Boaz, 2008b, Buse, 2005, Marmot, 2004).  
It has also been suggested that the opportunity for research to impact on policy 
is limited to small windows of time.  In Kingdon’s multiple streams model 
(Kingdon, 1984) the policy process is viewed as a mixture of three streams of 
actors and processes which generally operate independently of each other.  
These are: a problem stream consisting of various conditions that policy makers 
and citizens want addressed, a policy stream involving the ideas or proposed 
solutions to policy problems, and a politics stream consisting of elections and 
elected officials that is affected by the national mood, campaigning by pressure 
groups and administrative or legislative turnover.  Kingdon argues that policy 
choices are made when the three streams are joined together at critical 
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moments of time.  These opportunities for change are labelled as ‘policy 
windows’ and individuals or corporate actors who attempt to couple these three 
streams are ‘policy entrepreneurs’.  Policy entrepreneurs with greater access to 
policy makers and resources are more likely to be successful (Kingdon, 2003, 
Zahariadis, 2007). 
In contrast to those who suggest that research has a limited influence on policy 
development others have argued that in recent years research has actually had a 
substantial impact on health policy.  Indeed, it has been suggested that the 
recent political history in the UK, with the election of the previous Labour 
Government and its emphasis on ‘what works’, saw the re-emergence of a more 
evidence-informed policy process in the engineering mould (Nutley, 2000).  
Systematic reviews, with their focus on effectiveness have been seen as 
particularly key in this process.  In the economising model Fox argues that a 
dominant free market ideology in many Western countries has led to 
researchers, funders and policy makers adopting an increasing emphasis on 
efficiency and value-for-money.  Researchers have been able to influence policy 
because they are undertaking more policy relevant research and are producing 
research compatible with the dominant values and ideologies of those in 
positions of political power (Fox, 1990).  Fox sees the development of methods 
to evaluate effectiveness (such as systematic reviews and meta-analysis) as key 
to this process (Fox, 2006).  Whilst Fox’s theory is based on conditions in the USA 
his arguments can also be generalised to England where priorities for research 
are increasingly being defined by funders and policy makers in contrast to the 
predominantly investigator led or science driven systems of the past (Davies, 
2000c).  The idea of policy driven research is explored further in Chapter 7 where 
I consider the impact of a review (Bunn et al., 2006a) commissioned by NICE to 
inform the development of public health guidance.   
However, even if we accept that policy makers are willing to be influenced by 
evidence there are still a number of barriers to the use of evidence as a basis for 
policy making.  One such challenge is the extent of scientific uncertainty that 
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often exists; due to either a lack of available relevant research (Macintyre et al., 
2001) or what Weiss terms “the perennial problem of inconclusiveness” (Weiss, 
1976).  Harrison argues that effective implementation of research depends upon 
a number of factors including the existence of “comprehensive, authoritative 
statements based on systematic reviews of the research evidence” (Harrison, 
2001).  In reality it is uncommon for research to produce definitive conclusions 
with many studies showing little or no effect.  This may be exacerbated by 
evidence based practice and its emphasis on well-designed evaluations and ‘gold 
standard’ study designs such as RCTs.  Well designed controlled studies reduce 
the risk of bias and are, therefore, less likely to produce inflated treatment 
effects.  As Buse points out, “it is generally accepted that the better designed the 
evaluation, the smaller the effect it is likely to demonstrate” (Buse, 2005).  Even 
systematic reviews incorporating all the available evidence are often unable to 
deliver firm conclusions.  In such instances policy makers have to decide if the 
research is merely inconclusive, if the intervention is ineffective in the situation 
or context where it was evaluated or if it is genuinely ineffective.  This can be 
particularly difficult when complex health interventions are being evaluated.  
Even where reliable research evidence is available its influence on policy 
development may still be limited.  Research findings may be used selectively and 
are open to differing interpretations, misrepresentation, and controversy.  In a 
paper looking at five different reviews on mentoring Boaz explored the question 
of how useful they were for guiding policy and practice (Boaz, 2005).  She found 
that there were many ‘different viewpoints, incompatibilities and contradictory 
advice’ in the reviews and attributed this to a tendency by the reviewers to 
inflate their conclusions in an attempt to deliver clear policy recommendations.  
She argues that reviewers need to ‘rid themselves of the notion that there is a 
gold-standard method of research synthesis capable of providing unambiguous 
verdicts on programmes’ and that we need to be aware of, and accept, the 
limitations of systematic reviews. 
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Some theorists would argue that it is not just that research can be controversial, 
or open to differing interpretations, that is important but rather that policy 
makers see research purely in political terms and will interpret it to reinforce 
their own preferences.  For example, in the strategic model research is seen as a 
tool used by governments to reinforce pre-determined positions or to hinder or 
postpone difficult political decisions (Weiss, 1979).  Calls for further research 
before policy decisions can be made may be seen as a cynical attempt to remove 
an issue from the policy agenda (Buse, 2005).  Another explanation which draws 
on some of the same ideas but employing a less cynical interpretation is the 
elective affinity model.  This claims that research is more likely to have an effect 
on policy if members of the policy community have been involved in some way in 
the research process.  Although this model suggests that research will only have 
an impact if the findings are congruent with the values and beliefs of the policy 
audience it does allow that research that is initially disregarded may play an 
‘enlightenment’ role over a longer period of time (Short, 1997).  
Another potential barrier to the use of research in the policy process is that 
researchers may lack the will, or the necessary communication and marketing 
skills, to ensure their work receives sufficient publicity to enter the policy arena.  
However, although they have been accused of naivety in their perceptions of the 
policy process, many researchers have become increasingly aware that policy is 
derived from a mixture of social, cultural, political, economic and ideological 
factors and that if they are to contribute to the policy agenda they need to 
consider the utility of their research, work to improve relationships with policy 
makers and accept that creating change may be a long and difficult process 
(Black, 2001, Maynard, 2006).  Indeed the idea of collaborative research is 
becoming increasingly popular with both researchers (Lomas, 2000b, Patton, 
1997) and government (National Audit Office, 2003, Stationary Office, 1999).  
Denis and Lomas define collaborative research as “a deliberate set of 
interactions and processes designed specifically to bring together those who 
study societal problems and issues (researchers) with those who act on or within 
those societal problems and issues (decision-makers, practitioners, citizens)” 
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(Denis and Lomas, 2003); and have coined the phrase ‘linkage and exchange’ to 
describe one model of collaborative working (Lomas, 2000b).  Other processes to 
facilitate collaboration and describe collaborative research efforts include work 
on ‘collaborative evaluation processes’ (Patton, 1997), ‘knowledge utilization’ 
(Landry, 2001, Lavis et al., 2002) and ‘knowledge transfer’.  This trend towards 
collaboration is based on the belief that it is no longer appropriate to make a 
distinction between scientific experts and non-experts but that researchers, 
practitioners and lay people need to work together to produce scientific 
knowledge (Denis and Lomas, 2003).  These ideas about knowledge transfer and 
exchange are explored further in Chapter 2. 
The successful implementation of evidence-informed policy is of course a two 
way process requiring knowledge and understanding from both researchers and 
decision makers.  However, it has been suggested that many policy makers lack 
the necessary ‘research literacy’ (Boaz, 2008c) to engage fully with research.  
Although the ‘analysis and use of evidence’ is now seen as a core skill for civil 
servants (Professional Skills for Government initiative 
http://psg.civilservice.gov.uk) an analysis by the Government Social Research 
Unit on evidence-based policy in practice (Campbell, 2007) found that ‘the 
complexity and variety of different techniques were not well understood’ and 
that ‘specific techniques such as systematic reviews were even less well 
understood’.  They identified a need for policy officials to have a clearer 
comprehension of the relative merits of different types of research.  That policy 
makers were particularly unclear about what systematic reviews entailed or 
what they could offer, indeed many of the policy makers interviewed for the 
report had not even heard of systematic reviews, suggests that researchers still 
have a great deal more work to do to convince policy makers of the potential 
value of systematic reviews.  However, it was not clear how many of the policy-
makers interviewed were involved in health care where, I would suggest, it is 
likely that there would be greater awareness and use of systematic reviews than 
in other policy areas. 
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Many of the models described above, and the suggestions for how relationships 
between research and policy can be improved are dependent on the idea of 
researchers and policy makers as two distinct homogeneous groups engaged in 
different types of work and with different priorities, attitudes, career paths, 
rewards, training, knowledge and organisational constraints (Buse, 2005).  
However, it has been suggested that this notion of two distinct communities is 
overly simplistic with critics arguing that neither researchers nor policy makers 
are homogenous groups and that the translation, dissemination and 
communication of research findings are not the only barriers to translating 
research into policy.  An alternative view is to see policy making and research 
utilisation in terms of networks and communities of actors who shape policy 
(Adam and Kriesi, 2007, Sabatier and Jenkins-Smith, 1993).  These are formal and 
informal relationships that include all those who play a part in the generation, 
dissemination and evaluation of policy and can include researchers, politicians, 
journalists, civil servants, and members of the public.  In the advocacy coalition 
framework Sabatier suggests research enters policy as much through political 
argument as through the transmission of knowledge (Sabatier and Jenkins-Smith, 
1993). 
Conclusion 
There are then a variety of factors that need to be considered when assessing 
the influence of systematic reviews on policy.  Certainly systematic reviews 
appear to be uniquely placed to contribute to the development of health care 
policy.  Despite some criticism they hold an enviable position as a widely 
respected and used methodology, acknowledged by practitioners, funders and 
Government as central to the evaluation of evidence.  However, there remains 
much debate about the extent of their influence and many commentators have 
been disappointed at what they see as a lack of impact on policy.  This has been 
attributed to a number of causes including misconceptions about the nature of 
evidence, methodological shortcomings of systematic reviews, unrealistic 
expectations of what reviews can achieve, a fundamental misunderstanding of 
the way in which policy is developed and the role research plays in this, and a 
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lack of the necessary skills and competencies on the part of both researchers and 
policy makers.  These issues are explored further throughout the study. 
Aims & objectives 
In this study I intend to examine the extent to which systematic reviews can 
inform or influence the development of health care policy.  The study will be 
based on a significant amount of my own previously published research which I 
will use as illustrative examples to examine the following issues:  
 Is there any evidence that any of my own systematic reviews have 
influenced policy at either a national or a local level? 
 What factors play a role in the extent to which systematic reviews can 
influence policy e.g. review methods, funder, dissemination format, 
publicity, perceived importance of review question and ‘fit’ with values 
and ideologies of policy makers? 
 What are the barriers and facilitators to systematic reviews informing 
policy?  
 How can researchers produce systematic reviews that, whilst still 
methodologically rigorous, meet the needs of policy makers? 
Organisation of the submission 
In the following section I outline the organisation and content of the submission. 
Chapter 1 
In this first chapter I have set out the context and aims of the study by exploring 
the evolution of evidence based policy, the development of systematic reviews, 
barriers to the development of evidence based policy and key frameworks and 
theories for explaining the relationship between research and policy.   
Chapter 2 
Identifying ways of increasing the influence of systematic reviews on health care 
policy is a key aim of the study.  In Chapter 1 I have touched on some of the 
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interventions designed to promote the impact of research on health care policy; 
such as knowledge transfer and exchange strategies.  In Chapter 2 I examine in 
greater detail initiatives for promoting the use of research in the development of 
health care policy.  In particular I look at literature on promoting the impact of 
systematic reviews. 
Chapter 3 
In Chapter 3 I describe the overall methodology for the submission.  I begin by 
describing the integral part that my own published work plays in the submission 
and then go on to detail the methods employed to identify any evidence of 
impact that my reviews may have had on policy.  I critically examine potential 
evaluation frameworks and outline the process by which I arrived at the 
framework I use in this study.   
Chapters 4-8: Critique of methodological issues involved with 
systematic reviews and presentation of results of impact evaluation.  
In Chapters 4-8 I present the published systematic review work that forms the 
basis of the submission.  The rationale for the division of the reviews into these 
five chapters is based on differences in the review methods and in the subject 
matter of the reviews.  For example, the reviews incorporate a variety of 
methodological approaches, including meta-analysis of randomised controlled 
trials (RCTs), meta-analysis of non-randomised studies, and synthesis of 
qualitative research, and cover a diverse range of health and public health 
related topics.  The specific focus of Chapters 4-8 is presented below but each 
involves an evaluation of the impact of the review/s on health care policy.  The 
papers on which the chapters are based can be found in Appendix 2. 
Chapter 4 
This chapter includes five systematic reviews concerned with the fluid 
resuscitation of critically ill patients (Bunn et al., 2000a, Bunn et al., 2000d, CIG 
Albumin Reviewers, 1998, Kwan et al., 2003, Roberts et al., 2004).  All involved 
the statistical technique meta-analysis and they are used as illustrative examples 
to critically examine the methodological issues associated with this type of 
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review.  In addition, the reviews are used as examples to critique some of the key 
issues surrounding the influence of reviews of clinical questions on healthcare 
policy and practice.   
Chapter 5 
This chapter includes two road safety reviews, one on traffic calming (Bunn et al., 
2003a, Bunn et al., 2003b), and one on safety education of pedestrians (Duperrex 
et al., 2002a, Duperrex et al., 2002b).  I discuss the methodological challenges 
associated with these reviews, such as the difficulties associated with identifying 
relevant studies in road safety research and the issues involved in the quality 
assessment and analysis of non-randomised studies.  I also discuss some of the 
key barriers to the development of evidence-informed road safety policies. 
Chapter 6 
This chapter includes a review of qualitative studies evaluating barriers and 
facilitators to the successful delivery of falls prevention interventions (Bunn et 
al., 2008a).  I use the review as a basis to explore the issues associated with the 
systematic review of qualitative research and critique the methods available.  I 
also look more broadly at issues around the role of reviews of qualitative studies 
in informing policy decisions and examine methods that aim to increase the 
policy relevance of systematic reviews through the incorporation of qualitative 
research.   
Chapter 7 
This chapter is based on a systematic review evaluating the effectiveness of 
interventions for the prevention of teenage pregnancies and sexually 
transmitted infections (Bunn et al., 2006a).  The review was commissioned by the 
National Institute of Health and Clinical Excellence (NICE) to inform the 
development of Public Health guidelines.  I examine the extent to which the final 
guidelines were informed by the review and critically examine the role of 
guidelines in health care.   
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Chapter 8 
This chapter includes a systematic review evaluating the effectiveness of 
telephone consultation (Bunn et al., 2004a, Bunn et al., 2005).  This review 
differs from the others in the study because it is concerned with an issue relating 
to the way in which health services are organised and delivered.  As well as 
addressing the methodological issues specific to this review I look at the complex 
political and socio-economic factors that are involved in policy changes involving 
service delivery and organisation.  
Chapter 9 
This chapter summarises the study findings, discusses the study’s contribution to 
knowledge and looks at the implications of the findings.  This includes a summary 
of the results of the impact evaluation, an analysis of how the results contribute 
to our knowledge of barriers and facilitators and a consideration of the place of 
systematic reviews in the policy process.  It includes an overview of the 
methodological approach adopted and a discussion of the strengths and 
limitations of the study.    
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Chapter 2: Promoting the impact of research 
Introduction 
As discussed in the previous chapter there has been a growing interest in the role 
of evidence in the development of health care policy, a role advocated by 
Government, researchers and practitioners alike (Cabinet Office, 1999a, Cabinet 
Office, 1999b, Ham et al., 1995).  It has, however, become increasingly apparent 
that there are many barriers to evidence-informed policy and that ‘explicit and 
active strategies are required to ensure that research really does have an impact 
on policy and practice’ (Walter, 2003b).  In this chapter I begin by looking at what 
is meant by research impact and then move on to look at initiatives for 
promoting the use of research in the development of health care policy.  In 
particular I focus specifically on literature that relates directly to initiatives or 
interventions for enhancing the influence of systematic reviews on the policy 
process.  
Defining research impact 
A variety of terms have been used to describe the impact of research on policy 
and practice.  These include research impact, influence, outcomes, benefit, 
payback, translation, transfer, uptake and utilisation (Boaz, 2008a, Carden, 
2004b).  Research can be used either directly in decision-making related to policy 
or practice, or indirectly by contributing to the formulation of values, knowledge 
and debate.  Commentators have pointed out that there is a key distinction to be 
made between ‘conceptual’ use, which brings about changes in levels of 
understanding, knowledge and attitude, ‘symbolic use’ which can lead to the 
mobilisation of support, and ‘instrumental’, or direct use, which results in 
changes in practice and policy making (Amara et al., 2004, Huberman, 1992, 
Nutley, 2003b, Weiss, 1976).  Indeed, ‘research impact forms a continuum, from 
raising awareness of findings, through knowledge and understanding of their 
implications, to changes in behaviour’ (Nutley, 2003a).  Strategies to enhance 
impact may be focused on any point along this continuum.  
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Of course it is difficult to consider the literature on promoting the influence of 
research without considering how we measure impact.  In the field of health care 
there has been a fairly substantial amount of work exploring research impact but 
it has tended to focus on the impact on clinical practice rather than policy (Boaz, 
2008a).  The impact on practice may be more easily discerned than the impact 
on policy (Hanney, 2007); in contrast it may be more problematic to assess 
whether any changes in policy are attributable to research as it can be difficult to 
isolate the role research played in relation to the many other confounding 
factors that might be involved (Boaz, 2008a, Carden, 2004a, Hanney et al., 2000, 
Lavis et al., 2003a).  Determining the impact of a specific piece of research is 
even more difficult as payback may come from an accumulation of research, that 
is the general ‘stock or reservoir of knowledge’, rather than from a single study 
(Hanney et al., 2000).  Measuring impact is further complicated by the 
distinctions between direct or indirect influence.  Conceptual and symbolic 
influence may be far harder to distinguish than instrumental or direct use of 
research.  Methods for measuring research impact are considered further in 
Chapter 3. 
Promoting the impact of research on health care policy 
There is a distinction to be made between the natural uncontrolled spread of 
research and innovation (diffusion) and more active conscious efforts to spread 
research (dissemination) (Green et al., 2009).  In this chapter I am concerned 
with active strategies to promote research influence.  Isabel Walter and 
colleagues at the Research Unit for Research Utilisation (RURU) in Scotland 
developed a taxonomy of interventions which have been used to increase the 
impact of research (Walter, 2003b).  After reviewing over 100 papers, that 
evaluated or described specific interventions to enhance the impact of research, 
they categorized them by the type of intervention and type of mechanism used 
to increase impact.  They came up with 32 different categories of interventions 
which included: written materials (such as publication in journals), oral 
presentations, use of the mass media, research-based guidance, education, 
lobbying, research incentives, networks and collaboration.  These were grouped 
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into eight categories to reflect the mechanisms considered to drive research 
impact; more detail of these can be seen in Table 2.1.  These categories were 
designed to exist in parallel, rather than as a hierarchy, and are not mutually 
exclusive.   
Table 2.1 Mechanisms to drive research impact (adapted from Walter 2003b) 
Category Underlying mechanism Strategies Underpinning theory 
Dissemination Research-based messages The 
extent to which dissemination 
interventions are tailored to 
potential users can vary 
considerably 
Includes written 
materials, oral 
presentations 
Adult learning 
theories which argue 
personal motivation 
important for 
behaviour change 
Education Learning: increasing 
knowledge and understanding 
of research findings 
Includes lectures, 
interactive sessions, 
daily practice 
Variety of 
educational theories 
Social Influence Social influence: changing 
norms and values as a route 
to changing behaviour 
May include lobbying 
and patient-mediated 
interventions 
Social influence and 
social learning 
theories 
Collaboration Communication: improving 
the flow of information and 
ideas between researchers 
and potential users 
Aim to break down 
barriers between groups 
e.g. from differences in 
culture, timescales and 
values) 
Social learning theory 
Incentives Motivation through reward: 
ways of acting will be more 
likely to recur when they are 
followed by positive 
consequences 
Financial rewards, 
increase in professional 
status 
Learning theories and 
economic models of 
rational behaviour 
Reinforcement Reinforcement through 
information 
Audit, feedback and 
reminders 
Diverse learning 
theories 
Facilitation Facilitation: providing the 
means to take action and 
removing barriers to that 
action 
Financial, technical, 
organisational, or 
emotional assistance 
Change management 
theories 
Multifaceted 
initiatives 
Generally target multiple 
mechanisms 
Two or more 
interventions 
Variety of theories 
but supported by 
transtheoretical  
model & social 
learning theories 
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Walter and colleagues also reviewed the literature on approaches to enhancing 
research use from the education, healthcare, social care and criminal justice 
sectors (Walter, 2003a).  Of the literature they reviewed 60% were concerned 
with healthcare but, of those, many were focused on the impact of research 
upon practice rather than on policy.  For example, studies were evaluating 
interventions such as training, audit and feedback, education, guidelines, 
incentives and computer support systems, all of which were aimed at health care 
professionals rather than policy-makers.  However, they also consider some 
mechanisms relevant to increasing the influence of research on policy such as 
collaborative initiatives and active dissemination strategies.  These will be 
considered in more depth later in the chapter. 
Promoting the impact of systematic reviews on health care policy 
The primary aims of this chapter were to review literature that focused 
specifically on ways of promoting the impact of systematic reviews on health 
care policy and to distinguish potential facilitators to the use of systematic 
reviews to inform policy.  Although this was not a systematic review the aim was 
to identify as many relevant papers as possible.  I searched for papers that either 
described or evaluated interventions designed to promote the influence of 
systematic reviews or that evaluated the impact of systematic reviews.  Papers 
that appeared to be describing a process more akin to guideline development 
were excluded.  I included all study designs including qualitative and descriptive 
studies.  
To identify relevant studies I searched PubMed (2nd February 2009) with no date 
restrictions using the following search terms: policy OR policies AND knowledge 
transfer OR knowledge translation OR knowledge utilisation OR knowledge 
utilization OR knowledge broker* OR payback OR research impact OR research 
influence OR research uptake.  These were combined with the MeSH term 
systematic review.  In addition, I contacted experts in the area (Dobbins and 
Lavis at McMaster University in Canada) and used lateral search techniques such 
as checking reference lists, and using the ‘related articles’ function on Google 
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and ‘cited by’ function on Google Scholar for key papers.  Such lateral search 
techniques are recommended when searching for studies in a complex area 
(Greenhalgh and Peacock, 2005).  The searches were updated in February 2010. 
Only nine papers were found which specifically addressed promoting the 
influence of systematic reviews  on health care policy: (Atkins et al., 2005, 
Brussoni et al., 2006, Dobbins et al., 2001a, Dobbins et al., 2001b, Dobbins et al., 
2009, Dobbins et al., 2004b, Keown et al., 2008, Lavis et al., 2006a, Lavis et al., 
2005).  Two of these (Dobbins et al., 2001a, Dobbins et al., 2001b) reported the 
same study.  Three of the papers involved telephone surveys (Ciliska et al., 1999, 
Dobbins et al., 2001a, Dobbins et al., 2004a), two interviews (Lavis et al., 2005) 
and three described strategies used to increase the use and relevance of 
systematic reviews but included no formal evaluation of these methods (Atkins 
et al., 2005, Brussoni et al., 2006, Keown et al., 2008).  I found only one formal 
evaluation of a strategy to increase systematic review impact.  This was a 
randomised controlled trial to test the effectiveness of KTE strategies in 
Canadian public health decision making.  The intervention compared three 
different strategies: access to an online registry of systematic reviews evaluating 
public health interventions, targeted evidence messages and knowledge 
brokering (Dobbins et al., 2009).  More details of the included studies can be 
seen at the end of the chapter in Table 2.2. 
Policy makers views on systematic reviews 
There was some discrepancy in the literature as to the extent to which policy-
makers used systematic reviews as a source of research evidence.  In a study 
which used interviews with Canadian policy makers to explore how systematic 
reviews could better meet their needs (Lavis et al., 2005) it was found that none 
of the policy makers cited systematic reviews as a source of evidence but rather 
they were influenced by factors other than research including legal issues, 
pressure from stakeholders and public opinion.  Policy makers tended not 
explicitly to place a high value on research evidence and certainly not on 
systematic reviews (Lavis et al., 2005).  This was echoed in a recent UK report 
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that found few policy makers had heard of systematic reviews or meta-analyses 
nor were they aware of what these entailed or what they could offer (Campbell, 
2007).  However, more positive findings came from a number of other studies.  
In a telephone survey of public health policy makers in Ontario 57% of those 
surveyed had heard of systematic reviews and when prompted with a 
description of a review 86% said the description sounded familiar and 62% were 
able to give examples of reviews they knew about.  It is not possible, however, to 
discern from their study whether policy makers actively used the reviews (Ciliska 
et al., 1999).  In two later surveys, conducted to ascertain the role of recently 
completed systematic reviews in the development of public health policy, 
systematic reviews were seen as useful by policy makers and were valued above 
other types of research evidence (Dobbins et al., 2001a, Dobbins et al., 2001b, 
Dobbins et al., 2004a).  These studies by Dobbins and colleagues were, however, 
conducted in an area of Canada where there have been considerable efforts to 
develop a policy-making culture that values research evidence.  In addition, the 
nature of these studies, with their focus on systematic reviews, may have 
prompted policy makers to give more credence to systematic reviews than they 
otherwise might have done. 
Although the evidence base in this area is weak a number of potential facilitators 
were identified that might increase the influence of systematic reviews on health 
care policy.  These include collaboration between researchers and policy makers, 
incorporating examinations of context and applicability in reviews, appropriate 
dissemination strategies, responding to policy-makers’ need for timely 
information and the development of methods to increase the usefulness of 
systematic reviews for policy makers.  I will explore these in more detail in the 
sections below.  In each section I begin with a general overview of literature and 
then focus on the literature relating to systematic reviews. 
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Facilitators for promoting the influence of research on health care 
policy 
Collaborative approaches 
A key mechanism to drive research impact, and one that has received much 
attention in the literature, is initiatives to increase collaboration between 
researchers and decision makers.  Indeed, systematic reviews of barriers and 
facilitators to the use of research evidence by health policy makers have found 
that a key facilitator, and one supported by the most consistent and rigorous 
evidence, was interaction and personal contact between researchers and policy 
makers (Innvaer et al., 2002, Lavis et al., 2005).  Dopson argues that 
interpersonal networks are crucial for the circulation of knowledge (Dopson et 
al., 2002).  An example of this was the use of policy networks that brought policy-
makers together with researchers through formally structured mechanisms.  
Initiatives such as this also helped to foster trust between policy makers and 
researchers which in turn promoted the use of research (Lavis et al., 2005).   
In England a report by the National Audit Office states that ‘encouraging 
partnerships between researchers and users is a precondition of delivering 
evidence-based policy-making’ (National Audit Office, 2003).  One of the roots of 
current collaborative approaches is based in academic work around knowledge 
translation (Denis and Lomas, 2003).  Knowledge translation, which is also known 
as knowledge utilization, knowledge exchange, research transfer and research 
utilization, has been defined as ‘a process by which relevant research 
information is made available and accessible for practice, planning, and policy-
making through interactive engagement with audiences and supported by user-
friendly materials, and a communications strategy that enhances the credibility 
of the organization and, where relevant, reinforces key messages from the 
research’(Program in Policy Decision-Making, 2003).  Much of the recent work on 
research transfer has taken place in Canada where the promotion of research 
transfer and uptake and evidence-based decision making have been identified as 
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important priorities for the Canadian health-care system (National Forum on 
Health, 1997). 
The transfer of information from researchers to decision makers has been a 
subject of interest since the 1950s (Huberman, 1990).  The process was initially 
conceptualized as a logical flow of information from researchers to policy makers 
(Wingens, 1990) in line with the demand pull or problem solving model (Landry, 
2001, Weiss, 1979).  In the 1970s frustration over the ineffectiveness of 
knowledge transfer led to the dominance of the two communities model which 
attributed the lack of research impact to the cultural differences between the 
research and policy-making communities (Caplan, 1979).  Although critics later 
claimed that this model was inadequate and overly pessimistic (Dunn, 1983, 
Wingens, 1990) subsequent approaches to improve collaboration and impact 
have once again embraced the two communities model emphasising the 
differences in culture, goals, information needs, timescales, power, reward 
systems and language between the research community and policy makers 
(Huberman, 1994, Lomas, 2000a).   
These more recent approaches have, however, conceptualized knowledge 
translation not as a linear one-way transfer of information from researchers to 
policy makers but as a more collaborative process that involves interaction and 
exchange among researchers producing information and potential users such as 
policy makers and service providers (Huberman, 1994, Jacobson et al., 2003).  
Whilst proponents still see a distinction between the scientist and the non-
scientist there is a ‘mutual respect for the distinctive expertise that each brings 
to the research process’ (Denis and Lomas, 2003).  The producer-push and user-
pull models of knowledge transfer and uptake have been supplanted by an 
interaction model to enhance knowledge transfer and uptake (Landry et al., 
2001).  Key to this process is that knowledge producers and users are personally 
known to each other and, therefore, familiar with each others’ needs, priorities, 
aims and circumstances (Bogenschneider, 2000, Jacobson et al., 2003, Lomas, 
2000a).  For example, a UK study, describing a crime reduction initiative involving 
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researchers, policy makers and practitioners working closely together to develop 
and evaluate interventions, suggested that the co-location of research and policy 
teams was key to its success (Laycock, 2001).  Denis and Lomas suggest that for 
some the purpose of collaboration is to ensure the local application of specific 
research results whereas for others the aim is for the researcher and practitioner 
to better understand each other’s questions and approaches (Denis and Lomas, 
2003).  These aims echo the distinction between direct or instrumental use and 
conceptual or symbolic use.  
Such strategies to develop and strengthen contact between the two groups have 
been labelled by some as ‘linkage and exchange’(Lavis et al., 2002, Lomas, 2000a, 
Lomas, 2000b).  Lomas describes how the Canadian Health Services Research 
Foundation has built principles of linkage and exchange into its activities.  Health-
sector researchers, managers and policy makers come together to set research 
priorities and review funding applications.  To secure funding applicants must 
demonstrate both scientific merit and potential impact and investigative teams 
are required to include at least one decision maker actively engaged in 
management or policy in the area under study.  He claims that there is much 
evidence that involving decision makers in research and bringing researchers into 
the policy making process is the best way to ensure the transfer of research 
findings (Lomas, 2000b).  In a study of the role of health services research in 
public policy making Lavis and colleagues (Lavis et al., 2002) found that citable 
research was more likely to be a major influence in the policymaking process if 
policymakers had direct contact with researchers, for example through the 
establishment and maintenance of linkages with researchers.  However, they 
also found that many efforts at interaction by research units yielded no tangible 
impact. They recommend that researchers create more opportunities for 
interaction with the potential users of their research, and that they should 
‘consider such activities as part of the ‘real’ work of research, ‘not a superfluous 
add on’ (Lavis et al., 2002).   
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One suggested mechanism for bridging the gap between researchers and policy 
makers is the use of knowledge brokers with an understanding of the culture of 
both decision maker and researcher environments and with the necessary 
communication, networking, problem solving and negotiation skills (Lomas, 
2007).  In a review of the evidence on promoting innovations in service 
organizations Greenhalgh and colleagues use the term ‘boundary spanners’ to 
describe individuals with significant social ties both inside and outside the 
organization (Greenhalgh et al., 2004).  They suggest that such people can play a 
pivotal role in promoting the uptake of innovations. 
Collaborative approaches and systematic reviews 
Two studies looked specifically at collaborative approaches to promote the use 
of systematic reviews.  One paper described strategies to create opportunities 
for stakeholder engagement throughout the stages of a systematic review 
(Keown et al., 2008).  The authors describe how they have identified five 
potential opportunities for stakeholder engagement. These are:  
 In an initial consultation between researchers and policy makers to 
identify suitable review topics 
 At the beginning of the review process when questions are being 
defined and search strategies developed 
 Throughout the process with a stakeholder involved as a team 
member 
 At reaction meetings once preliminary findings are available 
 In the dissemination of review results 
From their observations of the process the authors have noted a number of 
benefits of stakeholder engagement which include an added depth to the 
review, better defined research questions, improved clarity of the final report 
and helpful input into recommendations.  They claim that policy makers feel the 
process makes the reviews more useful.  In the other study, the only RCT 
(Dobbins et al., 2009), it was found, somewhat counter-intuitively, that 
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knowledge-brokering was more effective in organisations that placed less value 
on research than those that already recognised the importance of evidence-
based decision making.  It could, however, be that there was less scope for 
improvement in organisations that already had a positive culture towards 
research use. 
Barriers to collaborative approaches 
Despite the increasing popularity of knowledge transfer strategies some 
commentators have been critical of what they see as an overly simplistic 
approach.  Davies and colleagues suggest that the terms knowledge transfer and 
knowledge translation are misconceived terms for applied social research and 
that they do not adequately reflect the challenges, subtlety and complexity of 
research use (Davies et al., 2008).  They argue that ideas of knowledge transfer 
are based in the traditional rational-linear models of research use and that ‘the 
baseline assumption of two communities too easily leads to unsophisticated 
notions of knowledge and knowledge transfer’ (Davies et al., 2008).  They 
suggest the term ‘knowledge interaction’ may be more appropriate to ‘describe 
the messy engagement of multiple players with diverse sources of knowledge’.  
In a systematic review of knowledge transfer and exchange (KTE) strategies 
(Mitton et al., 2007) the authors are also critical of the conceptualisation of KTE 
and argue that current ideas do not fit with the underlying complexities and 
politics of health policymaking.  
A number of barriers to collaborative approaches have been identified (Lomas, 
2000b, Walter, 2003a), both at the individual and the organizational level, and 
are linked to relationships between researchers and decision makers, modes of 
communication, time and timing, and context (Mitton et al., 2007).  Developing 
effective partnerships requires time and energy and researchers may not have 
sufficient time or resources to develop linkage with policy makers (Lomas, 
2000b, Walter, 2003a).  Researchers have also cited problems identifying the 
point of entry into decision making organisations, difficulties balancing the 
competing agendas of partnerships and organisations and frustration with the 
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frequent restructuring and changes of personnel in decision making 
organisations.  In addition, collaborative approaches may require some changes 
in the way researchers think, for example by broadening the range of 
methodologies used and rethinking the way problems are defined, (Denis and 
Lomas, 2003).  They may also necessitate the researcher developing new skills in 
communication and negotiation (Lomas, 2000b), skills they may currently lack or 
do not wish to acquire (Carden, 2004a).   
Barriers faced by policy makers included a lack of access to research findings, 
little time to read research, a poor understanding of research and inadequate 
skills to interpret it, and being overwhelmed by the sheer volume of research 
literature available (Nutley, 2003a, Walter, 2003a).  In addition decision makers 
often need results faster than researchers can produce them (Campbell, 2007, 
Lomas, 2000b).  Combined with these problems is the potential conflict between 
policy makers’ desire to control findings for political reasons with researchers’ 
need to publish (Lomas, 2000b).  In the light of the additional resources required 
for incorporating KTE strategies into projects, and the fact that such funding is 
very often lacking, some researchers have raised the question of who should be 
responsible for developing and initiating KTE strategies.  Should it be the role of 
researchers or policy makers (Mitton et al., 2007)? 
Although collaborative approaches have been found to be key in promoting the 
use of research evidence, it has been questioned whether researchers should be 
seeking to promote these relationships or whether they may be responsible for 
compromising quality.  It has been argued that if researchers do what is required 
for research to be used, then it may ‘fail to fulfil one of its most important 
functions which is to be objective, reliable and unbiased’ (Innvaer et al., 2002).  
Indeed, in the paper describing initiatives to involve stakeholders in the 
systematic review process the authors acknowledge that maintaining flexibility 
without compromising scientific rigour is a significant challenge (Keown et al., 
2008). 
The role of dissemination in enhancing research use 
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Another of the categories in Walter’s taxonomy is that of dissemination (Walter, 
2003b).  For the majority of researchers dissemination is most commonly 
constituted by traditional approaches such as publication in peer-review journals 
and conference presentations.  However, there is a lack of evidence as to 
whether such passive modes of dissemination are effective in driving research 
impact (Walter, 2003a).  Indeed, a number of studies have found that the format 
of communication and presentation by researchers is often not considered ‘user-
friendly’ by policy makers (Lomas, 2000b, Nutley, 2003a, Walter, 2003a).  
Research-use studies suggest that it is important to present research findings in 
formats that are tailored to potential customers (Lomas, 1991, Willison and 
MacLeod, 1999); systematic reviews of interventions to increase impact upon 
health care practice have found that active implementation strategies such as 
reminders, incentives, peer review, marketing and educational interventions are 
more effective in changing behaviour than passive distribution of 
recommendations, educational materials or guidelines (Walter, 2003a).   
There is also evidence that seminars and workshops can encourage more direct 
use of research.  Bogenschneider and colleagues used seminars to disseminate 
research findings to State-level policy makers in Wisconsin in the USA 
(Bogenschneider, 2000).  They assessed effectiveness using questionnaires and 
follow-up telephone surveys and found the seminars were rated highly by 
participants and that policy makers reported using the information obtained in 
diverse ways. More recently alternative mechanisms for dissemination and 
knowledge transfer have been developed including the use of knowledge brokers 
trained specifically in information exchange (Law et al., 2004, Mitton et al., 
2007).  However, research in this area is limited and the effectiveness and cost-
effectiveness of this strategy have been questioned (Pyra, 2003). 
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Dissemination strategies and systematic reviews 
Five studies looked specifically at dissemination strategies in relation to 
systematic reviews (Atkins et al., 2005, Ciliska et al., 1999, Dobbins et al., 2004a, 
Dobbins et al., 2009, Lavis et al., 2005).  In semi-structured interviews with 
managers and policy makers Lavis and colleagues found that barriers to research 
influence were the use of jargon and the fact that researchers often only publish 
for a scholarly audience in academic journals (Lavis et al., 2005).  They explored 
the optimal way to present systematic review evidence and found that most 
policy makers supported a 1:3:25 format (i.e. one page of take home messages, a 
three-page executive summary that summarizes the full report, and a 25 page 
report, as well as a longer technical report if necessary).  They argue that this 
format has the advantages of delivering research reports in a way that is more 
likely to be read, being tailored to meet the needs of different audiences, and 
helping researchers learn clarity and brevity.  The up-front placement of take-
home messages also reflects how many policy-makers actually read research 
reports (Lavis et al., 2005).  However, there is some research to suggest that such 
a format may, in some instances, alienate those who are in disagreement or less 
receptive to the conclusions presented (Lavis, 2004, Lavis et al., 2006b). 
In a telephone survey to determine whether recent systematic reviews of public 
health interventions were used in the development of new provincial public 
health policies in Canada it was found that policy makers valued systematic 
review evidence over other types of evidence.  The executive summary was 
considered to be the most influential part of the review.  The authors suggest, 
therefore, that researchers should put a great deal of effort into writing an 
executive summary (Dobbins et al., 2004b).  In a recent RCT, of KTE strategies in 
public health decision making, the use of targeted messages was more effective 
in promoting evidence-informed decision making compared with alternatives 
such as a website and knowledge-brokering groups (Dobbins et al., 2009).  In 
their guidance for undertaking reviews in health care the NHS centre for Reviews 
and dissemination suggest that dissemination is an integral part of the review 
process and should be considered from an early stage to allow time for planning, 
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development and implementation (CRD, 2009).  They have developed a 
dissemination framework which incorporates a number of key attributes 
including the characteristics of the research message, the setting in which the 
message is received, the characteristics of the target audience(s), the source of 
the research message and the communication channel(s) used. 
Another important point relating to dissemination is whether reviewers should 
make recommendations for policy and practice or if this is beyond their remit.  
One of the original tenets of systematic review methods, designed to maintain 
scientific rigour and reduce the risk of bias, was that reviewers should provide an 
accurate and unbiased assessment of what the data show rather than 
interpreting them in light of their own personal opinion.  This has, however, led 
to some readers being frustrated by a lack of firm recommendations from 
systematic reviews, and disappointment when reports conclude that there is 
insufficient information to answer critical questions (Atkins et al., 2005).  This 
tension is also reflected in the literature with managers and policy makers 
disagreeing about whether researchers should make recommendations (Lavis et 
al., 2005).   
A number of studies have supported the idea of reviewers developing 
recommendations.  For example, in a study of Canadian policy makers it was 
found that when reading systematic reviews they focused most on the results, 
conclusions and discussion sections (Ciliska et al., 1999) and, in a systematic 
review of evidence from interview studies of barriers and facilitators to the use 
of research evidence by policy makers, the inclusion of summaries with policy 
recommendations was a commonly reported facilitator (Innvaer et al., 2002).  
However, in his review of ways to improve the usefulness of systematic reviews 
for policy makers, Lavis suggests that researchers should avoid providing specific 
recommendations as research evidence alone is insufficient for making 
recommendations and researchers may not have a good sense of the values of 
those who will be affected by their decisions (Lavis et al., 2005).  His reservations 
are supported by a UK researcher, Annette Boaz, who suggests that pressure to 
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deliver clear policy recommendations may lead systematic reviewers to inflate 
their conclusions and ‘go beyond the evidence’.  She argues we need to ‘jettison 
the notion that a single review can deliver all-purpose policy advice’ (Boaz, 
2005).   
Initiatives to increase the usefulness of systematic reviews 
The influence of systematic reviews may also be increased by exploring ways of 
making them more relevant and useful to policy makers.  Some suggestions for 
how this might be achieved are discussed in the following sections. 
Context and applicability 
A number of commentators have argued that key to making systematic reviews 
more useful to policy makers, and therefore more influential, is for the 
researcher to include an assessment of both the context in which the research 
was conducted and the applicability to a local setting (Gruen et al., 2005, Lavis et 
al., 2005).  This echoes suggestions that it is important to go beyond simple 
questions of ‘what works’ to look at ‘what works for whom and in what setting’ 
(Solesbury, 2001).  Gruen suggests that reviewers should consider the relative 
importance of the health problem under study, the relevance of outcome 
measures used, the practicality of the intervention, the appropriateness of the 
intervention and  the cost-effectiveness of the intervention (Gruen et al., 2005).  
In reality, assessing context and applicability is not always straightforward.  
Although tools exist to assess applicability (Lavis et al., 2004, NICE, 2006)  as a 
reviewer I have found these subjective and unsatisfactory.  However, the biggest 
challenge that a reviewer faces when trying to assess applicability is that, in 
many instances, the content of interventions is poorly described and there is 
little detail of the providers, duration, intensity and setting, all of which is vital 
information if we are to make judgments about generalizability.  It has been 
suggested that context  may be more comprehensively examined by including 
published and unpublished (grey) research literature in a ‘state-of-the-evidence’ 
review that is broader than traditional systematic reviews (Benzies et al., 2006).  
However, such approaches may severely compromise review quality and validity 
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of the findings and there is, as yet, little evidence that incorporating ‘evidence’ of 
this nature improves assessments of local applicability.  In addition, because this 
involves intensive searches for grey literature, reviews of this nature have 
significant resource implications. 
Assessments of context are also dependent on the medium of dissemination and 
the audience.  For example, Cochrane reviews are designed to be suitable for 
international audiences and so are deliberately not specific to one context.  Lavis 
suggests that one way forward may be for researchers to produce reviews that 
can add to the international literature and that also include a locally adapted 
version (Lavis et al., 2005).  Cochrane reviews are also, for the most part, focused 
on questions of effectiveness and, at present, there is no coordinated effort akin 
to the Cochrane Collaboration that has been undertaken to address questions 
other than ‘what works?’ (Lavis et al., 2006a).  However, although the focus of 
the Cochrane Collaboration remains on randomised controlled evaluations of 
effectiveness, the latest version of the Cochrane handbook includes guidance on 
incorporating other study designs, such as qualitative research (Higgins, 2008).  
This might enable a greater breadth of questions to be considered in Cochrane 
reviews. 
It has also been suggested that a key role of the systematic reviewer is to look at 
applicability of interventions for certain groups and to describe any differential 
effects by subgroups such as ethnicity and culture (Lavis et al., 2005).  Although 
this is a laudable aim such analyses are often difficult to perform because of a 
lack of data from the primary studies.  For example, in a review of interventions 
to prevent STIs and teenage pregnancies (Bunn et al., 2006a) the funders, NICE, 
asked for subgroup analyses by ethnicity and socio-economic status.  This was 
understandable as the funders were keen to target interventions at those most 
at risk.  However, we found little reliable evidence on the differential effects in 
these groups and a concern is that reviewers may feel under pressure to present 
information about applicability that is not supported by the data.  Moreover, 
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there are a number of methodological concerns about the appropriateness of 
subgroup analyses (Higgins, 2008, Oxman and Guyatt, 1992).   
Methodological initiatives  
One of the criticisms of systematic reviews has been that a reliance on highly 
controlled research, such as RCTs, may limit their utility for policy makers and 
those in the ‘real world’.  Green argues that systematic reviews may ‘deepen the 
chasm between research and practice’ because ‘most of the research qualifying 
as worthy of systematic reviews … is highly controlled research under 
unrepresentative circumstances’ and that this in turn means research is not 
adopted or implemented (Green et al., 2009).  However, there is a growing 
literature on improving the usefulness of systematic reviews by incorporating a 
broader range of literature, including qualitative studies.   
In addition, researchers are developing methods that allow them to go beyond 
answering questions merely about ‘what works’ and have developed techniques 
that allow them to address questions about cost-effectiveness, process, 
mechanisms and meanings (Dixon-Woods et al., 2005, Harden et al., 2004, Mays 
et al., 2005, Oliver, 2005b, Pawson et al., 2005, Thomas et al., 2004).  The 
argument for such approaches is that they are more likely to yield reviews that 
are relevant to the decisions that policy-makers may face.  The arguments 
against these methods are that they may introduce bias into what would 
otherwise be an approach that strives to minimise bias (Lavis et al., 2006a).  To 
date, however, there is little evidence of whether such methodological initiatives 
improve research influence.  Some have taken this further to produce syntheses 
that incorporate published literature, grey literature, decision makers’ 
experience and researchers’ knowledge and experience together into a ‘policy 
synthesis’ (Canadian Health Services Research Foundation, 2004).  Such a 
technique is, however, relatively new and untested, presents formidable 
logistical challenges and should be used with caution (Lavis et al., 2005).   
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Timeliness 
Timeliness has also been identified as a facilitator of research use (Ciliska et al., 
1999, Lavis et al., 2005, Mitton et al., 2007).  Systematic reviews, even though 
quicker to produce than primary research, may still take too long to be useful to 
policy makers (Campbell, 2007).  In a review of evidence-based policy for practice 
for the Government Social Research Unit in the UK (Campbell, 2007) the authors 
suggest that to address the issue of timeliness there needed to be a modification 
of systematic reviews and the development of ‘rapid evidence assessments’ 
using similar rigorous techniques but in a much shorter time frame.  How the 
authors envisage a process that maintains the same standards but takes less 
time is not specified.  My own experience of producing a so called ‘rapid’ review 
for NICE (Bunn et al., 2006a) is that the funders wanted rapid delivery but did not 
want to compromise review quality, a situation that puts the researcher under a 
great deal of pressure.  It may be that less rigorous rapid reviews and HTA 
assessments could be a bridge between science and policy making (Campbell, 
2007, Rotstein and Laupacis, 2004, Watt et al., 2008).  However, the scope of 
such syntheses may be more limited and they may not  adhere to any single 
validated methodology (Watt et al., 2008).  In addition, there is an obvious 
tension between the need to make reviews more useful, by exploring context, 
applicability, views and experiences and process, and the demands for 
timeliness.  I have found that incorporating qualitative and quantitative research 
into the same review or searching for grey literature, whilst potentially valuable, 
are resource intensive and may lengthen the review process.  This has 
implications for timely delivery to policy-makers concerned with a rapid 
response. 
Conclusion 
Although there is an increasing focus on research impact and the role of 
evidence in health care policy there is a lack of good quality evidence of 
interventions to promote the use of systematic reviews in the development of 
health care policy.  This lack of established effective interventions is not limited 
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to systematic reviews.  In a review of knowledge transfer and exchange 
strategies for research in general (Mitton et al., 2007) the authors noted that 
they found only one randomised controlled study.  This lack of rigorous 
evaluation makes the transfer of findings to other or even similar, contexts 
difficult.  The ability to generalise results to England is further restricted as many 
of the studies were conducted in Canada in areas with a policy culture that 
values research evidence and where initiatives at KTE are more common. 
There is clearly some discrepancy in the literature over the extent to which policy 
makers actually make use of systematic review evidence in the policy 
development process.  Although some of the Canadian studies showed a positive 
response to the use of systematic reviews, evidence from the UK suggests that 
systematic reviews are not well used or understood by many policy makers 
(Campbell, 2007).  There are a number of well documented barriers that 
researchers and policy makers need to overcome before research can have an 
impact on policy.  Some of the barriers that policy makers face, such as a lack of 
access to journals, lack of time to read and appraise articles, and a lack of critical 
appraisal skills, could feasibly be overcome by systematic reviews where 
reviewers have already done the work of finding relevant research, appraising 
their quality, and synthesizing the results (Ciliska et al., 1999).  However, despite 
the potential advantages of reviews, barriers may remain as researchers may not 
be carrying out policy-relevant research, may be using inappropriate methods or 
may be using ineffective dissemination strategies.  In addition, attempts to 
increase the usefulness of reviews, such as incorporating a variety of types of 
evidence and widening searches to include grey literature, may directly mitigate 
against timely delivery.   
The literature does, however, point to a number of factors that may be key in 
promoting the use of systematic reviews.  Lavis and colleagues make a number 
of recommendations for making systematic reviews more user friendly and 
increasing their impact.  These include, involving policy-makers in setting 
questions and approach and interpreting the results, identifying benefits and 
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harms and describing any differential effects by subgroup (e.g. ethnicity and 
culture), looking at the context in which the research was conducted, developing 
a more user-friendly front end and adding additional local value to systematic 
reviews.  They also suggest that reviews are included in The Cochrane Library or 
another source that provides ‘one-stop shopping’ for high quality reviews.  It is 
clear that these strategies for increasing research impact require considerable 
investment on the part of the researcher in terms of time, resources and the 
development of new skills.  However, despite a growing body of work on 
increasing research impact, the benefit of such developments is not established.  
In particular there is little empirical research on ways of increasing the influence 
of systematic reviews on health care policy and further work in this area is 
needed.  In the next Chapter I describe the methods for the submission.   
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Table 2.2:  Studies promoting the use of systematic reviews  
Study ID Study Type Research aims & objectives Main results 
 
Comments 
Atkins 2005 
USA 
 
Discussion paper   Describe lessons learned about 
how to increase the efficiency and 
impact of systematic reviews from 
network of evidence-based 
practice centres across North 
America 
Say that reviews must produce knowledge that is relevant to specific 
clinical and policy decisions and present information in concise and 
easily understood format. 
Planning for translation and implementation should be part of initial 
planning of the review. 
Lessons learned: 
 Identify the right targets for evidence 
 Define appropriate questions and scope of a review 
 Working with partners important but reports need to address 
needs of partners without excessive tailoring to narrow interests 
of a single organisation 
 Balance consistency and flexibility in methods 
 Expand inclusion criteria to ‘best available evidence’ if higher 
quality evidence is lacking 
 Involving experts important but they need to be open minded 
enough to critically re-examine some of accepted conclusions in 
their field. 
No formal 
evaluation 
Brussoni 2006 
UK 
 
Description of 
process to 
translate 
evidence into 
practice 
To bring together scientific 
evidence of what works in injury 
prevention with the knowledge and 
experience of practitioners. 
Uses a case study of reviews of 
evidence of effectiveness of smoke 
Topics discussed: 
 National policies and drivers seen as important influence on 
resources and staffing 
 Multi-agency partnerships seen as crucial 
 Meetings acted as valuable training tools and provided 
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alarm installation 
Involved meetings with 
practitioners to discuss issues 
around implementation of 
interventions identified as 
effective. 
mechanism for strengthening local partnerships 
Describes a process that they say considers local context and results in 
practical recommendations that reflect real-world practice 
Ciliska 1999 
Canada 
Telephone survey 
(before and after 
receiving 
systematic 
reviews) with 
public-health 
policy makers in 
Ontario 
Focus groups 
used to develop 
survey tool. 
Questionnaire 
pre-tested for 
content validity, 
revised and 
retested. 
To gain an understanding of the 
research needs, perceptions of 
barriers to research utilization, and 
attitudes towards systematic 
reviews of decision-makers in 
public health at the levels of 
systems planning. 
277 people eligible.  87% participated in first survey, 93% at follow up. 
57% heard of systematic reviews, when prompted with a description 
86% said the description sounded familiar, 62% able to give examples 
of reviews they knew about.  When asked about priority reviews 
should be given in research agenda 62% said high and 9% top. 
For those who read the reviews most focused on the conclusions, 
discussion and results. Very few looked at tables. 
Barriers to research use: 
• Time  
• Availability of research results 
• Resources to implement research 
• Relevance 
• Policy climate 
• Timeliness 
Cannot discern 
from this survey 
whether policy 
makers actively 
use research 
Dobbins 2001 
(reported in 
two papers 
Dobbins 
2001a & 
Dobbins 
Telephone survey 
of decision 
makers from all 
public health 
units in Ontario 
To determine the extent to which 5 
systematic reviews influenced 
public health decisions and policy 
development and to determine 
which characteristics of the 
innovation, organisation, 
environment, and individual 
96% of decision makers participated in the survey, 63% reported using 
at least one SR in the past 2 yrs to make a decision, 50% perceived SR 
as having great deal of influence on program justification and 41% on 
planning decisions, 44% indicated SR has not influenced policy 
development at all 
Perception that one’s organisation valued the use of research 
Culture in Ontario 
that values 
research 
evidence. 
Results only 
generalisable to 
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2001b) 
Canada 
predicted the influence the reviews 
had on those decisions 
evidence for decision making and that ongoing training in critical 
appraisal was provided increased perception of the influence the 
systematic reviews had on public health decisions 
Most important predictors of use were position, expecting to use a 
review in the future, perceptions that reviews were easy to use and 
that they overcame barrier of limited critical appraisal skills. 
organisations 
included in this 
study. 
 
Dobbins 2004 
Canada 
Telephone survey To determine whether the results 
of recently completed systematic 
reviews evaluating the 
effectiveness of public health 
interventions were used in the 
development of new provincial 
policies for public health practice 
85% of decision makers participated in the survey, 96% of 
respondents reported that the systematic reviews played a part in 
developing new guidelines, 47% reported they contributed a great 
deal to the development of new recommendations for practice 
Decision makers valued the use of the systematic reviews to a greater 
extent than they did other types of information 
Significant predictor variables included the importance of the reviews 
in comparison to other sources of information and relevance of the 
reviews to policy decisions 
Majority of decision-makers rated executive summary as being the 
most important component of the systematic reviews 
Review topics 
chosen in 
collaboration with 
provincial 
advisory group so 
relevant to public 
health policies 
under 
consideration. 
Culture in Ontario 
that values 
research 
evidence. 
Small sample size. 
Dobbins 2009 RCT and 
qualitative 
interviews. 
 
108 of 141 (77%) 
of public health 
organisations in 
Canada 
To test the effectiveness of KTE 
strategies in Canadian public health 
decision making on programs 
related to the promotion of 
physical activity and healthy body 
weight in children.    
Involved three groups: 
1) Control (who had access to an 
Emerging findings from RCT include: 
 Having access to a registry of synthesised and translated research 
evidence (control grp) has no impact on evidence informed 
decision making (EIDM) 
 Targeted messaging significantly more effective in promoting 
EIDM than other strategies (p<.009) 
 A number of organisational factors modified the treatment effect 
 Simple KTE strategies may be as effective as complex ones (but 
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participated in 
the study. 
online registry of systematic 
reviews evaluating public health 
interventions)  
2) Targeted message group (same 
as control plus direct mailing)  
3) Knowledge brokering (KB) group 
who received one-to-one input to 
build capacity of EIDM and assist in 
translating research evidence. 
Data collected baseline, post 
intervention, and 12 months. 
need to be active rather than passive) 
Knowledge-brokering was more effective in organisations that placed 
less value on research evidence and less effective in those 
organisations that already recognised the importance of evidence-
based decision making. 
Qualitative findings contradicted quantitative results.  Participants in 
KB group perceived the KB to have significantly impacted EIDM 
capacity for them personally as well as for their organisation. 
Conclude that KB intervention may not have contained all the 
necessary components to produce a positive effect. 
Keown 2008 
Ontario, 
Canada 
Discussion paper  To describe various stakeholder 
engagement opportunities they 
employ throughout the stages of 
conducting a systematic review to 
increase knowledge utilization. 
Based on experience of 22 
systematic reviews over 4 yr 
period. 
They have identified 5 potential opportunities for stakeholder 
engagement: 
 Stakeholder topic consultation 
 Stakeholder input meeting (e.g. input into setting question, 
literature searches) 
 Stakeholder as review team member 
 Stakeholder reaction meeting (discuss draft findings) 
 Stakeholder involvement in dissemination 
Observed benefits 
 Added depth to review 
 Help to define research question and add search terms 
 Improve clarity of final report and input into recommendations 
 Policy-makers feel it helps to make reviews more useful 
 Building capacity 
 
Challenges 
 Maintaining flexibility without compromising scientific rigour 
Not a formal 
evaluation. 
Hard to 
generalise results 
to other settings 
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 Time and resource intensive 
 Difficult to find appropriate stakeholder to be review team 
member 
 Review may reveal controversial findings contrary to stakeholders  
 expectations 
Lavis 2005 Systematic 
Review and 
interviews. 
Review included 
17 studies 10 of 
which focused on 
health care 
policy-makers.  In 
addition, they 
carried out 
interviews with 
policy makers in 
Canada and the 
UK to elicit views 
and experiences 
of using or 
commissioning 
systematic 
reviews. 
To identify ways to improve the 
usefulness of systematic reviews 
for health care managers and 
policy makers. 
One of their main aims was to 
identify ways in which researchers 
could improve the usefulness of 
systematic reviews for health care 
managers and public policy-
makers. 
 
 
Ranked factors that influenced research-use by managers & policy 
makers from the most to the least rigorously demonstrated and 
consistent.   
 Most important facilitators appeared to be: 
 Interactions between researchers and health care policy makers  
 Timing and timeliness.   
Other factors included: 
 Policy networks that brought policy-makers & researchers 
together  through formally structured mechanisms  
 Trust in the researcher 
Barriers on the part of policy-makers included: 
 Negative attitudes towards research evidence  
 Lack of necessary skills and expertise 
 Lack of perceived relevance 
 Use of jargon 
 Only publishing for a scholarly audience in academic journals  
In those instances where policy makers reported using research 
evidence none cited systematic reviews.  Many factors other than 
research influenced decision including legal issues, pressure from 
stakeholders and public opinion. 
Overall there was 
a lack of research 
evidence in this 
area and it lacked 
rigour and 
consistency 
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Chapter 3: Methods 
Introduction 
In this chapter I describe the overall methodology for the submission, and detail 
the strategies I employed to identify any evidence of impact or influence that my 
reviews may have had on policy.  The core component of this submission is a 
body of my own published systematic review work and I begin by describing the 
role of that research and the way it is used and presented in the following 
chapters.  This is followed by a discussion of the key issues involved in 
determining impact, the different techniques I used for evaluating the impact of 
my own reviews, and the framework I chose for the analysis.   
The role of my own research  
One of the aims of this submission was to explore the influence of systematic 
reviews on health care policy and to identify factors that may facilitate or restrict 
their impact.  Central to this endeavour is a representation of my own previously 
published systematic reviews.  These reviews form an integral part of the impact 
evaluation and are used as illustrative examples to enable an investigation of the 
influence of reviews on policy.  The reviews are also used to critically explore the 
methodological issues associated with the systematic review process and to 
critique the different approaches adopted. 
Details of these papers including the specifics of my contribution to each review 
can be seen in Table 3.1.  The reviews form the basis for Chapters 4-8 with each 
chapter including a discussion of specific methodological issues and a 
presentation of any evidence of impact.  The rationale for the division of the 
reviews into a number of chapters is based on differences in the systematic 
review methods employed and the review topics.  For example, one chapter 
focuses on systematic reviews with meta-analysis of randomised controlled trials 
(RCTs) and another looks at meta-analysis of non-randomised studies.  There is, 
of course, much overlap in the methods germane for different types of reviews.  
Even between reviews of RCTs and reviews of qualitative studies there are a 
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number of similarities, such as the importance of setting well defined questions 
and critically appraising studies.  However, despite some overall methodological 
congruence there are significant differences between the various types of 
reviews and it is, therefore, appropriate to look at them separately.  A list of all 
my published work can be found in Appendix 1 and copies of the papers included 
in this study can be found in Appendix 2.  Five reviews were published in both 
the Cochrane library and a print journal and in these cases only one version of 
the review is included in the appendices. 
Table 3.1 Published systematic reviews included in submission  
Review Published 
in: 
First 
author 
Yes/No 
Contribution to review 
process 
Years  
published  
 
Relevant 
chapter  
Colloid 
Solutions for 
fluid 
resuscitation 
Cochrane 
Database of 
Systematic 
Reviews 
(CDSR) (1)* 
Yes 
 Developing review 
protocol  
 Contributed to 
search strategy 
 Screened search 
records 
 Data extraction 
 Assessment of study 
quality  
 Data analysis  
 Writing up 
 Review updates 
First 
published 
2000  
 
Updates: 
2001 
2003 
2008 
4 
Hypertonic 
versus isotonic 
crystalloid for 
fluid 
resuscitation in 
critically ill 
patients 
CDSR (2) Yes  Developing review 
protocol  
 Contributed to 
search strategy 
 Screened search 
records 
 Data extraction 
 Assessment of study 
quality  
 Data analysis  
 Writing up 
 Review updates 
First 
published 
2000 
 
Updates 
2002 
2004 
4 
Human albumin 
solution for 
resuscitation 
and volume 
expansion in 
critically ill 
CDSR (3a) 
 
BMJ (3b) 
No  Contributed to 
search strategy 
 Screened search 
records 
 Data extraction 
 Assessment of study 
First 
published  
1998 
 
4 
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patients quality  
 Commenting on the 
review 
Updates 
2002 
2004 
2009 
 
Timing and 
volume of fluid 
administration 
for patients 
with bleeding 
following 
trauma 
CDSR (4) No  Protocol 
development 
 Screened search 
records 
 Data extraction 
 Assessment of study 
quality  
 Commenting on the 
review 
 Review updates 
 
First 
published 
2001 
 
Updates 
2003 
2009 
 
4 
Colloids versus 
crystalloids for 
fluid 
resuscitation in 
critically ill 
patients 
CDSR (5a) 
 
BMJ (5b) 
No 
(involved 
in update 
not 
original 
review) 
 Data extraction 
 Assessment of study 
quality 
First 
published 
1998 
 
Updates 
2000 
4 
Area-wide 
traffic calming 
for preventing 
traffic related 
injuries 
CDSR (6a) 
 
Injury 
Prevention 
(6b) 
Yes  Developing review 
protocol  
 Contributed to 
search strategy 
 Screened search 
records 
 Data extraction 
 Assessment of study 
quality  
 Data analysis  
 Writing up 
 Review updates 
First 
published 
2003 
 
Updates 
2009 
5 
Safety 
education of 
pedestrians for 
injury 
prevention 
CDSR (7a) 
 
BMJ (7b) 
No  Contributed to 
search strategy 
 Screened search 
records 
 Data extraction 
 Assessment of study 
quality  
 Data analysis  
 Writing up 
First 
published 
2002 
5 
A systematic 
review of older 
people’s 
perceptions of 
Age and 
Ageing (8) 
Yes  Developing review 
protocol  
 Contributed to 
search strategy 
First 
published 
2008 
6 
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facilitators and 
barriers to falls 
prevention 
interventions 
 Screened search 
records 
 Data extraction 
 Assessment of study 
quality  
 Data analysis  
 Writing up 
Contraceptive 
advice and 
provision for 
the prevention 
of under 18 
conceptions 
and STIs: a 
rapid review 
NICE 
website (9) 
Yes  Contributed to 
search strategy 
 Screened search 
records 
 Data extraction 
 Assessment of study 
quality  
 Data analysis  
 Writing up 
 Input into 
development of 
guidance 
First 
published 
2006 
7 
The effects of 
telephone 
consultation 
and triage on 
healthcare use 
and patient 
satisfaction: a 
systematic 
review 
CDSR (10a) 
 
Br J Gen 
Pract (10b) 
Yes  Developed search 
strategy 
 Screened search 
records 
 Data extraction 
 Assessment of study 
quality  
 Data analysis  
 Writing up 
First 
published 
2005 
8 
* each paper is given a number for ease of identification in tables and figures throughout the 
submission. 
Methods for determining impact 
As reported previously (Chapter 1) the definition of policy I have adopted 
involves not only national policies of the government but also policies agreed at 
national or local level by groups of health-care practitioners in the form of 
clinical or local guidelines, as well as policies developed by those responsible for 
training and education in various forms (Hanney et al., 2003).  In addition, health 
policy covers both policy made in the public sector (by government) as well as 
policies in the private sector.  Health is influenced by many determinants outside 
the health system (Buse et al., 2005) and I am, therefore, also interested in the 
actions of organizations external to the health system which have an impact on 
health (for example, the pharmaceutical or motoring industries). 
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As I noted in Chapter 2 many different terms have been used to define research 
impact.  However, there is a general consensus of opinion that several types of 
research impact exist (Weiss, 1976, Huberman, 1992, Nutley, 2003b, (Estabrooks, 
1999), including instrumental or direct impact, conceptual impact and symbolic 
impact (these are defined in Chapter 2 p 25, and again later in this Chapter).  I 
was interested in exploring all these types of impact and for the purpose of my 
evaluation I took impact to mean any change that lay beyond the research 
process and its primary outputs (i.e. any change beyond the publication of the 
systematic review).  However, as I highlighted in Chapter 1, the real world of 
policy making is complex and messy and because of this discerning the role of 
research in relation to all the other factors that might influence the policy 
making process is particularly challenging.   
Although there is an increasing emphasis on research impact there are no agreed 
methods or instruments for measuring the impact of research (Boaz, 2008a).  A 
variety of methods to assess research impact have been described and 
recommended in the literature.  These include bibliometrics, documentary 
analysis, semi-structured interviews, case studies, panel review, surveys and 
network analysis (Boaz, 2008a, Hanney, 2007).  The methods most frequently 
suggested for analysing the impact of research are bibliometrics, documentary 
review and interviews (Boaz, 2008a, Hanney et al., 2004b).  Despite the potential 
for complex analysis using a range of techniques, the choice of methods for an 
evaluation of research impact should be realistic and fit with the scope of the 
task and the resources available (Boaz, 2008a).   
However, choosing the appropriate methodology for this evaluation was not 
straight-forward as although there are a number of examples of research impact 
evaluations in the literature these tend to focus on the impact of research on 
practice rather than policy.  In a recent review investigating the best way to 
evaluate the impact of research programmes on policy the authors found 35 
papers that addressed the impact of research on health policy (Boaz, 2008a).  
However, many of those were focused on the relationship between research and 
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policy, rather than the impact of research on policy, and much of the work was 
reflective rather than documenting empirical examples (Boaz, 2008a).   
Each of the methods has its own advantages and disadvantages and these 
needed to be considered when choosing methods fit for the purpose of my 
evaluation.  Quantitative methods such as bibliometrics are widely used to 
quantify the impact of research.  They can be used to manage large amounts of 
data, are transparent and reproducible and are suitable for comparisons across 
different research.  In addition, they are cost-effective and can be applied to 
retrospective evaluations. However, bibliometric data usually focus on research 
outputs rather than outcomes and can only be considered a proxy for policy 
impact.   
Qualitative methods such as semi-structured interviews, field visits and 
observations may generate rich descriptive data.  However, it might be difficult 
to generalise their findings and they run the risk of being anecdotal and 
subjective (Boaz, 2008a).  Such data may also be subject to a number of biases 
that lead policy makers to either overestimate or underestimate the influence of 
research.  Asking a policy maker to focus on a specific systematic review might 
lead them to overestimate its significance, particularly if they are operating in a 
climate that purports to consider evidence when making policy decisions.  On the 
other hand recall bias may mean that policy makers underestimate the influence 
of the research, particularly if there is a long gap between publication of the 
research and the interview.  In addition, high turn-over of policy makers makes 
identifying suitable interviewees problematic, particularly for retrospective 
evaluations.   
Although to date it has not commonly been used network analysis is a potential 
tool for impact evaluation.  It involves analysis of relationships between different 
actors and can be used to map both formal and informal networks.  The rationale 
for such an approach is that networks are important in disseminating research 
and shaping policy (Gray, 1973, Rogers, 1983, Sabatier and Jenkins-Smith, 1993).  
An advantage of such an approach is that it reflects the complex realities of 
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policy making.  However, the disadvantage is that it focuses more on tracing 
research pathways or looking at the relationship between research information 
and policy rather than measuring impact.  In addition, the identification of 
networks is likely to be more difficult in retrospective evaluations. 
Owing to the limitations associated with most methods the use of multiple 
sources of evidence to identify research impact has generally been 
recommended (Croxson et al., 2001, Hanney et al., 2004a, Hanney et al., 2003, 
Lavis et al., 2003a).  For example, in a study describing the methods used to 
determine the impact of research funded by the UK Arthritis Research Campaign, 
Hanney and colleagues used a mixture of documentary and literature review, 
semi-structured interviews with researchers and bibliometric analysis (Hanney et 
al., 2004b).  However, overly complex approaches may be too time consuming 
and resource-intensive, and may not be justifiable relative to the potential 
benefits (Anderson, 2006, Beacham, 2005, Boaz, 2008a).   
One of the challenges of this study was to identify appropriate methods for 
determining and comparing the impact of a group of reviews concerned with a 
range of topics and published over a ten year period.  In addition, methods 
needed to be suitable for a retrospective analysis that involved tracking forwards 
from specific pieces of research rather than tracing backwards from policy.  In 
light of these considerations I chose to use bibliometric analysis, documentary 
analysis and literature review, and some informal semi-structured email or 
telephone interviews with co-authors.  Whilst use of these approaches may not 
facilitate in-depth exploration of the contextual factors -interpersonal, 
organisational and political- which influence the impact of systematic reviews on 
policy, they do provide a systematic and verifiable method of evaluating their 
contribution to a range of documents which inform policy.  The use of more than 
one method enables richer data to be gathered and, also, allows for some 
triangulation.  These methods are discussed further below. 
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Bibliometric analysis 
One way of assessing research impact is to employ bibliometric methods.  
Bibliometrics employs quantitative analyses to measure patterns of scientific 
publication and citation, typically on journal papers (Ismail et al., 2009).  One of 
the most important of these is citation analysis.  This technique, which 
essentially involves counting the number of times a research paper or researcher 
is cited, works on the assumption that influential researchers and important 
works will be cited more frequently than others (Meho, 2007).  Advantages of 
using a technique such as this is that citation rates are seen as an objective 
quantitative indicator for scientific success (Bornmann et al., 2008), they are 
robust and transparent and it is a relatively simple and cost-effective method.  
However, there are disadvantages which any researcher using this technique 
should be aware of.  Whilst citation analysis may tell us the degree to which a 
piece of research has been useful to other researchers it does not give us an 
indication of the influence it may have had on decision makers; nor does it tell us 
how often reviews have been downloaded or read.  Other criticisms of 
bibliometrics are that they focus on quantity rather than quality and measure the 
number of research outputs rather than research outcomes or impact (Boaz, 
2008a). 
In addition it has been suggested that citation counts are biased towards papers 
published in open access journals (Murali et al., 2004).  The latter has been 
dubbed FUTON (full text on the internet) bias (Wentz, 2002).  However, the 
extent to which open access may result in greater citation counts is not clear.  In 
a longitudinal bibliometric analysis comparing cohorts of open access and non 
open access papers in one journal (Proceedings of the National Academy of 
Sciences) open access journals were twice as likely to be cited in the first 4-10 
months after publication as non open access articles (Eysenbach, 2006).  In 
contrast a recent RCT comparing open (free) full text access with subscription 
access found that although the open access articles were downloaded more 
often they were not cited more frequently than subscription access papers in the 
first year after publication (Davis et al., 2008).  The later study may be more 
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reliable because it assigned papers to open or subscription access randomly, 
included more papers and covered papers in a greater range of journals. 
As a result of these limitations citation analysis can only be considered as a 
surrogate or proxy measure for influence on policy and the results should be 
interpreted with some caution.  Furthermore it is a proxy measure not yet 
satisfactorily proven to be linked to impact (Hanney, 2007).  However, despite 
the potential drawbacks, bibliometric data were worth including in this study as 
they are a useful indication of the general influence of research. 
Methods for citation analysis 
The Thomson Scientific ISI citation databases which include the Science Citation 
Index (SCI) and the Social Sciences citation Index (SSCI) contain over 40 million 
records from more than 8700 journals and have traditionally been the main tool 
for citation analyses.  However, the advent of the web has had a huge impact on 
citation analysis and in 2004 Scopus from Elsevier and Google Scholar from 
Google emerged to challenge the monopoly of the ISI citation index (Bakkalbasi 
et al., 2006, Meho, 2007).  These bibliographic databases include additional 
document types such as books, chapters in books and conference proceedings 
that are not indexed in the ISI citation databases.  Research has shown that 
Scopus offers about 20% more coverage than the Web of Science (Falagas et al., 
2008) although it is limited to articles published after 1995.   
Google scholar is a research orientated search engine that accesses conventional 
print material and web based material.  It also extracts citation information and 
can be used as a citation index as well as a search engine.  However, Google 
Scholar needs to be used with some caution as there is a lack of transparency 
about the sources and selection criteria (Jacsó, 2005, Smith, 2008) and the 
citation information can be flawed or inadequate (Falagas et al., 2008).  Despite 
this, Google Scholar is a valuable tool as it contains significant resources not 
covered by other databases (Kousha and Thelwall, 2008), it can help in the 
retrieval of more obscure information, and is particularly useful for identifying 
60 
 
unpublished literature.  Owing to the strengths and weaknesses of the different 
databases the use of multiple sources is generally recommended (Bakkalbasi et 
al., 2006, Meho, 2007).  For this reason I used Scopus, Web of Science (WoS) (ISI 
citation indexes) and Google Scholar for my citation analysis.  
Citation counts for Cochrane reviews may be artificially low because citing 
authors have incorrectly referenced Cochrane reviews (The Cochrane Library, 
2008).  Therefore, in addition to the citation searches I contacted Wiley 
Interscience the publishers of the Cochrane Library to ask if data on the number 
of times Cochrane reviews were accessed was available.  They were able to 
provide me with data for 2008 and 2009.  This data included the number of full 
text views and how this placed the review in the world ranking.  They calculated 
world ranking by taking all the reviews on the Cochrane Library and ranking them 
based on the number of full text downloads.  The total number of reviews on the 
Cochrane Library was 6,232 in 2008 and 6,840 in 2009. 
Data from the citation analysis is considered in the context of the impact factor 
of the journal in which the research was published.  The impact factor is a 
measure reflecting the average number of citations and is often used as a proxy 
for the relative importance of a journal within its field.  Journals with higher 
impact factors are considered to be of greater importance than those with lower 
ones.  There have been criticisms of the use of journal impact factors (Brown, 
2007, Williams, 2007), including the claim that the use of impact factors conceals 
the large variation in the citation impact of individual papers within a journal 
(Seglen, 1997).  However, it is still useful to consider the journal impact factor of 
as it has been shown to be strongly associated with the likelihood of subsequent 
citations (Callaham et al., 2002). 
Documentary and literature review 
Documentary analysis allows for the ‘exploration and interpretation of existing 
documents and can elicit quantitative or qualitative findings’ (Boaz, 2008a).  
Although the reliance on identifying and accessing existing records can be a 
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disadvantage, benefits of this technique are that it can be applied to a range of 
sources, provides contextual understanding and is cost-effective (Boaz, 2008a).  
Documentary and literature review can include identifying key citing papers and 
relevant clinical guidelines (Hanney et al., 2004b).  As clinical guidelines fall 
within the definition of policy that I have adopted (Hanney et al., 2003), it was 
important to identify any guidelines that had incorporated evidence from any of 
the included systematic reviews.  In addition, I attempted to identify literature 
that gave an indication that practice or policy may have changed as a result of a 
particular review.  
To identify guidelines and relevant literature I undertook the following 
strategies: 
 Handsearched the Cochrane document on the dissemination of Cochrane 
evidence (Canadian Cochrane Centre, 2004) to identify potential sources 
for further investigation.  This document lists some of the bodies that use 
Cochrane reviews as a source of evidence for their guideline 
development.   
 Screened the titles and abstracts of those papers identified by the citation 
analysis to see if any of them were guidelines or policy documents 
 Searched The National Library of Guidelines and screened the list of 
guideline publishers on The National Health Service Library for Health 
(NHS NLH)  (NHS NLH, 2009) and TRIP database using the guidelines filter 
 Searched the following electronic databases: NHS NLH, PubMed and 
google.   
 Searched the websites of relevant organisations or societies that might be 
involved in developing and issuing guidance 
 Contacted Wiley Interscience, the publishers of the Cochrane Library, for 
information on the number of times reviews were downloaded 
The details of specific search terms used and databases and websites searched 
for each review can be seen in Table 3.2.  The searches on Google and Google 
Scholar were broad and generally resulted in many thousands of hits.  As results 
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in these databases are presented by relevance (with those most relevant coming 
first) I screened at least the first 10 pages of hits returned.  After that I stopped 
screening hits when it became clear they were no longer of any relevance.   
Table 3.2 Search Strategies for identification of evidence of impact  
Details of databases, search dates & search terms Websites Searched 
Chapter 4 
PubMed (searched April 22
nd
 2009) 
Search for practice guidelines 
(Albumin* OR colloid* OR fluid therapy OR fluid 
resuscitation OR hypertonic OR volume 
supplementation) AND trauma OR injury OR 
intensive care  
Limits: Humans, Last 10 years, Practice Guidelines 
Searches for other papers related to impact on the 
use of fluids 
Google Scholar and NHS NLH 
(albumins/therapeutic use OR colloids/therapeutic 
use) AND (demand* OR prescribe* OR prescription 
OR trend* OR change* OR decrease* OR usage OR 
fall OR decline) 
Limits: Humans, date Jan 1998 to the present 
Bunn AND Fluid resuscitation or Fluid therapy OR 
hypertonic OR isotonic OR albumin OR colloid* OR 
crystalloid OR burn OR injury 
 American Association of Neurological 
Surgeons 
 Association of Surgeons of Great Britain 
and Ireland 
 American Association for the Surgery of 
Trauma 
 Brain Trauma Foundation (USA) 
 Canadian Agency for Drugs and 
Technologies in Health Care (CADTH) 
 Royal college of Surgeons of England 
 Royal College of Surgeons of Edinburgh 
 Royal Australian College of Surgeons 
 Scottish Intercollegiate Guidelines 
Network (SIGN)Society of Critical Care 
Medicine 
Chapter 5 
Pubmed (searched 12
th
 June 2009 
Traffic calming OR Road Safety OR RTC OR RTA OR 
pedestrian OR road OR traffic 
Limits: Humans, Last 10 years, Practice Guidelines 
Google Scholar 
(Traffic OR Road safety Or road) AND policy AND UK 
OR united Kingdom OR England 
Traffic calming AND bunn 
Evidence-based road safety 
 AAA foundation for road safety research 
(USA) 
 ARRB Australian Road Research Board 
 Australian Transport Safety Bureau 
 Department for transport 
 Danish council for road safety research 
 Road Peace (UK) 
 Royal Society for the Prevention of 
Accidents (ROSPA) 
 SWOV (institute for road safety research) 
Chapter 6 
Google and Google Scholar (29
th
 March 2010) 
National Library of Guidelines (29
th
 March 2010) 
 American Geriatric Society 
 British Geriatrics Society 
 National Osteoporosis Society 
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Falls AND older people AND guidance 
Fall prevention AND older people 
Falls or Fall 
Chapter 7 
Google Scholar and Google  
Guidelines AND public health 
Guidelines AND sexual health 
Guidelines AND teenage pregnancy 
NICE guidelines STI 
NICE sexually transmitted infections 
NICE one to one interventions 
 PubMed not searched because review 
published on NICE website not in journal 
 Also searched ERNIE database and 
Shared Learning Database on NICE 
website for evidence on implementation 
Chapter 8 
Google and Google Scholar 
Guidelines AND telephone triage AND Bunn 
Guidelines AND telephone consultation AND Bunn 
National Library of Guidelines 
Guidance AND telephone triage AND Bunn 
Guidance AND telephone consultation AND Bunn 
Triage Telephone 
 
 
Interviews with key informants 
Many evaluations of impact are conducted by an independent party rather than 
the original investigator/s themselves.  Such appraisals, therefore, need to access 
the ‘insider account’ which often involves questionnaires or interviews with the 
principal investigators on a study (Hanney, 2007).  In this instance, however, I 
was assessing the impact of my own work and, therefore, already had the 
‘insider account’.  Whilst such an undertaking may be subject to problems with 
objectivity and bias, internal evaluators have the advantage of being in a better 
position to keep a record of impacts (Wooding, 2007).  For this study I have 
supplemented my own recollections by undertaking informal telephone or email 
interviews with co-authors.   
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Having examined some of the available methods for impact evaluation I now 
want to consider ways in which such evaluations can be organised.  Therefore, in 
the next section I look at some of the frameworks that have been developed to 
structure the assessment of research impact, and describe how I have drawn 
upon them to guide my own analyses. 
Evaluation frameworks 
In addition to the diversity in available methods for evaluating research impact 
there are also numerous frameworks available for structuring assessments of 
impact.  In a systematic review of impact assessment Boaz found fourteen 
frameworks for structuring and interpreting data that were either discussed or 
used in the literature although, of those, only a small number had actually been 
used in impact evaluations (Boaz, 2008a).  Although there are obviously areas of 
commonality between the domains included in the different frameworks there is 
no standard approach.  Some, such as the payback model and the ESRC 
framework, were devised specifically for assessing the impact of either health 
research or social research and others were developed either during a study or 
after the data had been collected (Hanney, 2007).  These frameworks have, in 
general, been designed to determine research impact in a range of domains, of 
which policy may just be one.    
It has been suggested that it may not always be necessary to use a framework for 
impact evaluation as long as there are clear objectives and explicit techniques or 
methods to gather data (Hanney, 2007).  However, frameworks can help to 
organize inquiry by identifying elements and relationships among elements that 
need to be considered for the generation of theory (Ostrom, 2007), although of 
course they do not of themselves predict behaviour or outcomes (Schlager, 
2007).  I felt, therefore, that it would be useful to refer to existing frameworks to 
structure my analysis.  What is more using a common structured approach has 
the advantage that it allows more easily for comparison across the reviews 
(Wooding et al., 2004).   
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To decide on which framework/s would be most appropriate I began by looking 
at the information about frameworks provided by two recent reviews on impact 
assessment (Boaz, 2008a, Hanney, 2007).  These reviews were used to identify 
frameworks and the key references associated with them.  This was followed up 
by more detailed reading on those models that appeared to be most 
appropriate.  I rejected frameworks for a number of reasons.  For example, the 
ROAMEF framework (PREST, 2006) reflects key stages of the policy process 
however, it was concerned with the impact of whole programmes, was designed 
to be put in place before the beginning of a programme and does not specify 
methods for conducting the evaluation.  The RAPID outcome assessment (ROA) is 
a visual mapping tool that evaluates the impact of a programme on policy and 
the policy environment.  Although it has been suggested that it provides useful 
insights into the process of research impact (Boaz, 2008a) data collection 
methods associated with this model are too complex and time consuming and 
not fit for my purpose.  In the end I looked in detail at three frameworks: 
 The payback framework and model 
 The Lavis knowledge transfer approach 
 The research impact framework 
These are described in more detail below.  
The payback framework 
I chose the payback framework (Buxton and Hanney, 1996, Buxton and Hanney, 
1997, Hanney et al., 2004a, Hanney et al., 2000) for a number of reasons.  It is 
the most commonly used framework in the evaluation of health research impact 
(Hanney, 2007), is well described in the literature and there are a number of 
publications detailing suggested methods for conducting evaluations.  In 
addition, although it was not developed specifically for systematic reviews, it has 
been used to assess their impact (Soper and Hanney, 2007).  This evaluation 
framework consists of a multidimensional categorization of the benefits, or 
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payback,  from health research (Hanney et al., 2000).  The five main categories of 
evaluation criteria for the framework are:  
(a) Knowledge production,  
(b) Research targeting, capacity building and absorption,  
(c) Informing policy and product development,  
(d) Health benefits  
(e) Broader economic benefits 
It has been suggested that, whilst the dimensions of the framework are useful, it 
may not be necessary for all evaluations to include all the dimensions (Boaz, 
2008a).  Although I am mostly interested in the first three categories, and in 
particular the category on informing policy development, all five categories are 
described below briefly.    
(a) Knowledge production 
The first category of the model is knowledge production.  Although this covers 
any type of publication peer-reviewed articles are considered to be most 
important.  Factors such as the impact factor of the journal and the existence of 
an accompanying editorial are also seen as being of particular significance 
(Hanney et al., 2004b).  Although as Hanney and colleagues point out there may 
be some journals that do not have an impact factor but that are still important 
vehicles for dissemination of the knowledge produced.  For example, although 
the Cochrane Library had long been acknowledged as an important source of 
high quality information it only received an impact factor in 2007.  What is more, 
the impact factor it now has may be an underestimation of the true impact of 
Cochrane Reviews worldwide and does not reflect their widespread use in 
guideline development, policy setting, and health care decision making by 
practitioners and consumers (The Cochrane Library, 2008).   
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(b) Research targeting, capacity building and absorption 
A potential benefit of research is the better targeting of future research.  Whilst 
this is, of course, relevant to all types of research it is particularly pertinent to 
systematic reviews which are often instrumental in the identification of areas for 
future research. This includes not only highlighting topics for research but also 
suggestions for the types of study design needed and the outcomes that should 
be measured.  This category of the model also includes any impact upon research 
training and capacity building.  Although my own analysis does not include an 
assessment of impact upon training and capacity building it is worth considering 
briefly here the potential role for systematic reviews in these areas.  Systematic 
reviews, with their emphasis on multi-disciplinary teams, including clinicians and 
researchers, are in a key position to develop research capacity.  The clear 
structure of a review and the guidance produced by organisations such as the 
Cochrane Collaboration and the Centre for Reviews and Dissemination also make 
systematic reviews feasible for those who do not have a great deal of previous 
research experience.  The process of being involved in a review facilitates the 
development of skills in critical appraisal, analysis and report writing.  Indeed, as 
a reviewer I have been involved in developing systematic review skills in health 
care professionals seconded to work on clinical questions relevant to their own 
area of practice (Cunningham et al., 2006, Petrie et al., 2007b, Pocock et al., 
2010, Yanagawa et al., 2000). 
(c) Informing policy development 
Most pertinent to my work is the section of the framework which addresses the 
impact of research on policy development.  As discussed earlier in the chapter I 
have adopted the definition of policy that is used by Hanney and colleagues in 
their framework; this is a broad interpretation of policy and includes the effect 
on policy locally and nationally and incorporates guidelines and the development 
of policies for education.   
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(d) Health benefits 
Hanney and colleagues say that it is benefits in terms of health gains that might 
be viewed as the ‘real’ payback from health research.  In this framework health 
benefits also include cost savings and improvements in the process of health care 
delivery.  The measurement of health benefits is, however, rarely investigated in 
impact evaluations because of the difficult of attributing particular health gains 
to specific pieces of research.  As such it is largely beyond the remit of this work.  
(e) Broader economic benefits 
The last category in the framework is that of the economic benefits that might 
accrue from research: for example potential benefits to the economy through 
the commercial exploitation of research, or the benefits gained through reducing 
the economic burden of disease and creating a healthy workforce.  The 
measurement of economic benefits is also beyond the remit of this submission. 
Payback model 
Hanney and colleagues have also developed a model for assessing payback which 
accompanies the evaluative framework described above (Hanney et al., 2000).  
The model includes seven stages which cover the whole research process 
including needs assessment, project specification, commissioning and outputs.  
Outputs are described as primary or secondary with primary outputs being the 
direct outputs of the research project, such as academic publications or 
presentations, and secondary outputs the wider impacts on policy and practice 
(for example citation in policy guidelines).  In this study it is the secondary 
outputs I am concerned with as the evaluation concerns the impact of research 
papers (primary outputs) rather than projects as a whole.  Stage 5 of the model is 
Applications which refers to actual changes in behaviour by practitioners and the 
public and the final stage involves impacts or final outcomes which include 
service and economic payback such as cost savings.  Although the model is 
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described in stages they accept that the process may not be strictly linear 
(Hanney et al., 2000). 
Knowledge transfer approach 
The second framework that I looked at in detail is that by Lavis and colleagues 
(Lavis et al., 2003a).  This is an assessment tool based on ideas of how best to 
transfer and facilitate the uptake of research knowledge.  In contrast to the 
Payback Model this tool focuses particularly on the impact of research on the 
decision making process.  The rationale for this approach is that it is too difficult 
to trace the complex pathways through which research might be translated into 
improved implementation or performance and from there into health gains.  
They argue, therefore, that it is the use of research knowledge to inform 
decision-making, rather than a change in health status, that constitutes the most 
appropriate generic measure of the impact of research (Lavis et al., 2003a).  The 
tool includes the following four steps: 
1. Identify the target audience for the research knowledge that has 
been funded or produced 
a. general public 
b. patients 
c. clinicians 
d. managers 
e. research and development officers 
f. public policy makers 
2. Select the appropriate category of measures e.g.  
a. Producer-push category if researchers led efforts 
b. User-pull category if decision makers led efforts 
c. Exchange categories if researchers and decision-makers 
have jointly led efforts 
3. Select evaluation measures given the resources available 
a. Process measures if limited resources  
b. Intermediate if sufficient resources to conduct a survey 
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c. Outcome measures if resources for case studies 
4. Identify data sources and/or collect data, analyse the data, 
identify areas for future improvement and feed-back information to 
those involved 
The advantages of this tool are that it focuses particularly on the decision making 
process and that it can be adapted to suit the resources available to the 
evaluator.  For example, the choice of evaluation measure is dictated by available 
resources.  They categorise outcome measures according to whether they 
capture a process associated with the pursuit of research impact (such as the 
number of papers published), an intermediate outcome (e.g. a change in 
awareness about a particular body of research knowledge) or an outcome (e.g. a 
decision to select one policy over another based on research evidence).  
The Research Impact Framework 
The third framework I considered was the Research Impact Framework.  
Developed by Kuruvilla and colleagues (Kuruvilla et al., 2006, Kuruvilla et al., 
2007) this is a conceptual framework that uses a standardised way of describing 
a wide range of potential areas of health research impact and is designed to be 
used by researchers without any specific training in research impact assessment.  
It was created by identifying potential areas of health research impact and draws 
on a number of other models including the two I have already described: the 
Payback model of health research benefits (Buxton and Hanney, 1996) and 
Lavis’s ‘knowledge transfer’ approach to assessing the impact of research (Lavis 
et al., 2003a).  It includes four broad areas of impact: research-related impacts; 
policy impacts; service impacts; and societal impacts and looks at both positive 
and negative impacts.  The authors of the framework acknowledge that there are 
many competing views on the role of science and its relationship with society, 
that there are various theories and models of the causal pathway of research 
impacts and that individual researchers may ‘ascribe to different worldviews’.  
However, they say that the framework ‘is not aligned with any particular 
philosophy, is not in itself evaluative and does not prioritise impacts or propose 
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causal pathways’ (Kuruvilla et al., 2006).  Whilst much of the framework covers 
areas that are outside the remit of my analysis I think it is worth considering in 
more detail the section of the framework concerning policy impacts as this is the 
focus of my own work.  The framework includes several potential areas of policy 
impact which are further broken down into descriptive categories.  These are:  
 Levels of policy-making 
o e.g. international, national or subnational 
o Different groups, e.g. national and local politicians, health service 
administrators, managers/directors, representatives of local, 
national and international professional groups 
 Type of policy 
 Nature of policy impact.  Further divided into four descriptive categories 
based on the work of Weiss (Weiss, 1998). 
o Instrumental use where research findings drive policy-making 
o Mobilisation of support where research provides support for 
policy proposals 
o Conceptual use where research influences the concepts and 
language of policy deliberations 
o Redefining/wider influence where research leads to rethinking 
and changing established practices and beliefs.   
 Policy networks 
 Political capital 
This consideration of research impact on policy, with the distinction between 
direct and indirect use of research, attempts to deal with the complexity of the 
relationship between research and policy.  However, in reality such distinctions 
may be difficult to make and judgments about which category to choose may be 
open to subjectivity.   
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Selected framework 
None of the models described above were entirely suitable for my evaluation.  
Although the Payback model has much to recommend it, it has been criticised for 
not fully explaining the complex interface between research and policy (Boaz, 
2008a).  Therefore, I chose to adopt several of the domains from the Payback 
model as a basic framework but to incorporate aspects of the Research Impact 
Framework.  This is shown in Box 1 below.   
Box 1 Framework for research impact evaluation  
1. Knowledge production 
 Publications (journal, impact factor) 
 Impact within research community (e.g. citation analysis) 
 Other methods of dissemination (e.g. oral presentations, press) 
2. Research targeting 
 Influence on other research (e.g. follow-on research) 
3. Informing policy development 
 Levels of policy-making 
I. e.g. international, national or subnational 
II. Different groups, e.g. national and local politicians, health service 
administrators, managers/directors, representatives of local, 
national and international professional groups 
 Type of policy 
 Nature of policy impact.  Further divided into four descriptive categories 
based on the work of Weiss (Weiss, 1998). 
I. Instrumental use where research findings drive policy making 
II. Mobilisation of support where research provides support for policy 
proposals 
III. Conceptual use where research influences the concepts and 
language of policy deliberations 
IV. Redefining/wider influence where research leads to rethinking and 
changing established practices and beliefs.   
 Policy networks 
4. Impact on practice 
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Although the Lavis tool is not incorporated in the framework, it is designed to be 
used prospectively; I have used it when considering the driver behind each 
review, for example who were the intended target audience for the review. 
Other methodological considerations  
There are several other aspects of a research impact evaluation that could affect 
the validity of the results.  These include the timing and direction of an 
evaluation and the possibility of bias or conflicts of interest.  These issues are 
addressed below.  
Timing 
The timing of an impact evaluation is also important.  There needs to be 
sufficient time since the research was completed for change to have occurred 
but not be so long that the recall of individuals is affected.  In this instance 
publication dates ranged from 1998 until 2008 and it is likely to be harder to 
discern evidence of impact for the more recently published reviews. 
Direction of travel 
Most evaluations of impact employ approaches that involve tracking forward 
from a piece of research or backward from a policy change or document (Boaz, 
2008a).  In this instance my evaluation involves using my reviews as a starting 
point and tracking forward from them.  The major advantage of a study that 
starts with specific research and tracks forward is that, because of its more 
tightly defined focus, it may be more likely to identify impact (Hanney et al., 
2003).  However, a weakness of the approach is that it may be associated with a 
tendency to exaggerate the impact of the specific research under consideration 
(Hanney, 2007).  Such studies may find it hard to distinguish between the specific 
research under investigation and other contributing factors. 
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Bias 
It is likely that those undertaking investigations of research impact are doing so 
on behalf of those with a vested interest in proving the value of research, for 
example researchers, research funders or organisations involved in research.  
Indeed, most evaluations are sponsored, or funded, by the body that originally 
funded the programme of research (Hanney, 2007).  As such many evaluations of 
research impact may be susceptible to bias or conflicts of interest with the risk of 
bias greater when a researcher is directly investigating their own research.  Post-
hoc analyses, such as mine, do not have the advantage of distinguishing the 
situation at baseline and determining before the project starts what measures of 
impact will be used. 
Conclusion 
There are a number of issues to consider when designing an investigation of 
research impact, including the choice of methods and framework, the direction 
and timing of the evaluation and the potential for bias.  In addition there are 
several important caveats to consider when attempting to establish the impact 
of research on policy.  For example, it is generally accepted that knowledge 
production activities are more easily discernable than impact on policy or health 
gain (Hanney, 2007).  Then if we do identify evidence of impact we need to 
consider whether this is real or a result of bias and whether it is attributable to 
the research we are investigating or if it is possible that such effects may have 
occurred anyway (Molas-Gallart et al., 2000).  Analyses of impact are further 
complicated by the convoluted nature of the relationship between research and 
policy.  Whilst it may be challenging to identify the direct or instrumental impact 
of policy research this challenge is even greater if we are trying to show the way 
research may have been influential indirectly. For example, it may be particularly 
difficult to attribute indirect outputs, such as the conceptual use or diffusion of 
research ideas, to a particular piece of research or research programme.  
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Chapter 4: Strategies for fluid resuscitation: systematic 
reviews of RCTs 
Introduction 
In this chapter I present five systematic reviews (seven papers) that all addressed 
topics related to the fluid resuscitation of injured patients (Bunn et al., 2004b, 
Bunn et al., 2008b, CIG Albumin Reviewers, 1998, Kwan et al., 2003, Roberts et 
al., 2004).  Full versions of the papers can be found in Appendix 2.  The reviews 
cover clinical questions relating to the type of fluid to use and the method of 
administration.  All of the reviews involved the employment of the statistical 
technique meta-analysis and they are used as illustrative examples to critically 
examine the methodological issues associated with this type of review.  In 
addition, the reviews form the basis for an impact evaluation and critique of 
some of the key factors that shape health care policy.  For example, by using 
these reviews as case studies, I examine the role that the pharmaceutical 
industry and the media play in decisions about health care policy. 
On two of the included reviews I am first author (Bunn et al., 2004b, Bunn et al., 
2008b) and on the other three (Alderson et al., 2004, Alderson et al., 2000, Kwan 
et al., 2003) I was a co-author.  The rationale for including reviews on which I was 
a co-author, rather than just those on which I was first author, is that all of the 
reviews were concerned with some aspect of fluid resuscitation for injured 
patients and that together they form a significant body of work on the subject.  
Moreover, the methodological requirements for systematic reviews mean that 
they are often very collaborative in nature.  All of the reviews were published in 
the Cochrane Library but two (Human albumin solution for fluid resuscitation 
and Colloids versus crystalloids for fluid resuscitation) were also published in the 
BMJ (CIG Albumin Reviewers, 1998, Schierhout and Roberts, 1998).  All the 
reviews have been updated, most on several occasions.  My specific contribution 
to each of the reviews is detailed in Chapter 3.   
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Drivers behind review question/s 
The driver/s behind research has been identified as a factor that may affect the 
impact of research.  Therefore, I begin by considering the drivers behind the 
systematic reviews included in this chapter.  The reviews were part of a group of 
systematic reviews on the fluid resuscitation of critically ill patients that were 
conducted by members of the Cochrane Injuries Group.  The Cochrane 
Collaboration consists of a number of collaborative review groups, such as the 
Injuries Group, that are concerned with preparing, maintaining and promoting 
high quality systematic reviews in a particular area of health care.  Protocols for 
systematic reviews and completed reviews are peer reviewed and published in 
the Cochrane Library where they are open to public and professional scrutiny.  
The Cochrane Library is published on CD-ROM and the internet and electronic 
publication means that reviews can be updated or amended in response to post-
publication criticism or new information.  The intended audience for the reviews 
includes providers, practitioners and patients. 
The scope of the Injuries Group covers the prevention, treatment and 
rehabilitation of traumatic injury; including the resuscitation of seriously injured 
and burned patients.  The impetus for the choice of Cochrane review topics 
tends to be largely researcher or clinician driven.  In this instance the choice of 
review topic was governed by several factors.  In the first instance review topics 
were chosen after a prioritisation process conducted by the editorial team of the 
Injuries Group when the group was first established.  However, the process then 
became more organic with one review question prompting another line of 
enquiry.  For example, the albumin review came about because the first author 
on the colloids versus crystalloids review (Dr Gillian Schierhout) felt that the data 
suggested albumin might be harmful and should be the subject of further 
investigation.  Likewise the finding that albumin was potentially harmful led to 
the review comparing the safety and efficacy of albumin with other synthetic 
colloids (Bunn et al., 2000a). 
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Systematic review methods 
In the following section I enumerate the methods employed for the included 
reviews and critically examine the key methodological factors in systematic 
reviews and meta-analysis of randomised controlled trials (RCTs).  These include 
an examination of issues around the following systematic review processes: 
 Question development 
 Identification of studies 
 Data extraction 
 Assessment of risk of bias 
 Data synthesis including meta-analysis 
 
Question development 
The starting point of a systematic review is a protocol detailing inclusion criteria 
and methods.  The use of a protocol provides researchers with the opportunity 
to define their question clearly and minimises the risk of ad hoc decisions that 
may introduce bias (Higgins, 2008).  The importance of protocols to the Cochrane 
review process is underlined by the fact that all protocols are peer reviewed and 
published on the Cochrane Library.  Central to the protocol is the development 
of a well-focused question which allows clear decisions to be made about what 
research to include in a systematic review and how to summarise it (Higgins, 
2008).  For a typical Cochrane review evaluating the effectiveness of an 
intervention the question is defined in terms of participants, intervention/s (and 
comparison/s), outcomes and types of study.  The acronym PICO (participants, 
interventions, comparison and outcomes) is frequently used as a reminder of 
these criteria.  One of the challenges for a reviewer is to construct a question 
that while focused is still meaningful.  A question that is too broad becomes 
unmanageable but a question that is to narrow may have limited usefulness.  In 
addition, any inclusion or exclusion criteria should have a rational justification 
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and be based on biological, sociological or other clearly warranted criteria (Bunn 
et al., 2001).   
Part of the process of developing the review question includes specifying the 
outcomes to be included in the review.  The outcomes chosen should include 
those that are likely to be meaningful to decision makers such as clinicians, 
patients and policy makers.  However, frustratingly, those outcomes considered 
important by the reviewer may not necessarily be reported in individual studies.  
For example, in the fluid therapy reviews included in this chapter many authors 
reported surrogate outcomes such as intermediate physiological outcomes 
rather than those we considered relevant such as mortality, morbidity and 
adverse effects.  Surrogate outcomes are flawed for a number of reasons.  They 
are subject to intra and inter-observer variation, they may not be stable over 
time and importantly they have no face value to patients, their relatives or many 
decision makers.  In addition, to be meaningful there would need to exist a 
strong predictive relationship between the variable and the primary outcome; a 
relationship that often is not proven.  
Another key protocol decision is which study designs will be included in the 
review.  As outlined in Chapter 1 RCTs are generally considered to be the optimal 
study design for unbiased estimates of intervention or treatment effects.  
Traditionally most Cochrane systematic reviews have focused on randomised 
controlled trials and all of the reviews included in this chapter are restricted to 
RCTs only.  The inclusion of other types of studies in systematic reviews will be 
considered in subsequent chapters. 
Identification of studies 
As already outlined in Chapter 1 there are a number of methodological 
characteristics of systematic reviews that distinguish them from non-systematic 
traditional literature reviews.  One of these is the emphasis on searching for all 
available literature regardless of publication status or country of origin.  The 
rationale for the development of such highly sensitive search strategies is to 
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prevent or reduce the possibility of introducing bias into the review by missing 
relevant studies.  One potential bias is publication bias where research with 
statistically significant findings is more likely to be published than is work with 
null or non-significant findings.  For example, National Institutes of Health-
Funded trials in the USA with significant results were more than twice as likely to 
be published than those showing non-significant results and in the UK among 
studies approved at the central Oxford research committee those with 
statistically significant results were more than twice as likely to be published as 
studies with null results (Easterbrook et al., 1991).  More recent research has 
found that publication bias is still a threat to the validity of systematic reviews.  
In a systematic review investigating the impact of grey literature in meta-
analyses of RCTs of health care interventions the authors found that published 
trials tended to be larger and show an overall greater treatment effect than grey 
trials such as abstracts and unpublished data (Hopewell et al., 2007b).  In 
addition, trials with positive results tended to be published sooner than other 
trials (Hopewell et al., 2007a); which is sometimes known as ‘time-lag bias’.  
Interestingly some investigators have found no association between the quality 
of study design and publication (Dickersin and Min, 1993, Easterbrook et al., 
1991, Elvik, 1998) but rather the most common reasons why trials went 
unreported was that the investigators thought the results ‘uninteresting’ or else 
they ‘did not have enough time’.  Indeed, the publication strategy for the reviews 
included in this chapter reflects such biases.  Those considered more ‘interesting’ 
were more likely to be submitted for dual publication in the Cochrane Library 
and another journal rather than just the Cochrane Library. 
Therefore, to minimise the risk of introducing bias through failing to identify 
relevant studies systematic review search strategies are generally designed to be 
highly sensitive.  In this context sensitivity refers to the ability of a search 
strategy to identify all relevant articles.  A search strategy that missed relevant 
studies would be considered to have low sensitivity.  However, the need for 
sensitivity must be balanced against the specificity or precision of a search.  
Specificity is a measure of the ability of the search strategy to exclude irrelevant 
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articles.  A search strategy that retrieves many studies that are not relevant to 
the review would be considered to have low precision.  Systematic review teams 
need to design search strategies that balance the requirement for maximising 
sensitivity against the practicalities of ensuring an adequate degree of specificity. 
The most important sources of studies for systematic reviews, in particular for 
reviews of RCTs, are electronic databases such as PubMed (MEDLINE), EMBASE 
and The Cochrane Central Register of Controlled Trials (CENTRAL).  The latter, 
which has been developed by the Cochrane Collaboration, is one of the largest 
repositories of controlled trials (Dickersin et al., 2002).  In contrast to reviews 
that include non-randomised studies (as some of those in later chapters) 
searching for RCTs is relatively straight forward, there are a number of 
methodological filters that can be used to restrict searches to RCTs and 
controlled studies, thereby ensuring greater specificity without sacrificing 
sensitivity.  As well as searches of the standard databases search strategies may 
also include the use of a range of specialist databases, handsearching of journals, 
searches of the internet for grey literature, contacting experts for information on 
possible studies and contacting drug companies or manufacturers to identify 
unpublished studies.  In this context grey literature refers to research that is not 
formally published and that cannot be found easily through conventional 
channels such as electronic databases.   
The augmentation of database searches with strategies such as handsearching 
and personal contacts can be time consuming and it is questionable whether the 
yields are always worth the effort involved.  For example, for the albumin and 
colloids reviews we contacted the drug companies that manufactured the 
products to request any relevant information about unpublished studies.  A 
number of the companies that manufactured colloids sent us information.  This 
information, which in some cases was extensive, was handsearched but yielded 
no relevant studies.  In an HTA report investigating the importance of 
comprehensive literature searches for systematic reviews of RCTs Egger and 
colleagues found that, although the worth of extensive searches to locate 
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difficult to find studies varied between specialities, in general trials which were 
harder to locate were often of poorer quality.  They argue that, as such poor 
quality trials may increase the risk of bias, in situations where resources are 
limited detailed quality assessment should take precedence over extensive 
literature searches and translations of articles (Egger et al., 2003).   
Data extraction 
One of the distinguishing features of a systematic review is a comprehensive and 
scientific approach to extracting the necessary data from any primary studies 
that meet the inclusion criteria.  This requires that a data collection tool, specific 
to each review, is developed and piloted.  Such a tool visually represents the 
review question and planned appraisal of included studies, records decisions 
taken during the review process; and records outcomes data to be analysed 
(Higgins, 2008).  The content and length of the form is largely dependent on the 
complexity of the review question with some reviews of complex interventions 
involving more detailed and lengthy data extraction procedures than the reviews 
in this chapter.  For example, in a review of interventions for the prevention of 
sexually transmitted infections and teenage pregnancy (Bunn et al., 2006a) the 
funders, NICE, asked that we considered effectiveness in the context of how, by 
whom and where the intervention was delivered.  We were also required to look 
at whether effectiveness was affected by socio-demographic characteristics such 
as sex, ethnicity and class.  These factors, around the process and delivery of an 
intervention, are of less concern in reviews such as those in this chapter but are 
considered further in later chapters. 
In the context of a systematic review, ‘data’ not only refer to results but also 
include any information about (or deriving from) a study, such as the methods, 
types of participants, the interventions, settings and context (Higgins, 2008).  
Owing to the high prevalence of data extraction errors (Gotzsche et al., 2007, 
Jones et al., 2005a), and the fact that independent double data extraction may 
result in fewer such errors (Buscemi et al., 2006) it is generally recommended 
that data extraction is performed by two reviewers independently (Higgins, 
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2008).  For all reviews in this submission screening of records and data extraction 
was done by two reviewers independently. 
Assessing the risk of bias 
There is evidence that the quality of studies included in systematic reviews can 
influence effect estimates and that more rigorous studies are more likely to yield 
results that are ‘closer to the truth’ (Higgins, 2008).  A bias is a systematic error, 
or deviation from the ‘truth’, in results or inferences and may lead to 
underestimation or overestimation of the true treatment effect (Higgins, 2008).  
Hence, it is vital to assess study quality.  There are a number of elements that are 
associated with study quality and two of the most key are randomisation and 
allocation concealment.   
Randomisation should involve both the generation of an unpredictable 
assignment sequence and the concealment of that sequence until allocation to 
study group occurs (Schulz et al., 1995).  Of these, the concealment of allocation 
appears to be the most important.  Analysing 250 trials from 33 meta-analyses, 
Schulz et al (Schulz et al., 1995) found that compared with trials with adequate 
allocation concealment, odds ratios were exaggerated by 41% for inadequately 
concealed trials and by 30% when the adequacy of concealment was unclear.  In 
a similar study, inadequate allocation concealment exaggerated the effect 
estimate by 37% (Moher et al., 1998).  More recent studies also substantiate 
these findings.  A pooled analysis of seven methodological studies found that 
effect estimates from trials with inadequate concealment of allocation or unclear 
reporting of the technique used for concealment of allocation were on average 
18% more ‘beneficial’ than effect estimates from trials with adequate 
concealment of allocation (95% confidence interval 5 to 29%) (Pildal et al., 2007).  
However, this exaggeration of effect estimates was found to be more of a threat 
when a subjective outcome (for example quality of life) was analysed with little 
evidence of bias in trials with objective outcomes (such as mortality) (Wood et 
al., 2008).   
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Allocation concealment is not the only factor associated with the risk of bias.  
Among adequately concealed trials and trials that did not clearly report about 
concealment, inadequate methods of sequence generation exaggerated effects 
by 25% and failure to double-blind by 17% (Schulz et al., 1995).  Other potential 
sources of bias are incomplete outcome data, the selective reporting of 
outcomes (for example investigators only reporting data for outcomes that were 
statistically significant) and inadequate blinding of outcomes assessors. 
There is debate about how to take account of quality assessment in a systematic 
review and, as more methodological research is conducted, recommendations 
for best practice have altered over time.  Many scales and checklists designed to 
assess the validity and quality of RCTs have been identified (Moher et al., 1995).  
However, serious doubts remain about the usefulness of many of these scales as 
they may contain items not directly related to internal validity.  At the time these 
reviews were originally conducted the Injuries Group policy was to judge quality 
primarily on allocation concealment as this was well known to be associated with 
bias (Schulz et al., 1995).  More recently the Cochrane Collaboration has 
developed a more detailed method for assessing the risk of bias that involves the 
creation of a risk of bias table.  This is a domain-based evaluation that looks at 
specific methodological factors known to be associated with bias, such as 
randomisation, allocation concealment and blinding of outcome assessment, and 
assesses studies on the level of bias likely to be present for each domain and for 
each study overall (Higgins, 2008).   
Data synthesis 
In a systematic review of RCTs data is often combined using the statistical 
technique of meta-analysis.  To decide whether it is appropriate to combine data 
quantitatively in a meta-analysis researchers must judge whether there is 
sufficient homogeneity in terms of participants, interventions, study design and 
outcomes in the studies included in the review.  This judgement may take into 
account, for example, known effect modifiers, biologic plausibility, 
methodological quality, relevance of outcomes and clinical experience or other 
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factors.  Ideally these are all issues that will have been considered when 
formulating the research question and choosing the inclusion criteria.  As well as 
the reviewer using their own judgement, prior to data synthesis, as to whether 
the use of meta-analysis is apposite heterogeneity can also be assessed once a 
meta-analysis has been conducted.  
One way we can identify heterogeneity in a meta-analysis is through a visual 
inspection of the forest plot1.  For example if studies are homogonous, that is 
they are estimating the same thing, we would expect that there would be an 
overlap of confidence intervals.  A poor overlap of confidence intervals, or the 
presence of obvious outliers2, may suggest statistical heterogeneity.  In addition, 
reviewers should use statistical tests to assess for heterogeneity.  When these 
reviews were first conducted the test used in Cochrane reviews was the Chi-
squared test which assesses whether the observed differences in studies are 
compatible with the play of chance alone.  However, it has since been argued 
that as clinical and methodological diversity always occur in a meta-analysis 
statistical heterogeneity is inevitable (Higgins et al., 2003).  Therefore, the focus 
has moved away from testing whether heterogeneity is present to measuring its 
impact or importance (Higgins and Thompson, 2002, Higgins et al., 2003).  The 
statistic for assessing this is called the I-square statistic and is now included along 
with the Chi-square test on all forest plots in Cochrane reviews.  
Of course even if tests show no statistical indication of heterogeneity this cannot 
be interpreted as evidence of homogeneity.  This is not only because a non-
significant test can never be interpreted as direct evidence in favour of the null 
hypothesis of homogeneity (Altman, 1991), but in particular because tests of 
homogeneity have low power, particularly where there are few trials, and may 
fail to detect as statistically significant even a moderate degree of genuine 
heterogeneity (Thompson and Pocock, 1991, Whitehead and Whitehead, 1991).  
Conversely, in meta-analyses with large number of trials the tests may be 
                                                          
1
 A graphical display designed to illustrate the relative strength of treatment effects.  Shows the 
results of each individual study and the overall pooled result. 
2
 An outlier is an observation that lies an abnormal distance from other values 
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oversensitive and detect heterogeneity that, while present, is not clinically 
significant.  In all but one of the reviews included in this chapter (Kwan et al., 
2003) there was no evidence of statistical heterogeneity, therefore, results for 
most outcomes were pooled in meta-analyses.  
When judged to be appropriate, performing a meta-analysis can make an 
important contribution to a systematic review.  Combining the results from 
similar randomised trials will increase the precision of the effect estimates and 
may allow the reliable estimation of even modest effects (Egger, 2001a).  There 
are several methods for pooling study results, all of which take a weighted 
average of the study-specific effect estimates, with the weights being inversely 
proportional to the variance of the effect estimates.  Clearly, in order to combine 
data, information on the effect estimate and its variance must be available and 
poor reporting of study results can therefore be an important obstacle to meta-
analysis (Wagenaar, 1999).  In the reviews in this chapter data for dichotomous 
outcomes, such as mortality, were pooled using the relative risk.  This is one of a 
number of summary statistics available for the presentation of such data and 
was chosen over the odds ratio or risk difference (or absolute risk reduction) 
because it is less open to the possibility of misinterpretation. 
Results of impact analysis 
In this section I document any evidence that demonstrates ways in which the 
reviews included in this chapter may have impacted or influenced health care 
practice and policy.  In addition I critically examine some of the issues related to 
policy impact.  The results of the impact evaluation are presented using the 
framework described in Chapter 3.  This includes the main headings of 
knowledge production, research targeting, informing policy development and 
impact on practice. 
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Knowledge production 
Publications and other methods of dissemination 
All the reviews were published in the Cochrane Database of Systematic Reviews 
(CDSR) on the Cochrane Library.  There is no restriction to the word limit for 
Cochrane Reviews and the full final documents tend to be quite lengthy, 
particularly when, as with the colloids review, there are a large number of 
included studies.  Reviews can be accessed and downloaded via subscription, 
although they are free to all UK residents via the NHS Health Information 
Resources (http://www.library.nhs.uk/Default.aspx), and PDFs of abstracts, 
standard or full versions of reviews are available.  Reviews are accompanied by 
plain language summaries which are designed with consumers and the lay public 
in mind.  Figures for 2007 show that CDSR has an impact factor of 4.654 which 
ranks it 14th out of 100 journals in the ISI category ‘Medicine General and 
Internal’.   
In addition to publication on CDSR the reviews on the use of human albumin and 
colloids versus crystalloids were also published in the BMJ (CIG Albumin 
Reviewers, 1998, Schierhout and Roberts, 1998).  The impact factor for the BMJ 
was 12.827 in 2008 giving it a ranking of 5th in  the category Medicine General 
and Internal (BMJ, 2010).  The albumin review suggested that the use of human 
albumin was associated with an increase in mortality and the nature of the 
findings meant that as well as publication in the BMJ and Cochrane Library the 
results of the review were widely reported in the television and print media both 
in the United Kingdom and elsewhere.  The reviews were also disseminated via 
conference papers, seminar and other forms of academic outputs. 
Impact within research community 
The citation analysis was initially performed between March and May 2009 and 
was updated in April 2010.  Unsurprisingly, given the publicity that surrounded 
the publication of the review, the human albumin review (CIG Albumin 
Reviewers, 1998) was the most cited of any of the reviews in this chapter with 
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481 citations in WoS and 579 in Scopus.  For some reason, possibly because of 
the way it was originally cited, data for the BMJ version was not available in 
Google Scholar.  The other review that received a high number of citations was 
the review comparing crystalloids with colloids for fluid resuscitation, particularly 
the version published in the BMJ (Schierhout and Roberts, 1998).  Of the other 
reviews the colloid solutions review (Bunn et al., 2008b) had 118 citations in 
Google Scholar, 23 in Scopus and 6 in WoS, the hypertonic versus isotonic review 
(Bunn et al., 2004b) had 104 in Google Scholar, 23 in Scopus and none in WoS, 
and the timing of fluid resuscitation review had 114 in Google Scholar, 25 in 
Scopus and none in WoS.  A comparison of the numbers of citations for each 
review from the different databases can be seen in Figure 4.1. 
 
Figure 4.1 Results of citation analysis: Fluid therapy reviews3 
There were a number of anomalies in the data, with considerable variation in 
citation counts for the same review in different databases.  For example, the 
reviews evaluating colloid solutions hypertonic saline and timing and volume of 
fluid administration each had over 100 citations in Google Scholar but few or 
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none in WoS.  In addition for the two papers that were published in two journals 
(albumin and colloids versus crystalloids) the BMJ version of the paper received 
substantially more citations than the version published in the Cochrane Library.  
Possible explanatory factors for this difference may be around the relative 
accessibility and visibility of the two reviews.  Open access to the Cochrane 
Library is not universally available, it is only available electronically, and unlike 
the BMJ does not have an easily digestible weekly output.  Furthermore, the 
format and length of Cochrane reviews may not be as user friendly for the 
reader.  However, it has been suggested that the citation counts for Cochrane 
reviews are artificially low because citing authors have incorrectly referenced 
Cochrane reviews (The Cochrane Library, 2008).  I investigate this further in 
Chapter 8 and my findings confirm that the citation data for Cochrane reviews in 
Scopus and WoS are inaccurate.   
All the reviews in this chapter were cited at least once and even for the reviews 
that were less frequently cited the number of citations is above average.  In a 
study of 493 published articles in emergency medicine the mean citations per 
year was 2.04 with 9.3% never cited (Callaham et al., 2002).  However, it may not 
be appropriate to directly contrast such figures as there is evidence that review 
articles are generally highly cited in comparison with primary research 
(Bornmann et al., 2008, Meho, 2007).  Other factors that may influence the 
probability of citations are impact, quality and prestige of the journal as well as 
journal accessibility, visibility and internationality (Bornmann et al., 2008, 
Callaham et al., 2002).   
Data on the number of times the Cochrane reviews were downloaded were 
available for 2008 and 2009.  The results of this can be seen in Table 4.1.  The 
review that was downloaded the most was the review comparing colloids and 
crystalloids, this was ranked at 35 out of 6840 reviews.  The review comparing 
hypertonic and isotonic crystalloid was downloaded the least but was still ranked 
in the top third of Cochrane review downloads for 2009.   
 
89 
 
Table 4.1 Downloads for Cochrane fluid resuscitation reviews 2008 & 2009 
Review Downloads 
2008 
Ranking 2008 
(from a total 
of 6232) 
Downloads 2009 Ranking 2009 
(from a total 
of 6840) 
 Full text*  Full text Abstract  
Colloid solutions for 
fluid resuscitation 
1516 170 1,387 2,457 327 
Hypertonic versus 
isotonic solutions for 
fluid resuscitation 
650 910 538 983 1620 
Timing and volume 
of fluid resuscitation 
691 823 694 1,153 1146 
Colloids versus 
crystalloids for fluid 
resuscitation 
2973 18 3,291 5,364 35 
Human albumin 
solution for fluid 
resuscitation 
1040 375 1,007 1,653 632 
* data on abstract download not available for 2008 
Research Targeting 
The administration of intravenous fluids to maintain intravascular volume is a 
common health care intervention and yet controversy over whether to choose 
crystalloids or colloids has existed for over five decades (Rizoli, 2003).  
Increasingly there have also been questions about when to administer fluids and 
in what volume (Revell et al., 2002).  The citation analysis described above 
demonstrates that the systematic reviews discussed in this chapter have 
contributed to the knowledge pool in this area and stimulated debate.  It has 
been found that many Cochrane reviews are a rich source of suggestions for 
further health-care research (Clarke et al., 2007) and there is certainly evidence 
that these reviews have been instrumental in influencing follow-on research 
(Cook and Guyatt, 2001).   
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For example, the original version of the albumin review highlighted the 
methodological weaknesses of the available studies and called for further well 
conducted RCTs in this area.  Subsequently researchers in Australia have 
conducted a large multicentre double-blinded randomised controlled trial which 
set out to compare the effects of two fluid resuscitation regimens (human 
albumin or saline) on 28 day all-cause mortality in critically ill patients requiring 
intravascular volume resuscitation (Finfer et al., 2004a).  The SAFE trial (saline 
versus albumin fluid evaluation) was conducted between 2001 and 2003 and 
included nearly 7000 participants.  They found no difference in mortality 
between patients who were resuscitated with albumin and those given saline 
although there was a slight difference, in favour of saline, in mortality in patients 
who had trauma and head trauma.  Although other factors may also have been 
involved it is clear that the review and surrounding controversy were 
instrumental in the initiation of this highly important trial. 
Informing Policy Development 
I begin this section by describing the impact of the human albumin review as this 
was clear and well documented at the time.  Human albumin solution is a blood 
product that has been used for over half a century in the treatment of blood loss 
and burns.  At the time, an estimated 100,000 patients were being treated in the 
UK alone with a cost to the NHS of close to 12 million (Roberts and Bunn, 2002).  
The Cochrane Injuries Group review found an increase in the risk of death in 
patients receiving albumin over those in the comparison group.  Overall, the risk 
of death in patients receiving albumin was 14%, and the risk of death in patients 
not receiving albumin was 8%.  The media were quick to pick up on a story that 
suggested that a widely used treatment may have harmed patients and most of 
the major newspapers in the UK carried headlines similar to this one in The 
Guardian: ‘Blood Product May Have Killed Burn Victims’.  As soon as the review 
had been completed the Cochrane Injuries Group wrote to the Chief Medical 
Office of Health giving early warning of the results.  Five months later, the day 
before the review was published in the BMJ, an Expert Working Party was set up 
to consider the safety of human albumin administration.  The Committee on the 
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Safety of Medicine took a whole year to reach a decision on albumin.  They 
concluded that ‘there is insufficient evidence of harm to warrant a withdrawal of 
albumin… the effect of albumin on mortality would only be answered by 
conducting a large RCT’. 
This case study demonstrates how various actors or stakeholders with competing 
interests are involved in the policy process.  In this instance stakeholders 
included the review authors, who had the support of the Cochrane Injuries 
Group and the Cochrane Collaboration, doctors involved in treating patients with 
human albumin, the pharmaceutical industry and the Government in the form of 
the medicines control agency.  Of those actors the pharmaceutical companies 
were perhaps the most powerful and certainly the best funded.  One of the 
reasons the Committee on the Safety of Medicines took a whole year to reach a 
decision was that the process involved lengthy negotiations with the plasma 
products industry.  In addition, alarmed by the decline in sales of albumin, 
albumin manufacturers put substantial funds into a campaign to increase the use 
of albumin.  In 2000 the Cochrane Injuries Group received a leaked document 
from the European Plasma Fractionation Association describing the ‘Albumin 
Support Programme’.  The albumin manufacturers had set aside $2.2 million 
dollars for the programme whose main aim was to disseminate medical evidence 
that supported the use of albumin.  
This attempt by pharmaceutical companies to boost sales of a product that at 
best was of doubtful value and at worst might be harmful is alarming but not 
that surprising.  The fact that one of the primary concerns of the pharmaceutical 
industry is to increase sales and maximise profit is well recognised.  Marcia 
Angell a former editor of the New England Journal of Medicine claims that the 
pharmaceutical industry has become ‘primarily a marketing machine’ (Angell, 
2005) that ‘co-opts every institution that might stand in its way’.  Spielmans and 
Parry use the phrase ‘marketing-based medicine’ saying that ‘science has largely 
been taken captive in the name of increasing profits for pharmaceutical firms 
(Spielmans and Parry, 2010).  A systematic review investigating whether the 
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funding source of trials introduced bias found that studies funded by a drug 
company were four times more likely to have results favourable to the company 
than those funded by other sources (Lexchin et al., 2003).  There is substantial 
evidence to suggest that this discrepancy is because drug companies suppress or 
manipulate data to make their products look more effective than they actually 
are (Angell, 2005, Smith, 2005, Spielmans and Parry, 2010). 
Ultimately, however, as I go on to show, this example illustrates how a 
systematic review can have an impact despite strong opposition from those with 
a vested interest.  Although whether such an influence would have occurred 
without the media furore that surrounded the review is unclear.  In an editorial 
in the Annals of Internal Medicine Cook and Guyatt write ‘the role of the intense 
reaction of the media to the Cochrane meta-analyses in influencing practice is 
difficult to prove, but easy to deduce’ (Cook and Guyatt, 2001).  A fuller account 
of the story of the human albumin review can be found elsewhere (Roberts and 
Bunn, 2002).  Although the other reviews included in this chapter incited no 
media interest, and had no dramatic or obvious impact in the way that the 
albumin review did, there is some evidence that they have been instrumental in 
changing policy and practice.  For example the review comparing colloids versus 
crystalloids (Schierhout and Roberts, 1998), which concluded that there was no 
evidence to support the continued use of colloids in the fluid resuscitation of 
critically ill patients, has been widely cited, included in many guidelines, and has 
been instrumental in fostering debate, and changing practice, in this area.   
Levels and type of policy making 
The impact of the reviews in this chapter can be seen on policy and practice at 
local, national and international levels.  However, although I was able to discern 
influence on Government policy, it does appear that the majority of the impact 
has been at the level of professional bodies developing guidelines.  Guidelines 
have been defined as ‘directions of principles presenting current or future rules 
of policy.  They may be developed by government agencies at any level, 
institutions, professional societies, governing boards, or by the convening of 
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expert panels (Biology Online, 2009).  Guidelines are intended to ensure that 
health care recommendations are informed by the best available evidence 
(Oxman et al., 2006).  The issues surrounding the development and use of 
guidelines are explored more fully in Chapter 7.  
Inclusion in such a number of guidelines shows that the research has had a 
demonstrable impact on policy.  The reviews discussed in this chapter have been 
widely cited in guidelines, with the albumin review (CIG Albumin Reviewers, 
1998) and the review comparing colloids and crystalloids (Roberts et al., 2004) 
the most frequently cited.  UK organisations drawing upon the reviews for the 
development of guidance include national Governmental bodies such as the HTA, 
NICE and SIGN, and professional bodies such as the Royal College of Surgeons 
Scotland, British Association for Immediate Care, National Blood Service and the 
British Committee for Standards in Haematology.  The reviews have also been 
included in guidelines in the USA, Canada and Europe and by several professional 
bodies developing international guidelines.  A list of guidelines that cite any of 
the fluid reviews presented in this chapter can be seen at the end of this chapter 
in Table 4.2.  It should be noted that in reality this list of guidelines may, in fact, 
be more extensive as my searches were restricted to guidelines published in 
English or with an English abstract. 
Nature of policy impact 
The framework that I have adopted for this evaluation assesses the nature of the 
policy impact based on the categories devised by Weiss (Weiss, 1998).  This 
attempts to distinguish between instrumental or direct impact as against 
conceptual or symbolic use.  In this case there was evidence that all of the 
included reviews had some direct or instrumental impact in that they were used 
to inform practice guidelines.  However, this evaluation only assessed whether 
the reviews were cited by guidelines and did not look in detail at whether those 
guidelines included recommendations that were in agreement with our review 
conclusions.  In addition, most guidelines are based on a number of different 
publications and it is not easy to determine the contribution of individual 
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reviews.  One of the categories in the framework is the extent to which research 
may have been influential in redefining, rethinking or changing established 
practices and beliefs.  Although colloids, including human albumin, are still 
widely used in practice, there is no doubt that their use has declined (Roberts et 
al., 1999).  In addition, the reviews, in particular the review comparing colloids 
and crystalloids, have stimulated the debate about fluid resuscitation and 
contributed to changes in practice. 
Impact on practice 
 Although the focus of this submission is primarily on the influence of systematic 
reviews on policy it is also worth considering whether there is any evidence of 
impact on practice.  To investigate the possible impact of the albumin review on 
sales of albumin in the UK one of the authors of the review (Ian Roberts) 
requested data on the monthly issues of albumin solutions between 1993 and 
1998 from the Bio Products Laboratory (which serves England and Wales) and 
the Protein Fractionation Centre of the Scottish National Blood Transfusion 
Service (which serves Scotland and Northern Ireland) (Roberts and Bunn, 2002, 
Roberts et al., 1999).  The Protein Fractionation Centre’s data reflected virtually 
all albumin used in Scotland and Northern Ireland but data on Bio Products 
Laboratory’s share of the market in England and Wales was not available 
(although it was believed to be substantial).  In July 1998, after the publication of 
the review, issues from the Scottish National Blood Transfusion Service fell 
steeply from 180 kg in June to 62 kg in December.  Issues from Bio Products 
Laboratory fell dramatically after July 1998 with a 40-45% drop in sales of 4.5% 
albumin and a 40% drop in 20% albumin (Roberts et al., 1999).  This decline in 
sales was despite vigorous criticism of the review in the letters pages of the BMJ 
and was well in advance of advice of from the Committee on the Safety of 
Medicines.  The decline in sales appears to be a clear indication that doctors took 
into account the evidence presented in the systematic review and that many 
doctors changed their practice in response.  
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 In a report on the payback model (Wooding et al., 2004) Wooding and 
colleagues point out that behavioural change by practitioners is necessary for 
research findings to result in ‘final outcomes’.  These changes may be brought 
about by the influence of secondary outputs, such as policy decisions or 
guidance, or may be a direct result of the primary outputs of the research.  In the 
case of the albumin review the changes in practice appeared to be a direct result 
of the primary output (the academic paper published in the BMJ) with the 
impetus for change coming from practice and practitioners rather than policy 
makers. 
In 2004 I was asked to give a paper about the review, and its impact on policy 
and practice, at an HTA conference in Poland.  For the presentation one of my 
co-authors, Ian Roberts, and I attempted to update the figures on the use of 
albumin in the UK and again contacted Bio Products Laboratory and the Scottish 
National Blood Transfusion Service.  Bio Products Laboratory declined to give us 
updated data on albumin issues but figures from Scotland and Northern Ireland4 
showed that the fall in the issue of 4.5% human albumin (HA) had been 
maintained.  However, there had been a recent increase in sales of 20% HA.  For 
the conference presentation I was also provided with data on the use of albumin 
in Sweden and Denmark by Professor Mona Britton from the Swedish Council for 
Technology Assessment in Health Care.  This data showed there was a fall in 
albumin use in Sweden and Denmark that coincided with the publication of the 
review.  In Denmark hospital costs for 1997-2002 fell from about 37 million 
Danish Crowns to under 15 million and in Sweden albumin sales fell from around 
70 million Swedish Crowns to 35 million (personal communication). 
Although the modified framework I have adopted for this evaluation does not 
include a consideration of the economic influence of the included reviews it is 
worth noting that there is evidence of considerable cost savings both to the 
health service in the UK and internationally.  Colloids are more expensive than 
crystalloids, and albumin is considerably more expensive than other synthetic 
                                                          
4
 Data provided by Neil Docherty 24
th
 April 2004 
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colloids (McClelland, 1990).  Therefore, the evidence provided that colloids are 
no more effective than crystalloids in reducing mortality, supports the adoption 
of a cheaper, but equally effective, treatment.  The figures provided above, 
showing documented reductions in the use of albumin, indicate that substantial 
cost savings have already been made. 
Conclusion 
The systematic reviews included in this chapter are concerned with clinical 
questions around appropriate fluid resuscitation strategies; an area of clinical 
practice that has been subject to significant debate and controversy.  They are 
exemplars of reviews employing rigorous Cochrane methodology to evaluate the 
effectiveness of clinical interventions and include the pooling of individual study 
results using the statistical technique meta-analysis.  From the impact evaluation 
evidence emerged that all of the reviews have had some influence on policy and 
practice, for example being used to develop national and international clinical 
guidelines.  In particular, two of the reviews (CIG Albumin Reviewers, 1998, 
Schierhout and Roberts, 1998) were found to have had a significant impact.  For 
the first of these (CIG Albumin Reviewers, 1998) the impact of the review was 
heightened by the suggestion that the intervention being evaluated may have 
significantly increased mortality and the surrounding media furore increased the 
impact further.  The other most influential review,  comparing colloids and 
crystalloids (Schierhout and Roberts, 1998) has contributed significantly in 
creating debate about fluid resuscitation strategies and has contributed to 
changes in policy and practice.  The reviews have also been instrumental in 
targeting future research.
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Table 4.2 Evidence of Fluid reviews’ influence on guideline development 
1. Colloid solutions for fluid resuscitation.   First published: 2000 
Guidelines Title Organisation producing guidelines Country 
Clinical effectiveness and cost-effectiveness of prehospital intravenous fluids 
in trauma patients. (Dretske, 2004) 
Health Technology Assessment (HTA)  UK 
The use of pre-hospital intravenous fluid therapy in trauma 2004 (NICE, 2004) National Institute for Health and Clinical Excellence (NICE) UK 
Fluid resuscitation in prehospital trauma care: a consensus view (Revell et al., 
2002) 
Consensus review including Royal college of surgeons Scotland, 
Ambulance service Association, The UK Military Defence Forces, 
British Association for Immediate Care (BASICS) and London 
Helicopter Emergency Medical Service 
UK 
Techniques For Assessing And Achieving Fluid Balance In 
Acute Renal Failure (Clark et al.) 
Acute Dialysis Quality Initiative 2
nd
 International Consensus 
Conference 
UK 
The management of a child with a decreased conscious level.  A nationally 
developed evidence-based guideline for hospital practitioners (The Paediatric 
Accident and Emergency Research Group) 
The Paediatric Accident and Emergency Research Group UK 
Albumin vs synthetic colloids for fluid resuscitation May 2007 Canadian Blood Service (Provincial Blood Coordinating Office) Canada 
Canadian Association of Emergency Physicians Sepsis Guidelines: the optimal 
management of severe sepsis in Canadian emergency departments (Green et 
Canadian Association of Emergency Physicians Canada 
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al., 2008) 
Recommendations for diagnosis and treatment of forms of shock of the IAG 
Schock of the DIVI. Part 2: Hypovolemic shock (Adams et al., 2005) 
German Interdisciplinary Association for Intensive and Emergency 
Medicine 
Germany 
Fluid resuscitation in neonatal and pediatric hypovolemic shock: a Dutch 
Pediatric Society evidence-based clinical practice guideline (Boluyt et al., 2006) 
Dutch Pediatric Society Netherlands 
Fluid Resuscitation (Orlando Regional Medical Center, 2005) Department of Surgical Education, Orlando Regional Medical 
Center 
USA 
2. Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients: First published: 2000 
Guidelines Title Organisation producing guidelines Country 
Clinical effectiveness and cost-effectiveness of prehospital intravenous fluids 
in trauma patients. (Dretske, 2004) 
HTA  UK 
The use of pre-hospital intravenous fluid therapy in trauma 2004 (NICE, 2004) NICE UK 
Spanish Consensus Statement on Alternatives to Allogeneic Blood Transfusion 
(Leal et al., 2006) 
Spanish Panel on alternatives to allogeneic blood transfusions Spain 
Guidelines for cardiopulmonary resuscitation (CPR) and emergency 
cardiovascular care (ECC) of pediatric and neonatal patients: Pediatric 
advanced life support (Atkins et al., 2006) 
American Heart Association USA 
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3. Human albumin solution for resuscitation and volume expansion in critically ill patients: First published: 1998 
Guidelines Title Organisation producing guidelines Country 
Clinical effectiveness and cost-effectiveness of prehospital intravenous fluids 
in trauma patients. (Dretske, 2004) 
HTA  UK 
The use of pre-hospital intravenous fluid therapy in trauma 2004 (NICE, 2004) NICE UK 
Resuscitation in hypovolaemic shock Patient UK UK 
Guidelines on the management of massive blood loss (Stainsby et al., 2006) British Committee for Standards in Haematology UK 
Transfusion guidelines for neonates and older children (Boulton, 2004) British Committee for Standards in Haematology UK 
Management of massive blood loss: a template guideline  
(Stainsby et al., 2000) 
National Blood service Northern Zone UK 
The management of a child with a decreased conscious level.  A nationally 
developed evidence-based guideline for hospital practitioners (The Paediatric 
Accident and Emergency Research Group) 
The Paediatric Accident and Emergency Research Group UK 
Consensus statement on the treatment of septic shock (Spapen et al., 1999) The Belgian Society of Internal Medicine Belgium 
Management of bleeding following major trauma: a European guideline 
(Spahn et al., 2007) 
Multidisciplinary Task Force for Advanced Bleeding Care in Trauma Europe 
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Recommendations for diagnosis and treatment of forms of shock of the IAG 
Schock of the DIVI. Part 2: Hypovolemic shock (Adams et al., 2005) 
German Interdisciplinary Association for Intensive and Emergency 
Medicine 
Germany 
Diagnosis and therapy of sepsis. S2 guidelines of the German Sepsis Society 
and the German Interdisciplinary Society of Intensive Care and Emergency 
Medicine (DIVI) (Reinhart et al., 2006) 
German Interdisciplinary Society of Intensive Care and Emergency 
Medicine (DIVI) 
Germany 
Albumin vs synthetic colloids for fluid resuscitation May 2007 Canadian Blood service Canada 
Canadian Association of Emergency Physicians Sepsis Guidelines: the optimal 
management of severe sepsis in Canadian emergency departments (Green et 
al., 2008) 
Canadian Association of Emergency Physicians Canada 
Fluid resuscitation in neonatal and pediatric hypovolemic shock: a Dutch 
Pediatric Society evidence-based clinical practice guideline (Boluyt et al., 2006) 
Dutch Pediatric Society Netherlands 
Evidence-based colloid use in the critically ill: American Thoracic Society 
Consensus Statement (American Thoracic Society, 2004) 
American Thoracic Society USA 
Guidelines for cardiopulmonary resuscitation (CPR) and emergency 
cardiovascular care (ECC) of pediatric and neonatal patients: Pediatric 
advanced life support (Atkins et al., 2006) 
American Heart Association USA 
Newer Guidelines for neonatal resuscitation (Bajpai et al., 2001).  
2000 conference on Cardiopulmonary Resuscitation & Emergency 
Adapted from recommendations of the pediatric working  group of 
the International Liaison Committee on Resuscitation (ILCOR) 
India 
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Cardiovascular Care.   
4. Colloids versus crystalloids for fluid resuscitation in critically ill patients: First published: 1998 
Guidelines Title Organisation producing guidelines Country 
Clinical effectiveness and cost-effectiveness of prehospital inravenous fluids in 
trauma patients. (Dretske, 2004) 
HTA  UK 
Fluid resuscitation in prehospital trauma care: a consensus view (Revell et al., 
2002) 
 
Consensus review including Royal college of surgeons Scotland, 
Ambulance service Association, The UK Military Defence Forces, 
British Association for Immediate Care (BASICS) and London 
Helicopter Emergency Medical Service 
UK 
The use of pre-hospital intravenous fluid therapy in trauma 2004 (NICE, 2004) NICE UK 
Guidelines on the management of massive blood loss (Stainsby et al., 2006) British Committee for Standards in Haematology UK 
Management of massive blood loss: a template guideline (Stainsby et al., 
2000) 
National Blood service Northern Zone UK 
British Consensus Guidelines on 
Intravenous Fluid Therapy for Adult 
Surgical Patients 
GIFTASUP (Powell-Tuck et al., 2008) 
Endorsed by: The British Association for Parenteral & Enteral 
Nutrition (BAPEN), Association for Clinical Biochemistry, 
Association of Surgeons of Great Britain & Ireland and Society of 
Academic and Research Surgery, the Renal Association and the 
Intensive Care Society. 
UK 
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Management of acute upper and lower gastrointestinal bleeding (SIGN, 2008) Scottish Intercollegiate Guidelines Network (SIGN) UK 
The management of a child with a decreased conscious level.  A nationally 
developed evidence-based guideline for hospital practitioners (The Paediatric 
Accident and Emergency Research Group) 
The Paediatric Accident and Emergency Research Group UK 
Management of bleeding following major trauma> a European guideline 
(Spahn et al., 2007) 
Multidisciplinary Task Force for Advanced Bleeding Care in Trauma Europe 
Consensus statement on the treatment of septic shock (Spapen et al., 1999) The Belgian Society of Internal Medicine Belgium 
Recommendations for diagnosis and treatment of forms of shock of the IAG 
Schock of the DIVI. Part 2: Hypovolemic shock (Adams et al., 2005) 
German Interdisciplinary Association for Intensive and Emergency 
Medicine 
Germany 
Diagnosis and therapy of sepsis. S2 guidelines of the German Sepsis Society 
and the German Interdisciplinary Society of Intensive Care and Emergency 
Medicine (DIVI) (Reinhart et al., 2006) 
German Interdisciplinary Society of Intensive Care and Emergency 
Medicine (DIVI) 
Germany 
Fluid resuscitation in neonatal and pediatric hypovolemic shock: a Dutch 
Pediatric Society evidence-based clinical practice guideline (Boluyt et al., 2006) 
Dutch Pediatric society Netherlands 
Evidence-based colloid use in the critically ill: American Thoracic Society 
Consensus Statement (American Thoracic Society, 2004) 
American Thoracic Society USA 
Guidelines for cardiopulmonary resuscitation (CPR) and emergency 
cardiovascular care (ECC) of pediatric and neonatal patients: Pediatric 
American Heart Association USA 
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advanced life support (Atkins et al., 2006) 
Surviving Sepsis Campaign: International guidelines for management of severe 
sepsis and septic shock: 2004 (Dellinger et al., 2004) 
Surviving Sepsis Campaign: International guidelines for management of severe 
sepsis and septic shock: 2008 (Dellinger et al., 2008) 
The International Surviving Sepsis Campaign Guidelines Committee International 
Canadian Association of Emergency Physicians Sepsis Guidelines: the optimal 
management of severe sepsis in Canadian emergency departments (Green et 
al., 2008) 
Canadian Association of Emergency Physicians Canada 
5. Timing and volume of fluid administration for patients with bleeding:  First published: 2001 
Guidelines Title Organisation producing guidelines Country 
Clinical effectiveness and cost-effectiveness of prehospital intravenous fluids 
in trauma patients. (Dretske, 2004) 
HTA UK 
The use of pre-hospital intravenous fluid therapy in trauma 2004 (NICE, 2004) NICE UK 
Management of bleeding following major trauma: a European guideline 
(Spahn et al., 2007) 
Multidisciplinary Task Force for Advanced Bleeding Care in Trauma Europe 
The new 2005 resuscitation guidelines of the European Resuscitation Council 
(Soar et al., 2006, Wenzel et al., 2006) 
European Resuscitation Council Europe 
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Chapter 5: The prevention of traffic related injuries: 
systematic reviews of road safety interventions 
Introduction 
The published work that I present in this submission includes systematic reviews 
covering a diverse range of subjects and employing a variety of methodological 
techniques.  In the previous chapter the focus was on the treatment of traumatic 
injuries whereas this chapter concerns the prevention of injury; in particular the 
prevention of road traffic related injuries.  The chapter includes two road safety 
reviews (four papers) one on area-wide traffic calming for preventing traffic 
related injuries (Bunn et al., 2003a, Bunn et al., 2003b) and one on safety 
education for pedestrians (Duperrex et al., 2002a, Duperrex et al., 2002b).  Full 
versions of the papers can be found in Appendix 2. 
I have already detailed the methods involved in undertaking systematic reviews 
of randomised controlled trials, much of which is also pertinent to these reviews.  
However, as there were particular methodological challenges associated with 
these road safety reviews, for example, the difficulties associated with 
identifying relevant studies in road safety research and the issues involved in the 
quality assessment and analysis of non-randomised studies (NRS), this chapter 
includes a critical discussion of these issues.  As before, I also include information 
about the drivers behind the review questions and assess the impact of the 
reviews on policy.  In addition, as there are differences in the culture of road 
safety research and policy compared to other areas of health care, particularly 
clinical research, I discuss some of the barriers to the development of evidence-
based road safety policies.  
Drivers behind review question/s 
The reviews in the previous chapter were concerned with the treatment of 
trauma and injury.  However, the remit of the Injuries Group also covers 
prevention and many of the review topics that were prioritised were concerned 
with the prevention of road traffic injuries.  Death and disability resulting from 
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road traffic crashes is a global problem.  At present 1.27 million people die each 
year and some 10 million people sustain permanent disabilities in road traffic 
crashes (WHO, 2008).  For people under 44 years, road traffic crashes are one of 
the top three causes of death and disablement worldwide (WHO, 2009), and are 
the leading cause of death for people under 50 in the European Union (European 
Transport Safety Council, 2003).  This is of particular concern to low and middle 
income countries where road traffic deaths are predicted to rise by 80% as these 
countries become increasingly motorised (Peden et al., 2004b).  The 
identification of effective strategies for the prevention of road traffic injuries is, 
therefore, of global health importance.    
Many of the casualties are vulnerable road users, such as pedestrians and 
cyclists, and the risks associated with walking, cycling and motorcycling remain 
very high in relation to those of car travel (Peden et al., 2004b, Sonkin et al., 
2006).  In Great Britain in 2008 there were 28,481 pedestrian casualties, 16,297 
casualties for pedal cyclists and 21,549 for motorcyclists (Department for 
Transport, 2009).  Although rates in the UK have fallen over the last few decades 
(Peden et al., 2004b), that downward trend may be because there has been a 
significant reduction in rates of people walking and cycling rather than due to 
improvements in safety (Roberts, 1993).  World-wide, 46% of road traffic deaths 
are among vulnerable road users (WHO, 2009) and in some low and middle 
income countries the proportion of road deaths involving vulnerable road users 
is as high as 80%  (Peden et al., 2004b).   
Despite these alarming statistics many road-safety interventions are still focused 
on improving safety for car occupants.  Therefore, in deciding upon review 
questions the co-ordinating editor of the Injuries Group, Professor Ian Roberts, 
was concerned that we gave priority to reviews with the potential to benefit 
vulnerable road users.  In addition, review questions were guided by a wish to 
challenge the orthodoxy that often favours politically safe but relatively minor 
interventions, such as safety-education, over less popular but potentially more 
important population-based environmental or legislative interventions.  Traffic 
106 
 
calming, for example, has the potential to impact not just upon injuries but on 
public health more widely.  The creation of safer streets may increase levels of 
active transport, such as walking and cycling, and thereby impact on rates of 
obesity, diabetes and cardiovascular disease (Roberts and Arnold, 2007).  In 
addition, as child pedestrian injuries and deaths disproportionately impact upon 
those from lower socio economic groups (Edwards et al., 2008, Lyons et al., 
2003, Roberts, 1996), the creation of safer environments has the potential to 
reduce inequalities in health (Jones et al., 2005b, Liabo et al., 2003, Lyons, 2005).  
As in the previous chapter, the identification of review questions was researcher 
led rather than driven by funders or policy makers. 
Review methods 
Question development 
As in the previous chapter one of the reviews presented here (Duperrex et al., 
2002a) included randomised controlled trials only.  Although RCTs are generally 
considered to be the optimum study design for evaluating the effectiveness of an 
intervention there are instances where it is appropriate to include non-
randomised studies (NRS) in a systematic review.  One justification for their 
inclusion is where the intervention being evaluated cannot be, or is unlikely to 
be, evaluated in a randomised trial for either ethical or practical reasons.  For 
example, Cochrane Injuries Group researchers in the US evaluated the 
effectiveness of fencing around swimming pools to prevent children drowning 
(Thompson and Rivara, 2000).  They included NRS as it was highly unlikely that it 
would ever be considered ethical to evaluate such an intervention in a 
randomised trial.    
In theory it should be possible to conduct an RCT of a road safety intervention 
such as traffic calming.  In reality, however, such interventions are rarely, if ever, 
evaluated in RCTs.  This is partly owing to the logistical and practical issues 
involved but also because RCTs have not been considered as an integral part of 
the road-safety research culture. Indeed road-safety interventions have typically 
been evaluated using uncontrolled before/after designs.  Another justification 
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for including NRS in a review is to provide evidence of effects that cannot be 
adequately studied in RCTs such as long-term or rare outcomes.  For example, 
the primary outcomes of interest in the traffic calming review were injuries and 
deaths.  These outcomes are relatively rare and studies need to be conducted 
over a number of years for any changes to be detected.  Owing to these factors 
the inclusion criteria for the traffic calming review was widened to include 
controlled studies as well as RCTs.  To reduce the risk of bias we specified that 
the control had to be concurrent and not historical.  Despite the fact that we 
broadened our inclusion criteria to include some NRS it has been suggested that 
those inclusion criteria are still too strict and that the review would have been 
more informative if we had included uncontrolled before/after studies (Lyons, 
2005). 
Identification of studies 
In the previous chapter I looked at the potential problems associated with 
publication bias in systematic reviews and how these form the basis for the 
rationale for searching for all available RCTs.  Much less methodological work has 
been done on the importance of comprehensive searches for other study designs 
and it is not clear if the same publication biases are relevant to NRS (Higgins, 
2008).  Indeed, it is possible that those studies that are hardest to find are the 
poorest quality and, therefore, the most biased (Egger et al., 2003, Higgins, 
2008).  However, although the benefits of comprehensive searching for NRS are 
not established, the approach we took for the traffic calming review was to apply 
standard methods for searching and to attempt to identify all available studies.  
This was not an easy undertaking.  NRS are harder to find than randomised 
studies as there are no registers of NRS, and many NRS are poorly indexed which 
makes developing reliable methodological search filters more difficult.  These 
problems are further compounded by the difficulties of searching for road safety 
studies.  For example, many studies are unpublished, are written in languages 
other than English and road safety databases are not user friendly.   
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The largest and most widely used road-related database is TRANSPORT.  This 
database contains approximately 600,000 records including grey literature.  To 
facilitate the identification of relevant studies in TRANSPORT we used word 
frequency analysis in an attempt to devise electronic search strategies with high 
sensitivity and positive predictive value (PPV) (Wentz et al., 2001).  Despite our 
best efforts we were unable to devise search strategies that combined 
acceptable sensitivity and PPV for the retrieval of controlled evaluation studies of 
road safety interventions.  Even strategies with a relatively low sensitivity (59%) 
had a low PPV (10%).  In contrast search strategies for controlled studies in 
medical databases can achieve high sensitivity and PPV because terms describing 
the study methodology are included among the indexing (descriptor) terms.  
Road safety databases, however, have a limited range of indexing terms 
describing the study methodology.  For example, one of the included studies in 
the traffic calming review is a prospective controlled study (Mackie et al., 1990), 
but nowhere in the TRANSPORT database record for this report is there an 
indication that it is a report of a controlled study.  Owing to this inability to 
devise a strategy combining sensitivity and PPV our searches generated nearly 
13,000 records which had to be screened for eligibility. 
There are also difficulties associated with screening the results of searches.  It is 
generally fairly easy to identify RCTs from the title or abstract but this is not the 
case with NRS where it is often not clear in either the title or abstract what study 
design was used.  This may necessitate a much greater percentage of papers 
being obtained so that the hard copy could be screened.  Again this was 
exacerbated by the shortcomings of the TRANSPORT database where limitations 
in the quality of abstracts (many of which were non-existent) meant that for the 
traffic calming review I had to obtain the hard copies of nearly 600 records, many 
more than would normally be retrieved for a comparable review of RCTs of a 
health care intervention.  Of those only 16 were eventually included in the 
review.  The need to obtain such a high proportion of hard copies was both time 
consuming and costly. 
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Critically Appraising Studies 
Critical appraisal is a vital part of a review of NRS as the potential biases are likely 
to be greater than with a review of RCTs.  In particular, studies are prone to 
selection bias and confounding.  Selection bias occurs when there are differences 
in the two groups under study and confounding occurs when selection bias gives 
rise to imbalances between intervention and control groups on prognostic 
factors (Higgins, 2008).  Confounding can have two effects in a meta-analysis, it 
can shift the estimate of the intervention effect (systematic bias) and increase 
the variability of the observed effects thereby introducing excessive 
heterogeneity among studies (Deeks et al., 2003).  At the time that the traffic 
calming review was first conducted the Cochrane handbook did not include any 
advice on reviews of non randomised studies, although a section on this has 
subsequently been added.  The handbook now advises looking at four areas for 
quality assessment: 
 Was there a comparison? 
 How were the groups created? 
 Which parts of the study were prospective? 
 On which variables was comparability (between the groups) 
assessed? 
In the traffic calming review we assessed the quality of the studies by extracting 
data on how well the intervention and control areas were matched and the 
length of the before and after data collection periods.  In addition, because of 
the risk of contamination, that is the potential for the effect on drivers’ 
behaviour of driving in traffic calmed areas to remain in nearby non-traffic 
calmed streets, we also recorded the distance between the intervention and 
control areas. 
Data synthesis 
Because of the increased potential for selection bias, residual confounding, and 
the greater risk of other biases through poor design and execution, meta-
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analyses of NRS are associated with an increased risk of heterogeneity.  There is 
no way of controlling for these biases in the analysis of primary studies and no 
established methods for assessing how, or the extent to which, these biases 
affect primary studies (Higgins, 2008).  Therefore, reviewers need to be aware of 
this increased potential for heterogeneity and take this into account when 
planning the analysis and interpreting the results.  For the traffic calming review 
we used a random effects meta-analysis to take the increased heterogeneity into 
account.  The assumption of random effects both allows for the anticipated 
heterogeneity between effects across studies and provides robustness if the 
assumption that events follow Poisson distributions is violated through 
overdispersion. 
In the meta-analyses discussed in the previous chapter, and in the pedestrian 
safety education review, we used ‘raw’ unadjusted data as this is considered 
appropriate for RCTs.  However, in NRS where there may be expected to be 
greater residual confounding it may be appropriate to use adjusted estimates.  
Meta-analysis of adjusted estimates can be performed using the generic inverse-
variance outcome in RevMan.  When we first conducted the traffic calming 
review this facility was not available within RevMan and the analyses were 
conducted in Stata version 7.0 (Stata corporation, College Station, Texas 77845 
USA).  The results for each study were expressed as rate ratios (the rate ratio is 
the ratio of event rates post and pre intervention in the intervention area divided 
by the corresponding post to pre-intervention event ratio in the control area).   
Results of impact analysis 
Knowledge production 
Publication and other methods of dissemination 
The pedestrian safety education review was published in the Cochrane Library 
(Duperrex et al., 2002b) and in an edition of the BMJ that focused on road safety 
(Duperrex et al., 2002a).  The traffic calming review was published in the 
Cochrane Library (Bunn et al., 2003a) and in the journal Injury Prevention (Bunn 
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et al., 2003b).  The Cochrane version of the traffic calming review was updated in 
2009 and its publication on the Cochrane Library was accompanied by a press 
release.  The press release resulted in the study being picked up by a number of 
media outlets both nationally and internationally.  The review was also 
accompanied by a podcast summarising the key points of the review; this 
podcast is freely available on the Cochrane Website5.  Podcasting is a method of 
publishing audio files via the internet in a format that allows users to download 
them and listen to them at their own convenience.  They are increasingly being 
used to enhance the communication of research and of the top 100 general 
medical and international journals eight offer regular podcasts (Wilson et al., 
2009).  One such is the Cochrane Library which has been offering podcasts of 
selected reviews since 2008.  It has been suggested though that the technical 
quality and listening experience of journal podcasts is variable (Wilson et al., 
2009). 
Impact within research community 
The citation analysis for the reviews in this chapter was first conducted in June 
2009 and updated in April 2010; results can be seen in Figure 5.1.  This shows a 
comparison of citations in Scopus, WoS and Google Scholar for each paper, this 
includes the CDSR and Injury Prevention papers on traffic calming and the CDSR 
and BMJ versions of the safety education review. 
The version of the traffic calming review published in Injury Prevention (Bunn et 
al., 2003b) had 20 citations in Scopus, 16 in Web of Science (WoS) and 36 in 
Google Scholar and the version published in the CDSR had no citations in either 
Scopus or WoS but 37 in Google Scholar.  The BMJ version of the review on 
safety education for pedestrians (Duperrex et al., 2002a) received 42 citations in 
Scopus, 33 in WoS and 78 in Google Scholar whilst the Cochrane version received 
none in Scopus or WoS and 44 in Google Scholar.  The average number of 
citations a paper receives may be affected by a number of factors including the 
impact factor of the journal and the type of speciality.  For example, previous 
                                                          
5
 http://www.cochrane.org/podcasts/issue/Issue%204%2C%20October%202009/100 
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research has found that the average number of citations in the five years after 
publication for a paper published in the BMJ is 32.5 (Perneger, 2004).  The Safety 
Education review was cited more frequently than the Traffic Calming review but 
that may be accounted for by the fact that it was published in the BMJ which is a 
general journal with a higher impact factor than Injury Prevention which is a 
more specialised journal.  As in the previous chapter, the versions in the 
Cochrane Library were not cited as often as their counterparts published in other 
journals, but this is likely to be because this citation information is flawed (the 
reliability of citation information for Cochrane reviews is investigated further in 
Chapter 8).  Data from Wiley on review downloads revealed that the traffic 
calming review was downloaded 812 times in 2008 (620/6,232) and 334 in 2009 
(2666/6840) and the pedestrian safety education review was downloaded 68 
times in 2008 (5105/6,232) and 214 times in 2009 (3693/6840).   
 
Figure 5.1 Results of citation analysis road safety reviews 
Research targeting 
In previous chapters I have described how the evidence-based practice 
movement, with its emphasis on rigour and insistence on high quality controlled 
evaluations of interventions, has become so dominant in health care research.  
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However, such attitudes, whilst beginning to filter into the road-safety discourse, 
are not as established or embedded in road-safety research.  This is partly 
because the application of rigorous experimental research designs and the 
concept of systematically reviewing studies are less well established than in 
clinical research.  Indeed, although a substantial amount of transport related 
research has been undertaken little of this has been directed towards ‘collating 
and evaluating evidence to inform policy or towards assessing effectiveness of 
policy’ (Terry, 2000).  In addition, much research is market driven and aimed 
towards improving technical efficiency and safety of vehicle occupants (Terry, 
2000) rather than improving the safety of pedestrians and cyclists. 
Although it is hard to quantify how significant the role the Cochrane Injuries 
Group has been in promoting evidence-based road safety, there is no doubt it 
has been involved in championing the production and use of systematic reviews 
of road safety interventions, many of which are aimed at improving safety for 
vulnerable road users.  In her essay entitled, ‘moving America towards evidence-
based approaches to traffic safety’ Deborah Girasek writes: 
‘Rigorous reviews of the state-of-our-art, such as those conducted by the 
Cochrane Injuries Group, must be consulted so that the science of the 
prevention strategies that are selected for promotion is beyond refute’ 
(Girasek, 2007). 
However, any impact on research targeting appears to be attributable to the 
collective road-safety output of the Injuries Group6 rather than as a result of any 
individual review.  Rather like the fluid reviews, much of their impact is because 
they form a coherent body of work that investigates many aspects of the same 
problem.  Whilst this is not proven the body of work and its timing suggests that 
the Injuries Group has been instrumental in promoting the application of 
systematic review methods to road-safety research and contributed to a change 
in attitudes towards the conduct of road safety research. 
                                                          
6
 There are 16 Injuries Group road-safety reviews published in the Cochrane Library in July 2010 
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Informing Policy Development 
Levels and type of policy making 
In the previous chapter I was able to present evidence of the way in which the 
reviews on fluid resuscitation strategies had influenced a range of clinical 
guidelines in both the UK and abroad.  In road-safety, however, the development 
and use of guidelines is not as common and, therefore, I looked for the inclusion 
of the reviews in documents or reports by agencies (local, national and 
international) who might be involved in guiding and developing road-safety 
policy; for example, injury prevention reports by the World Health Organization 
(WHO).  The results of this documentary review, including details about the 
report and organisation publishing it, are presented in Table 5.1.  
Both reviews have been cited in a number of publications by UK organisations 
concerned with safety and injury prevention.  These include charities, such as 
The Royal Society for the Prevention of Accidents and the National Children’s 
Bureau, national and local Government departments such as Department of 
Health and Department of Transport, and evidence based resources such as ‘best 
bets’ which provides summaries of the best available evidence.  Several of these 
reports were concerned with the role that interventions like safety education 
and traffic calming could play in reducing health inequalities. 
Much of the identified impact of the reviews has been at an international level, 
for example in publications by the World Health Organization (WHO).  The WHO 
aims to provide objective and reliable advice in the field of human health and to 
respond to the most pressing public health concerns around the world.  Their 
outputs include guidelines, consensus reports, manuals and reviews which are 
aimed at both health workers and decision makers (Peden et al., 2004b).   
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Table 5.1 Evidence of reviews influence on policy development 
Safety education for pedestrians (first published 2002) 
Guidelines/Report Title 
 
Organisation  Country 
A review of safety education: Principles for 
effective practice (McWhirter, 2008). This review 
then used to provide briefing paper on effective 
safety education for Department for Children, 
Schools and Families. 
The Royal Society for the 
Prevention of Accidents 
(ROSPA) 
UK 
Traffic calming and childhood injury on the road 
(Liabo, 2004) 
National Children’s Bureau 
(produced from a more 
detailed document 
produced by what works for 
children) 
UK 
Can traffic calming measures achieve the 
children’s fund objective of reducing inequalities 
in child health (Liabo et al., 2003) 
http://www.bestbets.org/bets/bet.php?id=218 
 
Best Bets (best evidence 
topics). Concluded traffic 
calming had greater 
potential than safety 
education to reduce 
childhood inequalities 
UK 
Interventions to improve pedestrian skills in 
children : provisional statement (EuroSafe, 2007) 
European Association for 
Injury Prevention and Safety 
promotion.  Funded by 
European Union and aims to 
explore priority issues in 
injury prevention work 
Europe 
World report on road traffic injury prevention 
(Peden et al., 2004b) 
World Health Organization International 
World report on child injury prevention (Peden et 
al., 2004a) 
World Health Organization International  
Promoting evidence-informed decision making  
http://health-evidence.ca/articles/show/15392 
 
Health Evidence Canada 
(funded by a number of 
research and government 
organisations to provide 
quality research evidence 
for decision makers) 
Canada 
Fact Sheet: Traffic education of children 4-12 years 
old (SWOV, 2009) 
 
SWOV (Institute for Road 
Safety Research) 
Netherlands 
The effectiveness of road safety education (SWOV, 
2009) 
 
SWOV (Institute for Road 
Safety Research) 
Netherlands 
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Traffic calming (first published 2003) 
Guidelines/Report Title 
 
Organisation Country 
Traffic calming and childhood injury on the road 
(Liabo, 2004) 
National Children’s Bureau 
(produced from a more 
detailed document 
produced by what works for 
children) 
UK 
Tackling the wider social determinants of health 
and health inequalities: evidence from systematic 
reviews (Bambra et al., 2008) 
Public Health Research 
Consortium on behalf of the 
Department of Health Policy 
Research Programme 
UK 
Joint Strategic Needs Assessment for Children in 
Kent (Kent PCT, 2008) 
 
Report prepared for PCT 
and Local Authority 
UK 
Traffic calming, childhood pedestrian injury and 
inequalities and politics in: fifteenth seminar on 
behavioural research in road safety (Lyons, 2005) 
Department for Transport 
(part of department of 
health accidental injury 
research initiative) 
UK 
How can injuries in children and older people be 
prevented? (Towner and Errington, 2004) 
 
World Health Organization International 
World report on road traffic injury prevention 
(Peden et al., 2004b) 
 
World Health Organization International 
World report on child injury prevention (Peden et 
al., 2004a) 
World Health Organization International  
Youth and Road Safety (Toroyan and Peden, 2007) World Health Organization International 
 
Prevention of chronic disease by means of diet 
and lifestyle changes (Willet et al., 2006) 
The International Bank for 
Reconstruction and 
Development/The World 
Bank 
International 
Health Impacts of Transport a review (Kavanagh et 
al., 2005) (Kavanagh et al., 2005) 
 
The Institute of Public 
Health in Ireland 
Ireland 
Strategies for Gain – the evidence on strategies to 
improve the health and well-being of Victorian 
children (Eagar, 2005) 
Centre for Health Services 
Development 
Australia 
Promoting evidence-informed decision making  
http://health-evidence.ca/articles/show/18458 
 
Health Rvidence Canada 
(funded by a number of 
research and government 
organisations to provide 
quality research evidence 
for decision makers) 
Canada 
Urban Transportation, a Question of Health 
(Quebec Sante publique, 2006) 
Agence de la Danté et des 
Dervices Sociaux de 
Montreal 
 
Canada 
Speed change management for New Zealand roads 
(Charlton, 2006) 
Land Transport New Zealand 
(involved in allocating 
resources for transport) 
New Zealand 
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Both reviews were cited in several reports from the WHO and in some instances 
contributed to the development of policy recommendations.  For example, in the 
world report on traffic injury prevention (Peden et al., 2004b) the results of the 
traffic calming review feed into recommendation 5 (p162) on specific actions for 
the prevention of road traffic crashes.  The recommendations in this report have 
been endorsed by member states through three United Nations General 
Assembly resolutions and one World Health Assembly resolution.  The reviews 
had also been cited in a variety of practice and policy documents around the 
world including Europe, Australia, New Zealand and Canada. 
The citation analysis presented here looks primarily at the number of citations 
and by whom they were cited.  In general it does not consider how the research 
was presented and whether it was interpreted in the way originally intended.  In 
a recent paper, using network analysis to explore how citation distortions can 
create unfounded authority for scientific ideas (Greenberg, 2009), Greenburg 
and colleagues use the phrase ‘citation diversion’.  By this they mean that the 
content of a paper is cited but that its meaning is altered in a manner that diverts 
its implications.  An example of this can be seen in the interpretation of the 
findings of the Pedestrian Safety Education review.  In our paper we wrote ‘our 
review indicates that there is no reliable evidence supporting the effectiveness of 
pedestrian education for preventing injuries in children and inconsistent 
evidence that it might improve their behaviour, attitudes, and knowledge’.  
However, when cited in the WHO report on road traffic injury prevention (Peden 
et al., 2004b) it was used to support the statement that ‘the use of information 
and publicity on their own is generally unsuccessful in reducing road traffic 
collisions’.  This represents perhaps only a subtle distortion but none the less 
demonstrates how papers may not always be interpreted as the authors 
intended. 
Nature of policy impact 
The framework I used for this evaluation recognises that policy impact may take 
different forms and work on different levels.  The section of the framework on 
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the nature of policy impact reflects this by including four categories based on the 
work of Weiss (Weiss, 1998): these are: 1) instrumental use, 2) mobilisation of 
support, 3) conceptual use and 4) redefining research practices and beliefs.  
There is, I believe evidence that the traffic calming and pedestrian safety 
education reviews have impacted to some extent at all of these levels.  For 
example, as described above the traffic calming review had an instrumental 
effect on the development of road-safety policy by the WHO, policy that has the 
potential to impact upon many different countries.  Although indirect impact is 
more difficult to measure, my own analysis, and informal interviews with co-
authors and road safety experts, has suggested that the reviews have also 
influenced the policy process at a more conceptual level.  There have been a 
number of shifts in the road safety paradigm including a change in emphasis 
from interventions that place the onus on the individual, such as education, 
towards more overarching population-based environmental or legislative 
interventions.  The extent to which the reviews in this chapter have been 
instrumental to this process is hard to define.  However, I believe that they, in 
conjunction with the whole road-safety output of the Injuries Group, have 
contributed to this process.  In addition, the reviews, and the work of the 
Cochrane Injuries Group have impacted upon research thinking, practices and 
beliefs by promoting the use of systematic review methods and emphasising the 
value of using rigorous scientific methods for the evaluation of road safety 
interventions.  
Impact on Practice 
Although it was clear that the reviews had influenced policy, I found no real 
evidence that they had impacted upon road-safety practice.  However, as the 
focus of my investigation was on policy rather than practice this is perhaps not 
surprising; there may well have been impacts that my evaluation methods were 
unable to identify.  In the previous chapter we saw how much clinical practice is 
now directed by guidelines issued locally and nationally.  The same is not true in 
road safety where many initiatives, such as traffic calming, may be implemented 
locally by local authorities rather than as a result of a central policy (Terry, 2000).  
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Terry argues that local authorities may have implemented traffic calming 
because it was seen as a relatively cheap way of improving noise abatement, air 
quality and pedestrian safety and one with a greater impact than some more 
expensive large scale construction projects.  Although the traffic calming review 
was found to be on the international policy agenda there is no guarantee that 
this ensures it will impact on actual practice.  In relation to other interventions 
traffic calming may be more expensive and logistically difficult to implement, 
particularly for low and middle income countries.  It may be easier, for example, 
to put in place legislation rather than make whole scale changes to the road 
environment.  Indeed, Cochrane reviews on the use of helmets for the 
prevention of injuries (Liu et al., 2008, Macpherson and Spinks, 2007, Thompson 
et al., 2000) have influenced the development of WHO policy on helmet laws 
(WHO, 2006); legislation that is now being widely implemented in Asia and 
Africa. 
Barriers to evidence-based road safety 
An unscientific approach to road safety? 
In the previous sections I have demonstrated that systematic reviews of road-
safety can influence policy.  However, that impact may be diluted or obstructed 
by a number of barriers (Breen, 2004, Girasek, 2007, Roberts et al., 2006, Terry, 
2000).  Many of these are, of course, the universal barriers that hinder 
knowledge translation and research impact upon policy.  For example, in her 
enlightenment model Weiss suggested that researchers may ignore research that 
does not support their own values (Weiss, 1976, Weiss, 1977) and there is 
evidence of this in road safety.  In a Dutch study into the use of scientific road 
safety knowledge in decision making (Bax, 2006), the author concluded that 
policy makers primarily use knowledge if it fits in with an existing policy line, if 
they have asked for the information themselves, or if the knowledge is relatively 
new.  Experts in the US have also commented on the use of road-safety 
interventions that are not based on scientific evidence (Hedlund, 2007) arguing 
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that there is a need to ‘make intuition-based road-safety delivery unacceptable’ 
(Hauer, 2005). 
The selective use of research evidence in the development of road-safety policy 
has also been critiqued by researchers in the UK (Achara et al., 2001).  In March 
2000 the previous UK Government launched its road safety strategy which aimed 
to achieve a 40% reduction in road deaths and serious injuries (DETR., 2000).  
One of the initiatives included in this plan was the introduction of school-based 
driver education.  This move to introduce school-based driver education was 
despite evidence from a previous systematic review that it may be associated 
with an increase in deaths and injuries in teenagers, possibly because it enables 
them to obtain a driving licence sooner than they otherwise might have (Vernick 
et al., 1999).  An update of this review by a team of Cochrane Injuries Group 
reviewers also found no evidence of any benefit from school-based driver 
education and a suggestion that it may be linked to an increase in the proportion 
of teenagers involved in traffic crashes (Roberts and Kwan, 2001).  In a paper in 
the Lancet (Achara et al., 2001) the Cochrane reviewers point out that the 
government had not taken previous randomised controlled trials into account 
but that instead the policy was supported by a poor quality uncontrolled 
before/after study.  This research, from the British Institute of Traffic Education 
Research, looked at attitudes, knowledge and intended behaviour.  These are 
surrogate outcomes and there is no reliable evidence that changes in self-
reported knowledge and attitudes lead to changes in behaviour or reduced crash 
rates.  Indeed, surrogate outcomes have been found to be misleading or 
dangerous (Grimes and Schulz, 2005).  In addition, the survey had a poor 
response rate of 36%.  This example reflects both the selective use of research 
and a lack of understanding on the part of policy-makers of the need for rigorous 
controlled evaluations in road-safety research. 
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The role of industry 
In the same way that the pharmaceutical industry is able to influence healthcare 
policy, those with a vested financial interest appear to be able to influence road-
safety policy (Roberts et al., 2006).  For example, the alcohol industry has been 
involved in lobbying against the introduction of random breath tests and 
reductions in legal blood alcohol limits for driving (Rutherford, 2002, WHO, 
2001).  The WHO recommendations for safe blood alcohol levels for driving are 
0.05 mg/ml whereas in the UK they remain at 0.08 mg/ml (ICAP, 2009).  Although 
the UK safety legislation record is generally good in relation to other European 
countries, in this instance the UK compares unfavourably with many other 
European countries.  This difference may, in part, be due to the power of the 
alcohol industry in the UK. 
Another group with a commercial interest in road-safety policy is car 
manufacturers.  Car manufacturers have become involved in road safety through 
the creation of the Global Road Safety Partnership (GRSP), an alliance between 
business, non-governmental organizations, and governments that aims to 
improve road safety. However, there is a concern that such involvement is 
inappropriate as ‘companies may only support their own commercial interests 
rather than implementing evidence-based interventions’ (Mohan and Roberts, 
2001).  In a word frequency analysis, comparing road safety documents 
produced by the GRSP and the WHO, researchers found important differences in 
the emphasis given to different road safety strategies.  The GRSP documents 
were found to be more likely to emphasise driver training and safety education 
over speed reduction despite a lack of strong scientific evidence for such a 
position (Roberts et al., 2006).  This discrepancy may be because the GRSP are 
not scientists and are unable to critically evaluate information in the way that 
researchers at the WHO can, or it may be that they are still stuck in the old 
paradigm that sees road-safety as the responsibility of the individual.  However, 
it is not hard to see how car manufacturers may prefer to promote educational 
strategies as these are less likely to impact upon them commercially.  In addition, 
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education may be attractive for policy makers who see it as politically safe and 
non controversial (Stone, 1989). 
The role of lobby groups 
However, industry and manufacturers are not the only powerful interest groups 
able to influence road safety policy.  Indeed car owners and the motoring public 
have a substantial impact in this arena.  Francis Terry argues that the 
government is reluctant to instigate road safety policy that is likely to invoke 
negative public reaction.  For example, although the benefits of wearing seat 
belts were conclusively demonstrated during tests in the early 1960s, ministers 
did not feel that they could introduce a seat belt law until 50% of the population 
were wearing them (Terry, 2000).  The first attempt to get seat belt legislation 
passed was in 1973 and there were many other unsuccessful attempts until the 
bill was finally passed in the Transport Act of 1981 (Transport Bill, 1981).  As 
seatbelts prevent around 25,000 serious injuries annually the delay had serious 
health and economic implications (Breen, 2004).  Similarly both previous and 
current UK governments have been reluctant to give priority or funding to 
20mph zones despite experiments showing a dramatic reduction (typically 60%) 
in the number of pedestrians killed or seriously injured.  Although tests were first 
conducted in 1990 it was at least five years before the Department of Transport 
would consider giving any priority to spending on 20 mph zones more generally 
(Terry, 2000).  Public acceptability may be a more important factor in 
determining road-related policy than the evidence. 
Indeed it would appear that certain vociferous minority groups have had a 
disproportionate effect on road safety policy, such as in the case of the use of 
speed cameras (Breen, 2004, Pilkington, 2003).  Despite surveys demonstrating 
widespread public support and the support of the select committee on transport 
(Select Committee on Transport, 2002), the use of speed cameras is still being 
questioned in the media (Breen, 2004).  This is largely as a result of campaigns 
against speed cameras waged by groups such as The Association of British 
Drivers (ABD) and Motorists Against Detection (MOD) (Breen, 2004, Pilkington, 
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2003).  Despite relatively small membership (ABD only has 1000 members) they 
have managed to get disproportionate TV and media coverage.  Pilkington 
argues that ‘such minority radical groups are the product of a dominant car 
culture’ and that they reject population measures to increase road safety such as 
speed cameras and traffic calming.  He argues that lobbying by pro-motorist 
groups has influenced government policy on speed cameras; for example, the 
decision by the previous Government that all speed cameras would have to be 
highly visible (bright yellow) despite there being no evidence on how increased 
visibility might impact on effectiveness. 
A large part of the socio-economic burden caused by road injuries is borne by the 
health sector, and health care professionals have been shown to influence the 
policy debate.  For example, although seat-belt legislation was slow in coming 
Breen argues that  lobbying by health care groups such as the British Medical 
Association (BMA), the Royal College of Surgeons, The British Paediatric 
Association, and the Child Prevention Committee was key in getting seat-belt 
legislation finally passed (Breen, 2004).  However, although health care groups 
can have some influence in the policy arena they are often up against powerful 
opposition from motoring groups and those with a vested commercial interest.  
The BMA, for example has campaigned unsuccessfully for the implementation of 
random breath testing since the 1980s (Peden et al., 2004b). 
Individualism versus collectivism 
There is another barrier to road safety and one that is at the heart of much of the 
protest against safety measures, such as traffic calming and speed cameras.  In 
western cultures, with their emphasis on individualism over collectivism, people 
may see the cause and solution of problems such as road traffic deaths and 
injuries in terms of individual behaviour rather than a collective response 
(Girasek, 2007).  Breen, for example, suggests that it was politicians opposed to 
what they saw as the ‘nanny state’ who blocked the introduction of seat-belt 
legislation (Breen, 2004).  One of the reasons that education may be so popular 
as an intervention, despite little evidence of effectiveness, is that it ‘appeals to 
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values of personal freedom and individual responsibility’ (Girasek, 2007).  
Commentators have argued that child pedestrian injuries have historically been 
seen as the responsibility of the child and that the solution lies with them rather 
than the environment (Stone, 1989).   
Conclusion 
In this chapter I have demonstrated how two road-safety systematic reviews 
have impacted on policy both directly and indirectly.  The reviews have been 
particularly influential on international policy which is in many ways 
understandable as road related deaths and injuries are a global phenomenon 
that is a rapidly increasing problem in low and middle income countries.  In 
addition, traffic calming may be seen as important as improvements to the road 
environment may have far reaching public health and environmental impacts 
that go beyond the prevention of traffic injuries (Roberts and Arnold, 2007).  
However, although these reviews appear to be on the policy agenda that, in 
itself, is no guarantee that they will be taken up and affect practice.  Some 
reviews may ultimately be more instrumental because they evaluate an 
intervention that is simpler to implement.  Indeed, one of the attractions of 
safety education is that it is relatively simple and inexpensive to implement.  
Although there is evidence of direct impact upon policy, much of the influence of 
the reviews may be more in line with Weiss’s ideas about the enlightenment role 
of research (Weiss, 1976) with the reviews influencing ideas of decision makers 
in a way that may eventually filter down to policy.  For example, the reviews may 
have challenged the over-reliance on politically safe interventions such as safety 
education and highlighted the need for more comprehensive population-based 
strategies.  The reviews may also have played a part in changing the thinking of 
road-safety researchers by emphasising the need for rigorous research designs 
and promoting the use of systematic reviews in injury prevention. 
It was, however, difficult to consider the impact of one review in isolation.  The 
Cochrane Injuries Group has now produced many road safety systematic reviews 
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and it appears that much of their influence may be as a collective body of work 
on road-safety.  These systematic reviews have highlighted the need for greater 
rigour in road-safety research and challenged and changed the existing research 
and policy culture in road-safety.  In addition, the focus on ‘what works’ has 
drawn attention to discrepancies between the evidence and existing road-safety 
policy and challenged the over-reliance on politically expedient but ineffective 
interventions. 
What is clear is that changing policy to increase road safety is often a long and 
arduous process.  Industry, motoring lobby groups and the general car-
dependent public are all influential in the policy process.  In such an arena the 
production and publication of research may not be enough to change policy.  
Researchers may need to be more vocal and pro-active in lobbying for changes 
to road-safety policy.  There also needs to be a recognition that to reduce the 
theory/practice gap requires ‘long-term commitment among researchers, 
practitioners and policy makers’ (Sussman et al., 2006). 
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Chapter 6: Identifying barriers and facilitators to fall 
prevention interventions: systematic review of qualitative 
research 
Introduction 
In the previous two chapters I focused on reviews that evaluated the 
effectiveness of interventions.  However, systematic review methodology can 
also be used to ask different types of questions; for example, questions that 
concern contextual factors such as beliefs and attitudes, or that examine the 
processes of implementing successful interventions.  Review questions such as 
these are not best answered using quantitative studies, such as randomised 
controlled trials, but instead may require qualitative approaches.  In this chapter 
I present a review which, because it was exploring factors around the 
implementation of interventions, focused on qualitative studies.  The review was 
designed to investigate the barriers and facilitators to the successful delivery of 
falls prevention interventions (Bunn et al., 2008a).    
Although reviews of qualitative studies in general adhere to the same structure 
and methodological approaches as reviews of effectiveness, there are a number 
of key differences.  This chapter, therefore, includes a critical discussion of the 
methodological issues associated with systematic reviews of qualitative studies.  
As the place of qualitative research in systematic reviews has been more 
controversial and is less well-established I include a critical examination of the 
role of qualitative research in evidence based practice and systematic reviews.  
As before, I discuss the drivers behind the review question and assess the impact 
of the review on policy.   
Drivers behind review question 
The review was conducted as part of a Department of Health funded project 
exploring barriers and facilitators to fall prevention in older people.  Although 
previous systematic reviews had evaluated the effectiveness of fall prevention 
interventions (Gillespie et al., 2001, Gillespie et al., 2009) they had also identified 
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that compliance with these interventions was not always good.  There was, 
therefore, a need to examine more fully issues around uptake and participation.  
The main aim of the review was to appraise the existing research evidence of 
barriers and facilitators which influence compliance with, and adherence to, 
interventions to reduce falls and fall-related fractures in older people. 
The role of qualitative research in systematic reviews 
Much of the discourse around evidence-based practice in health care and public 
health is based on the assumption that when we talk about evidence we mean 
quantitative research, in particular randomised controlled trials (Rycroft-Malone 
et al., 2004b).  Systematic reviewers, for example, have prioritised the 
randomised controlled trial over any other type of evidence.  One of the reasons 
for this is that evidence-based medicine had its roots in the discipline of 
epidemiology (Swanson, 2001) and epidemiologists predominately use 
quantitative methods, with an underlying positivistic paradigm (Jack, 2006).  
Proponents of such approaches have perceived qualitative research as less 
rigorous and, in traditional hierarchies of research, qualitative research has often 
been absent or poorly ranked (Upshur, 2001).  Black argues that health services 
research is only considered ‘real and serious’ when it uses quantitative 
approaches (Black, 1994).  It should be noted though that many of these 
research hierarchies were based primarily on methods for addressing questions 
of effectiveness or causation, for which qualitative approaches are not designed.  
Many hierarchies now include qualitative research and the emphasis has shifted 
to choosing the appropriate methodological approach for the research question 
(Petticrew and Roberts, 2003). 
Systematic reviewers in the fields of health and social care have begun to 
recognise that for many interventions, in particular complex interventions, we 
need to go beyond merely addressing questions of ‘what works’.  Instead we 
need to seek an understanding of the influence of contextual factors and the 
social, political and economic determinants of health and health-related 
behaviours (Hills, 2000).  To gain a greater understanding of these factors it is 
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increasingly recognised that researchers may need to ‘conduct research within a 
naturalistic paradigm using qualitative research approaches (Jack, 2006).  
Qualitative research can help us go beyond questions purely about what works 
and help us to explore questions such as: why does an intervention work and for 
whom does it work and in what circumstances (Barbour, 2000)?  It can help us 
plan and interpret quantitative research, allow us to explore contradictions in 
the evidence, access sensitive or hard to reach settings where RCTs would be 
unethical or unfeasible, explore barriers and facilitators to the successful 
implementation of interventions and programmes and allow for the 
development of theory.  
Qualitative research, therefore, has a number of roles within systematic reviews, 
both in conjunction with quantitative research and in its own right.  A chapter on 
the role of qualitative research within Cochrane reviews has recently been added 
to the Cochrane Handbook (Noyes et al., 2008).  The authors of this chapter list a 
number of ways in which qualitative research might contribute to reviews of 
effectiveness.  This includes:  
 Helping to define the question  
 Enhancing reviews by synthesizing evidence from qualitative research 
identified whilst looking for evidence of effectiveness  
 Extending reviews by undertaking a search to specifically seek out 
evidence from qualitative studies to address questions directly related 
to the effectiveness review  
 Supplementing reviews by synthesizing qualitative evidence within a 
stand-alone, but complementary, qualitative review to address 
questions on aspects other than effectiveness   
The above are all concerned with how qualitative research might enrich 
traditional reviews of quantitative studies.  Many qualitative systematic reviews, 
however, are not associated with particular evaluations of effectiveness although 
by gaining a greater understanding of human behaviour or beliefs they may 
further the development of appropriate interventions. 
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However, although the use of qualitative research in systematic reviews has 
become relatively commonplace there are those who have argued that it is 
inappropriate to attempt to synthesize qualitative research.  The basis for such 
criticisms is that systematic reviews are reductionist, that you cannot make any 
form of generalisation from qualitative research, and that the uniqueness and 
complexities of qualitative studies resist ‘summing up’ (Light, 1984).  Dixon 
Woods is a qualitative researcher who has done much work around systematic 
reviews.  Whilst she is an advocate of systematic reviews of qualitative research 
she does acknowledge that a basic tension exists between qualitative research, 
which relies on interpretation and reflection, and the more rigid structured 
processes associated with systematic reviews (Dixon-Woods and Fitzpatrick, 
2001).  Despite such concerns about the place for systematic reviewing in 
qualitative research it has been suggested that a failure to synthesise means 
qualitative researchers are working in isolation and are in danger of reinventing 
the wheel (Sandelowski et al., 1997).  As with quantitative research there is a 
danger of duplication and there may be benefits to situating qualitative research 
within larger programmes of work so that it forms part of the whole research 
body and contributes to the development of policy and practice in a meaningful 
way.   
Conceptual approaches/methodologies 
The methods for systematic review of quantitative studies are well established 
and widely acknowledged.  Although various guidelines exist for the conduct of 
systematic reviews, such as those produced by the Cochrane Collaboration 
(Higgins, 2008), the NHS Centre for Reviews and Dissemination (CRD, 2009) and 
the National Institute for Health and Clinical Excellence (NICE, 2006), these 
manuals by and large propose similar methods.  The conceptual basis of these 
methods is that the adoption of a structured approach is essential to minimise 
bias and error.  The need for a well-defined question, comprehensive searches 
and critical appraisal of included studies are well accepted, and methods for 
synthesis widely agreed upon.  In contrast such concord does not exist amongst 
those synthesising qualitative research.  Indeed, there are a variety of methods 
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for synthesis guided by a number of different conceptual approaches. Methods 
can broadly be grouped into those designed for use with quantitative and 
qualitative data, such as thematic analysis, realist synthesis, and Bayesian meta-
analysis, and those such as meta-ethnography which are intended for the 
synthesis of qualitative data only. These and other approaches are summarised 
in Table 6.1.  This table combines previous overviews (Barnett-Page and Thomas, 
2009, Dixon-Woods et al., 2006a) with my own observations. 
Qualitative systematic reviews have been conceptualised as ‘interpretive’ as 
distinct from the more ‘integrative’ approach taken in quantitative reviews 
(Noblit and Hare, 1988).  Integrative reviews primarily involve the synthesis of 
quantitative studies, are concerned with combining or amalgamating data and 
may involve techniques such as meta-analysis.  Interpretive reviews, on the other 
hand, are suitable for synthesising qualitative research and involve both 
induction and interpretation.  Synthesis is achieved through subsuming the 
concepts identified in the primary studies into a higher order theoretical 
structure.  Dixon-Woods expands on this by saying that ‘the defining 
characteristic of an interpretive synthesis is its concern with the development of 
concepts, and with the development and specification of theories that integrate 
these concepts... the main concern is not aggregations  of data but theory’ 
(Dixon-Woods et al., 2005).  However, despite their differences, there is overlap 
between the methods with integrative reviews involving elements of 
interpretation and  interpretive syntheses involving elements of aggregation of 
data (Dixon-Woods et al., 2005).  Indeed, not all qualitative reviews fall into the 
interpretive paradigm with some taking a more quantitative integrative approach 
than others.  For example, Dixon-Woods argues that some methods such as 
narrative summary, meta-ethnography and meta-synthesis lie more at the 
interpretive end of the spectrum whilst others such as content analysis and 
comparative analysis are more integrative.  In addition, some methods are 
designed purely for the synthesis of qualitative research whereas others are 
intended to be used for the synthesis of quantitative and qualitative research, 
often integrated into the same review.   
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In a critical review of methods for the synthesis of qualitative research Barnett-
Page and Thomas suggest that many of the differences in approaches are 
explained by epistemological positions; in particular whether they can be 
categorised as falling into ‘realist’ or ‘idealist’ epistemologies (Barnett-Page and 
Thomas, 2009).  They used categories based on those of Spencer and colleagues 
(Spencer et al., 2003) which are organised into the following spectrum: 
 Subjective idealist: there is no shared reality independent of multiple 
alternative human constructions 
 Objective idealism: there is a world of collectively shared 
understandings 
 Critical realism: knowledge of reality is mediated by our perceptions 
and beliefs 
 Scientific realism: it is possible for knowledge to approximate closely 
an external reality 
 Naive realism: reality exists independently of human constructions 
and can be known directly 
Barnett-Page and Thomas classify different methods by where they fit on this 
spectrum and argue that iterative methods such as critical interpretive synthesis 
and meta-study are at the ‘subjective idealist’ end of the spectrum.  For example 
when describing meta-study Patterson argues that as primary studies are 
themselves constructs then syntheses are constructs of constructs (Paterson et 
al., 2001) and that there is no such thing as an ‘absolute truth’.  Meta-
ethnographic approaches and grounded theory they categorise as methods 
informed by objective idealism.  In contrast thematic synthesis and framework 
synthesis, which are designed to directly inform policy and practice, take more 
realist approaches to synthesis (Barnett-Page and Thomas, 2009). 
Whilst there may be some justification for such a diversity of methodological 
approaches there is also a real danger of duplication.  Dixon-Woods warns that 
‘in seeking methodological developments, existing methods will be overlooked, 
and there will be a proliferation of methods that risk re-inventing the wheel 
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(Dixon-Woods et al., 2005).  In addition, the profusion of terms can be confusing 
and may mask some of the basic similarities in methodological approaches 
(Barnett-Page and Thomas, 2009). Indeed, many reviews of qualitative studies, 
such as the one presented in this chapter, do not strictly adhere to one 
methodology but rather incorporate aspects from several.   
Review methods 
Question Development 
One of the first things we teach those new to systematic reviewing is how to 
develop a well defined question.  This generally involves specifying the type of 
intervention, participants, outcomes and study designs we intend to include.  We 
stress the importance of getting this part of the review process right before we 
begin our searches as post-hoc changes to the question are discouraged because 
they are considered to increase the risk of bias.  However, a number of 
researchers have suggested that with qualitative reviews a more iterative 
approach to question development may be more appropriate.  Dixon-Woods, for 
example, argues that there are ‘strong epistemological reasons for adopting a 
position closer to that of primary qualitative research in formulating a question 
for a review that includes qualitative research (Dixon-Woods et al., 2006a).  
Unlike a purely quantitative review the definition of what the phenomenon of 
interest is may be generated through the process of searching for and identifying 
papers.  Indeed, it has been suggested that the question should be treated as ‘a 
compass rather than an anchor, and as something that is not finally settled until 
the end of the review’ (Eakin and Mykhalovskiy, 2003).  My own experiences 
would support the view that more iterative processes are appropriate for 
systematic reviews of qualitative studies.  However, it is still important to have a 
well defined question before significant data extraction, analysis and 
interpretation of results is undertaken. 
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Identification of studies 
There are a number of factors that can make the identification of qualitative 
studies problematic.  One of these is the lack of reliable search filters that filter 
out those studies using the research methods of interest.  Such methodological 
filters are ‘predetermined search strategies that use terms related to research 
design to identify all those studies using the research methods of interest to the 
reviewer’ (Evans, 2002); and methodological filters have been used to great 
effect for the identification of RCTs.  The development of search filters for 
qualitative studies is difficult partly because at present most databases do not 
have reliable indexing terms for qualitative research (Barroso et al., 2003, Dixon-
Woods et al., 2001, Evans, 2002) and formal indexing terms may perform poorly 
for identifying relevant studies (McKibbon et al., 2006).  For example the 
descriptor for qualitative research in Medline is of limited value as it was only 
introduced in 2003.  Before that it came under the heading of ‘nursing-
methodology research’.  In contrast CINAHL introduced the term ‘Qualitative 
Studies’ in 1988 which reflects a greater interest in qualitative research for 
nursing researchers.  In addition developing search filters is complicated by the 
fact that qualitative research encompasses many different research methods and 
approaches, such as ethnography, phenomenology and grounded theory (Evans, 
2002), and that the term ‘qualitative’ is used and understood in a variety of ways 
(Dixon-Woods et al., 2006a, Grant, 2004). 
Another reason that qualitative research is hard to identify is that qualitative 
research reports are renowned for producing poor descriptors of the research 
methods, with neither the title nor abstract stating the methods used (Evans, 
2002).  For example, the title may be more likely to reflect some aspect of the 
findings rather than the methods used in the study (Evans, 2002).  In comparison 
the methods would almost always be reflected in the title of an RCT.  
Furthermore, many abstracts for qualitative studies may be missing.  In an 
evaluation of different search strategies Shaw and colleagues found that 23 per 
cent of relevant qualitative studies on breastfeeding did not have an abstract in 
the database (Shaw et al., 2004). 
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However, there has been significant progress in identifying and developing 
methodological filters for qualitative studies.  The Cochrane handbook (Noyes et 
al., 2008) points out that there are now empirically-tested methodological filters 
for MEDLINE (Wong et al., 2004), CINAHL (Wilczynski et al., 2007), Psychinfo 
(McKibbon et al., 2006) and EMBASE (Walters et al., 2006).  Research suggests 
that of the major databases CINAHL may be the best source of qualitative studies 
as the methodological indexing terms they use will identify a greater number of 
qualitative studies than in other databases such as medline or Psychinfo (Evans, 
2002, Flemming and Briggs, 2007). 
So far the discussion in this section has been based on the assumption that we 
should take a similar approach to searching for reviews of qualitative studies as 
we would in a quantitative review; i.e. we should attempt to identify all the 
available research and our search strategies should be transparent and 
reproducible.  Such comprehensive search strategies are one of the cornerstones 
of systematic reviewing and considered crucial for minimising bias.  This is the 
approach that we adopted for the paper included in this chapter.  However, it 
has been suggested that the justification for exhaustive search strategies is not 
as great in systematic reviews of qualitative research and that is may be 
appropriate to take a more purposive sampling approach, ‘aiming to provide a 
holistic interpretation of a phenomenon, where the extent of searching is driven 
by the need to reach theoretical saturation and the identification of the 
disconfirming case may be more appropriate’ (Dixon-Woods et al., 2006b).  After 
all qualitative studies themselves do not claim to be representative or 
generalisable.    
Critically Appraising Studies 
Traditionally a key component of systematic reviews of quantitative studies, and 
one that distinguishes them from conventional literature reviews, is the critical 
appraisal of included studies.  As discussed in Chapter 4, quality assessment is 
considered essential as it enables us to make judgments about the potential level 
of bias in a review.  In comparison, the role of critical appraisal in systematic 
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reviews of qualitative research is less well established, with much debate about 
whether reviewers should critically appraise qualitative research at all.  
Arguments against critical appraisal are generally constructed around the 
uniqueness of qualitative research.  As Mays and Pope point out extreme 
relativists may take the position that all research is unique and valid in its own 
terms (Mays and Pope, 2000).  In addition, it has been argued that quality 
assessment stifles the interpretive and creative aspects of qualitative research 
(Schwandt, 1996) and that qualitative research represents a distinctive paradigm 
and as such should not be judged by conventional measures of validity, 
generalisability and reliability.  However, it has been suggested that such a 
position would find little support among health researchers (Murphy et al., 
1998).  Despite such concerns qualitative researchers involved in evidence 
synthesis generally agree that some form of quality assessment is important 
(Campbell et al., 2003, Dixon-Woods and Fitzpatrick, 2001, Noyes et al., 2008, 
Popay et al., 1998), as poor quality studies may distort findings and lead to 
difficulties in interpretation. 
Although there is now a growing consensus that quality assessment of qualitative 
studies is important there is, as yet, no agreement about the form such 
appraisals should take.  Qualitative researchers may have very different 
disciplinary, philosophical, and theoretical ideas and researchers from different 
paradigms may hold very diverse opinions about the characteristics that define a 
good qualitative study (Dixon-Woods et al., 2004, Sandelowski et al., 1997).  
Dixon-Woods points out that a key problem is that ‘much of the work on 
developing appraisal criteria for qualitative research has been the tendency to 
treat it as a unified field, both at the level of data collection (such as focus 
groups) and at the level of the methodological approach (such as grounded 
theory)’ (Dixon-Woods et al., 2004).  In qualitative research the methodological 
approach is generally closely linked to the theoretical perspective adopted by the 
researcher, and reflecting such differences in quality assessment can be a 
considerable challenge.  What might be considered essential for one 
methodology or perspective may not be deemed important for another.  
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Quality assessment checklists and guidelines 
Even if a reviewer accepts the position that critical appraisal is a necessary part 
of the review process they are still faced with the question of how they go about 
quality assessment and whether or not they should use a formal framework or 
checklist as a guide.  Reviewers of quantitative studies also face these dilemmas 
but despite a proliferation of quantitative checklists there is good agreement on 
what the important quality domains are; for example randomisation, allocation 
concealment, blinding and attrition rates.  There are now over 100 sets of quality 
criteria for qualitative research but many of these take ‘non-reconcilable 
positions’ on a number of issues (Dixon-Woods et al., 2004) and fail to distinguish 
between different study designs or theoretical approaches (Dixon-Woods et al., 
2006a).  No single set of guidelines is definitive (Mays and Pope, 2000).  In 
response to this dilemma a project by the UK National Centre for Social Research 
attempted to further a consensus on quality criteria by producing a framework 
for assessing qualitative research.  The development of this framework was 
guided by a number of existing frameworks,  interviews with those active in the 
area and a workshop (Spencer et al., 2003).  This framework is one that is 
recommended in the Cochrane handbook and is the one that we used for the 
review presented in this chapter.  However, like Dixon-woods, we found the 
framework lengthy and unwieldy (Dixon-Woods et al., 2004) and had to shorten 
it to make it fit for our purpose.  Even the shortened version remains lengthy and 
time-consuming to complete. 
Whilst all quality assessment is to some extent subjective, even for quantitative 
studies, my experience of assessing qualitative studies is that subjectivity is even 
more of a concern.  We overcame this to some extent by two reviewers 
independently assessing quality and then meeting to discuss the criteria and 
agree final decisions. It may be though that quality assessment of qualitative 
studies will always be inherently subjective.  Dixon-Woods argues that some 
aspects of qualitative research, particularly those relating to insight and 
interpretation, are difficult to appraise and may remain very difficult to measure 
except through the subjective judgement of experienced qualitative researchers 
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(Dixon-Woods et al., 2004, Dixon-Woods et al., 2007).   In a comparison of three 
methods for quality appraisal (Dixon-Woods et al., 2007) researchers found that 
structured approaches, such as the use of frameworks, did have some 
advantages but that they did not result in higher agreement between reviewers 
than unprompted judgment.  However, the use of judgement alone may require 
a reviewer to have a greater depth of expertise than a more structured 
approach.  As a reviewer with a quantitative rather than qualitative background I 
found the checklist a useful guide despite its flaws. 
How should quality information be incorporated into a review? 
In addition to concerns about the objectivity of quality assessment a reviewer 
must also consider which quality domains to include and if they should be 
weighted in any way.  For example, with RCTs allocation concealment is regarded 
as a key marker of quality because of empirical evidence that poor allocation 
concealment can lead to distortion of treatment effects (Schulz et al., 1995).  As 
with the appraisal of quantitative studies, there is also a need to distinguish 
between those criteria which are about quality of process and analysis and those 
which concern transparency of reporting (Dixon-Woods et al., 2004).  In recent 
years the advent of guidelines for reporting RCTs , diagnostic and observational 
studies (CONSORT (Begg et al., 1996), STARD (Bossuyt et al., 2003) and STROBE 
(Vandenbroucke et al., 2007)) has meant that reports of quantitative studies are 
more likely to be reported in a standardised way.  In addition, I would argue that 
systematic reviews with their emphasis on quality assessment of individual 
studies have highlighted the need for improved quality and reporting in primary 
studies.  In contrast reports of qualitative studies tend to vary in writing styles 
and publication formats with detailed descriptions of methods and data analysis 
procedures typically lacking  (Harden et al., 2004).  
Finally, and very importantly, the reviewer is faced with the question of how to 
use information on quality within the review.  For reviews of quantitative studies 
that include a meta-analysis we can explore the impact of quality by performing 
sensitivity analyses.  Such a statistical option is not available to us when 
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reviewing qualitative studies.  Alternatives may be to use quality as a criteria for 
excluding studies (Campbell et al., 2003, Estabrooks et al., 1994), or to grade the 
studies so that those considered better quality are given more weight in the 
analysis than those of poorer quality (Attree, 2004).  Researchers are 
undertaking more methodological work in this area and in a paper describing the 
methods used for thematic synthesis of qualitative studies (Thomas and Harden, 
2008) the authors describe how they investigated the contribution studies made 
to the synthesis in light of their quality.  They found that better studies appeared 
to contribute most to the synthesis.  In the review included in this chapter we did 
not undertake sensitivity analyses although this is something that I would 
consider for future review of qualitative studies.  Such strategies are, however, 
complicated by the lack of consensus on what constitutes a ‘good’ quality 
qualitative study.   
Data synthesis 
Methods for synthesis 
As discussed earlier in the chapter there has been a proliferation of 
methodological approaches to the systematic review of qualitative studies.  A 
number of commentators have attempted to describe the similarities and 
differences between methods for synthesis of data (Barnett-Page and Thomas, 
2009, Dixon-Woods et al., 2005).  Clearly some methods reflect a more 
quantitative logic than others with the main concern being to summarise, map or 
catalogue the findings often through the identification of common themes and 
concepts.  In meta-summary, for example, Sandelowski describes an aggregative 
method that involves summarising rather than ‘transforming’ findings and that 
even allows for the calculation of ‘effect sizes’ (Sandelowski and Barroso, 2007).  
In contrast other methods are much more concerned with the development of 
theory.  Dixon-Woods describes her method of critical interpretive synthesis and 
says that the ‘defining characteristic of an interpretive synthesis is its concern 
with the development of concepts, and with the development and specification 
of theories that integrate those concepts’ (Dixon-Woods et al., 2006a).  The main 
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product is not aggregations of data but theory.  Similarly Britten talks about the 
development of first, second and third order constructs suggesting that 
systematic reviews may allow the development of new higher order theoretical 
ideas (Britten et al., 2002).  Some methods, such as meta-ethnography and meta-
synthesis are designed for use with qualitative studies only, whereas the 
instigators of methods such as critical interpretive synthesis and realist synthesis 
claim that they can be used to synthesise all types of evidence. It is also 
important to remember that the interpretative emphasis of qualitative reviews 
may mean that, unlike quantitative reviews which are in theory reproducible, 
reviewers will not necessarily come to the same conclusions (Dixon-Woods et al., 
2006a). 
It has been suggested that variations in the extent to which methods attempt to 
‘go beyond’ the primary study is influenced by the epistemological position 
where those from a more idealist perspective ‘seek to push beyond the original 
data to a fresh interpretation of the phenomena under review’.  In contrast 
those taking a more ‘realist’ perspective may focus on describing and 
summarising their data.  Indeed, as a reviewer with a predominantly quantitative 
background the approach I took in our review could be described as more 
‘realist’ than ‘idealist’.  
Sampling 
In the earlier critique of issues around the identification of studies I noted that 
some researchers do not feel that it is necessary to identify all available studies 
but that a purposive approach, whereby the reviewer chooses papers they think 
are relevant, could be appropriate.  The issue of sampling rather than a 
comprehensive approach is also relevant when we talk about analysis.  Reviews 
of qualitative studies may identify many studies, and assessment and analysis 
may be time consuming and costly.  It has been suggested that it is not necessary 
to include all identified studies but that instead the reviewer could adopt an 
approach similar to that of sampling for primary qualitative research (Dixon-
Woods et al., 2006a, Schreiber et al., 1997).  Such an approach, however, would 
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rely on the reviewer deciding which papers to include, and this could be 
problematic for a number of reasons.  As Dixon-Woods acknowledges, such an 
approach could leave the review open to the accusation that it is no longer 
objective or ‘systematic’. Indeed, one of the major criticisms of the traditional 
literature review was the subjective way in which studies were chosen for 
inclusion.  In addition, there is concern that sampling would mean missing 
relevant studies which could have usefully contributed to the phenomenon 
under study (Jensen and Allen, 1996).  Our approach for this review was to 
include all relevant studies in the analysis.   
Results of impact analysis 
Knowledge production 
Publication and other methods of dissemination 
The review was published in the journal Ageing and Society in 2008 (Bunn et al., 
2008a) and was also disseminated via conference papers and seminars. 
Impact within research community 
When the citation analysis for the paper was carried out on the 18th August 2009 
there were no citations in Scopus or Web of Science and only one in Google 
Scholar.  The latter was a citation in a thesis from the University of Hong Kong.  
This lack of citations may be explained by the fact that the paper was only 
published in 2008 and had, therefore, had little time to make an impact.  It has 
been found that on average it takes three years for a paper to be cited (Grant 
and Lewison, 1997) and the median time lag between the publication of a paper 
and its inclusion in published guidelines is eight years (Grant et al., 2000).  
Indeed, when I repeated the citation analysis in April 2010 there was one citation 
in Scopus and Web Of Science, a Danish paper looking at barriers to participation 
in a hospital falls clinic, and five citations in Google Scholar (one of which was a 
self-citation). 
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Informing policy development 
I was unable to identify any discernable effect on health care policy in response 
to the publication of this review.  As already suggested one explanation for this 
may be the relatively short time since publication.  In his work on the policy cycle 
Sabatier argues that the process of policy change ‘requires a time perspective of 
a decade or more’ (Sabatier, 1988).  This ties in with Weiss’s ideas of the 
enlightenment function of research (Weiss, 1977) that argues that a focus on 
short-term impact will underestimate the influence of research because one of 
the functions of research is to alter perceptions and concepts of policy makers 
and researchers over time.  In addition, it is worth considering whether it is 
appropriate for all research to impact on policy.  The impact of a review must, to 
some extent, be related to the aim or purpose of the study. In this instance the 
review was part of a larger project and was designed to inform the development 
of a qualitative study. Indeed the purpose of systematic reviews is often to 
inform the development of a piece of primary research, or to justify the need for 
primary research, and its impact on policy may be through the primary study it 
informed.  
As I found so little evidence of any influence upon policy this chapter does not 
include a detailed evaluation of impact.  Instead in the following section I look 
more broadly at issues around systematic reviews of qualitative research and 
their role in informing policy decisions. 
Do reviews of qualitative research impact upon policy? 
In an examination of the role of qualitative research in influencing the policy 
process Rist argues that qualitative research may impact upon policy at a number 
of levels (Rist, 1994, Rist, 2003).  He takes the position, as do others (Chelimsky, 
1985, Guba E, 1984, Nakamura R and Smallwood, 1980), that the policy making 
process is a cycle that involves three phases; policy formulation, policy 
implementation and policy accountability.  Each phase has its own order and 
logic, own information requirements and own policy actors (Rist, 1994).  At the 
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policy formulation stage policy makers need to define clearly and understand the 
problem or condition that they are facing.  He suggests that qualitative research 
may be highly relevant at this stage; for example looking at the social 
construction of problems, and community and organizational receptivity.  
However, he argues that because ‘the window for policy formulation is small’ it 
may not allow for the conduct of new qualitative research.  Therefore, ‘the 
information that can be passed through has to be ready and in a form that 
enhances quick understanding’ (Rist, 1994).  Risk also suggests that qualitative 
research may inform policy implementation arguing that the ‘ground-level view 
of implementation is best done through qualitative research’.  In the final stage 
of policy accountability he says that qualitative research may allow for an 
examination of the strengths and weaknesses of a programme’.    
Rist suggests, however, that qualitative research has not fulfilled its potential 
contribution to the policy process because ‘there is no broad-based and 
sustained tradition within contemporary social science of focusing on qualitative 
research specifically on policy issues’ (Rist, 1994).  Others have argued though 
that qualitative studies have been routinely excluded from evidence review and 
policy development (Graham and McDermott, 2006).  However, there is now a 
growing support for the inclusion of qualitative research in systematic reviews.  
Many commentators have claimed that reviews of quantitative research may be 
too narrow to help policy-makers and practitioners make decisions (Greenhalgh 
et al., 2003, White, 2001) and suggested that incorporating qualitative research 
will increase their utility and relevance (Oliver, 2005b, Oliver, 2001).  Indeed, 
discussions with policy makers have found that qualitative research, and the 
stories of individuals, are an important part of what they see as evidence 
(Petticrew et al., 2004, Whitehead et al., 2004).   
Several methods have been developed that aim to increase the policy relevance 
of systematic reviews through the incorporation of qualitative research.  Oliver 
and colleagues (Nilsen et al., 2006, Oliver, 2005b, Oliver et al., 2008) describe 
how they have developed a framework to enable them to synthesise findings 
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from both qualitative and quantitative studies in the same review.  The 
framework, which includes a theoretical component, allowed them to examine 
evidence for effectiveness alongside qualitative evidence on barriers and 
facilitators.  Data is displayed in a way that enables readers to navigate the 
charts presented to find evidence relevant to their circumstances (Oliver et al., 
2008).  Such an approach they suggest enabled them to make explicit 
recommendations for policy and practice based on ‘transparent evidence’ 
(Oliver, 2005b) and allows policy makers to draw out relevant implications for 
themselves (Oliver et al., 2008).  They cite how a review on promoting healthy 
eating and physical activity for young people (Shepherd et al., 2001) was able to 
directly influence health care policy such as the National Service Framework for 
coronary heart disease (DOH., 2000). 
An alternative approach is Bayesian meta-analysis.  From a Bayesian perspective 
(Spiegelhalter et al., 2000, Sutton and Abrams, 2001) synthesis of research 
evidence is a decision-making process and as such ‘pre-existing beliefs, subjective 
judgments and access to external sources of evidence will all shape 
interpretation’ (Roberts et al., 2002).  In a review of factors affecting the uptake 
of childhood immunisation, qualitative research was used to revise the pre-
existing subjective beliefs of the reviewers; beliefs that were then used to inform 
the analysis.  The reviewers concluded that ‘the use of either qualitative or 
quantitative research alone might not identify all relevant factors, or might result 
in inappropriate judgments about their importance’ (Roberts et al., 2002). 
Another technique for incorporating qualitative research, and one that claims to 
increase relevance to policy makers, is Realist Synthesis.  This is concerned with 
explanations of the mechanisms of programmes in particular contexts and 
settings rather than overall judgements of effectiveness.  It has its roots in 
philosophy and Pawson and colleagues suggest that it is an appropriate 
methodological approach for complex policy interventions (Pawson et al., 2005).  
Their support of the realist approach is based on the complex, active and 
dynamic nature of complex service interventions; interventions that are subject 
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to reinvention and adaptation in different circumstances and contexts.  They 
suggest that under a realist evaluation the basic question changes from ‘what 
works’ to ‘what is it about this programme that works for whom in what 
circumstances’ (Pawson et al., 2005).  Realist synthesis does not distinguish 
between, or prioritise, different research designs but instead takes the position 
that ‘multiple methods are needed to illuminate the richer picture’.  Like 
framework synthesis existing theoretical standpoints form the basis of the 
review, with prevailing theories mapped, tested and refined.   
Whilst the realist review may use conventional systematic review headings as a 
starting point it is methodologically very different.  The process is far more 
iterative and non-linear than a traditional systematic review with steps of the 
process overlapping each other.  Owing to the emphasis on refining theories they 
argue that ‘second thoughts can (and should) occur at any stage’ (Pawson et al., 
2005).  They claim this method is particularly relevant to policy makers because 
‘realist review raises the status of linkage from a recommendation to a 
methodological requirement’ (Pawson et al., 2005).  In addition, they take the 
standpoint that research influences policy according to Weiss’s theory of 
enlightenment and that realist review is particularly suited to informing policy 
through the ‘drip drip of enlightenment’. 
The methods for systematic review described above all make claims for 
increasing policy relevance.  However, one of the dilemmas is whether some of 
these approaches are compatible with the basic systematic review principles of a 
rigorous scientific approach.  For example, although I can see the rationale of 
realist synthesis it is not a methodology that I would choose.  Although realist 
synthesis can supposedly incorporate all types of research, including quantitative 
research, it does not, to my mind, satisfactorily address questions around the 
effectiveness of interventions.  Although ‘what works’ is not the only question 
we should be asking I still believe it is a fundamental question and one that we 
need to approach with rigour.  I would also argue that it is appropriate to 
prioritise some research designs over others.  This does not mean prioritising 
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quantitative research over qualitative research but rather it means recognising 
that they might contribute to different parts of the evidence ‘jigsaw’ (Whitehead 
et al., 2004).  In addition, I believe it is right to regard some quantitative designs, 
such as RCTs, as superior to other quantitative designs, such as uncontrolled 
studies, because RCTs are less susceptible to bias. 
The approaches above all are concerned with reviews that include both 
quantitative and qualitative research in the same review.  Whether reviews, such 
as ours, that only include qualitative research can be as useful for policy makers 
is not clear.  Indeed, in an echo of Rist’s claim that qualitative researchers have 
not focused on influencing policy I was able to find little literature that 
specifically addressed the question of the impact of qualitative systematic 
reviews upon policy.  It may be that qualitative research is primarily seen by 
decision makers as useful for explaining the results of quantitative research or 
for developing quantitative research (Olson, 2001); indeed this is how it is 
conceptualised in Cochrane handbook. 
Conclusion 
Although there is increasing support for the inclusion of qualitative research in 
systematic reviews there remains some debate and confusion about the most 
appropriate methods and whether systematic reviews of qualitative research can 
be conducted using the same structures as those offered by conventional 
systematic review methodology (Dixon-Woods et al., 2006a).  These concerns 
arise both because of technical issues, such as how to identify studies, but also 
due to epistemological questions about what constitutes qualitative research, 
what constitutes a good quality study and should searches be comprehensive.  
Unlike conventional systematic reviews, processes for reviews including 
qualitative research may need to be more iterative and organic (Greenhalgh et 
al., 2005).  Despite the diversity of techniques none, as yet, seem to have 
secured a dominant position. 
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I found no evidence that the systematic review presented in this Chapter (Bunn 
et al., 2008a) has had any impact or influence upon health care policy in England.  
This lack of impact is perhaps not particularly surprising when we consider the 
fact that the review is only recently published and has not yet had time to 
influence the policy process.  In addition, it should be noted, that the purpose of 
the review was to inform the development of a primary study and, thus, fulfilled 
the purpose for which it was designed.  Most of the work that I found on 
improving the policy relevance of qualitative reviews concerned reviews 
incorporating both quantitative and qualitative studies; I found little that 
addressed reviews that only included qualitative research.  It is possible that 
qualitative reviews may have greater impact if they are formally linked to a 
review of quantitative studies evaluating effectiveness.  It would appear that 
more work is needed to explore whether reviews that only include qualitative 
research can impact upon policy and to identify ways of facilitating their 
influence. 
Finally it is worth considering how the approach chosen to synthesise qualitative 
research might impact upon its relevance or utility for policy makers, and 
therefore upon its potential to impact upon the development of health care 
policy.  Rist argued that qualitative research needed to be in a form that 
‘enhances quick understanding’ (Rist, 1994) and this must be as pertinent to 
systematic reviews as it is to primary research.  It has been suggested that some 
methodological approaches to the synthesis of qualitative research may be more 
useful to policy makers than others. Some of the more interpretive approaches 
may be more complex, and may operate at a conceptual or symbolic level that 
may require further interpretation by policy makers before they can usefully 
inform practice (Barnett-Page and Thomas, 2009). 
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Table 6.1 Methods for Systematically Reviewing Qualitative Evidence 
Method Author/examples Main features 
 
Advantages Disadvantages 
Bayesian Meta-
analysis 
Example of this 
approach (Roberts 
et al., 2002) 
• Qualitative evidence used to identify 
variables to be included in meta-
analysis 
• Prevents partial synthesis 
by including both 
quantitative and qualitative 
 
• Not easy to implement 
• Techniques still under 
development 
Content analysis  
• Technique for categorising data and 
determining frequencies of categories 
• Transparent processes 
• Converts qualitative data 
into quantitative form and 
makes it easier to 
manipulate within 
quantitative frameworks 
 
• Reductive 
• Results may be oversimplified 
• Diminishes complexity and 
context 
Critical interpretive 
synthesis 
 
Dixon-Woods 
(Dixon-Woods et 
al., 2006b) 
 
Adaptation of 
meta-ethnography 
and also borrows 
techniques from 
grounded theory 
 Adaptation of traditional meta-
ethnographic methods 
 Aim is generation of a synthesising 
argument (lines of argument) 
 Sampling highly iterative, sample 
rather than identify all literature 
 Development of theoretical categories 
based on analysis of conceptual 
similarities and differences that 
identified in the literature, and 
constant comparison across these  
 Critique rather than critical appraisal – 
treats literature as an object of 
inquiry 
 Recognises the partial nature of any 
account of the evidence but is explicit 
and reflexive about this 
 
 Provides guidance on 
sampling and critical 
appraisal 
 Can be used to 
synthesis all types of 
evidence including 
quantitative evidence 
 Puts the author back in 
 
 Only suitable for 
experienced qualitative 
researchers 
 More work is needed on 
the impact of appraisal on 
synthesis 
 Not inherently 
reproducible 
 Many issues remain to be 
resolved 
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Framework 
synthesis 
Brunton and Oliver 
(Brunton et al., 
2006, Oliver et al., 
2008) 
Based on 
framework analysis 
as outlined by Pope 
and colleagues 
(Pope et al., 2000) 
 Rationale is that qualitative research 
produces large amount of textual data 
 Framework synthesis provides highly 
structured approach to organising and 
analysing data 
 Uses a priori framework 
 Indexing using numerical codes 
 Can be used to map nature and range 
of concepts under study 
 Potentially useful for policy 
makers 
 
Grounded theory 
approach 
Based on work by 
Glaser and Strauss.  
Developed as 
method for 
synthesis e.g. 
(Eaves, 2001, 
Kearney, 2001) 
 Over-riding concern is generation of 
theory 
 Inductive approach to analysis – 
allowing theory to emerge from data 
 Uses constant-comparison method 
 Generation of higher order themes 
 Theoretical sampling and saturation 
means number of papers for review 
can be limited 
 
 Potential for generation of 
new theory 
 Not well established as a 
method for synthesis 
 Few examples 
 Lacks transparency 
 No guidance for how to 
critically appraise studies 
Meta-ethnography Based on work by 
Noblit and Hare 
(Noblit and Hare, 
1988) 
Involves 3 major strategies: 
 Reciprocal translational analysis (RTA) 
– key themes or concepts are 
identified 
 Refutational synthesis – contradictions 
between reports are examined 
 Lines of agreement synthesis (LOA) – 
involves building a general 
interpretation grounded in the findings 
of the separate studies 
 Developed to include qualitative 
research using diverse methodological 
approaches 
 Systematic approach – 
preserves interpretive 
approaches of primary data 
 Greater methodological 
work has been done than 
for some other methods 
 Is solely a method for synthesis 
with no guidance on sampling 
or critical appraisal. 
 Demanding and laborious 
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Meta-narrative Greenhalgh 
(Greenhalgh et al., 
2005) 
Approach informed 
by Thomas Kuhn’s 
ideas that 
knowledge 
produced within 
particular 
paradigms (Kuhn, 
1962) 
 Designed to synthesise evidence to 
inform complex policy-making 
questions 
 Involves multi-disciplinary team 
 Synthesised research from wide range 
of disciplines 
 Unit of analysis was unfolding storyline 
 Key dimensions or themes identified 
 Potentially useful for policy 
makers 
 Time consuming and complex 
requiring multi-disciplinary 
team 
 Few examples 
Meta-summary Sandelowski 
(Sandelowski and 
Barroso, 2007) 
 Aggregative 
 Findings accumulated and summarised 
rather than ‘transformed’ 
 Reflects a quantitative logic 
 
 Can be used to discover 
patterns or themes 
 No theory generation 
 Calculation of ‘effect sizes’ may 
be inappropriate 
Meta-synthesis Sandelowski 
(Sandelowski and 
Barroso, 2007) 
• Interpretive integration of qualitative 
findings  
• Goes beyond summaries to offer novel 
interpretations of findings 
• More penetrating than meta-summary 
 
 
 
Meta-Study (Paterson et al., 
2001) 
 
 Interpretive approach grounded in 
constructivist orientation to 
epistemology 
 Involves 3 components: meta-
data-analysis, meta-method, and 
meta-theory 
 No such thing as absolute truth 
 Involves analysis of theory, 
methods and findings of 
qualitative research and synthesis 
 Allows for theoretical 
development 
 Involves consideration 
of 
theoretical/conceptual  
basis of included 
studies 
 Time consuming & lengthy 
 Although critical appraisal 
recommended criteria not 
established  
 May only be suitable for 
experienced qualitative 
researchers 
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into new ways of thinking 
 Requires adoption of theoretical 
framework 
 Involves identifying all relevant 
studies 
 Advanced method for seasoned 
researchers 
 
Narrative summary Examples of this 
approach (Fairbank 
et al., 2000, Popay 
et al., 2006) 
• Varies from simple description of 
findings to more interpretive and 
reflexive accounts 
 
• Can be used to integrate 
quantitative and qualitative 
research  
 
• May be criticised for its lack of 
transparency 
Realist synthesis 
 
Pawson (Pawson et 
al., 2005) 
 Theory driven 
 Integrates diverse forms of evidence 
by using them for proof or refutation 
of theory 
 
 Can be used for synthesis of 
quantitative and qualitative 
data together 
 Treats all forms of evidence as 
equally authoritative 
 May lack rigour in evaluation of 
effectiveness 
Thematic analysis Example of this 
approach (Garcia et 
al., 2002, Thomas 
and Harden, 2008) 
 Some overlap with methods for 
narrative summary 
 Involves identification of prominent or 
recurrent themes 
 Summarises findings of different 
studies under thematic headings 
 
 Flexible and allows 
integration of quantitative 
and qualitative research 
 Allows for transparency 
 Process has been well 
described 
 
 
 Failure to distinguish between 
data or theory driven 
approaches  
 Not clear how different themes 
weighted 
 More work needed on how to 
use quality data within the 
review 
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Chapter 7: Systematic review to inform the development of 
NICE public health guidance 
Introduction 
In this chapter I present a systematic review of interventions for the prevention 
of sexually transmitted infections and teenage pregnancies (Bunn et al., 2006a).  
The review was funded by the National Institute of Health and Clinical Excellence 
(NICE) to inform the development of public health guidance.  As in previous 
chapters I will examine the drivers behind the review, discuss the methods used 
and evaluate the impact of the review.  In addition, as the review was designed 
to inform guidelines, I critically explore issues around the development and 
implementation of guidelines.  This includes the rationale for guidelines, a 
consideration of potential limitations of guidelines, a description of the guideline 
development process and an examination of the impact of guidelines on practice 
and the potential barriers to their successful implementation. 
The nature of the impact evaluation in this chapter differs from the others in this 
submission because the review was specifically commissioned to inform 
Government guidelines; and therefore the link between the review and policy is 
already established.  In addition, the review was not published in a journal but 
rather is published on the NICE website; where it is included as a background 
document to the guidance.  Therefore, although the review is in the public 
domain, it is the guidance, rather than the review, that is most likely to be 
accessed.  In evaluating the impact of the review and guidance I begin by 
examining the extent to which the recommendations in the guidelines are 
concordant with the evidence presented in the systematic review; then I present 
evidence relating to the impact of the review or the guidance.   
Drivers behind review question 
The review in this chapter was commissioned by the National Institute of Health 
and Clinical Excellence (NICE).  NICE was created in 1999 as an independent body 
to appraise the clinical and cost-effectiveness of health technologies referred to 
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it from the Department of Health; its guidance covers England and Wales.  It 
produces guidance in three areas: public health (the promotion of good health 
and prevention of ill health), health technologies (guidance on new and existing 
medicines, treatments and procedures within the NHS) and clinical practice 
(specific conditions and treatments).  Despite ongoing controversy over its role 
and criticisms of a number of its decisions NICE is now well established and has 
become ‘a core policy driver within the national health service in England and 
Wales’ (Collier, 2008). 
The review included here (contraceptive advice and provision for the prevention 
of under 18 conceptions and STIs) was one of three reviews commissioned to 
inform the development of public health guidance on the prevention and 
treatment of sexually transmitted infections and under 18 conceptions.  The 
others, produced by researchers from different institutions, considered evidence 
for the effectiveness of screening for chlamidyial infection in sexually active 
young men and women, and effectiveness of partner notification for sexually 
transmitted infections including HIV.  The three effectiveness reviews, along with 
an economic evaluation, were used to develop guidelines which were published 
in February 20077.   
Topics for NICE reviews generally come directly from the Department of Health.  
However, topics for consideration can come from a number of sources including 
clinical and public health professionals, patients, carers and the general public, 
and the Department of Health's national clinical directors.  In addition, 
suggestions can come from within NICE itself.  A number of criteria are taken into 
account when selecting topics.  This includes the following: 
 burden of disease (population affected, morbidity, mortality) 
 resource impact (i.e. the cost impact on the NHS or the public sector) 
 policy importance (i.e. whether the topic falls within a government 
priority area) 
                                                          
7
 http://www.nice.org.uk/PHI003 
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 whether there is inappropriate variation in practice across the country 
 factors affecting the timeliness or urgency for guidance to be 
produced. 
In this case guidance on sexual health was felt to be needed because there had 
been large increases in many sexually transmitted infections in the UK over the 
previous 10 years, with diagnoses of chlamydia, gonorrhoea and infectious 
syphilis having more than doubled since 1995.  The UK also had the highest rate 
of teenage pregnancy in Western Europe (UNICEF, 2001).  In response to these 
problems the Government of the time set out a number of targets concerning 
sexual health and the prevention of unwanted teenage pregnancies which the 
guidance was designed to promote.  This included a joint Public Service 
Agreement (PSA) target for the Department of Health (DH) and the Department 
for Education and Skills (DfES) to reduce under eighteen conceptions by 50% by 
2010.  In addition, the guidance was intended to support the delivery of a range 
of measures for improving sexual health as set out in the public health white 
paper Choosing Health (DOH., 2004), and the implementation of the National 
Service Framework for Children, Young People and Maternity Services (DOH, 
2004) which set standards for health promotion and prevention with young 
people to reduce the risk of both teenage pregnancy and acquiring a sexually 
transmitted infection.  These measures also all supported the national teenage 
pregnancy strategy (Social Exclusion Unit, 1999) and the national strategy for 
sexual health and HIV (DOH, 2001) which had a number of aims including 
reducing the transmission of HIV and STIs, and reducing the rates of unintended 
pregnancies. 
The full version of the review produced for NICE is over 250 pages long.  
Therefore, only the executive summary of the report is presented in Appendix 2.  
The full version of the report can be found on the NICE website at the following 
address: 
http://www.nice.org.uk/nicemedia/pdf/STI_University_Of_Hertfordshire_Final.p
df 
154 
 
Rationale for guidelines 
Clinical guidelines have been defined as ‘an attempt to distil a large body of 
medical expertise into a convenient, readily usable format’ (Cook et al., 1997)’ 
and as ‘systematically developed statements to assist practitioner and patient 
decisions about appropriate health care for specific clinical circumstances’ 
(Woolf et al., 1999).  NICE claims that their guidelines can be used to: 
 Provide recommendations for the treatment and care of people by 
health professionals 
 Develop standards to assess the clinical practice of individual health 
professionals 
 Assist in the education and training of health professionals 
 Help patients to make informed decisions 
 Improve communication between patient and health professional 
Although guidelines are not a new technology, in recent years they have 
attracted increasing attention and the use of guidelines is now widespread not 
just in the UK but also internationally.  The increasing emphasis on developing 
and using guidelines is undoubtedly associated with the rise of the evidence-
based practice movement (Timmermans and Mauck, 2005).  However, there are 
other factors, rooted in issues that most health care systems face,  that have also 
contributed to their ascendency (Woolf et al., 1999).  One of the most significant 
of these is the rising cost of health care which is fuelled by an increasing demand 
for care, more expensive technologies and an ageing population.  Before 
interventions are recommended for widespread use NICE assesses both clinical 
effectiveness and cost-effectiveness.  However, the extent to which guidelines 
are seen as mandatory regulations rather than recommendations varies from 
body to body and from country to country.  NICE is the most influential guideline 
development body in England, although the current Government has recently 
reduced its power by stipulating that its guidance is no longer legally binding in 
England and Wales.  The public health guidance has never been mandatory. 
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Of course one of the aims of guidelines is to improve the quality of health care.  
In Chapter 1 I discussed how variations in service delivery and treatment were a 
factor behind the growth of the evidence-based practice movement.  Guidelines 
are designed to reduce variations in services delivery among different providers, 
hospitals and geographical regions.  This is to make care consistent and provide 
equal access to health care and because it is presumed that some of this 
variation is attributable to inappropriate care.  Woolf and colleagues suggest a 
number of potential health and service related benefits of clinical practice 
guidelines (Woolf et al., 1999).  These can be seen in box 2 below.  
Box 2. Potential benefits of guidelines  
The use of guidelines may: 
 Improve health outcomes 
 Improve quality of clinical decisions 
 Improve consistency of care 
 Empower patients and the public by improved access to 
information 
 Promote fair distribution of care and resources 
 Improve efficiency, free up resources and optimise value for 
money 
 Support quality improvement activities 
 Identify gaps in the evidence 
 Identify interventions of proven worth and call attention to 
ineffective, dangerous and wasteful practices 
 Through critical appraisal of evidences identify design flaws in 
existing studies 
 Influence public policy by calling attention to under recognised 
health problems, clinical services and preventive interventions 
and to neglected populations and high risk groups 
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Potential problems with clinical guidelines 
However, despite claims that guidelines improve patient care, their widespread 
use is not accepted by everyone as a good thing.  Arguments against their use 
include the assertions that recommendations in guidelines may be inaccurate, 
that they may not take into account the needs of individual patients, that they 
may be used to ration or divert resources inappropriately and that their use may 
be detrimental to practitioners.  These issues are explored more fully below. 
Recommendations may be wrong 
Commentators have argued that a key limitation of guidelines is that they may 
often be wrong.  They suggest that one major reason for this is that scientific 
evidence about what to recommend is often lacking, misleading or 
misinterpreted and that even when the evidence is good recommendations will 
still involve subjective value judgements when the benefits of an intervention are 
weighted against the potential harms (Woolf et al., 1999).  The sort of evidence 
considered to be ‘gold standard’ by many proponents of evidence-based 
practice, such as RCTs, is often not available (Timmermans and Mauck, 2005).  
Even when RCTs are available they may be flawed; for example follow-up may be 
too short and relevant outcomes not measured (Spence, 2009).  It has also been 
suggested that as the evidence base for many technologies and practices is often 
ambiguous and contested that evidence must be ‘continually interpreted and 
reframed in accordance with the local context and priorities’ (Ferlie et al., 2001). 
An examination of the use of effectiveness and cost-effectiveness reviews by 
Government bodies, including NICE, to make decisions about health care 
provision in Britain, Australia and Canada found that all had ongoing issues with 
the quality and strength of the experimental evidence (Clement et al., 2009).  In 
another paper examining the data used for pharmacoeconomic analyses for a 
publicly funded insurance program in Australia the authors found that for a 
number of questions no randomised trials were available and that even when 
they were available they often had serious methodological flaws and that there 
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was uncertainty around the estimates of effectiveness.  In addition, they felt that 
some of the assumptions on which economic models had been based could be 
open to challenge (Hill et al., 2000).  Although both these papers concern 
decisions about clinical therapies, in particular drug therapy, this lack of evidence 
applies to public health guidance as well.  Indeed, the lack of ‘gold standard’ 
evidence is likely to be even more of a problem for complex public health 
interventions.  When undertaking the review included in this chapter (Bunn et 
al., 2006a) I found limited evidence and, of that which was available, little was 
from the UK. 
Another reason why guidelines may be wrong is because they are unduly 
influenced by the opinions, clinical experience and composition of the group 
developing the guidelines (Kane, 1995, Woolf et al., 1999).  An overreliance on 
expert opinion may be particularly dangerous (Kane, 1995) and factors such as 
professional role and status may distort group processes (Pagliari and Grimshaw, 
2002, Pagliari et al., 2001).  In addition, guidelines may be wrong because 
patient’s needs may not be the only factor considered when making 
recommendations and practices may be recommended to help control costs, 
serve societal needs or protect the special interests of clinicians, policy makers or 
managers (Woolf et al., 1999). 
Guidelines too inflexible for the needs of individual patients 
Another criticism of guidelines is that they are inflexible and do not take into 
account the circumstances, medical history and values and preferences of 
individual patients (Woolf, 1997); what is best for patients overall may not be 
appropriate for individuals.  Guidelines tend to focus on individual conditions 
whereas, in reality, many patients have complex health care needs with multiple 
health care problems.  These concerns have led to doctors, faced with non-
uniform clinical problems, criticising guidelines as ‘cookbook medicine’ (Woolf et 
al., 1999).  Researchers in the USA have suggested that there is the potential for 
conflict between medical humanism, which seeks to understand the patient as a 
person and emphasises ‘shared decision making’ between health care 
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professionals and patients, and evidence-based practice which aims to put 
medicine on a firm scientific footing and emphasises the use of standardised 
guidelines.  They argue that an outright collision between these two movements 
can only be avoided if guidelines remain as ‘recommendations rather than 
mandates’(Hartzband and Groopman, 2009). 
In addition, it has been suggested that guidelines are often flawed because they 
are derived from studies carried out in selected groups of patients who may not 
be representative  of all populations (Spence, 2009), particularly if they have 
coexisting conditions (Hartzband and Groopman, 2009).  Certainly in my 
experience RCTs often have strict inclusion criteria which mean that patients 
with comorbidities or complex medical conditions are excluded from studies.  
This may limit the generalisability of the findings beyond the particular group of 
participants in the trial. 
Guidelines used to ration health care 
One of the greatest areas of controversy surrounding guideline use in the UK is 
whether they should be used to make mandatory recommendations about 
health care provision.  Until recently health technology guidance has been legally 
binding in England and Wales which has led to the accusation that they were 
used as a tool to ration health care (Gingrich, 2009).  Critics of NICE have argued 
that its decisions are not based on effectiveness so much as cost-effectiveness 
and that even if a treatment is shown to be effective it may be rejected if it is too 
expensive (Smith, 2000).  However, others have pointed out the dilemma faced 
by the majority of health care systems, namely that resources are scarce but 
competing demands are infinite (Walker et al., 2007).  Sir Michael Rawlins the 
Chairman of NICE argues that ‘some form of rationing is inevitable in every 
health care system and that the issue is not whether to ration but how to go 
about it’.  He suggests that some countries, such as the USA, ration on the basis 
of  individual wealth or income whereas in Europe ‘no citizens are denied access 
to basic health care merely because they are poor’(Rawlins, 2009).   
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It has also been argued that the development of formal guidelines may channel 
resources inappropriately or unfairly.  For example, Woolf and colleagues argue 
that ‘imprudent recommendations for costly interventions may displace limited 
resources that are needed for other services of greater value to patients’.  They 
suggest that guidelines may be used by advocacy groups (and health 
professionals) to give inaccurate impressions about the relative importance of 
diseases and the effectiveness of interventions (Woolf et al., 1999).  In an 
editorial in the BMJ Richard Smith also makes this point (Smith, 2000) when he 
says that although patients may receive a drug which could benefit them they 
may end up worse off overall because the cost of the drug may mean that there 
will be cuts to other services, such as nursing and social care, instead.    
Disadvantages for practitioners 
It has also been claimed that guidelines may have negative effects on health care 
practitioners.  Practitioners may find guidelines inconvenient and time 
consuming to use (Woolf et al., 1999) and be confused by conflicting guidelines 
on the same topic.  In addition, it has been suggested that a widespread reliance 
on guidelines may deskill practitioners and that ‘simplistic algorithms may not 
take into account the complexity of clinical practice and the parallel and iterative 
thought processes inherent in clinical judgement’ (Woolf et al., 1999).  Instead of 
using clinical judgement practitioners will be encouraged to follow guidelines 
that treat all patients as the same and, therefore, will be ‘poorly equipped to 
contend with the variations between patients they will encounter in actual 
clinical circumstances’ (Timmermans and Mauck, 2005).  Clinicians may also 
resent guidelines because they feel they are a threat to their personal autonomy 
and because algorithms and guidelines may results in health care professionals 
being replaced by less expensive, less skilled workers (Timmermans and Mauck, 
2005). 
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The development of NICE Guidelines 
One of the criticisms levelled at NICE is that its decision making process is too 
lengthy (Martin, 2007).  Some critics have compared it unfavourably with the 
Scottish Medicines Consortium which they claim is able to make decisions more 
quickly and cheaply.  However, as Minhas and Patel point out the process used 
by NICE includes greater mechanisms for scoping, public consultation, revision 
and appeals (Minhas and Patel, 2008).  Despite some criticisms of NICE and their 
processes several reviews from independent agencies have reported favourably 
on their work.  These include two reviews from the House of Commons Health 
Committee (House of Commons Health Committee, 2002, NICE, 2008) and a 
review by the World Health Organization (Hill et al., 2003).  It has also been 
acknowledged in a select committee report that ‘the job of NICE is much more 
difficult than we first imagined’ (NICE, 2008). 
The development of NICE guidelines is a process that involves a number of 
stages.  Once the Department of Health has referred a topic to NICE then 
national organisations representing patients, carers, and health professionals 
involved in their care, can register as stakeholders.  These stakeholders are 
consulted throughout the guideline development process.  The next step 
involves the preparation of a scope statement which sets out what the guideline 
will, and will not, cover.  NICE, registered stakeholders and an independent 
guideline review panel can all contribute to the development of the scope.  Then 
a guidelines development group made up of health professionals, 
representatives of patient and carer groups and technical experts is established.  
Once the review evidence is produced the guideline development group assesses 
the available evidence and produce a draft guideline.  There is at least one public 
consultation period for registered stakeholders to comment on the draft 
guideline.  An independent guideline review panel reviews the guideline to check 
that stakeholder comments have been taken into account.  After the guideline 
development group finalises the recommendations, the collaborating centre 
produces the final guideline; NICE formally approves the final guideline and 
issues its guidance to the NHS.  As a reviewer my involvement in the process 
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began only once the scope statement had been finalised.  My role included 
producing the review to time, presenting the findings to PHIAC (Public Health 
Interventions Advisory Committee), revising the review in light of PHIACs 
comments, and commenting on the draft guidance.  
Methods for NICE reviews 
The methods used for the review presented in this chapter were those stipulated 
in the NICE handbook (NICE, 2006).  As the methods were generally similar to 
those recommended for Cochrane Reviews I do not enumerate the methods of 
the review in detail but instead discuss aspects of the review process or methods 
which were different from those discussed in previous chapters.   
Question development 
This review differs significantly from any of the others presented in this 
submission because the way it was commissioned meant that the question was 
driven by policy makers rather than researchers.  The title, subject and inclusion 
criteria all reflect the scope statement8 which, as is usual practice, was decided 
upon by NICE and the various stakeholders involved in the guideline 
development process.  The review question included the prevention of sexually 
transmitted infections in all age groups and all populations and the prevention of 
conceptions in the under 18s.  NICE conceptualised this as one review, whereas it 
may have been better as two separate reviews.   
The breadth of the question was narrowed somewhat by a focus on one-to-one 
(i.e. individual rather than group-based) interventions only.  This excluded many 
studies which were delivered to groups rather than individuals.  Whether it was 
appropriate to exclude group based interventions is debatable.  Field work to 
test the review findings showed that practitioners would have liked more 
evidence about the relative effectiveness of one-to-one interventions compared 
with other interventions, such as group based sessions (Cook et al., 2007).  It is 
possible that the guidance may have been more useful if it had included group-
                                                          
8
 http://www.nice.org.uk/guidance/index.jsp?action=download&o=31896 
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based interventions although this would have made the review very large, less 
focused and would have taken much longer to complete.  In addition, it could be 
argued that the focus on one-to-one interventions made the guidance of direct 
relevance to practitioners in clinical settings who would typically see patients on 
an individual, rather than a group, basis. 
The scope of the review was broader than Cochrane reviews because it also 
included systematic reviews, and controlled before/after studies as well as RCTs.  
The rationale for including systematic reviews is that they provide a synthesis of 
the evidence and may give more information than a single study.  However, 
reviewing systematic reviews can be problematic.  For example, other systematic 
reviews may have addressed slightly different questions and may not have 
presented the required detail from the primary studies.  In this case it is 
necessary to go back to those studies for further information.  In this instance, 
however, we found no systematic reviews that met our inclusion criteria and so 
the dilemma of how to deal with them did not arise.  The review also included 
qualitative studies that either looked at the process of the interventions (e.g. 
how and why they do/do not work) and/or focused on the user perspective of 
potential barriers and facilitators.  In Chapter 6 I looked in depth at the rationale 
and methods for including qualitative studies.  The inclusion of qualitative 
studies was, therefore, intended to allow us to address some of these more 
complex questions and go beyond simple questions about ‘what works’. 
Data extraction 
The processes for data extraction were similar to those used for Cochrane 
reviews and involved independent double data extraction.  However, the 
complexity of the interventions under study, the need to go beyond simple 
questions about ‘what works’ and the need to address effectiveness in different 
groups of participants meant that the data extraction form was lengthy and 
complex.  
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Critical appraisal 
Critical appraisal for NICE reviews is done using quality assessment checklists.  
The domains included in the checklist are similar to those recommended in the 
Cochrane handbook.  However, unlike Cochrane reviews, which generally don’t 
include summary scores, NICE quality assessment requires that studies are given 
an overall summary score.  Studies are graded as (++), ( +) or (– ), with (++)  
meaning studies are judged to be of high quality and (–) that they are of poor 
quality.  Summary scores are not recommended in the Cochrane handbook 
because they involve assigning weights to different items in the scale which can 
be difficult to justify (Higgins, 2008).  Furthermore they have been shown to be 
unreliable as assessments of validity (Juni et al., 1999).  
Analysis 
Owing to the wide scope of the research question, and the heterogeneity in 
interventions, participants and outcomes, I did not consider meta-analysis to be 
appropriate.   Instead data were presented in the text of the review and in the 
results column of the evidence tables.  Although the guideline development 
group agreed with the decision not to pool studies in a meta-analysis they did 
find it difficult to interpret the results without an overall summary statistic.  
Therefore, I suggested that in the final draft of the review, the results be 
presented graphically in forest plots but without pooled summary statistics.  The 
chair of PHIAC felt this was very useful and something that they should consider 
for future reviews.  Indeed, the updated NICE methods manual (NICE, 2009) now 
includes a recommendation that  
‘Forest plots should be used to show effect estimates and confidence 
intervals for each study (when available, or when it is possible to 
calculate them). If possible, they should be used even when it is not 
appropriate to do a metaanalysis and present a pooled estimate’.   
This is accompanied in the handbook (p81) by an example of a forest plot taken 
from the review presented in this chapter (Bunn et al., 2006a).   
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This debate about how best to present the results is indicative of the difficulties 
reviewers can face presenting results in systematic reviews where it has not 
been appropriate to pool studies in a meta-analysis.  In complex reviews with 
large number of studies it can be particularly difficult to present the results in a 
coherent and easily understood way.  NICE have tried to address this to some 
extent by presenting results in tables with an indication of whether the 
intervention had a positive effect (+), a negative effect (-) or no statistically 
significant effect (0).   Although this does give a snapshot of whether or not a 
result was statistically significant it could be misleading as a non significant result 
is not necessarily an indication that the intervention is not effective; many trials 
lack the power to detect moderate treatment effects (Tarnow-Mordi and Healy, 
1999).  NICE also require that each review question is accompanied by at least 
one evidence statement that reflects the strength (quality, quantity and 
consistency) of the evidence and makes a statement about its applicability.  
These statements can also be used to highlight the lack of evidence (NICE, 2009).  
Reducing large amounts of complex data into clear, self-contained statements is 
challenging.  The accuracy of these statements was particularly important as they 
were used by the guidelines development group as a basis for their 
recommendations.  
The use of guidelines by practitioners 
It is important to look at the impact of the public health guidelines on sexual 
health within the context of current thinking about guideline implementation.  
Therefore, before I look at the impact of the review I will critically explore some 
of the current research around the implementation of guidelines, including the 
impact of NICE guidelines.  This includes the extent to which guidelines are used 
by practitioners and the potential barriers to their successful implementation. 
There is evidence that clinical guidelines can be effective in changing the process 
and outcome of care (Grimshaw et al., 1995, Grimshaw and Russell, 1993, 
Thomas et al., 2000), although it has been found that some are adhered to more 
closely than others (Grol, 2001).  These differences in concordance could be 
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explained by a variety of factors such as the type of health problem involved, the 
method of development used, the content of the recommendations, the source 
of dissemination, or the format and layout (Davis and Taylor-Vaisey, 1997).  
Compliance has been found to be better for guidelines of acute care than chronic 
care and is associated with a better quality of evidence supporting the 
recommendations, compatibility of the recommendations with existing values, 
less complexity of the decision making needed, more concrete description of the 
desired performance, and fewer new skills and organisational changes needed to 
follow the recommendations (Burgers et al., 2003, Foy et al., 2002, Grilli and 
Lomas, 1994, Grol et al., 1998). 
The mode of dissemination may have a bearing on the uptake of guidelines.  A 
number of studies have found passive dissemination of guidelines ineffective 
(Lomas, 1991, Oxman et al., 1995) or of only limited effectiveness (Farmer et al., 
2008).  However, other studies have suggested that passive dissemination of 
guidelines does have an effect.  Two separate studies looked at the effect of an 
Effective Health Care Bulletin for glue ear issued in 1992 (Black and Hutchings, 
2002, Mason et al., 2001).  Effective Health Care Bulletins were produced by the 
National Centre for Reviews and Dissemination funded by the Department of 
Health.  In both studies they found that the passive dissemination of the 
guidelines was associated with a significant decline in rates of surgery for glue 
ear and conclude that ‘distributing printed recommendations to decision makers 
may influence surgery rates’ (Mason et al., 2001) .  However, determining how 
much of the change is attributable to the guidelines and how much to other 
confounding factors is not easy.  The authors acknowledge that there may be a 
number of contextual factors that contributed to this decline.  This includes pre-
existing professional concerns about the value of surgery, the introduction of an 
internal market into the NHS, and growing apprehension among patients fuelled 
by scepticism in the mass media (Black and Hutchings, 2002). 
Sheldon and colleagues undertook an evaluation to assess the extent of 
implementation of NICE guidance (Sheldon et al., 2004).  This involved 
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interrupted time series analysis, review of case notes, a survey and interviews to 
evaluate the implementation of 12 sets of guidelines.  They found that 
implementation of NICE guidance was variable; some had been associated with 
changes in practice and others had not.  However, the retrospective 
observational nature of their study made it difficult to separate the effect of the 
guidelines from other factors that may have influenced professional practice. 
The effect of NICE guidelines on practice is also assessed in another paper which 
looked at the effect of NICE guidance on wisdom tooth extraction and primary 
total hip replacement  (Ryan et al., 2004).  NICE guidance recommended that 
pathology free impacted wisdom teeth should not be operated upon.  The 
authors looked at hospital activity data for 88 trusts that could provide three 
years data from before guidance published and two years afterwards.  Although 
there was a downward trend in extraction, this appeared to have started before 
the NICE guidance and may be a response to previously issued professional 
guidelines.  They found no significant change in behaviour relating to total hip 
replacement.  They suggest that one reason for this lack of impact is the 
relatively passive dissemination of the guidelines (Ryan et al., 2004).  However, 
Michael Rawlins the Chairman of NICE suggests that implementation of NICE 
guidance is better than some commentators have suggested.  In a letter 
defending NICE’s role in implementing their guidelines (Rawlins and Dillon, 2005) 
he cites a report by Abacus International (Howard and Harrison, 2005) which 
looked at the impact of 28 appraisals.  The results showed that 12 appraisals 
were implemented fully, 12 were incompletely implemented, and four were 
over-implemented. 
The quality of the evidence supporting recommendations has also been found to 
be a facilitator in the implementation of guidelines.  In a pilot study, of a national 
initiative funded by  the DOH to demonstrate how practice could successfully be 
changed to bring it into line with research evidence, they found the most 
influential factors were strong evidence, supportive opinion leaders and 
interaction within a committed organization.  Unclear evidence was a real barrier 
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(Dopson et al., 2001).  In addition, guidelines that are easy to understand, can be 
tried out, and do not require specific resources, have a greater chance of 
implementation (Francke et al., 2008).  Health-care professionals were less likely 
to use guidelines for patients who had complex conditions or co-morbidities.   
The difficulties associated with changing the behaviour of health care 
professionals may be a significant barrier to guideline implementation.  
Practitioners may be resistant to guidelines because they are seen as a threat to 
the use of autonomy and discretion in professional work (Timmermans and 
Mauck, 2005).  An extensive review of the evidence suggests that changing 
behaviour is possible, but that this change generally requires comprehensive 
approaches at different levels (practitioner, team practice, hospital, wider 
environment), tailored to specific settings and target groups (Grol and Grimshaw, 
2003).  There is also substantial literature to suggest that the successful 
implementation of most clinical guidelines requires organizational as well as 
individual change (Grimshaw et al., 2004, Rycroft-Malone et al., 2004a) and that 
effective strategies generally have multiple components (Francke et al., 2008).  
Cultural and environmental characteristics such as poor leadership, a lack of 
support from peers, little emphasis on continuing education and insufficient staff 
and time can be major barriers to the implementation of evidence (Francke et 
al., 2008, Kitson et al., 1998). 
Results of impact analysis 
Were the guidelines evidence-based? 
Before I present the results of the impact evaluation I consider to what extent 
the guidelines are ‘evidence-informed’.  In other words I wanted to assess 
whether the recommendations in the guidelines were consistent with the 
evidence presented in the review itself.  The final guidelines are, after all, 
influenced by a number of factors, including evidence from the other reviews 
and economic evaluation, the results of the fieldwork, and the views of the 
stakeholders and guideline development group.  In addition, it is possible that 
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guideline developers are subject to financial and political pressures that may 
influence their recommendations.   
To evaluate the extent to which the guidelines were informed by the review I 
compared the recommendations with the evidence from the review.   Overall, 
the recommendations appeared to be in line with the evidence from the review.  
However, there were some slight discrepancies.  For example, in 
recommendation two in the guidelines it recommends that health care 
practitioners should: 
‘have one-to-one structured discussions with individuals at high risk of STIs.  
The discussions should be structured on the basis of behaviour change 
theories.  They should address factors that can help reduce risk-taking and 
improve self-efficacy and motivation.  Ideally, each session should last at least 
15-20 minutes.  The number of sessions will depend on individual need’ (NICE, 
2007b). 
Although there was evidence in the review that 15-20 minute sessions could be 
effective, the review suggested that the most effective interventions were those 
with sessions that were longer than that; for example 60 or 90 minutes.  
However, a recommendation suggesting sessions of such length is unlikely to be 
practical or possible in a typical UK health setting.  Guideline developers have to 
take into account the context and feasibility of intervention delivery.   
Having been involved in the review and seen the process of guideline 
development at first hand has made me cognisant of the difficulties involved in 
creating guidelines when the evidence base is poor. Although there were some 
good quality studies they were all done in the USA and there was little UK-based 
evidence.  The original scope specified a number of sub-questions looking at 
effectiveness in high risk groups, such as looked after children and sex workers.  
However, for many of these groups, there was little or no relevant evidence.   
 
169 
 
Knowledge production 
Publication and methods of dissemination 
The guidance was published on the NICE website in February 2007.  A number of 
documents were available including the full guidance, a summary of the 
guidance and all background documents including the full reviews, the scope 
statement, and fieldwork evaluations.  In addition the guidance was 
accompanied by a press release (NICE, 2007a) and implementation advice.  The 
implementation advice includes information on identifying a project lead, 
carrying out a baseline assessment, assessing cost, and building and 
implementing an action plan. 
Impact within research community 
Because the review was an unpublished report, and therefore would not be 
indexed in WoS or Scopus, I only performed the citation analysis in Google 
Scholar.  The review had only been cited once and this was a self-citation in a 
book chapter on which I was an author (Trivedi et al., 2007a).  I did, however, 
search the internet for research papers and organisations that had cited the 
guidance.  There were a number of commentaries or discussion papers relating 
to the guidance and one of these referred to the review but did not formally cite 
it (Ward, 2007).  Considering that the review is only published on the NICE 
website, that review authors are not specifically mentioned in the guidance, and 
that the reviews are not as easily accessible as the guidance, this lack of citation 
is hardly surprising.  It was also not possible to do a formal citation analysis on 
the published guidance but internet searches found a number of references to 
the guidance.   
The organisations or websites where the guidance was discussed or cited can be 
seen in Table 7.1. 
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Table 7.1 Results of internet searches to identify organisations citing the 
guidelines 
Organisation or place where guidance cited 
NICE guidance cited in guidelines produced by British Association for Sexual Health 
and HIV (Rogstad et al., 2008) 
Improvement and Development Agency 
http://www.idea.gov.uk/idk/core/page.do?pageId=6034364  (website that 
mentions guidance) 
East midlands Public Health Observatory 
http://www.empho.org.uk/THEMES/teenagepregnancy/tp9.aspx (website link to 
guidelines) 
NHS Clinical Knowledge Summaries 
http://www.cks.nhs.uk/contraception_emergency/evidence/references (cites 
guidelines) 
The National Guideline Clearinghouse™ (NGC).  US based database of evidence-
based clinical practice guidelines and related documents. 
http://www.guideline.gov/summary/summary.aspx?doc_id=10789&nbr=005617&st
ring=chlamydia 
Research targeting  
In the concluding section of the review (Bunn et al., 2006a) I highlighted some of 
the gaps in the evidence.  These included a need for studies that were based in 
the UK and were large enough to detect primary outcomes such as a reduction in 
STIs or conceptions.  ln addition, I suggested there was a lack of information on 
the effectiveness of peer-led and school-based interventions, and little evidence 
on one-to-one interventions in vulnerable groups such as young people in or 
leaving care, young people from some ethnic backgrounds (primarily Pakistani & 
Bangladeshi), sex workers, refugees and asylum seekers.  The gaps in the 
evidence that I identified are largely reflected in the final NICE guidance 
(Appendix B p36).  This information on gaps in the evidence was then used by 
PHIAC to make recommendations about future research questions.  These 
included recommendations for further research about effectiveness of 
interventions delivered in different settings and by different professionals and 
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for more work in high-risk groups.  However, I was unable to ascertain to what 
extent these recommendations had been acted upon and whether the review or 
guidance had been instrumental in directing future research. 
Informing policy development 
As already mentioned, public health guidance is not mandatory and local service 
providers are under no obligation to follow it.  The extent to which the 
recommendations have been adopted is difficult to ascertain and is, in reality, 
beyond the scope of this work.  Certainly a number of commentaries published in 
response to the guidance highlighted the difficulties of implementing 
recommendations in busy and hard pressed health services.  Helen Ward, a 
specialist in infectious disease epidemiology, points out that because sexual 
health services in the UK have been streamlined, with a move towards rapid 
testing, single visits and, in some cases, self-completed sexual histories and self-
collected specimens, adding one or two 20 minute counselling sessions into such 
a service provides a major challenge (Ward, 2007).  In a critique of how the 
guidance might apply to general practice Oakeshott and Graham identify a 
number of barriers to implementation (Oakeshott and Graham, 2007).  These 
include a lack of time to identify high risk individuals, a lack of personnel trained 
in sexual health counselling and the challenges of working with young people 
who may not return for follow up appointments or may not wish to attend 
counselling sessions.  To what extent service providers have attempted to 
overcome these barriers or the extent to which they may have been successful in 
implementing guidance is unclear. 
NICE was not initially explicitly responsible for promoting and monitoring the 
implementation of their guidelines.  However, this has now changed and since 
2004 the institute has had an implementation support strategy.  The NICE 
website now includes two databases which include details of implementation.  
One is the Evaluation and Review of NICE implementation evidence database 
(ERNIE) which is a source of information on the implementation and uptake of 
NICE guidelines.  The other is The Shared Learning database which provides 
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examples from organisations implementing NICE guidance and the lessons they 
have learnt.  I searched both of these databases but was unable to find any 
information relating to the implementation of the sexual health guidance with 
which this chapter is concerned.  Indeed, although there was data on a number 
of health technology and clinical practice guidance there was very little 
information on any of the public health guidance. 
Conclusion 
In this chapter I have examined the impact of a systematic review on the 
development of NICE guidance.  As the review was specifically commissioned as 
part of the guideline development process the link between the review and 
policy is clearly established.  It is apparent, therefore, that the review had a 
direct impact on Government policy in England.  However, there are a number of 
barriers to the implementation of guidelines and there has been some debate in 
the literature about the extent to which NICE guidance has been successfully 
implemented.  I found little information to indicate whether or not the guidance 
considered in this chapter (NICE, 2007b) had been successfully implemented.   
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Chapter 8: Evaluating the safety and efficacy of telephone 
consultation: a systematic review to inform service delivery 
& organization 
Introduction 
In previous Chapters the focus of the included reviews has largely been on 
interventions for preventing or treating ill health; for example the prevention of 
injuries or sexually transmitted infections or the treatment of critically ill 
patients.   In contrast the review presented in this chapter, which looks at the 
effectiveness of telephone consultation and triage (Bunn et al., 2004a, Bunn et 
al., 2005), is primarily concerned with an issue relating to the way in which 
health services are organised and delivered.  The review, which was published in 
the Cochrane Library and the British Journal of General Practice, was conducted 
using methods which were largely similar to those already described in previous 
chapters, in particular Chapters 4 and 5.  However, there are some 
methodological issues specific to this review, such as the inclusion of interrupted 
time series designs, which I examine further in this chapter.   
As before, I also include information about the drivers behind the review 
question and assess the impact of the review on policy.  The systematic review 
presented in this chapter relates to the effectiveness of telephone consultation, 
a topic that was subject to considerable controversy and debate at the time we 
conducted the review.  Therefore, I end the chapter by looking at the impact of 
the review in light of the political and socio-economic context of the time and 
consider the relationship between evidence, political agendas and professional 
interests.  I am first author on the papers and was responsible for all stages of 
the review including:  developing a review protocol, screening search records, 
data extraction, critical appraisal, data analysis and writing up.   
Drivers behind review question 
Many systematic reviews are undertaken to inform the development of primary 
research and, indeed, that was the main impetus behind this review.  A colleague 
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was planning a study to evaluate the impact of the advice given by NHS direct 
staff (Byrne et al., 2007) and, as we were unable to find a previous systematic 
review on the subject, we felt that it was important to review the existing 
evidence.  NHS Direct is a 24-h telephone advice service, based in England and 
Wales, which is designed to help callers to self-manage problems and reduce 
unnecessary demands on other National Health Service (NHS) provision (Munro 
et al., 2000).  Set up in December 1997 NHS Direct was promoted as part of the 
previous Governments modernising strategy which included improving access 
and providing patient centred, technologically sophisticated care in the NHS 
(Executive, 1998, Executive, 2000).  NHS Direct is staffed by nurses and reflected 
a move towards extending the role of nurses so that they take on responsibility 
for tasks previously done by doctors.  At the time NHS direct was a relatively new 
initiative and, despite its rapid expansion, there was a lack of studies evaluating 
its effectiveness or safety (Byrne et al., 2007).   
Although the focus of the primary research study was on NHS Direct we chose to 
set the inclusion criteria for the review somewhat wider and included all forms of 
telephone consultation or triage delivered by any type of health care worker.  
The rationale for this was that telephone consultation was being used in a 
number of settings (not just NHS Direct) and an overview of any information 
about its safety and efficacy was required.  However, despite broadening our 
inclusion criteria in this way, we found only 11 relevant studies.  
Review methods 
The Cochrane Collaboration is structured so that different reviews fall under the 
remit of different Collaborative Review Groups who each have their own 
editorial team.  The reviews in Chapters 4 and 5 fall under the scope of the 
Cochrane Injuries Group, of which I am an Editor, whereas the review in this 
chapter was conducted for the Cochrane Effective Practice and Organisation of 
Care Group (EPOC).  EPOC differs from most other Cochrane Groups in that its 
scope is concerned not with a particular medical condition or area of health care 
but instead is focused around the way services are organised and delivered.  The 
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focus of EPOC is on reviews of interventions designed to improve professional 
practice and the delivery of effective health services. This includes various forms 
of continuing education, quality assurance, informatics, financial, organisational 
and regulatory interventions that can affect the ability of health care 
professionals to deliver services more effectively and efficiently. Organisational 
interventions are defined as those which involve a change in the structure or 
delivery of health care.  In other words, an organisational intervention is a 
change in who delivers health care, how care is organised, or where care is 
delivered’ 9; telephone consultation may involve any or all of those changes. 
Types of studies 
Although each Collaborative Review Group is largely guided by the methods set 
down in the Cochrane handbook there are some differences between the 
processes and methods of different Review Groups.  This is largely a result of the 
differing Group scopes although, of course, it is also influenced by the 
backgrounds, beliefs and attitudes of the different editorial teams.  The EPOC 
editorial team have developed methods and procedures that they consider to be 
appropriate for the kind of reviews that they produce.  One of the key 
differences is that EPOC argue that it may not be feasible to evaluate many 
organisational or professional interventions in an RCT and that it may be 
necessary to consider other study designs.  For example, although the 
introduction of small scale telephone consultation, such as in one particular GP 
practice, may be amenable to evaluation in an RCT the introduction of more 
widespread organisational changes (such as nationwide introduction of 
telephone consultation) maybe difficult to test in an RCT.  Of course EPOC are 
not alone in including non randomised studies in their reviews.  In Chapter 5 I 
have already described a systematic review of traffic calming that included 
controlled before and after studies (CBAs).  However, unlike the traffic calming 
                                                          
9 http://www.epoc.cochrane.org/en/scope.html 
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review, the review in this chapter also includes Interrupted time series designs 
(ITS).   
ITS are quasi-experimental studies that may or may not involve a control group 
and involve multiple data collection points before and after an intervention or 
natural event.  The trend in pre-tests is then compared to the trend in post-tests.  
The problem with ITS, and the reason why many Cochrane Groups do not include 
them, is that are more susceptible to bias than RCTs and controlled evaluations.  
For example, ITS may be subject to threats to internal validity such as maturation 
bias, where there is a pattern of improvement in the group prior to the 
intervention, or instrumentation bias where there are changes in the way record 
are kept or outcomes measured (EPOC, 1998).  In addition, it is difficult to be 
sure if any change is a result of the intervention or whether it can be attributed 
to some other confounding factor.   
In response to such concerns EPOC have developed detailed quality assessment 
criteria for non controlled studies.  Some of the quality criteria for ITS are those 
that are applicable to other study designs, such as blinded assessment of primary 
outcomes and whether the primary outcome measures are reliable, but others 
are specific to ITS.  For example, an assessment of whether there were sufficient 
data collection points before and after the intervention (EPOC guidance specifies 
at least three points before and three points after), whether the intervention is 
independent of other changes (e.g. changes to policy and practice which may 
have contributed to any change in outcome) and whether the data was analysed 
appropriately (formal test for trend using appropriate methods).  
Interrupted time series can be classified as long time series, which require at 
least 20 observation points pre-intervention, and short time series which require 
at least three observation points pre-intervention and three post-intervention.  
The review presented here included three short time series.  In, general, the 
studies were felt to be of reasonable quality.  In all three the intervention 
appeared to be independent of other changes, they had blinded assessment of 
the primary outcome and the number of data collection points before and after 
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the intervention was considered to be sufficient.  One study was judged to be at 
risk of instrumentation bias as methods of data collection changed from manual 
to electronic recording after the start of the intervention.  In addition, the data in 
this study was not analysed appropriately and the analysis was redone, by an 
EPOC statistician, using time series regression techniques.  However, despite a 
generally favourable assessment of their methodological quality, the increased 
risk of bias associated with ITS means that their results need to be considered 
with some caution. 
Types of outcomes 
When deciding on appropriate outcomes to include reviewers need to consider 
whether they should include adverse effects and, if so, how they should go about 
this.  Although this is relevant to all reviews it was particularly important to 
consider possible adverse outcomes for this review as concerns exist about the 
safety of telephone consultation, particularly when it is undertaken by nurses 
substituting for doctors (Crouch and Dale, 1998, Florin and Rosen, 1999, Salk et 
al., 1998). 
Data on adverse events may be sparse, and indeed it was in this review, but the 
absence of information does not mean that the intervention is safe.  Reviews of 
RCTs may not pick up adverse events as they may be too uncommon or too long 
term to be observed within RCTs (Higgins, 2008).  Two of the RCTs included in 
the review reported mortality but both were underpowered for this outcome.  It 
might be argued that if review criteria were broadened to include observational 
studies such as cohort studies or case-control studies they would be more able to 
detect adverse events.  However, in an article looking at issues associated with 
assessing harmful effects in systematic reviews, McIntosh and colleagues caution 
against an unquestioning assumption that observational studies are the best 
source of harmful effects data.  They suggest that the difficulty of interpreting 
observational study data may outweigh the benefits (McIntosh et al., 2004). 
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Analysis 
As with a number of the reviews presented in this submission heterogeneity 
meant that it was not appropriate to pool studies in a meta-analysis; in this case 
there was heterogeneity in study design, interventions, outcomes and 
participating health professionals.  Therefore, we presented a narrative and 
tabular summary of findings which, where possible, included an assessment on 
the size of the effect observed and statistical significance of the studies.  For each 
study where possible we reported the main results in natural units in the results 
table and post-intervention differences and 95% confidence intervals or P values. 
For interrupted time series where possible we calculated a change in the level of 
outcome at the first point after the introduction of the intervention, and 
estimated a change in the slopes of the regression line (calculated as post-
intervention minus pre-intervention slope). 
Results of impact analysis 
Knowledge production 
Impact within research community 
The citation analyses were conducted in January 2010.  When I first ran the 
citation analysis the Cochrane Library version of the review had no citations in 
Web Of Science (WoS), two in Scopus and 48 in Google scholar.  The version of 
the review published in the British Journal of General Practice had six citations in 
WoS, 11 in Scopus and 18 in Google Scholar.  In the citation analysis for this 
chapter, as for some of the others, the citation count in Google Scholar was far 
higher than for the other databases.  The discrepancy was particularly 
pronounced for the Cochrane version of the review; there were 48 citations in 
Google Scholar and only two in Scopus and none in WoS.  Even taking into 
account the fact that Google Scholar includes grey literature whereas Scopus 
does not this difference between the two seemed very great.  I wanted to 
explore this further to see what this disparity could be attributed to.   
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It has been suggested that the citation information in Google Scholar is flawed 
(Falagas et al., 2008) and it could, therefore, be that the citation count from 
Google Scholar is inaccurate.  However, it has also been noted that citation 
counts for Cochrane reviews may be artificially low because citing authors have 
incorrectly referenced Cochrane reviews (The Cochrane Library, 2008).  To 
investigate the accuracy of the citation information in Google Scholar I began by 
checking the 48 citing documents in Google Scholar to see whether they were 
correct.  This involved looking at each of the citing papers or reports and 
checking that it had cited the Cochrane version of the review.  Of the 48 citations 
46 were found to be correct.  I then checked to see which of those 46 papers or 
reports were indexed in Scopus and Web of Science.  Of those 46 papers or 
reports from Google Scholar 20 were indexed in Scopus and 17 in Web of 
Science.  Therefore, the total citation counts for the review should have been 22 
for Scopus (there were an additional two citations in Scopus not picked up by 
Google Scholar) and 17 for Web Of Science.  The results of both the original 
citation analysis and the revised analysis can be seen in Figure 8.1.   
 
 
Figure 8.1 Results of original and revised citation analyses: telephone 
consultation review 
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Information from Wiley Interscience10 suggests that the review was of interest to 
the research and practice communities.  Data on full text downloads was 
available for 2008 and 2009.  In 2008 the review was accessed 681 times which 
gave it a world ranking of 841 out of 6,232, and in 2009 it was accessed 886 
times which gave it a world ranking of 778 out of 6840.   
Research targeting 
Telephone consultation and triage continues to be an issue receiving attention 
on the research agenda.  To what extent the review presented in this chapter 
may have contributed to this is difficult to gauge.  However, a cluster randomised 
trial of telephone triage in general practice that has recently been funded under 
the NIHR Health Technology Assessment Programme cites the review in the 
study protocol (Campbell J, 2009).  In setting out the rationale for their choice of 
intervention and outcome measures the authors refer to the review when they 
say ‘the identification and choice of the most relevant outcomes have been a 
contentious issue in previous evaluations of triage systems in primary care’. 
Informing policy development 
Levels and type of policy development 
In the payback model outputs from research are classified as primary or 
secondary (Wooding et al., 2004).  Primary outputs are the direct outputs of the 
research project, such as academic publications or presentations, and secondary 
outputs are the wider impacts on policy and practice.  Table 8.1 shows the 
details of the secondary outputs from the review (results from both papers are 
combined).   
Once duplicate citations had been discounted there were 39 citations in peer 
reviewed journals and a further seven papers (most of which were not in English) 
where it was unclear whether it was a peer review journal or other type of 
publication.  There was evidence that the review had had an impact both 
                                                          
10
 Personal communication from Laura Sampson Associate Editor Wiley-Blackwell 26/2/2010 
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nationally, locally and internationally.  The review was cited in national policy 
documents, including Scottish and Welsh policy documents, and in local policy 
documents in England.  The review was also cited in a number of international 
reports and papers, some of which appeared to be feeding into policy.  For 
example, a review of patient safety in primary health care produced by the 
Australian Commission of Safety and Quality in Health Care (Australian 
Commission safety and quality in health care, 2009). 
Table 8.1 Secondary outputs from telephone triage review 
Type of output 
 
Number Example/s 
Peer reviewed article 
 
39 British Medical Journal 
Other type of article (e.g. not 
clear if peer reviewed journal, 
not English Language) 
7 Bollettino dei medicine Svizzeri 
 
Australian Family Physician 
 
National policy 
 
3 Shifting the Balance of Care (NHS Scotland) 
 
Rapid review of hospital element of 
unscheduled care services in North  Wales 
 
Local policy 
 
2 Strategy for commissioning of Urgent Care 
Services for NHS  Birmingham and North 
East NHS Trust 
National practice guideline 
 
3 Rapid review of brief interventions and 
referral for smoking cessation (NICE  2006) 
Telephone advice lines for people with long 
term conditions (Royal College of Nursing) 
 
Grey literature 
 
8 Salisbury – An Evaluation of Advanced 
Access in General Practice (NIHR SDO 2007) 
Singh – Making the Shift (NHS Institute for 
Innovation and Improvement 2006) 
 
Thesis 
 
2 Swedish medical dissertation 
 
Book chapter 2 Moore 2008 in From General Practice to 
Primary Care: The industrialization of family 
Medicine (Illiffe S) 
 
Total 
 
66  
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Nature of policy impact 
The citation of the review in various policy documents provided some evidence 
that the review had had a direct impact on policy.  However, interestingly the 
review was interpreted differently in different documents with some using it to 
support telephone consultation and others using the review to suggest that the 
safety and efficacy of telephone consultation were unproven.  For example, in 
the document shifting the balance of care by NHS Scotland (NHS Scotland) the 
review is used to support the use of tele-medicine and tele-health whereas in a 
rapid review for the National Public Health Services for Wales (Webb, 2009) the 
authors conclude that there is a lack of evidence to support telephone 
consultation.  My own feeling would be that the latter interpretation would be 
more accurate and that, whilst it may be a promising intervention, data on some 
important outcomes, such as patient satisfaction and adverse events, is lacking.  
Whether the review had any impact at a more indirect level was hard to judge.  
However, this review is the only piece of work I have been involved in that is 
related to telehealth and it is possible that this makes it more unlikely that I 
would be aware of indirect impacts.  For example, in areas where I have done 
more work, such as the prevention and treatment of injury, I am more familiar 
with the field and, therefore, more able to identify examples of indirect impact.  
Type of policy 
Black identifies three types of policy including practice policies (use of resources 
by practitioners), service policies (resource allocation and pattern of services) 
and governance policies (organisational and financial structures) (Black, 2001).  
He argues that the influence of research on the latter has generally been limited 
as decisions about governance are driven by many factors including ideology, 
value judgements, financial and economic considerations and political 
expediency.  Changes to service policies may be influenced by evidence.  
However, whether the move to introduce nationwide telephone consultation, in 
the form of NHS Direct, was primarily driven by evidence or by ideology or 
economic or political expediency is debatable.   
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Research impact and the social construction of policy 
Evidence is, of course, only one factor in determining policy.  Numerous 
commentators have pointed out that diverse political, economic and social 
factors contribute to the formulation of health care policy.  This systematic 
review of telephone triage provides an opportunity to examine more fully the 
interplay between research evidence, political and social expediency and 
professional agendas.   
A variety of ‘actors’ including individuals, groups and organizations contribute to 
the policy process.  Walt and Gilson (Walt and Gilson, 1994) depict this 
interaction in their policy analysis triangle which focuses on the content, context, 
process and actors involved in the policy process (see Figure 8.2). 
 
Figure 8.2 Policy analysis triangle (source: Walt and Gilson 1994) 
Although this triangle is an over-simplification of the complex relationships and 
inter-relationships involved in the policy process it does provide a useful way of 
looking at the different factors that might affect policy.  It shows how actors are 
at the centre of health policy.  In the pluralist model of policy development 
power is dispersed throughout society and health policy emerges as the result of 
conflict and bargaining among large numbers of groups organized to protect the 
specific interests of its members (Buse et al., 2005).  In the example we are 
focusing on here, NHS Direct, the main actors were the Labour Government, who 
saw NHS Direct as a key part of their modernising plan, and professional interest 
groups such as the medical and nursing professions.  Many doctors were 
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opposed to the scheme, questioning its safety, effectiveness, and cost-
effectiveness (Ferriman, 2005, Hayes, 2000), with the British Medical Association 
claiming that  the service had expanded too fast before being adequately 
evaluated (Glasper, 2000).   
Traditionally the medical profession have been a powerful interest group and 
health care systems have tended to be organized in deference to their 
preferences (Buse et al., 2005).  Although the medical profession is still a 
powerful interest group in the UK, recent years have seen a number of 
challenges to their status.  Some of these challenges, such as a growing 
recognition of the expertise of patients in relation to their own health 
(particularly for chronic conditions) and increasing the skills of nurses so that 
they can take over clinical tasks and responsibilities that were previously the 
remit of the doctor, were core components of the previous governments 
modernising agenda and NHS direct.  Although some of the criticisms of NHS 
Direct from doctors may have been valid they may also have been opposed to 
NHS Direct because of the challenge it represented to their authority and their 
position as ‘gatekeepers’ of the NHS (Chiam, 2000).  In such a context 
professional agendas might outweigh the desire for, or recognition of, the 
evidence however good it may be.  
Although it is certainly true that many actors may influence the policy process, 
and in previous chapters I have provided examples of the power of industry and 
other lobbying groups, the role of the state cannot be ignored.  Pluralism has 
been criticised as a model because it portrays the state as a neutral umpire 
arbitrating between the needs of other interest groups.  In contrast public choice 
theorists suggest that the state is in itself an interest group which wields 
considerable power over the policy process, often to further the interests of 
bureaucrats and policy makers.  Those espousing Elitism theories go further and 
argue that key economic and political decisions tend to be taken by a small elite 
in order to preserve the existing economic regime (Buse et al., 2005).  In Chapter 
1 I documented how the previous Government had given increasing credence to 
the notion of evidence-informed policy, a notion reinforced by a number of 
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policy documents (Cabinet Office, 1999a, Cabinet Office, 1999b).  However, in 
reality, political and economic expediency may, and I would suggest often does, 
take precedence over evidence.   
The way many major changes to service delivery and organisation come about 
illustrates how political and economic factors and intellectual fashion are often 
far more powerful than evidence.  Although frameworks for the design and 
evaluation of complex interventions suggest that evaluation should be 
sequential, moving from theory to modelling, explanatory trials, pragmatic trials, 
and ultimately long term implementation (Campbell et al., 2000) in reality this 
sequence is rarely followed.  The Government often introduce new services 
before evaluation can take place and subsequent evaluations may have to use 
unreliable methods such as uncontrolled before and after studies (McDonnell et 
al., 2006).  When conducting the review of telephone consultation the only 
studies we found evaluating NHS Direct did not meet our inclusion criteria even 
though these had been broadened to include controlled studies and ITS’s.  This 
use of research to reinforce and support positions that Government have already 
adopted is in line with ideas proposed by Weiss in her strategic model of the 
policy process which was discussed in Chapter 1 (Weiss, 1979).  Of course once a 
service, such as NHS Direct, is widely established not only is it more difficult to 
evaluate but it is difficult to withdraw the service without substantial 
reorganisation and disruption of other services (McDonnell et al., 2006). 
Conclusion 
I did find examples that the review had had some impact on policy, both in the 
UK and internationally.  Interestingly the review had been interpreted and used 
in different ways with some policy makers using it to support the use of 
telephone consultation and others suggesting that the safety and efficacy of 
telephone consultation is unproven.  This suggests that evidence may be used to 
reinforce positions already adopted.  There was no evidence the review had 
impacted on policy relating to NHS Direct.  However, this was not particularly 
surprising as NHS direct was well established before we conducted the review, 
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and the evaluations of NHS Direct that we found were uncontrolled studies and 
did not meet our inclusion criteria.   
The impact of the review should be considered in light of the political and socio-
economic context of the time.  In previous chapters I have discussed how 
complex social, cultural, political, economic and ideological factors may 
contribute to the development of health policy (Davis and Howden-Chapman, 
1996).  The way in which services are organised and delivered may be even more 
subject to such factors that a more discrete medical intervention.  For example, 
in the case of an intervention like telephone consultation it easy to see that 
political and economic factors may take precedence over research evidence. 
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Chapter 9: Discussion & Conclusions 
Introduction 
The aim of this study was to examine the extent to which systematic reviews can 
influence the development of health care policy in England, to identify factors 
that might be important in increasing the impact of reviews and to examine how 
researchers can produce systematic reviews that meet policy makers’ needs 
without sacrificing methodological rigour.  Integral to this submission are ten of 
my own previously published systematic reviews (15 reports or papers).  These 
have been used as illustrative examples to investigate the questions addressed in 
this study.  The reviews cover a range of health and public health related topics.  
They provide information on: 
 Fluid resuscitation for critically ill patients (Alderson et al., 2000, Bunn et 
al., 2000b, Bunn et al., 2004b, Bunn et al., 2008b, CIG Albumin Reviewers, 
1998, Kwan et al., 2003) 
 The prevention of road-traffic injuries (Bunn et al., 2003a, Bunn et al., 
2003b, Duperrex et al., 2002a, Duperrex et al., 2002b) 
 Barriers to participation in fall prevention interventions (Bunn et al., 
2008a) 
 The prevention of sexually transmitted infections and teenage 
pregnancies (Bunn et al., 2006a) 
 The effect of telephone consultation on service use and patient 
satisfaction (Bunn et al., 2004a, Bunn et al., 2005) 
Systematic reviews by nature are collaborative endeavours that ideally involve 
more than one author in order to ensure that the review team has both 
methodological and clinical or subject expertise.  In addition, ‘gold standard’ 
methods for reviews (Higgins, 2008) stipulate that data extraction and critical 
appraisal should be undertaken by two reviewers independently.  The particular 
contribution that I made to each review is documented in Chapter 3.  Although 
the level of my input varied between reviews, in general I have chosen to use 
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reviews to which I made a significant contribution.  I am first author on six of the 
ten reviews included.  This final chapter includes: 
 An overview of the results of the impact-analysis 
 An examination of the factors that might play a role in the extent to 
which systematic reviews can influence policy 
 An analysis of how the results contribute to knowledge about barriers 
and facilitators  
 An examination of how researchers can produce systematic reviews 
that meet the needs of policy makers  but are still methodologically 
rigorous 
 An overview of the methodological approach and the strengths and 
limitations of the study 
 Conclusions about the implications of the study including 
ramifications for systematic reviewers and future research 
Overview of the impact analysis 
A primary aim of this study was to examine whether a cohort of my own 
previously published work had had any influence on the development of health 
care policy.  In this section I present an overview of impact and provide some 
evidence to suggest that systematic reviews can influence policy.  The results of 
the impact evaluation are structured using a framework that combined domains 
from two separate frameworks, the Payback model and the Research Impact 
Framework.  The framework includes the domains: knowledge production, 
research targeting, informing policy development and impact on practice.  The 
outcome of interest in this study was any evidence of direct or indirect impact on 
policy, with policy making understood in a broad rather than narrow sense.   
I adopted a conceptual approach to the study which was based on Weiss’s work 
on the relationship between research and policy (Weiss, 1976, Weiss, 1977, 
Weiss, 1998).  In her work she makes the distinction between impact that is 
direct, i.e. research is instrumental in driving policy making, and that which is 
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more indirect, for example involving the use of research to mobilise support, 
influence concepts and language, or question established practices and beliefs.  
This conceptual approach is generally accepted by policy scholars as an accurate 
reflection of the way research outputs feed into the policy process.  A summary 
of the findings from the impact analysis in Chapters 4-8 can be seen in Table 9.1.  
It is structured to reflect the domains of the framework used for the analysis and 
includes any evidence of impact on knowledge production, including total 
number of citations in Google Scholar for each review; any evidence of research 
targeting; levels of policy making, including the number of guidelines and policy 
documents citing the paper; the type of policy; and the nature of the policy 
impact, for example evidence of direct or indirect impact, and any evidence of 
impact on practice.   
Knowledge production 
The papers were published over a ten year period, between 1998 and 2008.  Of 
the ten reviews included in the analysis nine were published in peer-reviewed 
journals, the other (Bunn et al., 2006a) was published on the website of the 
National Institute for Health and Clinical Excellence.  Some of the most 
frequently cited papers were the five reviews on fluid therapy (Chapter 4).  All 
had an impact on the research community although this was particularly 
significant for two (Alderson et al., 2000, CIG Albumin Reviewers, 1998).  The 
least cited of all the papers was the review of qualitative studies (see Chapter 6) 
looking at barriers and facilitators to the uptake of fall prevention interventions 
(Bunn et al., 2008a).  However, this was also the most recently published paper.   
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Table 9.1:  Summary of main impacts on health care policy 
Review and year first 
published 
 
Knowledge 
production 
Research targeting Levels of policy making  Type of policy Nature of policy impact (e.g. 
direct or instrumental or 
indirect or conceptual) 
 
1. Colloid solutions 
2000 
 
Outputs 
Published in CDSR 
 
Citations  
GS= 118 
No evidence of 
research targeting 
identified 
Impact largely at level of practice 
guidelines.  
 
Guidelines/policy documents 
UK=5  
Non UK = 5 
International =1 
 
Influence of reviews appears to 
be largely related to practice 
policies (e.g. use of resources by 
practitioners)  
Instrumental use: informing the 
development of practice 
guidelines (e.g. by NICE and HTA) 
 
Indirect impact of review unclear 
2. Hypertonic vs. 
Isotonic 
2000 
 
Outputs 
Published in CDSR 
 
Citations  
GS = 104 
 
No evidence of 
research targeting 
identified 
Impact largely at level of practice 
guidelines.  
 
Guidelines/policy documents 
UK =2 
Non UK =2 
International =0 
Influence of reviews appears to 
be largely related to practice 
policies 
Instrumental use: informing the 
development of practice 
guidelines (e.g. by NICE and HTA) 
 
Indirect impact of review unclear 
3. Albumin 
1998 
 
Outputs 
Published in 
CDSR/BMJ 
 
Significant impact 
in research 
community 
Citations: 
CDSR version 
received 177 
citations in GS 
Review played a 
role in the 
initiation of large 
multi-centre RCT 
conducted in 
Australia 
Guidelines/policy documents 
UK=7 
Non UK = 8 
International =2 
Influence of reviews appears to 
be largely related to practice 
policies 
Instrumental use: informing the 
development of practice 
guidelines (e.g. by NICE and HTA) 
 
Direct impact on practice with 
40% reduction in use of human 
albumin in UK; also evidence of 
reduction in use in other 
countries 
 
Indirect impact by stimulating 
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BMJ version 
received 579 
citations in 
Scopus (data from 
GS not available) 
 
debate and changing thinking 
and established practices around 
fluid resuscitation 
4. Timing and volume 
2001 
 
Outputs 
Published in CDSR 
 
Citations: 
GS=114 
 
No evidence of 
research targeting  
Impact largely at level of practice 
guidelines.  
 
Guidelines/policy documents 
UK =2 
Non UK =2 
International = 2 
Influence of reviews appears to 
be largely related to practice 
policies 
Instrumental use: informing the 
development of practice 
guidelines (e.g. by NICE and HTA) 
 
Indirect impact of review unclear 
5. Colloids vs 
crystalloids 
1998 
Outputs 
Published in 
CDSR/BMJ 
 
Significant impact 
in research 
community 
Citations: 
GS=359/551 
 
Review suggested 
albumin might be 
harmful which led 
to CIG undertaking 
review focusing on 
albumin. 
Guidelines/policy documents 
identified 
UK =8 
Non UK=7 
International=2 
Influence of reviews appears to 
be largely related to practice 
policies 
Instrumental use: informing the 
development of practice 
guidelines (e.g. by NICE and HTA) 
 
Indirect impact by stimulating 
debate and changing thinking 
and established practices around 
fluid resuscitation  
6. Traffic calming 
2003 
 
Outputs 
Published in 
CDSR/Inj Prev 
 
Citations: 
GS=54/46 
 
No evidence of 
research targeting 
identified but may 
have impacted on 
research thinking 
in road safety. 
Guidelines/policy documents 
identified 
UK=4 
Non UK=5 
International=5 
Greatest evidence of impact was 
found on international policy in 
form of WHO road safety 
guidance.  Review fed directly 
into development of policy 
recommendations which were 
endorsed b y member states 
through UN resolution. 
 
Instrumental use: informing the 
development of international 
policy 
 
Indirect impact: may have 
contributed to a shift in road 
safety paradigm (e.g. 
highlighting need for more 
population based strategies) 
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7. Pedestrian safety 
education 
2002 
 
Outputs 
Published in 
CDSR/BMJ 
 
Citations: 
GS= 54/95 
 
No evidence of 
research targeting 
identified but may 
have impacted on 
research thinking 
in road safety. 
Guidelines/policy documents 
identified 
UK=3 
Non UK=3 
International=3 
Informed the development of EU 
and WHO policy documents  
Indirect impact: may have 
contributed to a shift in road 
safety paradigm (e.g. 
highlighting lack of evidence to 
support road safety education 
for children as a road safety 
strategy) 
8. Fall prevention: 
Barriers/facilitators 
 
Outputs 
Published in Age 
& Ageing 
 
Citations: 
GS = 5 
Review informed 
the design and 
conduct of primary 
study  
No evidence of impact at any 
level of policy.  Not cited in any 
guidelines/policy documents. 
 
No evidence of impact on policy No evidence of direct or indirect 
impact 
9. Contraceptive 
advice 
2006 
 
Outputs 
Published on NICE 
website  
 
Citations 
GS= 0 
No evidence of 
research targeting 
identified 
Review directly informed 
practice guidelines for England 
and Wales.  No evidence of 
international impact. 
 
 
Directly informed the 
development of NICE guidance 
Instrumental use: clear link 
between review and 
development of NICE guidance 
 
Unclear if NICE guidance has 
been implemented or impacted 
on practice 
10. Telephone 
consultation 
2005 
 
Outputs 
Published in 
CDSR/BJGP 
 
Citations: 
GS =55/23 
 
Review informed 
the design and 
conduct of primary 
study 
Guidelines/policy documents 
identified 
UK=8 
Non UK=0 
International=0 
Little evidence of impact on 
policy 
No evidence of direct impact on 
policy or practice. 
 
Indirect impact of review 
unclear. 
CDSR= Cochrane Database of Systematic Reviews, GS = Google Scholar 
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Eight of the reviews were published in the Cochrane Library, five of which were 
also published in an additional peer review journal.  On first inspection it 
appeared that the Cochrane versions were cited far less than the versions 
published elsewhere, for example the BMJ albumin paper was more highly cited 
than the Cochrane version.  This discrepancy may be a reflection on the 
prominence, accessibility or readability of Cochrane reviews in comparison to 
those published in other journals.  However, it may also be because citation 
counts for Cochrane reviews are artificially low because they have been 
incorrectly cited (The Cochrane Library, 2008).  My investigations (see Chapter 8) 
substantiate the latter theory.  I found that the citation information for Cochrane 
reviews in Scopus and WoS is highly flawed and does not reliably reflect the 
impact of the papers on the research community. 
The impact of the Cochrane reviews within the research and practice community 
was further assessed by an analysis of the frequency with which the reviews 
were downloaded.  Data for 2008 and 2009 can be seen in Table 9.2.  Although 
there was considerable variation between the reviews the data do suggest that 
all of the reviews have been of interest to decision makers.  The figures, 
however, only give an indication of the popularity of the reviews in comparison 
with other Cochrane reviews and do not provide any information on who 
downloaded them or how they were subsequently used.  Interestingly despite 
the fact that the albumin review had had the highest overall citation figures of 
any of the reviews it is now downloaded less than some of the other fluid 
therapy reviews.  It is possible to speculate that this recent lack of interest is 
because the review, and subsequent RCT on the subject, have affected practice 
to such an extent that albumin is no longer widely used in clinical practice. 
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Table 9.2 Number of downloads for Cochrane reviews 
Review Downloads 
2008 
Ranking 2008 
(from a total 
of 6,232) 
Downloads  
2009 
Ranking  
2009 (from a 
total of 6840) 
1. Colloid solutions 1516 170 1387 327 
2a. Albumin 1040 375 1653 632 
3. Hypertonic vs. Isotonic 650 910 538 1620 
4a. Colloids vs crystalloids 2973 18 3291 35 
5. Timing and volume 691 823 694 1146 
6a. Traffic calming 812 620 334 2666 
7a. Pedestrian Safety 
Education 
68 5105 214 3693 
9a. Telephone Consultation 681 841 886 777 
Research targeting 
I also assessed whether research had contributed to the setting of future 
research agendas.  Such ‘research targeting’ is not always easy to determine or 
prove but there was one example of a systematic review leading to further 
research.  The human albumin review discussed in Chapter 4 (CIG Albumin 
Reviewers, 1998) was a significant driver in a subsequent large RCT undertaken 
in Australia (Finfer et al., 2004b).  
Informing policy development 
The main purpose of the impact evaluation was to assess whether the reviews 
had influenced the formulation of health care policy in any way.  I found a 
number of examples where the reviews had appeared to influence policy.  In 
particular the reviews had had an impact on the development of policies in the 
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form of guidelines at a local level or for professional bodies, with nine of the ten 
reviews contributing to the development of practice guideline (see Table 9.1).  
There was also some evidence of impact on Government policy with six reviews 
cited in NICE guidelines, and one used to develop NICE guidance.  In addition, a 
number of the reviews had impacted on international policy.  This was 
particularly the case for the road safety reviews (Chapter 5) that had fed directly 
into the development of policy recommendations by the WHO (Peden et al., 
2004b), recommendations which have been endorsed by member states through 
United Nations General Assembly resolutions.  This is especially notable because, 
in an examination of the development of recommendations by WHO 
departments, Oxman and colleagues found that systematic reviews were rarely 
used for developing recommendations but instead the process usually relied 
heavily on experts (Oxman et al., 2007).   
Levels and type of policy impact  
This evidence relating to the impact of the reviews should be considered in the 
context of how, where and at what level we can realistically expect reviews to 
support the development of health care policy.  In theory systematic reviews 
might support the policy process in a number of ways, including setting the 
policy agenda by providing evidence that a problem exists, giving examples of 
the impacts of policies on people and organisations, evaluating policy initiatives 
and providing feedback from experiments (Whitehead et al., 2004).  However 
Lomas suggests that the functional role of research in setting agendas may be 
relatively small because civil servants dislike inputs being pushed at them (Lomas 
and Brown, 2009).  In addition, some levels of policy may be more difficult to 
influence than others.  ‘Macro’ policies emanating from the Department of 
Health may be particularly difficult to influence as they tend to be the result of a 
closed system of decision making (Walt, 1994).  Indeed, much of the impact of 
the reviews in this study was in the development of a range of ‘micro’ policies, 
such as guidelines for professional bodies.  The reviews which appeared to have 
the most influence were those related to clinical practice questions around 
appropriate fluid resuscitation strategies.  This is perhaps unsurprising as it has 
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been suggested that some policy and practice areas lend themselves more 
readily than others to being informed by research.  For example, it may be easier 
for research to influence the development of practice policies, such as the use of 
resources by practitioners, rather than governance policies that relate to 
organisational and financial structures.   
It has also been suggested that we have misguided expectations about the 
extent to which scientific evidence can influence behaviour (Green et al., 2009, 
Weiss, 1979).  Green argues that the literature on diffusion and dissemination 
tells us that people, whether policy makers, practitioners or the public, will filter 
the information they receive, and selectively choose information that fits with 
their perceived needs, priorities, and circumstances (Green et al., 2009).   
Nature of policy impact 
In a recently published study exploring ways of measuring research utilization 
Estabrooks and colleagues attempt to clarify the construct of research utilization 
and identify observable indicators of research use (Estabrooks, et al 2011).  
Although their focus is on research utilization by practitioners, in particular the 
use of research in nursing practice, some of their work is applicable to the use of 
research by policy makers.  Like others, they construct research use in terms of 
instrumental, conceptual and symbolic impact and suggest that the use of 
evidence to develop or update educational material, policy and guidelines is an 
indicator of instrumental research impact.  Similarly in this study I took inclusion 
of one of the reviews in a guideline or other policy document as an indicator of 
instrumental research impact, and, as previously reported found a number of 
examples of such impact.   
However, many have argued that much of the impact of research on policy is 
likely to be conceptual or symbolic rather than instrumental (Black, 2001, Lavis et 
al., 2003b, Lomas and Brown, 2009, Weiss, 1976) and it is well documented that 
such indirect impacts are difficult to determine.  Estabrooks and colleagues 
suggested that questioning of current practice, revising ideas and engagement 
with relevant research are all indicators of conceptual use of research.  In 
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Chapter 4 I suggested that there was evidence that the reviews relating to 
human albumin and colloids versus crystalloids created debate and discussion 
about established practices and beliefs.  Indeed, the high number of citations 
associated with these reviews is potentially an indicator of their importance in 
this debate.  In addition, the reviews in Chapter 5 may have influenced thinking 
about the evaluation of road safety interventions and been used to mobilise 
support in favour of environmental and legislative interventions.  However, in 
both cases this indirect impact is difficult to substantiate. For the remaining 
reviews I found no discernable indication of conceptual or symbolic impact. 
Impact on practice 
The main focus of the evaluation was the extent to which the reviews had 
impacted on policy.  However, there was an obvious example of a review 
impacting directly on practice.  The albumin review (CIG Albumin Reviewers, 
1998) had a significant impact on practice leading to a 40% decrease in the use of 
human albumin in the UK and documented falls in other countries.  Interestingly, 
practitioners made changes to their clinical behaviours well before the 
protracted deliberations of policy makers had been concluded.  In this instance 
improvements in health care delivery were achieved directly in response to the 
review rather than because of a policy directive.  However, policy in the form of 
guidelines may have subsequently played a role in further embedding these 
changes into clinical practice. 
 
Factors that play a role in the extent to which systematic reviews 
can influence policy 
It is apparent from the results of the impact evaluation that some reviews have 
had a greater impact than others.  In this section I draw upon findings from the 
impact evaluation and current literature to examine the factors that play a part 
in the influence of systematic reviews on policy.   
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Dissemination  
One factor that may have contributed to the degree of impact that different 
reviews have had was the mode of dissemination.  Most of the reviews were 
disseminated traditionally via publication in peer-review journals.  Eight reviews 
were published on the Cochrane library and, although Cochrane reviews have 
been found to be of comparable or better quality to those published in print 
journals (Jadad et al., 1998), the format may not be particularly user friendly 
(Grimshaw, 2004).  Many of the reviews are lengthy and decision makers may 
find the detailed tables, forest plots, figures and quality assessment information 
difficult to interpret.  Of course reviews in print journals, while generally shorter, 
are also often full of academic language and tables and statistics that policy 
makers may find daunting (Lavis et al., 2005).  It is possible that the impact of the 
reviews in this study may have been increased by more active or user-friendly 
dissemination strategies.  From the overview of the literature on the 
dissemination of reviews (Chapter 2) it was clear that the inclusion of short 
summaries of review findings is particularly important for policy makers (Dobbins 
et al., 2004b, Lavis et al., 2005).  However, few studies compared different 
review formats and it is clear that more work is needed on the development of 
appropriate methods for disseminating reviews.  Although the Cochrane 
Collaboration has made efforts to improve dissemination, such as through lay 
summaries and podcasts, more work is needed to improve the readability of 
Cochrane reviews. 
The dissemination of research results through the media appeared to be a 
significant factor in determining the degree to which the reviews influenced 
policy.  Gold talks about how rare it is for a single paper to make an impact on its 
own (Gold, 2009).  When it does she describes this as a ‘big bang’ where the 
results of a single study frame the debate in new ways, or drive initiatives.  She 
argues that in reality most studies by themselves will not have the scope, 
robustness or focus for a ‘big bang’ but suggests that publication in a prestigious 
journal can generate press coverage that propels the communication and uptake 
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of key messages from research.  Of the ten reviews included in this study there 
was one example of a review making a ‘big bang’.  This was the study on human 
albumin (CIG Albumin Reviewers, 1998), and the fact that it was widely reported 
in the media both in the UK and internationally undoubtedly increased the 
impact of the review.  The 2009 update of the Cochrane traffic calming review 
was also picked up by a number of media outlets.  This was largely because the 
publication of the update was accompanied by a press release.  Of course it is 
difficult to quantify the influence of a press release.  It is generally only reviews 
that are considered ‘newsworthy’, for example showing clear evidence of benefit 
or harm, that tend to get accompanied by a press release and such reviews may 
be more likely to have an impact anyway.  However, the updated review 
received more press coverage than the original version that had no press release. 
Despite the undoubted influence of the media some commentators have 
questioned whether traditional media still has the same power to spark trends 
and create opinion.  Green suggests that the explosion of the Internet and the 
saturated media environment have generated a new type of audience that is 
more critical of mass media and more reliant on other people’s opinions at the 
interpersonal level (Green et al., 2009).  In such an environment innovations in 
connectivity such as two way electronic devices, text messaging, blogging and 
twitter may be as influential as more traditional forms of media.  Researchers 
should explore how such technology can be used to communicate the findings of 
systematic reviews in a format that would make them more accessible for 
decision makers. 
Drivers behind review question 
The drivers behind a review may also determine how influential reviews are; 
including who initiated the question and why, the type of question being asked, 
the perceived importance of the question and whether it fits with the values and 
ideologies of policy makers.  It has been suggested that researcher-initiated 
syntheses run the risk of addressing questions that are of interest to other 
researchers rather than policy makers (Gold, 2009).  Eight reviews were 
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Cochrane reviews, seven of which were undertaken while working for the 
Cochrane Injuries Group.  The set up of the Cochrane Collaboration has meant 
that Cochrane reviews have typically reflected the interests of individual 
researchers rather than being priority-driven (Grimshaw, 2004).  In this instance 
the choice of questions for the Injuries Group reviews (Chapters 4 & 5) was 
influenced by a prioritisation process undertaken by the group when it was first 
established. This process drew on the expertise of an international group of 
researchers and practitioners but, for the most part, did not include policy 
makers.  The impact of many of these reviews indicates that such a collaborative 
prioritisation process can be a successful way of identifying review questions of 
importance to decision makers and practitioners.  Of the other three reviews, 
two were specifically undertaken to inform the development of primary research 
(Bunn et al., 2005, Bunn et al., 2008a) (Chapter 6 & 8) and one was initiated by 
policy makers to inform the development of NICE guidance (Bunn et al., 2006a) 
(Chapter 7).  Although the latter was initiated by policy makers its impact on 
practice may have been limited because the recommendations did not fit well 
with current practice and service organisation.   
Review methods 
The reviews in this study incorporate a range of study types and involve a variety 
of techniques for analysis including meta-analysis, narrative presentation of 
results and thematic analysis of qualitative studies.  In general, however, the 
majority are conducted according to Cochrane principles and primarily ask 
questions about ‘what works’ with controlled studies prioritised over other study 
designs.  The exceptions to this were the review commissioned by NICE, in which 
I looked at context and applicability and attempted to answer questions about 
‘what works for whom in what circumstances’ (Bunn et al., 2006a, Bunn et al., 
2008a), and the review of qualitative studies exploring attitudes to fall 
prevention interventions (Bunn et al., 2008a).  
The choice of study types to include in each review was affected by a number of 
considerations including rigour, suitability and the complexity of the question.  
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For example, although it was appropriate to restrict clinical questions about fluid 
resuscitation to RCTs, more complex public health questions, such as the review 
concerning sexual health, may need to involve more diverse study types 
including qualitative studies.  Despite the inclusion of non randomised studies in 
a number of the reviews, my approach may still be considered by some to be 
overly positivist and biomedical (Morgan and Ziglio, 2007).  However, I would 
argue that although reviewers may need to look beyond questions about what 
works it is still of fundamental importance to establish the effectiveness of 
interventions.  We should not be neglecting the question ‘what works’ but in 
some instances should also be asking additional questions, such as ‘what works 
for whom and why’. 
Barriers & facilitators to research impact   
Policy makers and determinants of research use 
There is evidence to suggest a positive attitude towards research is an important 
determinant of research use (Estabrooks et al., 2003).  In Chapter 2 I reviewed a 
number of studies that explored policy makers’ attitudes towards the use of 
systematic reviews.  The extent to which policy makers knew about or valued 
systematic reviews as a source of evidence was the subject of some discrepancy.  
However, overall it appeared that policy makers were not always familiar with 
systematic reviews and did not necessarily place a high value on systematic 
review evidence.  This is likely to be a barrier to research impact.  There are, of 
course, other potential determinants of research use and in Chapter 7 I explored 
some of the factors that might influence the use of guidelines by health care 
professionals.  The nature and strength of the evidence has been found to be a 
facilitator for research use (Dopson et al., 2001) and this might explain why some 
of the reviews in this study had a greater impact than others.  In addition, the 
cultural and organisational environment in which policy makers operate is likely 
to influence their use of research (Grimshaw et al., 2004, Rycroft-Malone et al., 
2004a).  In Chapter 2 some of the studies that reported the most positive 
attitudes towards systematic review evidence were conducted in Canada where 
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there have been considerable efforts to develop a policy-making culture that 
values research evidence. 
Social networks  
An important factor in determining impact may be the interactions and 
connections between researchers and other actors in the policy process.  There 
is evidence to suggest that the social networks of researchers play a vital role in 
the communication and dissemination of research (Gray, 1973, Rogers, 1983) 
and the degree of impact.   Although there is a variety of definitions and ideas 
about what constitutes a network, most agree that it involves groups of actors 
linked together, either loosely or closely structured, but capable of working 
together collectively (Walt et al., 2008).  Although initially policy analysis focused 
on the role of the state, more recent work acknowledges the involvement of a 
much larger number of actors in the policy process with policy decisions less top 
down and taking into account the values and beliefs of expanded networks (Buse 
et al., 2005, Hajer and Wagenaar, 2003). 
Although difficult to quantify, the impact of some reviews may have been 
facilitated by informal and formal social networks.  For example, links between 
the Cochrane Injuries Group and the Unintentional Injury Prevention (UIP) Team 
at the WHO may have increased the impact of the road safety reviews on WHO 
policy.  These links may be stronger because the UIP team at WHO operates from 
a similar epistemological position (many researchers are epidemiologists) to the 
CIG and it may be easier to disseminate research within networks where 
messenger and audience are similar.  Indeed, some organizations may be more 
‘permeable’ to outside knowledge because of their institutional philosophies, the 
positioning of influential staff members, or financial strength (Greenhalgh et al., 
2004).  In addition it should be noted that the Cochrane Collaboration is itself an 
influential organization involved in many networks in the UK and internationally.  
203 
 
Knowledge transfer and exchange strategies 
Although many networks involving researchers are informal and not specifically 
intended to facilitate dissemination, there is an increasing emphasis on the 
development of more formal networks whose primary aim is the transfer of 
research knowledge to decision makers.  The adoption of such knowledge 
transfer and exchange (KTE) strategies appears to make inherent sense.  Gold 
says that networking and trust are important in knowledge transfer and so 
researchers ‘willing to engage in communications that go beyond publication are 
likely to find a greater payoff’ (Gold 2009, p1131).   
Chapter 2 provides some evidence to support the use of KTE strategies to 
improve the dissemination and uptake of systematic reviews. However, much of 
the research in this area is anecdotal or descriptive and the benefits of KTE 
strategies need to be further established in robust evaluations.  There is also 
some concern that the adoption of collaborative or interactive approaches might 
compromise the scientific rigour of research (Innvaer et al., 2002, Keown et al., 
2008).  I was unable to draw any conclusions about the benefits of KTE from the 
impact evaluation in this study.  This was because only one review, the review 
conducted to inform NICE guidance, included any formal KTE strategies.  This KTE 
was led by the policy makers at NICE rather than initiated by the researchers and 
it is not clear what impact this had on dissemination.  It is possible that the 
impact of other reviews might have been greater if more formal KTE strategies 
had been employed. 
A key consideration is that substantial investment may be required in order to 
understand the audience and its needs’, build credibility, develop actionable 
audience-specific messages, and continue the exchange of ideas (Lavis et al., 
2005, Lavis et al., 2002).  For KTE to be effective activities may need to be 
sustained for a considerable length of time which may be costly and beyond the 
resources of many researchers.  Although researchers have a responsibility for 
KTE this must be shared with policy makers, and funding bodies need to be 
aware of the resources required to support such initiatives.  In addition 
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researchers may need to be supported in the development of appropriate KTE 
skills. 
Meeting the needs of policy makers whilst maintaining 
methodological rigour 
Throughout this study I have grappled with the question of how we produce 
reviews that are useful to policy makers whilst still methodologically rigorous.  Of 
course ‘rigour’ may mean different things to different people and my idea of 
rigour may well differ from someone coming from a less ‘positivist’ background.  
From my perspective, rigour means adhering closely to Cochrane standards for 
evaluating effectiveness.  However, I am aware of the limitations of such an 
approach and some reviews, particularly those asking complex public health 
questions, may require a broader approach; for example incorporating 
qualitative research.  
I discussed earlier how a consideration of context, for example does an 
evaluation work in particular settings and for particular populations, may be 
important in order to make reviews relevant to policy makers.  However, asking 
more questions and including a greater diversity of study designs within a review 
increases the complexity of the task that in turn means that more resources are 
required.  Increasing the cost and time taken to do a review has implications for 
whether the review might impact on policy.  It has been suggested that there are 
only small windows of time where research may impact on the policy process 
(Kingdon, 1984) and the window of opportunity may have passed by the time a 
synthesis is commissioned and completed (Gold, 2009).  One alternative is for 
researchers to do a synthesis of previous reviews in a ‘review of reviews’ (Bunn 
et al., 1999, Bunn et al., 2000c, Trivedi et al., 2007b).  This is an increasingly 
viable option as the burgeoning interest in systematic reviews means there is 
now a substantial reservoir of reviews to draw upon.  However, it is only feasible 
if previous good quality reviews have addressed the question of interest.  The 
resource constraints under which policy makers often operate have also led to 
the suggestion that some parts of the review process could be made less time 
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consuming. For example, there is some interest in more iterative methods for 
searching (personal communication NICE).  In addition, there is scope for further 
work on methods for qualitative reviews and whether ‘sampling’ of the 
literature, rather than including all available studies, might be appropriate.  Such 
initiatives will need to be thoroughly evaluated to ensure that we are not 
sacrificing methodological rigour in favour of expediency. 
Methodological approach and limitations of the study 
Much previous work on the impact of research on policy is reflective rather than 
documenting empirical examples (Boaz, 2008c) and there are few impact 
evaluations that focus on the impact of research on policy.  In addition, although 
received wisdom suggests that systematic reviews are useful tools for policy 
makers, there is a lack of data to support this.  In this study I have explored these 
issues further by taking methods previously used for evaluating the impact of 
research and applying them to systematic reviews.  I found only one other 
example of an impact analysis concerned with systematic reviews (Soper and 
Hanney, 2007).  This study, therefore, provides further information on the 
application of impact evaluation methods for systematic reviews.  My analysis 
also differs from many in that the focus is on specific outputs in the form of 
published papers rather than the impact of whole projects or programmes.   
There are a variety of methods available for evaluating the impact of research.  I 
used primarily quantitative methods, including bibliometrics and literature and 
documentary review.  I chose this approach because they are methods that could 
be used for comparison across reviews, are transparent and reproducible, and 
are suitable for retrospective evaluations.  There may, however, be an inherent 
contradiction in the use of quantitative methods such as bibliometrics to 
measure the messy, complex process of policy making and it has been suggested 
that qualitative methods such as observations and semi-structured interviews 
may generate useful descriptive and explanatory data for examining the policy 
context and the pathways to research use.  However, as methods they run the 
risk of being anecdotal and subjective and it can be difficult to generalise their 
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findings (Boaz, 2008a).  Although I conducted some informal interviews with co-
authors, and with other colleagues who might be aware of evidence of impact, 
this was limited as I already had the ‘insider account’.  Interviews with policy 
makers might have added useful additional information to the study but were 
not considered feasible given the breadth of subject areas covered in the 
analysis.  Moreover, interviews would be subject to recall bias and it is unlikely 
that it would have been possible to identify individuals involved in policy 
decisions relating to specific reviews, some of which were published over a 
decade ago.  High turnover of policy makers is a problem even for prospective 
evaluations (Dobbins 2009).   
Although a number of frameworks for structuring research impact exist none 
were entirely suitable for the purposes of this study.  Therefore, I took 
components from two established frameworks (the Payback Model and the 
Research Impact Framework) to create a framework for this study.  This had the 
advantage of using a well respected framework (The Payback Model) but making 
it more relevant for a study focused on policy.   
Limitations 
Limitations of methods for impact analysis  
Evaluating the impact of research is complex and difficult and there are a 
number of methodological issues that might have a bearing on the validity of the 
results of this study.  At present there are no agreed instruments or methods for 
determining impact (Peckham et al., 2008) and many of the methods currently 
used focus on outputs rather than outcomes or processes.  My primary outcome 
was impact on policy and although I took citation in a policy document as an 
indicator of influence on policy, this was a proxy for impact and, furthermore, 
can only be considered an intermediate outcome.  It does not tell us if a policy 
was implemented.  However, the implementation of policy is difficult to measure 
and the farther you travel away from the policy or policy document the harder it 
is to attribute such changes to specific pieces of research.  In addition, although 
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the focus of my research was on policy impact that, in itself, is only ultimately of 
interest if that policy leads to improvements in patient or system related 
outcomes.  Such outcomes were beyond the remit of this study. 
Limitations of bibliometrics and documentary review 
Another potential limitation of this study is that the methods I chose to use have 
not been developed for the specific purpose of evaluating the impact of research 
on policy (Boaz, 2008a).  It could be argued that as bibliometrics and 
documentary review do not involve enquiry in the real world of policy making 
such methods fail to capture the complexities of the policy making process.   
Indeed, there are a number of limitations associated with the use of 
bibliometrics to assess the impact of research in general.  A major criticism of 
bibliometric techniques is that they tend to focus on quantity rather than quality, 
measuring the number of research outputs rather than research outcomes or 
impact (Boaz, 2008a).  In my analysis I took citation in a policy document (such as 
guidelines) as an indicator of evidence of impact.  However, as I was generally 
not party to the process by which such guidelines were developed it was unclear 
how significant a role the reviews played in the guideline development process 
and what influence they might have had in relation to other competing factors.   
Another possible limitation of the citation analysis in this study was that I 
focused on whether a paper was cited rather than the context in which it was 
cited.  There are many reasons why people cite work and, as well as 
acknowledging the contribution of previous work, the purpose of the citation 
may be to dispute the claims of previous work or criticise it (Garfield, 2006).  For 
example, many of the papers citing the albumin review were critical of the 
methods of the review or conclusions drawn.  In addition, citations may be 
distorted or manipulated so that the findings are not used as the researchers 
originally intended (Greenberg, 2009, Hoyt and Garrison, 1997).   
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Risk of bias 
Another potential threat to the validity of this study is the risk of bias.  This was a 
retrospective analysis and as such may be at greater risk of bias than one where 
data is collected prospectively.  Evidence from the citation analysis and 
documentary review was supplemented by my own recollections of instances of 
impact.  Whilst information provided by researchers themselves may provide 
examples of impact not available through documentary review or bibliometric 
analysis (Bunn and Kendall, 2011, Kalucy et al., 2009) such information may be 
subject to recall bias.  In addition, the risk of bias in an impact evaluation is 
greater when the researcher, as is the case in this study, is directly investigating 
her own research, and it has been suggested that strong evaluations would 
include elements of both internal and external review (Hovland, 2007).  In reality, 
however, most impact evaluations are carried out by those with a vested interest 
and, as such, are subject to the risk of bias.  Furthermore, internal evaluations 
have the advantage of the ‘insider account’ which means they may have greater 
access to information that allows them to unravel the complexity of the policy 
making process (Walt et al., 2008).  
The direction of travel is another potential source of bias in an impact evaluation.  
I tracked forward from research papers and, although this has the advantage of a 
more tightly defined focus, which may help to identify any contribution that the 
research has made, such an approach may be more likely to inflate the impact of 
research than tracing backwards from policy (Hanney et al 2007).  Hanney and 
colleagues suggest that starting with research may imply a linearity that obscures 
the complex reality of how policy changes occur.  However, they acknowledge 
that it is difficult to see how the approach of tracing backwards could be applied 
to diverse research programmes (Hanney, 2007).   
The papers included in the impact analysis were self-selected and do not 
represent all the systematic reviews I have authored.  Indeed, the choice of two 
of the papers (Alderson et al., 2000, CIG Albumin Reviewers, 1998) was governed 
by the knowledge that they had had an impact, and would, therefore, make good 
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case studies.  However, although I have not included all my publications, those 
that I have chosen represent a substantial body of my published systematic 
review work (see Appendix 1 for a full list of publications).  The breadth of 
systematic reviews included in this study was both a strength and a limitation.  
Whilst, the range of topics covered, allowed for wide-ranging consideration of 
potential barriers and facilitators, and of the extent to which such barriers might 
be subject specific or more generic, the scope of the evaluation limited the 
choice of data collection methods. 
In this study I have compared the impact of a variety of reviews.  However, direct 
comparisons of the reviews are problematic for a number of reasons.  One 
consideration is the variation in citation windows.  The reviews were published at 
different times over a ten year period and those reviews published recently may 
not yet have had time to impact on policy.  In his work on the policy cycle 
Sabatier notes that it may take up to a decade for the full impact of research to 
be apparent (Sabatier, 1988).  In addition, citation volume typically peaks in the 
third or fourth year post-publication and, therefore, a window of five years has 
been suggested as most appropriate for research assessment (Ismail et al., 2009, 
van Leeuwen et al., 1999).  Furthermore, the diverse nature  of the review topics 
means that one should be cautious when comparing the impact of reviews 
because, as I have previously discussed, some policies and policy-making 
processes may lend themselves more readily than others to being informed by 
research (Lavis et al., 2002).   
It has been suggested that comparative assessment of scientometric indicators, 
such as citation rates, may be hindered by different standards valid in different 
science fields and subfields, and that direct comparison is only possible after 
standardization or normalisation (Schubert and Braun, 1996).  As I did not 
undertake formal normalization, direct comparisons of citation rates across the 
different chapters should be interpreted in light of the differing journals and 
their respective impact factors.  In the ISI WoS database, the BMJ, Cochrane 
Library, and British Journal of General Practice are all categorised as ‘Medicine, 
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General and Internal’.  As these journals are classified in the same subcategory it 
is reasonable to make some comparisons across these journals.   Of the other 
two journals in which I published papers, Ageing and Society is classified in the 
subcategory ‘Gerontology’ and Injury Prevention is in the subcategory ‘Public, 
environmental and occupational health’.  The impact factors of the various 
journals (ISI WoS 2009) ranged from 13.660 (BMJ) to 1.770 (Ageing and Society).  
Furthermore, normalisation is more important when trying to make direct 
comparisons of the impact of individual researchers rather than the impact of 
different papers; in this study the major purpose of the citation analysis was to 
trace the flow of knowledge, for example looking to see if reviews were cited in 
particular policy documents, rather than to draw any conclusions from direct 
comparisons of citation counts. 
Implications of the findings 
This submission contributes to knowledge in several ways.  It is based on a 
number of previously published reviews which offer a unique interpretation of 
knowledge in a range of subject areas.  In addition the study offers insight into 
the application of methods for evaluating the impact of a diverse group of 
systematic reviews.  Whilst there has been much written on the relationship 
between research and policy there are few examples of impact evaluations  
(Boaz 2008a) and this study represents a documented example of an empirical 
evaluation.  Finally the submission contributes to our understanding of how 
researchers might increase the impact of systematic reviews. 
The results of the impact analysis presented in this study provide some evidence 
that systematic reviews influence health care policy.  However, there are 
significant difficulties associated with determining the impact of specific pieces 
of research on health care policy (Hanney 2007).  The real world of policy making 
is complex and messy and questions remain about the validity of current 
methods for evaluating impact of research on policy.  As with many impact 
evaluations I used bibliometric indicators to measure research impact.  Whilst 
they were a reliable measure that could be used across a diverse group of 
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reviews questions remain about what meaning we can attach to them in terms of 
policy impact (Hanney 2005).  Although documentary review suggested that a 
number of the reviews had impacted on practice guidelines the methods I used 
did not enable me to quantify the extent of their contribution.  Neither was I able 
to assess whether policies were implemented or if they impacted on practice. 
Identifying suitable methods for the evaluation of impact on policy is particularly 
difficult.  It is possible that qualitative methods, such as interviews with policy 
makers or direct observation of decision making processes may be more 
appropriate than quantitative methods for evaluating research impact on policy.  
However, such methods can be difficult to generalise and may not fit with 
retrospective evaluations of specific pieces of research.  The retrospective nature 
of the study made it more susceptible to recall bias.  Nevertheless, whilst 
prospective evaluations may have many advantages they also run the risk of 
underestimating research influence as it may take a number of years for research 
to impact on the policy process.   
The conceptual approach that I used for my study was based on three main types 
of research impact; instrumental, conceptual and symbolic.  This classification of 
research utilisation is well established and commonly used (Weiss 1976, Stetler., 
1985, Estabrooks,. 1999).  However, although it is generally agreed that much 
research impact is conceptual or symbolic these are far harder to distinguish 
than instrumental impact (Hanney et al., 2000).  This proved to be the case in my 
study where indirect impacts were difficult to substantiate. 
My study included ten systematic reviews which were concerned with a variety 
of topics.  The rationale for including such a diverse group of reviews was to 
evaluate the impact of a body of my own work and explore how researchers can 
increase the impact of systematic reviews.  My focus was on the impact of 
systematic reviews more generally rather than being subject specific.  However, 
it is possible that a narrower focus on reviews in one subject area (i.e. road 
safety) may have made identifying evidence of impact easier.  In such an 
evaluation it would be more feasible to employ a greater mix of quantitative and 
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qualitative methods and could involve both tracking forwards from specific 
reviews and tracking backwards from policy documents.   
Although I found evidence of impact there was substantial variation in the 
influence of individual reviews.  The extent to which systematic reviews 
contribute to the development of health care policy is dependent on a variety of 
methodological, organisational, political and economic factors.  Some of these 
imperatives that drive policy formulation may be more difficult to influence than 
others, in particular the political and economic ones may often be beyond the 
control of individual researchers.  However, researchers generally have greater 
governance over the methodological and organisational elements of the 
systematic review process, and manipulating these may allow them to increase 
the influence of their work on health care policy. 
The methodological approach adopted by a researcher undertaking a review 
might be a contributing factor to its overall impact and, as such, the approach 
should be chosen in the light of the desired impact of the review.  Is the primary 
purpose to impact on practice and/or policy or to inform research?  Such 
considerations will have a bearing on the way the question is formulated and the 
review undertaken.  For example, some review questions, particularly those 
concerned with public health or complex interventions, will need to be framed to 
include a consideration of contextual factors and applicability to particular 
settings or populations.  This may necessitate mixed methods reviews including 
quantitative and qualitative studies.  However, for many clinical questions, such 
as those considered in Chapter 4, a focus on RCTs remains appropriate. 
Throughout this study the importance of using appropriate dissemination 
strategies has been a recurring theme.  Researchers need the skills and 
knowledge necessary to disseminate their work and developing these should be 
a part of their professional development.  Some dissemination strategies are 
reasonably simple, for example the adoption of user friendly review formats and 
inclusion of executive summaries and key messages summarising salient points 
of the review.  Researchers should consider other formats for dissemination 
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instead of relying simply on dissemination via peer review journals.  In Lavis’s 
knowledge transfer tool (see Chapter 3) he suggests that it is important to 
identify the audience for whom the research is planned (Lavis et al., 2003a).  This 
might include the general public, patients, clinicians, managers and public policy 
makers.  Considering for whom the research is intended may make it easier for 
researchers to target and evaluate their dissemination activities.  In addition it is 
worth addressing at the outset what processes are available for transferring the 
knowledge and the desired impact of the transfer of knowledge (Gold, 2009, 
Lavis et al., 2005, Mitton et al., 2007). For instance, in a review I am currently 
involved in we are holding focus groups involving policy makers, service 
providers and patient representatives to disseminate and discuss the findings 
and develop recommendations relevant to our local setting.  Investing time and 
effort into developing appropriate networks, for example through building links 
with local service providers, commissioners and representatives from the 
voluntary sector, may be key to dissemination. 
Even when researchers have the skills and knowledge to disseminate their work 
they may not have the time or financial resources required.  Knowledge transfer 
and exchange strategies, such as the use of knowledge brokers, have been put 
forward as a means of improving impact but these may require substantial 
investment from both researchers and policy makers.  Simpler methods such as 
targeted messaging have been found to be effective (Dobbins et al., 2009) and 
may be a more realistic alternative.  Ultimately however, if KTE is considered an 
essential part of the review process then funding bodies and research 
institutions need to provide support for such initiatives. 
It is frequently argued that systematic reviews are of limited use when they lack 
firm conclusions or recommendations; Gold suggests that although syntheses 
identifying gaps in the evidence may be useful those drawing more concrete 
conclusions may be more likely to be valued by policy makers (Gold, 2009).  
There is, however, a tension between the established tenet of systematic 
reviewing that emphasises an unbiased presentation of the evidence and the 
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need to make reviews of interest to policy makers.  Researchers have been 
criticised for going ‘beyond the evidence’ in an effort to increase the impact of 
their reviews (Boaz, 2005) and, indeed, ultimately it is unhelpful to policy 
makers, practitioners or service users to make inflated claims that are not 
substantiated by the evidence.  I would argue that calls for ‘further research’ 
whilst frustrating may sometimes be appropriate.  In such cases decision-makers, 
researchers and service users may work together to produce recommendations 
whilst acknowledging the limitations of the recommendations and the need for 
further work. 
Implications for future research 
This study has identified a number of gaps in the evidence base.  Areas for future 
research identified by the study include a need for the following: 
 The development and testing of qualitative methods for measuring the 
impact of research on policy 
 Evaluation of different methods of dissemination, including more user 
friendly presentation and the use of technologies such as podcasts and 
interactive media 
 Evaluation of methods for improving the presentation of reviews so that 
they are easier for decision makers to understand 
 Evaluation of the most appropriate formats for reviews including how to 
present complex scientific information in a format that is accessible for 
decision makers.   
 Development and evaluation of different methods for search strategies 
including work on the use of iterative rather than comprehensive 
methods 
 Qualitative work looking at how decision makers interpret and 
understand systematic reviews and how this could be facilitated  
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Conclusion 
The last few decades have seen a growing emphasis on evidence-based decision 
making in health care, with research-syntheses such as systematic reviews seen 
as key sources of evidence.  In addition, more recently, there has been 
burgeoning interest in the way in which research is used; researchers are 
increasingly expected to demonstrate that their work has contributed to society 
in some way, whether this is through an impact on the economy, culture, quality 
of life or public policy.  This study brings these two trends together in an 
exploration of the impact of systematic reviews on health care policy. 
Those seeking to influence policy through the findings of systematic reviews 
need to be aware of the social, cultural, political, economic and ideological 
factors that contribute to the development of health care policy.  Evidence may 
play its part in decision making but researchers must be realistic about what 
evidence-syntheses can achieve.  However, despite this competition from other 
influences, some of which are very powerful, this study provides some evidence 
that systematic reviews can influence health care policy at a variety of levels.  
Although much of the impact is at a ‘micro’ level systematic reviews can 
influence national and international policy.  These impacts are, however, not 
inevitable and need to be routinely and actively encouraged.   
As a researcher who has undertaken a number of systematic reviews across a 
range of subject areas I have come to realise that producing a rigorous review of 
the evidence is not in itself always enough to influence policy making.  The 
process of dissemination must be seen as part of the review process and 
reviewers must adopt suitable methods for conducting and disseminating their 
research.  In addition, it is important to have a clear idea of the desired impacts 
of a review as there is now a substantial literature to suggest that it is naïve to 
conceptualise the impact of research on policy and practice in the same way.  
The needs and methods of working of policy-makers may be fundamentally 
different from those of practitioners, and systematic reviewers seeking to 
influence policy may need to adapt their approach to reflect the needs of their 
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target audience.  Finally, whilst it is important for researchers to consider how 
they might increase the influence of their work, such impacts are difficult to 
measure.  Questions remain about how we define and measure policy impact 
and more work is needed to develop suitable methods for impact analysis.   
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A B S T R A C T
Background
Colloids are widely used in the replacement of fluid volume. However doubts remain as to which colloid is best. Different colloids vary
in their molecular weight and therefore in the length of time they remain in the circulatory system. Because of this and their other
characteristics, they may differ in their safety and efficacy.
Objectives
To compare the effects of different colloid solutions in patients thought to need volume replacement.
Search strategy
We searched theCochrane InjuriesGroup specialised register, CENTRAL (2007, Issue 1),MEDLINE (1994 toMarch 2007), EMBASE
(1974 to March 2007), and the National Research Register (2007, issue 1). Bibliographies of trials retrieved were searched, and drug
companies manufacturing colloids were contacted for information. The search was last updated in March 2007.
Selection criteria
Randomised and quasi-randomised trials comparing colloid solutions in critically ill and surgical patients thought to need volume
replacement. The outcomes measured were death, amount of whole blood transfused, and incidence of adverse reactions.
Data collection and analysis
Two authors independently extracted the data and assessed the quality of the trials.
Main results
Seventy trials, with a total of 4375 participants, met the inclusion criteria. Quality of allocation concealment was judged to be adequate
in 24 trials and poor or uncertain in the rest.
Deaths were obtained in 46 trials. For albumin or PPF versus hydroxyethyl starch (HES) 25 trials (n = 1234) reported mortality. The
pooled relative risk (RR) was 1.14 (95% CI 0.91 to 1.43). For albumin or PPF versus gelatin, seven trials (n = 636) reported mortality.
The RR was 0.97 (95% CI 0.68 to 1.39). For albumin or PPF versus Dextran four trials (n = 360) reported mortality. The RR was
3.75 (95% CI 0.42 to 33.09). For gelatin versus HES 18 trials (n = 1337) reported mortality and RR was 1.00 (95% CI 0.80 to 1.25).
RR was not estimable in the gelatin versus dextran and HES versus dextran groups.
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Thirty-seven trials recorded the amount of blood transfused, however quantitative analysis was not possible due to skewness and variable
reporting. Nineteen trials recorded adverse reactions, but none occurred.
Authors’ conclusions
From this review, there is no evidence that one colloid solution is more effective or safe than any other, although the confidence intervals
are wide and do not exclude clinically significant differences between colloids. Larger trials of fluid therapy are needed if clinically
significant differences in mortality are to be detected or excluded.
P L A I N L A N G U A G E S U M M A R Y
There is no strong evidence to be certain of the safety of any particular type of colloid solution for replacing blood fluids
When a person is bleeding heavily, the loss of fluid volume in their veins can lead to shock, so they need fluid resuscitation. Colloids
and crystalloids are two types of solutions used to replace lost blood fluid (plasma). They include blood and synthetic products. Both
colloids and crystalloids appear to be similarly effective at resuscitation. There are different types of colloids and these may have different
effects. However, the review of trials found there is not enough evidence to be sure that any particular colloid is safer than any other.
B A C K G R O U N D
Colloids are used as plasma substitutes for short-term replace-
ment of fluid volume, while the cause of the problem is being
addressed (for example, stopping bleeding). These solutions can
be blood products (human albumin solution, plasma protein frac-
tion [PPF]) or synthetic (modified gelatins, dextrans, etherified
starches). Colloid solutions are widely used in fluid resuscitation
(Yim 1995) and they have been recommended in a number of re-
suscitation guidelines and intensive care management algorithms
(Armstrong 1994; Vermeulen 1995). Previous systematic reviews
have suggested that colloids are no more effective than crystalloids
in reducing mortality (CIGAR 2004; Roberts 2004). Despite this,
colloid solutions are still widely used as they are thought to remain
in the intravascular space for longer than crystalloids and, there-
fore, be more effective in maintaining osmotic pressure.
It is plausible that colloids may vary in their safety and effective-
ness. Different colloids vary in the length of time they remain in
the circulatory system. It may be that some low tomediummolec-
ular weight colloids (for example, gelatins and albumin) are more
likely to leak into the interstitial space (Traylor 1996), whereas
some larger molecular weight hydroxyethyl starches are retained
for longer (Boldt 1996). In addition it is thought that some col-
loids may effect coagulation or cause other adverse effects.
The previous review of colloids against crystalloids only allows
indirect comparison of the different colloids. This review examines
direct comparisons of the different colloid solutions in randomised
trials to complement the earlier reviews on colloids compared to
crystalloids (Roberts 2004) and human albumin (CIGAR 2004).
O B J E C T I V E S
To quantify the relative effects on mortality of different colloid
solutions in critically ill and surgical patients requiring volume re-
placement, by examining direct comparisons of colloid solutions.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised and quasi-randomised (for example, allocation by
hospital number or alternation) controlled trials.
Types of participants
Patients clinically assessed as requiring volume replacement or
maintenance of colloid osmotic pressure. Administration of fluid
2Colloid solutions for fluid resuscitation (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
253
for preoperative haemodilution or volume loading, during plasma
exchange, for priming extracorporeal circuits or following para-
centesis are excluded.
Types of interventions
The colloid solutions considered are human albumin solutions,
plasma protein fraction, modified gelatins, dextran 70, or etheri-
fied starch solutions.
Trials of other blood products not used primarily for volume re-
placement (for example, fresh frozen plasma, pooled serum) were
excluded.
The review compares the administration of any regimens of dif-
ferent classes of colloids with each other.
Types of outcome measures
The primary outcome measure is mortality from any cause at the
end of the study period.
We also attempted to find data on incidence of adverse reactions,
allergies or anaphylactic shock, and the amount of blood (whole
blood or red blood cells) transfused in each group. Some of the
synthetic colloids may have anticoagulant properties and, there-
fore, we felt that some measure of blood loss or haemorrhage was
important. However, as blood loss is vulnerable to measurement
error, we decided to use the amount of blood products transfused
as an outcome measure.
Intermediate physiological outcomes were not used for several rea-
sons. These were that they are subject to intra- and inter-observer
variation, they have no face value to patients and relatives, and the
ones seen as appropriate are not stable over time. Also there would
need to exist a strong predictive relationship between the variable
and mortality.
Search methods for identification of studies
Electronic searches
We searched the following electronic databases:
• Cochrane Injuries Group trials register (searched 23 March
2007),
• CENTRAL (The Cochrane Library issue 1, 2007),
• MEDLINE (1966 to March 2007),
• EMBASE (1974 to March 2007),
• National Research Register (issue 1, 2007),
• Zetoc (searched 23 March 2007).
Full search strategies can be found in Appendix 1.
Searching other resources
We searched the bibliographies of the retrieved trials, and con-
tacted drug companies manufacturing colloids for information.
We also identified trials by using the searches undertaken for the
pre-existing review of colloids versus crystalloids (Roberts 2004),
which included BIDS Index to Scientific and Technical Proceed-
ings, drawing on the handsearching of 29 international journals
and the proceedings of several international meetings on fluid re-
suscitation, and checking the reference lists of the trials found.
There were no language restrictions in any of the searches.
To identify unpublished trials we searched the register of theMed-
ical Editors’ Trial Amnesty and we contacted the UK Medicines
Control Agency.
For the first version of the review (published 1999) we also con-
tacted the medical directors of the following companies which all
manufacture colloids:
• Alpha Therapeutic UK Limited (Albutein),
• American Critical Care McGraw (Hespan),
• Bayer (Plasbumin),
• Baxter (Gentran),
• Bio Products Laboratory (Zenalb),
• Cambridge Laboratories (Rheomacrodex),
• Centeon Limited (Albuminar),
• CIS UK Ltd,
• CP (Lomodex),
• Common Services Agency,
• Consolidated (Gelofusine),
• DuPont (Hespan),
• Fresenius (eloHAES and HAES-Steril),
• Geistlich Sons Ltd (Hespan and Pentaspan),
• Hoechst (Haemaccel),
• Mallinckrodt Medical GMBH (Infoson),
• Nycomed, Oxford Nutrition (Elohes),
• Pharmacia and Upjohn Ltd (Rheomacrodex), and
• Sorin Biomedica Diagnostics Spa.
Data collection and analysis
Selection of studies
One author examined the electronic search results for reports of
possibly relevant trials and these reports were then retrieved in full.
Two authors applied the selection criteria independently to the
trial reports, resolving disagreements by discussion.
Data extraction and management
Two authors independently extracted information on the follow-
ing:
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• method of allocation concealment,
• number of randomised patients,
• type of participants,
• the interventions, and
• outcome data (numbers of deaths, volume of blood
transfused, and incidence of adverse or allergic reactions).
The authors were not blinded to the authors or journal when doing
this, as the value of this has not been established (Berlin 1997).
Results were compared and any differences resolved by discussion.
Where there was insufficient information in the published report,
we attempted to contact the trial authors for clarification.
Assessment of risk of bias in included studies
Since there is evidence that the quality of allocation concealment
particularly affects the results of studies (Schulz1995), two authors
scored this quality on the scale used by Schulz 1995 as shown
below, assigning C to poorest quality and A to best quality:
• A = trials deemed to have taken adequate measures to
conceal allocation (that is, central randomisation; numbered or
coded bottles or containers; drugs prepared by the pharmacy;
serially numbered, opaque, sealed envelopes; or other description
that contained elements convincing of concealment).
• B = trials in which the authors either did not report an
allocation concealment approach at all or reported an approach
that did not fall into one of the other categories.
• C = trials in which concealment was inadequate (such as
alternation or reference to case record numbers or to dates of
birth).
Where the method used to conceal allocation was not clearly re-
ported, the author was contacted, if possible, for clarification. We
then compared the scores allocated and resolved differences by
discussion.
Data synthesis
The following comparisons were made:
• albumin or PPF versus etherified starch.
• albumin or PPF versus modified gelatin.
• albumin or PPF versus dextran 70.
• modified gelatin versus etherified starch.
• modified gelatin versus dextran 70.
• etherified starch versus dextran 70.
For each trial we calculated the relative risk (RR) of death and 95%
confidence interval (CI), such that a RR of more than 1 indicates
a higher risk of death in the first group named. We chose RR, as
it is more readily applied to the clinical situation.
We examined the groups of trials for statistical evidence of het-
erogeneity using chi-square and I2 tests. If there was no obvious
heterogeneity on visual inspection or statistical testing, we calcu-
lated pooled RRs and 95% confidence intervals using a fixed-ef-
fects model.
We assessed the skewness of continuous data by checking themean
and standard deviation (if available). If the standard deviation is
more than twice the mean for data with a finite end point (such
as 0 in the case of bleeding), the data are likely to be skewed and
it is inappropriate to apply parametric tests (Altman 1996). This
is because the mean is unlikely to be a good measure of central
tendency. If parametric tests could not be applied, we tabulated
the data.
We examined the effect of excluding trials judged to have inade-
quate (scoring C) allocation concealment in a sensitivity analysis.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
For more detailed descriptions of individual studies, please see the
table ’Characteristics of included studies’.
Seventy trials met the inclusion criteria, with a total of 4375 par-
ticipants. The earliest trial was from 1980 and the most recent
from 2006. From the drug companies we contacted, we were sent
information by Hoechst, Baxter Health Care Ltd, Fresenius Ltd,
CIS UK Ltd, and Rhemoacrodex. No new trials were identified
from the information sent to us.
The trials included the following comparisons:
Albumin or PPF versus starch (n=41 trials with 1839
participants in these groups)
Arellano 2005; Boldt 1986; Boldt 1993a; Boldt 1995; Boldt
1996a; Boldt 1996b; Boldt 1996c; Boldt 1998; Boldt 2006;
Brock 1995; Brutocao 1996; Claes 1992; Diehl 1982; Falk
1988; Fulachier 1994; Gahr 1981; Gallagher 1985; Gold 1990;
Hausdorfer 1986; Hiippala 1995; Huskisson 1993; Jones 2004;
Kirklin 1984; London 1989; Mastroianni 1994; Moggio 1983;
Munoz 1980; Munsch 1988; Niemi 2006; Prien 1990; Rackow
1983; Rackow 1989; Rosencher 1992; Shatney 1983; Veneman
2004; Verheij 2006; Vogt 1994; Vogt 1996; Vogt 1999; von
Sommoggy 1990; Woittiez 1997.
Albumin or PPF versus dextran (n=6 trials with 410
participants in these groups)
Hedstrand 1987; Hiippala 1995; Jones 2004; Karanko 1987;
Lisander 1996; Tollofsrud 1995.
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Albumin or PPF versus gelatin (n=12 trials with 1024
participants in these groups)
Boldt 1986; Du Gres 1989; Evans 2003; Huang 2005; Huskisson
1993; Karanko 1987; Niemi 2006; Stockwell 1992; Stoddart
1996; Tollofsrud 1995; Verheij 2006; Wahba 1996.
Starch versus gelatin (n=20 trials with 1545
participants in these groups)
Allison 1999; Asfar 2000; Beards 1994; Berard 1995; Beyer 1997;
Boldt 1986; Boldt 2000; Boldt 2001; Carli 2000; Dytkowska
1998; Haisch 2001a; Haisch 2001b; Huskisson 1993; Huttner
2000; Molnar 2004; Niemi 2006, Rittoo 2004; Schortgen 2001;
Van der Linden 2004; Van der Linden 2005.
Starch versus dextran (n=1 trial with 30 participants
in these groups)
Hiippala 1995.
Dextran versus gelatin (n=2 trial with 42 participants
in these groups)
Karanko 1987; Tollofsrud 1995.
The trials involved patients with hypovolaemia, sepsis, trauma,
and patients who had undergone surgery.
The trials tended to report surrogate outcomes such as hemody-
namic variables. Data on death were obtainable from 46 trials.
Information on the amount of blood transfused was available in
38 trials. However, the data were reported in a variety of different
ways that made combining the data in a meta-analysis unfeasible.
Inclusion and exclusion criteria varied, but many of the studies
excluded patients with previous adverse reactions to colloids, clot-
ting problems, or renal disease.
Risk of bias in included studies
Using predefined criteria (Schulz 1995) the quality of allocation
concealment was judged to be adequate in 24 trials, unclear in 37
trials and inadequate in nine trials.Where themethod of allocation
concealmentwas unclear, we attempted to contact all of the trialists
and we obtained information from 11 of them. However, due to
the lack of reported information on the process of randomisation
and allocation concealment, we were unable to properly assess the
quality of the majority of the trials.
Thirteen trials mentioned that some form of blinding was used. In
nine, some, or all, of the staff giving treatmentwere blinded, in four
those giving post-operative care were blinded, in two the outcome
assessors were blinded and in one the statisticians performing the
analysis were blinded to treatment group.
Effects of interventions
Mortality
Of the 70 trials identified, 33 reportedmortality data. Information
on death was obtained from a further 13 trials by contact with the
trial authors. We, therefore, had data on death from 46 trials.
Albumin or PPF versus hydroxyethyl starch (HES)
Twenty-five trials (1234 participants) reportedmortality data. The
pooled RR (relative risk) was 1.14 (95% CI 0.91 to 1.43).
Albumin or PPF versus gelatin
Seven trials (636 participants) reported mortality but only one of
those trials had any deaths. The RR was 0.97 (95% CI 0.68 to
1.39).
Albumin or PPF versus dextran
Four trials (360participants) reportedmortality andwere included
in themeta-analysis. Only one of these (Hedstrand 1987) reported
any deaths. The RR was 3.75 (95% CI 0.42 to 33.09).
Gelatin versus HES
Eighteen trials (1337 participants) reported mortality and the
pooled RR was 1.00 (95% CI 0.80 to 1.25).
Gelatin versus dextran 70
There were two trials (42 participants) which reported mortality.
There were no deaths so the RR was not estimable.
HES versus dextran 70
No trials reported mortality.
Amount of blood transfused
Thirty-eight trials recorded the amount of blood transfused. As
the data was reported in various ways, often lacking a measure of
variation, and was also skewed we did not attempt a quantitative
synthesis. These data can be seen in the ’other data’ table.
Adverse events
Nineteen trials reported the incidence of adverse or allergic reac-
tions or anaphylactic shock: all reported that there were no such
incidents.
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Sensitivity analysis
The effect of excluding trials judged to have inadequate or unclear
(scoring B or C) allocation concealment was examined in a sub-
group analysis. This made no significant difference to the results
(albumin or PPF versus HES pooled RR 1.16 95% CI 0.90 to
1.50; gel versus HES pooled RR 1.07 95% CI 0.78 to 1.46).
D I S C U S S I O N
Despite finding 70 trials we cannot make any conclusions about
the relative effectiveness of different colloid solutions. Previous
systematic reviews have suggested that colloids are no more effec-
tive than crystalloids in reducingmortality (CIGAR 2004; Roberts
2004), but there are too few data available to show in direct com-
parisons whether any of the colloids are safer or more effective
than another. The confidence intervals are wide and do not ex-
clude clinically significant differences between colloids.
Mortality was selected as the main outcome measure in this sys-
tematic review for several reasons. In the context of critical illness,
death or survival is a clinically relevant outcome that is of imme-
diate importance to patients, and data on death are reported in
many of the studies. Furthermore, one might expect that mor-
tality data would be less prone to measurement error or biased
reporting than would data on pathophysiological outcomes. The
use of a pathophysiological end point as a surrogate for an ad-
verse outcome assumes a direct relationship between the two, an
assumption that may sometimes be inappropriate. Finally, when
trials collect data on a number of physiological end-points, there
is the potential for bias due to the selective publication of end-
points showing striking treatment effects.
There was wide variation in the participants, intervention regi-
mens, and the length of follow-up. The length of follow-up is not
reported in many of the studies. Where it is reported it ranges
from a matter of hours to months, which may explain a lot of
the heterogeneity in overall event rates. The effect of these factors
was not examined in a sensitivity analysis, as there was felt to be
insufficient data to justify examining subgroups.
Many of the trials were small, and some had been done some time
ago. Although older trialswill not necessarily be of poorer quality, it
may be that treatment protocols have subsequently alteredmaking
these trials less relevant to current clinical practice.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Previous reviews have failed to show any benefit of colloids
over crystalloids for volume replacement (CIGAR 2004; Roberts
2004).
This review does not provide any evidence that one colloid is safer
than another, but does not rule out clinically significant differ-
ences.
Implications for research
Trials of fluid therapy need to be larger in order to exclude clin-
ically significant differences between colloids in patient relevant
outcomes. However, trials should probably first address the ques-
tion of whether colloids are any more effective than crystalloid
solutions.
Use of surrogate outcomes, such as physiological measurements
should be discouraged unless there is a strong relationship with
outcomes of interest to patients and relatives.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Allison 1999
Methods Randomised controlled trial. Randomisation was based on date of admission (on even dates patients
received HES).
Analysis not intention to treat.
Participants 45 patients with blunt trauma who required colloid infusion. Patients were excluded if they were less
than 12 years old, did not require admission to the ITU, died within 24 hours, were pregnant or in renal
failure.
8 gelatin and 6 HES patients excluded after randomisation.
Interventions 1) HES (200/0.45 Pentaspan)n=24.
2) Gelatin (Gelofusine)n=21.
After 24 hours, colloid administration was at the discretion of the clinician.
Outcomes Death.
Glasgow coma score.
Volumes of blood and platelets infused.
Haematological parameters.
Notes Data were collected until the patient left the ITU or for a maximum of 5 days. Main outcome of interest
was capillary leak.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Arellano 2005
Methods Randomised controlled trial. Study colloids placed in masked container by nurse not involved in other
aspects of trial.
All participants, health care workers and study personnel blinded to allocation.
Participants 50 adults undergoing surgical ablation of oropharyngeal cancer with free flap reconstruction (mean age
55). Exclusion criteria-ASA physical status classification iii-iv, cardiac insufficiency, pancreatitis, severe
hepatic dysfunction, renal dysfunction, anaemia, coagulation abnormalities, ingestion of NSAID or ASA
within 10 days of surgery and previous major head and neck surgery with free flap reconstruction.
Interventions 1) 5% HA (n=25).
2) HES 264/0.45 (n=25).
CVP was maintained between 7-10 mmHg.
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Arellano 2005 (Continued)
Outcomes Clinical indices of coagulation.
Number of units of blood transfused.
Notes Follow-up 24 hours. One patient in each group did not complete the study because planned surgical
procedure was abandoned.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Asfar 2000
Methods Randomised controlled trial. Allocation using sequentially numbered sealed opaque envelopes (informa-
tion obtained on contact with the author).
Participants 34 septic, hypovolaemic, ventilated and hemodynamically controlled patients.
Inclusion criteria: patients aged over 16 years, systolic arterial pressure higher than 90mmHg and hypov-
olemia defined by PAOP of 12mmHg or less.
Patients were excluded if they had an overt hemodynamic, ventilatory or acid base status instability. Sepsis
was identified by either positive bacterial blood cultures, bronchoalveolar lavage or clinical evidence of
infection.
Interventions 1) 6% HES (n=16).
2) 4% Modified fluid gelatin (MFG) (n=18).
Outcomes Death.
Haemodynamic variables.
Notes Follow-up was for one hour. Two patients in the HES group were excluded because they experienced
haemodynamic instability. The final analysis was made on remaining 16 patients.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Beards 1994
Methods Randomised controlled trial. Allocation by alternation. (Information on allocation concealment was ob-
tained on contact with the author).
Participants 28 patients with hypovolaemia, mechanically ventilated for concurrent acute respiratory failure. Patients
fulfilled the following inclusion criteria: age >16 years, body weight between 50 and 85kg, mean arterial
pressure <80mmHg (or 30mmHg less than previously recorded); pulmonary artery occlusion pressure
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Beards 1994 (Continued)
<10mmHg with oliguria (i.e urine output <15 ml/hr).
Interventions 1) Rapid infusion of 500ml modified fluid gelatin (n=15).
2) Rapid infusion of 500ml hetastarch (n=13).
Outcomes Death.
Haemodynamic variables.
Oxygen variables.
Notes Follow-up was 30 minutes for haemodynamic variables and until discharge for deaths.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Berard 1995
Methods Randomised controlled trial. A set of 200 tickets (type 1) and another set of 200 tickets (type 2) weremixed
in a box. One ticket was drawn at random for each patient. Information on method of randomisation was
obtained on contact with the author. Blinding not mentioned.
Participants 319 patients in a resuscitation service receiving medical (gastrointestinal haemorrhage)and surgical cases.
Patients were excluded if they had had a prior allergic reaction.
Interventions 1) Gelatin (n=153).
2) HES (n=146).
The prescribers chose the quantity of colloid, guided by normal practice.
Outcomes Death.
Amount of colloid and red blood cells given.
Cost.
Notes 20 patients lost to follow up, no explanation given. Follow-up to discharge.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
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Beyer 1997
Methods Randomised controlled trial.
Allocation was by a list of random numbers read by someone not entering patients into the trial (closed
list). Information on method of allocation concealment was obtained by contact with the author. No
blinding.
Participants 48 patients undergoing major elective hip surgery with an expected blood loss of >1000 ml. Exclusion
criteria were haemoglobin concentration < or equal to 11g/dl, heart failure and coronary artery disease,
myocardial infarction within the past 6 months, hypertension (>180mmHg systolic), impaired renal
function, pregnancy, known hypersensitivity to HES or gelatin, patient taking drugs that may specifically
affect blood viscosity, diuresis or clotting.
Interventions 1) 3% modified fluid gelatin (n=22).
2) 6% HES (n=19).
Both groups also given Ringer’s lactate. Fluids administered according to haemodynamic and clinical
parameters.
Outcomes Death (information on death was obtained by contact with the author).
Haemodynamic variables.
Packed cell volume, haemoglobin, clotting times.
Incidence of allergic reactions.
Notes Seven patients were lost to follow up but only 5 were accounted for.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Boldt 1986
Methods Randomised controlled trial, using sealed opaque envelopes.
Information on allocation concealment was obtained on contact with the authors.
Blinding not mentioned.
Loss to follow up not mentioned.
Participants 55 patients undergoing elective aorto-coronary bypass surgery.
Exclusion criteria were ejection fraction < 50% and LVEDP >15 mmHg.
Interventions 1) 500ml 20% HA (n=15).
2) 500ml 3% HES (n=13).
3) 500ml 3.5% gelatin (n= 14).
A fourth group received no colloid (n=13).
Outcomes Haemodynamic variables.
Incidence of anaphylactic shock.
Amount blood transfused.
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Boldt 1986 (Continued)
Notes Follow-up until discharge from intensive care.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Boldt 1993a
Methods Randomised controlled trial. Allocation by sequentially numbered sealed opaque envelopes (information
obtained on contact with author).
Participants 75 men undergoing elective aortocoronary bypass grafting, who had a pulmonary capillary wedge pressure
of less than 5mmHg after induction of anaesthesia.
Interventions 1) HA 5% (n=15).
2) 6% HES, HMW (n=15).
3) 6% HES, LMW (n=15).
4) Gelatin 3.5% (n=15).
5) No additional volume.
Outcomes Death (information obtained on contact with author).
Haemodynamic variables.
Notes Follow-up 1 day.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Boldt 1995
Methods Randomised controlled trial. Randomisation was by the use of sequentially numbered sealed opaque
envelopes. Information on allocation concealment was obtained on contact with the author. Blinding of
outcome assessors not mentioned.
Participants 30 consecutive trauma patients (injury severity score >15) and 30 consecutive septic patients who un-
derwent major surgery. Exclusions: patients suffering from renal failure requiring haemofiltration, severe
liver dysfunction or coagulation abnormalities in their history were excluded as were patients who were
receiving aspirin or other cyclooxygenase inhibitors.
Interventions 1) 10% HES, LMW (n=15 trauma patients and 15 sepsis patients).
2) 20% human albumin (n=15 trauma patients and 15 sepsis patients).
Fluid was given to maintain CVP and PCWP between 12 and 16mmHg.
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Boldt 1995 (Continued)
Outcomes Death.
Haemodynamic variables.
Notes Follow-up at 5 days.
Deaths were reported within the study period and later (time not specified).
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Boldt 1996a
Methods Randomised controlled trial. Allocation by sequentially numbered sealed opaque envelopes.
Outcome assessors blinded to treatment.
Participants 30 trauma patients and 30 patients suffering from sepsis secondary to major general surgery. Exclusions
were patients with renal impairment, liver insufficiency, disseminated intravascular coagulation or septic
shock.
Interventions 1) 10% HES (n=30).
2) 20% HA solution (n=30).
All patients also received Ringer’s lactate solution.
Volume therapy was given to maintain PCWP between 12 and 18mm Hg.
Outcomes Death.
Haemodynamic variables.
Notes Follow-up at 5 days and at discharge from intensive care.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Boldt 1996b
Methods Randomised controlled trial. Randomisation was by the use of sequentially numbered sealed opaque
envelopes. Information on allocation concealment was obtained on contact with the author.
The doctors giving the fluidwere blinded to the solution but blinding of outcome assessors notmentioned.
Loss to follow up not mentioned.
Participants 45 consecutive trauma patients transferred to the surgical intensive care unit. Inclusion criteria were an
injury severity score of >15 points.
All patients were haemodynamically stable before being admitted to the study.
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Boldt 1996b (Continued)
Interventions 1) 10% HES (n=15).
2) 20% HA (n=15).
3) unspecified volume therapy regime (n=15).
The allocated solution was given to maintain CVP and or PAWP between 12 and 18mmHg.
Outcomes Death.
Haemodynamic variables.
Circulating adhesion molecules.
Notes Deaths were reported within the study period and later (left ITU).
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Boldt 1996c
Methods Randomised controlled trial. Allocation by sequentially numbered sealed opaque envelopes. Outcome
variables were collected by an investigator who was blinded to the treatment.
Loss to follow up not mentioned.
Participants 56 patients from the surgical intensive care unit. 28 patients with an injury severity score >15 and 28
patients with sepsis secondary to major surgery. Patients with renal insufficiency, urine output <20ml h,
severe liver dysfunction or disseminated intravascular coagulation were excluded.
Interventions 1) 10% HES, LMW (trauma n=14, sepsis n=14).
2) 20% HA (trauma n=14, sepsis n=14).
Fluid was infused to maintain PCWP at 10-15mmHg.
Outcomes Death.
Haemodynamic variables.
Notes Follow-up was 5 days.
Deaths were reported within the study period and later (time not specified).
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Boldt 1998
Methods Randomised controlled trial. Allocation by sequentially numbered sealed opaque envelopes (information
on allocation concealment was obtained on contact with the authors).
Blinding of outcome assessors not mentioned.
Loss to follow up not mentioned.
Participants 150 traumatised patients (injury severity score >15) and 150 postoperative patients with sepsis. Patients
suffering from renal failure, severe liver insufficiency, or with major coagulation abnormalities were not
included.
Interventions 1) 10% HES, LMW (n=150).
2) 20% HA (n=150). Both for 5 days to maintain the pulmonary wedge pressure between 12 and 15
TORR.
Outcomes Death.
Haemodynamic variables.
Organ function.
Coagulation.
Notes Deaths were reported within the study period and after the study period (time not specified).
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Boldt 2000
Methods Randomised controlled trial. Allocation by sequentially numbered sealed opaque envelopes (information
obtained by contacting the author).
Participants 150 patients undergoing major abdominal surgery.
Interventions 1) 6% HES, LMW (n=50).
2) 6% HES, MMW (n=50).
3) 3% modified fluid gelatin (n=50).
To keep MAP more than 70 mm Hg and CVP between 10 and 14 mm Hg.
Volume was given perioperatively until the morning of the first post-op day. For each hour of surgery
500-800ml of crystalloids was routinely infused.
Outcomes Death.
Haemodynamic variables.
Blood loss.
Blood transfused.
Cost.
Notes Follow-up for one day post-op. Deaths recorded after study period.
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Boldt 2000 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Boldt 2001
Methods Randomised controlled trial. Allocation by a “closed envelope system”.
Volume therapy was done by doctors who did not know the aim of the study.
Participants 75 patients undergoing major abdominal surgery.
Volume was administered to keep the CVP between 8 and 12mmHg.
Interventions 1) 6% HES (n=25).
2) 6% HES (n=25).
3) 4% modified fluid gelatin (n=25)
All groups also received 500ml of ringers lactate for each hour of surgery.
Outcomes Death.
Haemodynamic variables.
Blood loss.
Blood units transfused.
Notes There were no deaths in the study period (until first Follow-up until first day post-op. Deaths until
discharge.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Boldt 2006
Methods Randomised controlled trial.
Allocation by closed envelope. Blinding was done the by a pharmaceutical study and the statistician who
perform all statistical analyses was also blinded to the grouping.
Participants 50 patients undergoing major abdominal surgery for malignancies (average age 74.5). Exclusion criteria
were: cardiac insufficiency, altered liver function, preoperative anaemia or coagulation abnormalities,
chronic use of corticosteroids or diuretics.
Interventions 1) 5% HA (n=25).
2) 6% HES (n=25).
HA patients received 3960+/-590 ml of HA and 5070+/-1030 ml of RL.
HES patients received 3500+/-530 ml of HES and 4500+/-880 ml of RL.
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Boldt 2006 (Continued)
Outcomes Death.
Haemodynamic variables.
Notes Follow-up at 30 days and also one year for mortality.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Brock 1995
Methods Randomised controlled trial. Allocation by list of random numbers read by someone entering patients
into the trial (open list). Data on allocation concealment was obtained on contact with the authors.
Participants 21 patients who had undergone cardiac surgery.
Interventions 1) 10% HES. 200/0.5 in 7.2% saline (n=7).
2) 5% HA (n=7).
3) 6% hydroxyethyl starch in 0.9% saline (n=7).
Outcomes Death (data obtained on contact with author).
Hemodynamic variables.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Brutocao 1996
Methods Randomised double-blind controlled trial with pharmacy controlled randomisation. Information on al-
location concealment was obtained on contact with the authors.
Participants 38 children aged1 year ormorewhowere undergoing surgical repair of a congenital heart disease. Exclusion
criteria included amrinone therapy, renal disease, coagulopathy or a known bleeding diathesis.
Interventions 1) 5% albumin (n=18).
2) 6% HES (n=20).
Volume expansion was administered as clinically indicated to maintain adequate central venous pressure,
perfusion and urine output. The total amount of colloid therapy was determined by care providers blinded
to the randomisation.
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Brutocao 1996 (Continued)
Outcomes Death (information on death was obtained on contact with the authors).
Haemodynamic variables.
Coagulation variables.
Notes Follow-up was until discharge from hospital.
9 children excluded post randomisation because they did not require colloid.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Carli 2000
Methods Randomised controlled trial. Each centre received instructions from the coordinating Institute on the
treatment to give the patient.
Not intention to treat analysis.
Participants 164 trauma patients. Patients were included if their SBP was less than 100mmHg, associated with signs
of hypoperfusion.
Interventions 1) HES (Hesteril 6%) (n= 85).
2) Gelatin (Plasmion) (n=79).
Outcomes Glasgow coma score.
Haemodynamic variables.
Units of blood transfused.
Adverse reaction.
Notes There were 13 deaths from heart failure but these patients were excluded from the final analysis.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Claes 1992
Methods Randomised controlled trial. No information given on method of randomisation.
Blinding not mentioned.
No loss to follow up.
Participants 20 patients undergoing brain tumor surgery and 20 patients undergoing transabdominal hysterectomy.
Exclusion criteria were preexisting coagulopathies; abnormal preoperative coagulation screening tests;
intake of drugs affecting haemostasis within 2 week preoperatively as well as liver or kidney dysfunction.
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Claes 1992 (Continued)
Interventions 1000ml of fluid for volume replacement, either as
1) 6% HES (n=19).
2) 5% HA solution in 0.9% NaCl (n=21).
Outcomes Haemodynamic variables.
Coagulation variables.
Notes Follow-up 48 hrs post-op.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Diehl 1982
Methods Randomised controlled trial. Patients were allocated to groups according to their hospital identification
number.
Blinding not mentioned.
No loss to follow up.
Participants 60 Patients undergoing coronary artery bypass.
Interventions 1) 6% HES (n=27).
2) 5% albumin (n=33) for volume expansion during the first 24 hours postoperatively. Neither hetastarch
or albumin was used intraoperatively or in the pump prime.
Outcomes Death.
Coagulation data.
Haemodynamic variables.
Notes Follow-up 7 days post-op.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
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Du Gres 1989
Methods Randomised controlled trial. No information given on method of randomisation.
Blinding not mentioned.
No loss to follow up.
Participants 30 patients post cardiac surgery. Patients were included if theywere haemodynamically stable, were without
serious ’rhythm’ problems, had a mean arterial pressure less than 90mmHg, a mean pulmonary artery
pressure less than 20mmHg and a central venous pressure less than 10mmHg. Patients excluded if they
needed blood transfusion, had a hematocrit less than 28% or haemoglobin less than 9g/100ml.
Interventions 1) 4% HA (n=15).
2) Haemaccel (n=15).
Outcomes Haemodynamic parameters.
Notes Follow-up 4 hours.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Dytkowska 1998
Methods Randomised controlled trial. No information given on method of allocation concealment.
Participants 40 patients post cardiac surgery. Patients were excluded if they had co-existing cardiogenic shock, renal
failure with creatine level over 3.0mg or severe clotting disorders.
Interventions 1) 200/0 HAES 6% (n=20).
2) Gelafundin (n=20).
Colloids were administered to patients with diagnosed symptoms of hypovolaemia, during the first 24
hours post-op. Infusion rate was adjusted to patients needs but it did not exceed 1000ml/h.
Outcomes Haemodynamic parameters.
Biochemical parameters.
Adverse reactions.
Notes Follow-up 2 hours.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Evans 2003
Methods Randomised controlled trial.
Allocation concealment by use of ’sealed envelopes’ (not enough information to be classified as adequate)
.
Treatment blinded (fluid set up by independent operator & covered with opaque black bag).
Participants 55 Patients undergoing unilateral cemented hip replacement.
Exclusion criteria: cardiac insufficiency, renal insufficiency, altered liver function, preoperative anaemia,
preoperative coagulation abnormalities and chronic use of corticosteroids and diuretics.
Interventions 1) 4.5% HA (n= 13).
2) 4% Gelosulfine (n=14).
3) Haemacel (n=14).
2L of fluid was infused during the operative period.
One other group received normal saline (n=14).
Outcomes Haemodynamic variables.
Total blood loss.
Notes Follow-up before surgery, at the end of the surgery and 2 hour post-op.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Falk 1988
Methods Randomised controlled trial. No information given on method of randomisation.
Blinding not mentioned.
No loss to follow up.
Participants 12 patients with septic shock. Patients were excluded from the study if the pretreatment PAWP was greater
than 10mmHg.
Interventions 1) 250ml of 5% albumin (n=6)
2) 250ml of 6% HES (n=6)
every 15 minutes until the PAWP was increased to 15mmHg. The test infusion was then continued at
100 mL/hour to maintain PAWP at 15 mm Hg for the next 24 hours.
Outcomes Haemodynamic variables.
Clotting variables.
Notes Follow-up 24 hours.
Risk of bias
Item Authors’ judgement Description
26Colloid solutions for fluid resuscitation (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
277
Falk 1988 (Continued)
Allocation concealment? Unclear B - Unclear
Fries 2004
Methods Randomised controlled trial.
Allocation Concealment unclear.
Treatment not blinded.
Participants 60 Patients undergoing primary knee replacement surgery.
Exclusion criteria: contraindications for regional anaesthesia and puncture of the radial artery, any known
allergies, primary and secondary haemostatic disorder.
Interventions 1) 4% gelofusine (n=20).
2) 6% HES (n=20).
A 3rd group received ringers lactate.
Before administrating spinal anaesthesia all patient received 500 ml RL. All patient intra operatively.
Outcomes Haemodynamic variables.
Notes Follow-up 2 hours post-op.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Fulachier 1994
Methods Randomised controlled trial. No information given on method of randomisation.
Blinding not mentioned.
No loss to follow up.
Participants 16 patients undergoing cardiac surgery (8 were undergoing valve replacement and 8 coronary bypass)
Patients were excluded if they were over 80, under 18 years of age, had been included in other studies, had
received colloids in the month preceding surgery, had coagulation abnormalities or who were undergoing
inotropic treatment.
Interventions 1) 500ml of a 4% solution of HA in Ringer’s lactate (n=8).
2) 500ml of HES (n=8) until starting cardiopulmonary bypass.
Outcomes Haemodynamic variables.
Notes Follow up 30 minutes.
Risk of bias
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Fulachier 1994 (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Gahr 1981
Methods Randomised controlled trial. No information given on method of randomisation.
No loss to follow up.
Participants 20 patients with hypovolaemia following abdominal surgery for malignoma.
Interventions 1) 500ml HES 450/0.7 (n=10).
2) 500ml HA 5% (n=10) during the first 24 hrs after the operation.
Outcomes Haemodynamic parameters.
Coagulation data.
Notes Follow-up 6 hrs.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Gallagher 1985
Methods Randomised controlled trial. Allocation concealment by computerised system - patient details were entered
before treatment assignment was revealed (data on allocation given on contact with author).
Participants 10 patients after coronary artery bypass graft surgery.
Exclusions: patients with significant left main coronary artery stenosis, poor left ventricular function or
poor pulmonary function.
Interventions 1) 5% albumin (n=5).
2) 6% HES (n=5).
Outcomes Death (data on deaths from author).
Haemodynamic data.
Notes Follow-up 1 day.
Risk of bias
Item Authors’ judgement Description
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Gallagher 1985 (Continued)
Allocation concealment? Yes A - Adequate
Gold 1990
Methods Randomised controlled trial. Randomisation was done by alternation. Colloid solution was blinded by
covering with foil. Information on allocation concealment was obtained by contact with the author.
No loss to follow up.
Participants 40 Surgical patients undergoing abdominal aortic aneurysm surgery.
Interventions 1) 1g/kg of albumin 5% solution (n=20).
2) 1g/kg or hetastarch 6% solution (n=20).
Outcomes Death (data on death was obtained on contact with the author).
Haemodynamic and coagulation variables.
Notes Follow-up not specified.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Haisch 2001a
Methods Randomised controlled trial. No information given on method of allocation concealment.
Patient management by doctors who were blinded to the grouping.
Participants 42 patients undergoing cardiac surgery. Patients were excluded if they had: an MI within previous 3
months, renal insufficiency, liver insufficiency, non controlled diabetes mellitus, preoperative coagulation
abnormalities or patients treated with heparin or cyclooxygenase inhibitors within last 7 days.
Interventions 1) Gelatin (n=21).
2) HES (n=21).
Outcomes Death.
Use of blood products.
Notes Follow-up until first postoperative day.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Haisch 2001b
Methods Randomised controlled trial using computer generated random numbers. No information given on allo-
cation concealment.
Participants 42 patients undergoing major abdominal surgery for malignancies.
Patients were excluded if they had cardiac insufficiency, renal insufficiency, altered liver function, pre-
operative anemia, pre-operative coagulation abnormalities or if they had had cycloxygenase inhibitors.
Interventions 1) HES (n=21).
2) Gelatin (n=21)
until the morning of the first post-operative day.
Outcomes Death.
Use of allogenic blood products.
Coagulation variables.
Notes Follow-up until first postoperative day.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Hausdorfer 1986
Methods Randomised controlled trial. No information given on method of randomisation.
Participants 30 children undergoing major surgery. During about 3 hours of surgery, the patients lost up to 15% of
blood volume.
Interventions 1) Human albumin 5% (n=15).
2) HES 6% (n=15) with 14ml/kg body weight each, respectively.
Outcomes Haemodynamic variables.
Notes Follow-up 24 hours post-op.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Hedstrand 1987
Methods Randomised controlled trial. no information given on method of randomisation.
Post-op care staff were blinded.
No loss to follow up.
Participants 275 patients undergoing major surgery. Patients were excluded if they if theywere known to have decreased
serum albumin levels or expected to sustain plasma loss, or had pronounced cardiovascular disease.
Interventions 1) PPF (n=142).
2) Dextran (n=133).
Outcomes Volume transfused.
Complication rates.
Serum albumin.
Deaths.
Notes Follow-up one month.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Hiippala 1995
Methods Randomised controlled trial. No information given on method of randomisation.
Blinding not mentioned.
3 patients lost to follow up (explanation given).
Participants 60 patients undergoing major abdominal or urological surgery. Patients who had used platelet inhibiting
drugs or had a diagnosed haemostatic defect were excluded.
Interventions 1) 3% dextrose (n=15).
2) 4% HES (n=15).
3) 6% HES (n=15).
4) 5% albumin (n=15).
Outcomes Haemodynamic variables.
Clotting variables.
Blood loss.
Notes Follow-up 3 days post-op.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Huang 2005
Methods Randomised controlled trial.
Allocation concealment and blinding was not clear.
Participants 20 patients with burns over 40% of total body surface area admitted 4-8 hour after injury.
Interventions 1) PPF (n=9).
2) Gelofusine (n=11).
In a third control group patients did not receive fluid resuscitation.
Outcomes Haemodynamic variables.
Notes Follow-up 48 hours.
No relevant outcome data.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Huskisson 1993
Methods Randomised controlled trial. No information given on method of randomisation.
Participants 27 children returning to the intensive care unit following hypothermic open heart surgery.
Interventions 1) Albumin.
2) Gelatin.
3) Hetastarch.
Outcomes Haemodynamic variables.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Huttner 2000
Methods Randomised controlled trial. Allocation concealment using ’blind envelopes’. Anaesthetists responsible
for patients management were blinded to the grouping.
Participants 60 patients undergoing major abdominal surgery. Patients were excluded if they had any of the following:
cardiac insufficiency, renal insufficiency, liver dysfunction, pre-operative anaemia or coagulation abnor-
malities, or were on cyclooxygenase inhibitors or non steroidal therapy.
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Huttner 2000 (Continued)
Interventions 1) 4% Gelatin (n=20).
2) 6% LMW HES (n=20).
3) 6% MMW HES (n=20).
Outcomes Haemodynamic variables.
Clotting. variables.
Death.
Notes Follow up until first day post-op.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Jones 2004
Methods Randomized controlled trial. Surgeons blinded to the fluid administered although the anaesthetist was
aware of the fluid administered to a given patient.
Allocation Concealment-unclear.
Participants 40 adults scheduled to undergo radical retropubic prostatomy.
Exclusion criteria: coagulation disorder, platelet count <100,000/mm3, preoperative Hb <12 gm/dL, if
anticoagulant therapy within 10 days of the surgery, aspirin or NSAID use less than 10 days before surgery
or if they had documented allergy to any of the IV fluids used in the protocol.
Interventions 1) 5% HA (n=10).
2) 6% dextran 70 (n=10).
3) 6% HES (n =10).
A 4th group received ringers lactate.
Hemodilution was done with the target of 9 gm/dL.
All patient underwent moderate hemodilution to a target of Hb 9 gm/dL.
Outcomes Haemodynamic variables.
Blood loss and units transfused.
Notes Follow-up was for 3 days.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Karanko 1987
Methods Randomised controlled trial. Patients were randomised in blocks of four. Paper was put into a hat and
taken out by an independant person. Information on method of randomisation was obtained on contact
with the author.
Blinding not mentioned.
No loss to follow up.
Participants 48 patients who had undergone coronary bypass surgery 20 hrs earlier.
Interventions 1) 4% PPF (n=15).
2) 6% dextran-70 (n=10).
3) 5.5% Oxypolygelatin (n=12).
A 4th group (not randomly selected) acted as a control (n=11).
Outcomes Death (data on death was obtained on contact with the author.
Hemodynamic variables.
Notes Follow-up 28 hrs.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Kirklin 1984
Methods Randomised controlled trial. No information given on method of randomisation.
Blinding not mentioned.
No loss to follow up.
Participants 30 patients undergoing coronary artery operations. Patients were excluded if they had undergone previous
cardiac operations, if they had severe coagulopathies, anemia or chronic renal failure.
Interventions 1) 6% HES (n=15).
2) 5% albumin (n=15).
Both fluids infused over 24 hours to maintain left artrial pressure between 6 and 12mmHg and cardiac
index greater than 2.0L/min/m2.
Outcomes Death.
Haemodynamic and coagulation variables.
Adverse reactions.
Notes Follow-up until discharge from intensive care.
34 patients were originally included in the trial but data from 4 of them was not included in the final
analysis.
Risk of bias
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Kirklin 1984 (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Lisander 1996
Methods Randomised controlled trial. Randomisation using sequentially numbered sealed opaque envelopes. In-
formation on allocation concealment was obtained on contact with the author.
No loss to follow up.
Blinding not mentioned.
Participants 40 patients undergoing revision hip arthroplasty.
Interventions 1) albumin 40g/L (n=20).
2) dextran 70 60g/L (n=20).
Patients all received enoxaparin 40mg daily.
Outcomes Death (data obtained from contact with author).
External blood loss.
Red cell balance.
Packed cell volume.
Notes Follow-up until discharge from hospital.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
London 1989
Methods Randomised controlled trial. No information given on method of randomisation.
Blinding not mentioned.
No loss to follow up.
Participants 93 male cardiac surgical patients. Patients were excluded from the study if they had a significant coagu-
lopathy or were anaemic (haematocrit value <30%).
Interventions 1) 10% pentastarch in 0.9% saline (n=50),
2) 5% HA in 0.9% saline (n=44),
to provide volume expansion during the first 24 hours after cardiac operations.
Outcomes Haemodynamic variables.
Coagulation variables.
Death.
Length of stay.
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London 1989 (Continued)
Notes One patient was treated twice with an 8-month interval. Follow up until discharge from hospital.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Mastroianni 1994
Methods Randomised controlled trial. No information given on method of randomisation.
Blinding not mentioned.
Participants 34 patients undergoing open heart surgery were enrolled.
Interventions 1) 10% pentastarch. (n=12).
2) 5% albumin (n=17).
Outcomes Death.
Haemodynamics variables.
Clotting variables.
Pulmonary oedema.
Notes Follow-up 7 days.
Four patients in the pentastarch group, and one patient in the albumin group were excluded after ran-
domisation.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Moggio 1983
Methods Patients were randomised according to the last digit of their hospital identification numbers.
No loss to follow up.
Blinding not mentioned.
Participants 47 postoperative open heart surgery patients. Operations performed included coronary revascularisation,
valve operations, and combined coronary and valve procedures. Patients with pre existing hepatic or renal
disease were not eligible for the study.
Interventions 1) 5% albumin in 0.9% NaCl (n=23).
2) 6% HES in 0.9% NaCl (n=24).
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Moggio 1983 (Continued)
Outcomes Haemodynamic variables.
Clotting variables.
Notes Follow-up not specified.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Molnar 2004
Methods Randomised controlled trial.
Allocation concealment and blinding unclear.
Participants 30 hypovolemic patients with Intra thoracic blood volume index (ITBVI)<850 in septic shock with acute
lung injury.
Exclusion criteria: CVS failure (NYHA class iv), chronic respiratory failure (chronic hypoxia, hypercapnia)
CRF requiring renal replacement therapy, chronic liver failure or those with diabetes mellitus or with
known aortic aneurysm.
Interventions 1) 6% HES (n= 15).
2) 4% GEL (n=15).
250ml/15min boluses (max 1000 ml) were given until the end point ITBVI>900 ml/m2.
Outcomes Death.
Haemodynamic variables.
Notes Follow-up 60 min after the end point was reached. Follow up for deaths was not clear.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Munoz 1980
Methods Randomised controlled trial. No information given on method of allocation.
Blinding not mentioned.
No mention of loss to follow up.
Participants 14 patients with shock due to haemorrhage or sepsis.
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Munoz 1980 (Continued)
Interventions Patients received either.
1) HES (hespan).
2) 5% albumin.
Number in each group not reported.
Outcomes Haemodynamic variables.
Notes Follow-up 4 hours post infusion.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Munsch 1988
Methods Randomised controlled trial. No information given on method of randomisation.
Blinding not mentioned.
No loss to follow up.
Participants 40 consecutive patients undergoing elective coronary artery bypass graft surgery.
Interventions 1) HES 6% (n=20) or
2) PPF (n=20)
as their postoperative volume expander.
Outcomes Haemodynamic variables.
Clotting variables.
Death.
Adverse reactions.
Notes Follow-up 7 days post-op.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Niemi 2006
Methods Randomised controlled trial. Allocation by closed envelope (not enough information provided to classify
as adequate).
Blinding not clear.
Participants 45 patients post cardiac surgery.
Exclusion criteria: pre operative coagulation disorders, renal or hepatic failure or taking medication with
coumarin anticoagulants, heparin, and/or salicylic acids within the previous 5 days.
Interventions 1) 4% HA (n=15).
2) 4% gelatine (n=15).
3) 6% HES (n=15).
Outcomes Death (data on death obtained on contact with the author).
Clotting variables.
Blood transfused.
Notes Follow-up 1 day post-op.
54 patients gave consent but 9 later excluded.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Prien 1990
Methods Randomised controlled trial. Method of allocation concealment unknown.
Blinding not mentioned.
Loss to follow up not mentioned.
Participants 18 patients undergoing modified Whipple’s operation (hemipancreato-duodenectomy). Patients were
eligible for the study if there was an absence of major organ dysfunction and serum protein, sodium,
glucose, blood urea nitrogen, haematocrit, aPTT and PT times, and platelet times were within normal
limits. Specific exclusion criteria included compensated myocardial insufficiency, chronic hypertension,
chronic obstructive airways disease and insulin-dependent diabetes mellitus.
Interventions 1) 10% HES (n=6).
2) 20% HA (n=6).
A third group were given ringer’s lactate (n=6)
All given as a volume replacement solution, which was given to maintain central venous pressure at the
pre-operative level.
Outcomes Death (data on death was obtained on contact with the author).
Haemodynamic variables.
Clotting variables.
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Prien 1990 (Continued)
Notes Follow-up unspecified.
Study was intra-operative.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Rackow 1983
Methods Randomised controlled trial, method of allocation concealment not mentioned.
Blinding not mentioned.
Participants 18 patients with hypovolemic and septic shock. Patients were excluded if they were less than 18 yrs of age,
considered to be in a terminal state, or had a significant coagulopathy.
Interventions 1) albumin (n=9).
2) HES (n=9).
Patients received 250ml of the treatment fluid every 15 minutes as a fluid challenge. The fluid challenge
ended when the WP equalled 15 mmHg. Thereafter the treatment fluid was given in sufficient quantities
to maintain the WP at 15 mmHg for the next 24h, at which point the study was completed.
Outcomes Death.
Haemodynamic variables.
Respiratory variables.
Notes Deaths given for study period and for length of hospital stay. Survival until discharge was used for the
mortality data for this review.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Rackow 1989
Methods Randomised controlled trial. Method of allocation concealment was not recorded.
No loss to follow up.
Blinding not mentioned.
Participants 20 patients with severe sepsis and systemic hypoperfusion. Patients were excluded from the study if they
were <21 yrs of age, pregnant, considered to be terminal, or they manifested spontaneous bleeding.
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Rackow 1989 (Continued)
Interventions 1) 5% albumin (n=10).
2) 10% hydroxyethyl starch (pentastarch)(n=10).
Each group received 250ml of the treatment fluid every 15 mins until either the WP was > or equal to
15mm Hg or a maximum volume of 2000ml of study colloid was infused.
Outcomes Death.
Haemodynamic variables.
Clotting variables.
Allergic reactions.
Notes Follow-up unspecified.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Rittoo 2004
Methods Randomised controlled trial.
Allocation by sealed envelopes (not enough information provided to classify as adequate).
Blinding-not clear.
Participants 40 patients undergoing abdominal aortic aneurysm surgery.
Exclusion criteria: ejection fraction of <40% with poor pulmonary function with micro albuminuria and
a creatinine concentration of >150 micro ml per litre.
Interventions 1) 6% HES (n=20).
2) 4% Gelosulfine (n=20).
All patients received crystalloid. Colloid infused to maintain stable heart rate, CVP 8-10 cm H2O and
steady mean arterial pressure and urine output of
>40ml/hr.
Outcomes Lung function.
Adverse events.
Notes Follow-up 24 hours.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Rosencher 1992
Methods Randomised controlled trial. Randomisation done using sequentially numbered, sealed, opaque envelopes.
Information on allocation concealment was obtained on contact with the author.
No mention of blinding.
Loss to follow up not mentioned.
Participants 32 patients undergoing total hip replacement.
Interventions 1) 4% albumin (n=16).
2) LMW HES (n=16).
Outcomes Death (data obtained on contact with author).
Bleeding.
Clotting variables.
Notes Follow-up for 5 days post-op.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Schortgen 2001
Methods Randomised controlled trial. Allocation was by sealed opaque envelopes serially numbered and used in
sequence.
Participants 129 patients with severe sepsis or septic shock over 18 years of age. Patients were excluded if they were
pregnant, had a history of allergy to HES or gelatin, had severe acute or chronic renal dysfunction or
previous administration of HES or mannitol.
Interventions 1) 6% hydroxyethyl starch (n=65).
2) 3% fluid-modified gelatin (n= 64).
Outcomes Death (data obtained on contact with author).
Length of stay in ITU.
Acute renal failure.
Notes Follow-up while in ITU.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Shatney 1983
Methods Controlled clinical trial. Patients were assigned to groups in an alternating fashion.
No loss to follow up.
No mention of blinding.
Participants 32 patients with multisystem trauma and/or haemorrhagic shock. Patients with cardiac arrest on hospital
admission or during the first half hour after admission were excluded from the study.
Interventions 1) PPF 5% solution (n=16),
2) Hetastarch 6% (n=16).
Study patients continued to receive the assigned colloid solution for the first 8 days whenever colloid was
thought necessary.
Outcomes Hepatic, pulmonary and renal function.
Clotting variables.
Volume of fluids infused.
Deaths.
Notes Follow-up 8 days.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Stockwell 1992
Methods Randomised controlled trial. No information given on method of randomisation.
No loss to follow up.
Blinding not mentioned.
Participants 475 patients admitted to the intensive care unit. Patients were excluded from the study if they were under
18 years or if admitted for cardiac monitoring or cardiac thrombolytic therapy.
Interventions 1) 4.5% albumin (n=226).
2) A synthetic colloid polygeline (Haemaccel)(n=249)
for intravenous volume replacement.
Outcomes Death.
Length of stay in ITU.
Incidence of renal failure.
Pulmonary oedema.
Notes Follow-up until discharge from ITU.
Risk of bias
Item Authors’ judgement Description
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Stockwell 1992 (Continued)
Allocation concealment? Unclear B - Unclear
Stoddart 1996
Methods Randomised blinded trial. Sequentially numbered sealed opaque envelopes were used. Information on
allocation concealment was obtained on contact with the author.
Anaesthetist unaware of intervention.
No loss to follow up.
Participants 30 neonates undergoing major surgery. They were excluded if the body weight was less than 2kg or more
than 5kg, the preoperative haemoglobin was less than 14g/d1, they had previously received blood or
colloid, or they had suspected major cardiac, renal, metabolic or chromosomal abnormalities. Neonates
were withdrawn from the study if either blood or more than 40ml/kg of colloid was required either during
or within the first 24hr after surgery.
Interventions 1) HA 4.5% (n=15).
2) Haemaccel (n=15).
Outcomes Haemodynamic variables.
Plasma albumin.
Haemoglobin.
Notes Follow-up 24 hrs post op.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Tollofsrud 1995
Methods Randomised controlled trial. Allocation concealment was by the use of sequentially numbered sealed
opaque envelopes. Information on allocation concealment was obtained on contact with the authors.
No loss to follow up.
Blinding not mentioned.
Participants 30 patients undergoing elective coronary artery bypass surgery. Patients with left ventricular ejection
fraction less than 40%, valvular heart disease, ventricular aneurysm, arrhythmia, diabetes mellitus, renal
failure or lung disease were excluded.
Interventions 1) Polygeline (Haemaccel)(n=10).
2) Dextran 70 (n=10).
3) Albumin 40 (n=10).
A 4th group received ringers lactate (n=10).
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Tollofsrud 1995 (Continued)
Outcomes Death.
Haemodynamic variables.
Respiratory data.
Cost of fluid regimens.
Notes Follow-up 48 hours during and after surgery.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Van der Linden 2004
Methods Randomised controlled trial.
Patients were randomly allocated by opening an envelope (not enough information provided to classify
as adequate).
Blinding not clear.
Participants 110 patients (average age 63) undergoing cardiac surgery under cardiopulmonary bypass (elective coronary
artery or single valve surgery). Exclusion criteria: undergoing combined cardiac surgery or redo operations,
history of allergic reactions to starches or gelatins, significant liver or renal dysfunction.
Interventions 1) 6% HES (n=55).
2) 3.5% urea-lined gelatine (n=55).
If additional colloid required 4.5% HA given.
Outcomes Death.
Hemodynamic variables.
Blood transfused.
Notes Follow-up 18 hours after surgery.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Van der Linden 2005
Methods Randomised controlled trial.
Allocation concealment and blinding unclear.
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Van der Linden 2005 (Continued)
Participants 132 patients with a preoperative left ventricular ejection fraction more than 355 undergoing elective
primary cardiac surgery.
Interventions 1) 6% HES 130/0.4 [48.9+/-17.2 ml/kg] (n=64).
2) 3% GEL [48.9+/-14.6 ml/kg] (n=68).
Outcomes Hemodynamic variables.
Blood loss.
Notes Follow-up until 5 days post-op.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Veneman 2004
Methods Randomised controlled trial. Allocation by sealed envelopes kept outside of hospital.
Participants 61 critically ill hypoalbuminic patients (serum concentration < 20g/l).
Interventions 1) Albumin (n=15).
2) HES 10% 500ml (n=15).
3) HES 10% 1000ml (n=15).
A fourth group received saline.
Outcomes Death.
Hemodynamic variables.
Adverse events (from author).
Notes Follow-up 72 hours post-op, mortality 30 days.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Verheij 2006
Methods Randomised controlled trial. Hospital pharmacy assigned patients via sealed enveloped method.
Participants 67 patients undergoing either vascular (n=28) or cardiac surgery (n=40).
Exclusion criteria: age > 79 years and known anaphylactoid reactions to colloids.
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Verheij 2006 (Continued)
Interventions 1) 4% Gelatine (n=16).
2) 6% HES (n=18).
3) 5% HA (n=18).
A 4th group received normal saline.
Outcomes Death.
Haemodynamic variables.
Notes Follow-up not clear.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Vogt 1994
Methods Randomised controlled trial. No information given on method of randomisation.
Participants 40 patients undergoing major surgery. Exclusion criteria included anaemia, renal, liver and coagulation
disorders.
Interventions 1) 5% HA (n=20).
2) 6% hydroxyethyl starch (n=20).
Outcomes Haemodynamic variables.
Coagulation.
Haematological parameters.
Blood loss and blood intake.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Vogt 1996
Methods The patients were divided into two groups using random numbers.
Blinding not mentioned.
No loss to follow up.
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Vogt 1996 (Continued)
Participants 41 patients undergoing total hip arthroplasty during the perioperative period. Exclusion criteria were
weight <60 kg, age <18 yrs, ASA grade>III, haematocrit <34% or >44%, history of coagulopathies or a
Quick’s prothrombin test of < 75%, partial thromboplastin time (PTT) > 45s, platelet count < 100,000/
mm3, impaired liver function and renal failure.
Interventions 1) 6% HES (n=20).
2) 5% HA (n=21).
Outcomes Haemodynamic and clotting variables.
Notes Follow-up 6 hrs post-op.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Vogt 1999
Methods Randomised controlled trial. No information given on method of randomisation.
Participants 50 patients undergoing radical prostatectomy or cystectomy with bladder replacement.
Exclusion criteria were: weight less than 60kg,
age less than 21 years, ASA 1 or 2,
haemoglobin less than 12g/dl,
history of clotting disorders,
liver function disorders,
advanced renal insufficiency or hypoproteinaemia.
Interventions 1) 5% HA.
2) 6% HES 200/0.5.
Outcomes Haemodynamic variables.
Blood loss.
Notes Follow-up for 3 days.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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von Sommoggy 1990
Methods Randomised controlled trial. No information given on method of randomisation.
No loss to follow up.
Participants 24 patients undergoing infrarenal aortofemoral bifurcation grafting.
Interventions 1) FFP and 5% HA (n=13).
2) HES 200 10% and HES 450 6% (n=11).
Outcomes Haemodynamic variables.
Clotting variables.
Influence on organ function.
Notes Follow-up 6 hours post-op.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Wahba 1996
Methods Randomised controlled trial. Computerised system was used for randomisation. Data on method of
allocation concealment was obtained on contact with the author.
Blinding not mentioned.
Loss to follow up not mentioned.
Participants 20 patients who had had coronary artery bypass grafting. Patients with abnormal left-ventricular function
as judged from cine-angiography were excluded as were patients on anticoagulants less than 10 days before
the operation.
Interventions 1) 5% albumin (n=10).
2) Haemaccel (n=10).
Outcomes Death (data on death was obtained on contact with the author).
Haemodynamic variables.
Notes Follow-up was 2 weeks.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Watkins 1990
Methods Randomised controlled trial. No information given on method of randomisation.
Participants 12 patients undergoing major surgery.
Interventions 1) LMW polystarch or
2) Polygelatine (Haemaccel)
for postoperative volume replacement.
Outcomes Death.
Adverse reactions.
Notes Follow-up was for 24 hours after the infusion.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Woittiez 1997
Methods Randomised controlled trial.
Allocation concealment by sequentially numbered sealed opaque envelopes.
Participants 60 patients who had developed hypoalbuminaemia (<20g/l) after major surgery.
2 patients died after randomisation and before treatment started. These were excluded from the analysis.
Interventions 1) albumin 20% (300 ml/24h) (n=15).
2) HES 10% (500ml/24h) for 3 days (n=27).
Aim was to restore colloid osmotic pressure.
A 3rd group received saline (n=16).
Outcomes Death (data on death obtained on contact with the author).
Changes in fluid balance, serum albumin, COP and clinical signs of oedema were followed daily.
Notes Follow-up unspecified.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
ALI = Acute lung injury
CVS = cardiovascular system
COP = Colloid osmotic pressure
CVP = central venous pressure
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CRF = chronic renal failure
EVLW = Extra vascular lung water
HA = Human albumin
HES = hydroxyethyl starch
HMW = high molecular weight
ITBVI = Intra thoracic blood volume index
LIS = Lung Injury Scale
LMW = Low molecular weight
LVEDP = left ventricular end diastolic pressure
MMW = medium molecular weight
MAP = mean arterial pressure
PAWP = pulmonary artery wedge pressure
PAOP = pulmonary artery occlusion pressure
PCWP = pulmonary capillary wedge pressure
PPF = plasma protein fraction
Characteristics of excluded studies [ordered by study ID]
Boldt 1993 Pre-bypass volume loading.
Boldt 2000b Compares two starches with each other.
Brehme 1993 Haemodilution.
Bremerich 2000 Compares two different starches (acetyl starch with hydroxyethyl starch).
Charlet 1991 Study compared two different gelatins with each other and not with other colloids.
Christ 1997 Non-randomised trial.
Emery 1992 Trial compares 20% and 4.5% albumin with each other and not with other colloids.
Gan 1999 Compares Hextend (a plasma volume expander based upon 6% hetastarch)with 6% hetastarch in saline (HES).
Hankeln 1990 Haemodilution.
Harke 1976 Unable to find out if a randomised controlled trial. Methodology unclear.
Hiippala 1996 Patients were expected to have minimal blood loss.
Huet 2000 Compares two starches with each other.
Jones 2004a Haemodilution.
Jovanovic 1997 Does not mention if study was randomised. Unable to contact author for further information.
Korttila 1984 Healthy volunteers and cross over trial.
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(Continued)
Langeron 2001 Compares two starches with each other.
Palumbo 2006 Authors do not report the number of patients randomised to each group.
Puri 1983 There is no mention of a method of randomisation. Just says “Twenty-five patients studied in each group were
well matched”.
Rauch 2000 Compares two starches with each other.
Rehm 2000 Haemodilution.
Strauss 1985 Healthy volunteers.
Waxman 1989 Cross-over study.
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D A T A A N D A N A L Y S E S
Comparison 1. Albumin or PPF versus HES
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death 25 1234 Risk Ratio (M-H, Fixed, 95% CI) 1.14 [0.91, 1.43]
2 Blood/red cells transfused
(skewed or inadequate data)
Other data No numeric data
Comparison 2. Albumin or PPF versus Gelatin
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death 7 636 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.68, 1.39]
2 Blood/red cells transfused
(skewed or inadequate data)
Other data No numeric data
Comparison 3. Albumin or PPF versus Dextran
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death 4 360 Risk Ratio (M-H, Fixed, 95% CI) 3.75 [0.42, 33.09]
2 Blood/red cells transfused
(skewed or inadequate data)
Other data No numeric data
Comparison 4. Modified Gelatin versus HES
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death 18 1337 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.80, 1.25]
2 Blood/red cells transfused
(skewed or inadequate data)
Other data No numeric data
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Comparison 5. Modified Gelatin versus Dextran
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death 2 42 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2 Blood/red cells transfused
(skewed or inadequate data)
Other data No numeric data
Comparison 6. HES versus Dextran
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death 0 0 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2 Blood/red cells transfused
(skewed or inadequate data)
Other data No numeric data
F E E D B A C K
Colloid solutions for fluid resuscitation
Summary
1. Please explain, in the ’what’s new’ section, in what respects this update differs from the previous version.
2. The drug companies listed in the acknowledgments are not in alphabetic order: please do so or explain the reason for the order
shown (e.g. in order of helpfulness).
3. Fresenius is misspelt.
4. In the references to included trials, please use an asterisk to identify those trials which are the main publication where there are more
than one article referring to a trial.
Reply
1. The review has been marked as an update by mistake. As of September 1999 no substantial updates have been made.
2. The drug companies have been re-ordered alphabetically.
3. The spelling of Fresenius is corrected.
4. The primary reference has been marked with an asterisk.
Contributors
Comment by Andrew Herxheimer
Response by Frances Bunn
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WH A T ’ S N E W
Last assessed as up-to-date: 1 October 2007.
11 July 2008 Amended Converted to new review format.
H I S T O R Y
Protocol first published: Issue 4, 1998
Review first published: Issue 2, 1999
2 October 2007 New search has been performed The search for the review was updated inMarch 2007 and thirteen new studies
were added to the review.
C O N T R I B U T I O N S O F A U T H O R S
FB screened citations for eligibility, obtained references, contacted authors, extracted data, entered data and wrote up the review. DT
and SA obtained references, screened citations for eligibility and extracted data. PA and VH contributed to earlier versions of the review.
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• University of Hertfordshire, UK.
External sources
• NHS Research and Development Programme, UK.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Fluid Therapy; Blood Proteins [∗therapeutic use]; Colloids [therapeutic use]; Dextrans [∗therapeutic use]; Plasma Substitutes
[∗therapeutic use]; Randomized Controlled Trials as Topic; Rehydration Solutions [∗therapeutic use]
MeSH check words
Humans
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A B S T R A C T
Background
Hypertonic solutions are considered to have a greater ability to expand blood volume and thus elevate blood pressure and can be
administered as a small volume infusion over a short time period. On the other hand, the use of hypertonic solutions for volume
replacement may also have important disadvantages.
Objectives
To determine whether hypertonic crystalloid decreases mortality in patients with hypovolaemia.
Search strategy
We searched the Cochrane Injuries Group’s specialised register, MEDLINE, EMBASE, The Cochrane Library, issue 3, 2007, The
National Research Register issue 3, 2007 and the British Library’s Electronic Table of Contents ZETOC. We also checked reference
lists of all articles identified. The searches were last updated in October 2007
Selection criteria
Randomised trials comparing hypertonic to isotonic and near isotonic crystalloid in patients with trauma or burns or who were
undergoing surgery.
Data collection and analysis
Two authors independently extracted the data and assessed the quality of the trials.
Main results
Fourteen trials with a total of 956 participants are included in the meta-analysis. The pooled relative risk (RR) for death in trauma
patients was 0.84 (95% confidence interval [CI] 0.69 to1.04); in patients with burns 1.49 (95% CI 0.56 to 3.95); and in patients
undergoing surgery 0.51 (95% CI 0.09 to 2.73). In the one trial that gave data on disability using the Glasgow outcome scale, the
relative risk for a poor outcome was 1.00 (95% CI 0.82 to 1.22).
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Authors’ conclusions
This review does not give us enough data to be able to say whether hypertonic crystalloid is better than isotonic and near isotonic
crystalloid for the resuscitation of patients with trauma or burns, or those undergoing surgery. However, the confidence intervals are
wide and do not exclude clinically significant differences. Further trials which clearly state the type and amount of fluid used and that
are large enough to detect a clinically important difference are needed.
P L A I N L A N G U A G E S U M M A R Y
More evidence needed as to the best concentration of crystalloid to use in resuscitation fluids
Fluid resuscitation is usually given when a patient has lost a lot of blood, but there is continuing uncertainty as to the best sort of fluid
to use. Some of the fluids used contain substances classified as “crystalloids”, but should the concentration of crystalloids in the fluid be
about the same as their concentration in human blood (“isotonic”) or higher (“hypertonic”)?It is commonly believed that hypertonic
crystalloid is the more effective at increasing blood volume but that there could be some disadvantages to using it. This review has
assessed the evidence from studies that compared the use of the two types of fluid with patients who had been injured or burned, or
were having surgery. Not enough evidence is available, however, to decide which crystalloid concentration is best. More research is
needed.
B A C K G R O U N D
Fluid resuscitation is a mainstay of the medical management of
haemorrhagic hypovolaemia. However, there is continuing uncer-
tainty about the most appropriate fluid (Krausz 1995). Isotonic
crystalloid solutions are often used to replace blood loss until a
blood transfusion can be administered, but the wish to administer
large volumes (advanced trauma life support [ATLS] guidelines
suggest two litres of isotonic crystalloid), particularly in the pre-
hospital phase when there may be problems with venous access,
has stimulated the development of alternative approaches. One
such approach is the use of hypertonic saline. Hypertonic solu-
tions are considered to have a greater ability to expand blood vol-
ume and thus elevate blood pressure, and can be administered as
a small volume infusion over a short time period (Krausz 1995).
Infusion of hypertonic saline is believed to act by causing an os-
motic shift of fluid from the intracellular and interstitial spaces
to the extracellular compartment. The resulting auto-transfusion
of fluid increases blood pressure and circulating volume. The use
of hypertonic solutions has the potential to provide rapid volume
resuscitation but with less interstitial oedema than with isotonic
saline solutions (Shackford 1983).
It has also been suggested that hypertonic solutions may be the
fluid of choice in hypovolaemic patients with head injuries (
Khanna 2000; Peterson 2000; Walsh 1991). Cerebral perfusion
pressure (CPP) depends on both intracranial pressure (ICP) and
mean arterial blood pressure. (CPP =mean arterial blood pressure -
mean ICP.) Patients in hypovolaemic shockwho have head injuries
may require rapid blood pressure elevation to maintain cerebral
perfusion pressure, but excessive fluid and salt administration may
result in brain swelling with an increase in intracranial pressure.
Hypertonic solutions, however, are believed to reduce intracranial
pressure by establishing an osmotic gradient across the blood brain
barrier that draws water from the brain tissue into the vascular
space (Fisher 1992). Hypertonic solutions, therefore, have the po-
tential to restore blood pressure rapidly, but without increasing
intracranial pressure. Hypertonic solutions are also thought to be
beneficial in preventing the ’water logging’ effect when there is in-
terstitial lung injury, for example as occurs both in elective surgery
and in trauma.
On the other hand, the use of hypertonic solutions for volume
replacement may also have important disadvantages. In situations
where haemorrhage is on-going, hypertonic solutions may result
in continued bleeding from injured vessels. A potential problem
in head injuries is that, in patients with a disrupted blood brain
barrier, excess sodium may leak into brain tissue drawing water
with it, thus worsening cerebral oedema. At present, there are no
clinical ways to assess the integrity of the blood brain barrier. Fur-
thermore, not only could the integrity of the blood brain barrier
vary among patients with head injury, but it might also vary in
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different parts of the brain in a single patient. The possibility that
hypertonic fluids may worsen outcome following head injury can-
not therefore be dismissed (Krausz 1995, Shenkin 1976).
O B J E C T I V E S
To determine whether hypertonic crystalloid decreases mortality
in patients with hypovolaemia with and without head injuries, we
conducted a systematic review of randomised controlled trials.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials. Crossover trials were excluded.
Types of participants
Patients with trauma, burns or surgery. Trials in both the pre-
hospital and hospital setting were included.
Types of interventions
Trials that compare hypertonic to isotonic and near isotonic crys-
talloid. Trials of hypertonic crystalloid with an add-on colloid (e.g.
hypertonic saline and dextran) are not included. This compari-
son has been dealt with in a previous systematic review by the
Cochrane Injuries Group (Perel 2007).
Types of outcome measures
The principal outcome measure is mortality from all causes and
disability assessed at the end of the follow-up period scheduled for
each trial. Disability was assessed using the Glasgow outcome scale
(Jennett 1975) which includes the following categories: death,
persistent vegetative state, severely disabled, moderately disabled
and good recovery. For the purpose of this review, the scale was
dichotomised with death, persistent vegetative state and severe
disability denoting a poor outcome, and moderate disability and
good recovery denoting a good outcome.
Intermediate physiological outcomes were not used for several rea-
sons. Such outcomes are subject to intra and inter-observer vari-
ation, they have no face value to patients and relatives, and those
seen as appropriate are not stable over time. Also, there would
need to exist a strong predictive relationship between the variable
and mortality.
Search methods for identification of studies
The search was last updated in October 2007.
Electronic searches
We searched the following electronic databases;
• Cochrane Injuries Group’s specialised register
• CENTRAL
• MEDLINE
• EMBASE
• National Research Register
• Zetoc.
The original search strategies were based on the terms listed below.
The full search strategies for the most recent search update are
listed in Appendix 1.
1. Saline solutions hypertonic (MeSH)
2. Isotonic solutions (MeSH)
3. Hypertonic or isotonic or hyperosmotic or hyperoncotic
4. Hypotensive resuscitation
5. #1 or #2 or #3 or #4
6. random*
7. double-blind-procedure (MeSH)
8. #6 or #7
9. #5 and #8
Data collection and analysis
Selection of studies
One reviewer (FB) examined the electronic search results for re-
ports of possibly relevant trials and these reports were retrieved in
full. Two reviewers applied the selection criteria independently to
the trial reports, resolving disagreements by discussion.
Data extraction and management
Two reviewers independently extracted information on the follow-
ing: study quality, number of randomised patients, type of partici-
pants and the interventions. The outcome data sought were num-
ber of deaths and disability. The reviewers were not blinded to the
authors or journal when doing this, as evidence for the value of
this is far from conclusive (Berlin 1997). Results were compared
and any differences resolved by discussion.
For each trial the relative risk of death and 95%confidence interval
were calculated. The relative risk was chosen as it is more readily
applied to the clinical situation.
The groups of trials were examined for statistical evidence of het-
erogeneity using a chi squared test. As there was no obvious het-
erogeneity on visual inspection or statistical testing, pooled rela-
tive risks (RR) and 95% confidence intervals (CIs) were calculated
using a fixed effects model.
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Assessment of risk of bias in included studies
Since there is evidence that the quality of allocation concealment
particularly affects the results of studies (Schulz 1995), two review-
ers scored this quality on the scale used by Schulz (Schulz 1995) as
shown below, assigning C to poorest quality and A to best quality:
A = trials deemed to have taken adequate measures to conceal allo-
cation (i.e. central randomisation; numbered or coded bottles or
containers; drugs prepared by the pharmacy; serially numbered,
opaque, sealed envelopes; or other description that contained ele-
ments convincing of concealment).
B = trials in which the authors either did not report an allocation
concealment approach at all or reported an approach that did not
fall into one of the other categories.
C = trials in which concealment was inadequate (such as alterna-
tion or reference to case record numbers or to dates of birth)
In addition, data was extracted on blinding and loss to follow-
up. Where the method used to conceal allocation was not clearly
reported, the author was contacted, if possible, for clarification.
We then compared the scores allocated and resolved differences
by discussion.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Eighteen randomised controlled trials were identified by the
searches. However, four (Gunn 1989; McGough 1990; Younes
1988a; Younes 1988b) did not provide data on the outcomes spec-
ified in the review. Details of these studies are also reported in the
table of included studies for completeness.
In the 14 trials reported in the meta-analysis, patients with burns
were included in three (n=72) (Bortolani 1996; Caldwell 1979;
Jelenko 1978), patients undergoing surgery in five (n= 230) (Croft
1992; Cross 1989; Jarvela 2002; Shackford 1983; Shackford 1987)
and trauma patients in six (n= 654) (Cooper 2004; Simma 1998;
Vassar 1990; Vassar 1993a; Vassar 1993b; Younes 1992).
Eleven trials compared hypertonic saline versus Ringer’s lactate
(Bortolani 1996; Caldwell 1979; Cooper 2004; Croft 1992;
Jelenko 1978; Shackford 1983; Shackford 1987; Simma 1998;
Vassar 1990; Vassar 1993a; Vassar 1993b), and the rest compared
hypertonic saline with normal saline.
For more detailed descriptions of individual studies, please see the
table of included studies. No additional studies were identified for
this latest update.
Risk of bias in included studies
Allocation concealment was judged to be adequate in five trials
(Cooper 2004; Simma 1998; Vassar 1990; Vassar 1993a; Vassar
1993b), inadequate in three (Caldwell 1979; Shackford 1983;
Shackford 1987), and unclear in the rest. Five trials reported the
use of identical bags or containers for the fluids, so that staff were
blinded to the identify of the solutions (Cooper 2004; Cross 1989;
Vassar 1990; Vassar 1993a; Vassar 1993b).
Effects of interventions
Death was reported either in the paper, or the information was
obtained by contacting the researcher, in 14 studies. Data on death
were not obtained for four trials (Gunn 1989; McGough 1990;
Younes 1988a; Younes 1988b). Data on disability was obtained
from the author of one trial (Cooper 2004).
Due to the clinical heterogeneity of the different patient groups
it was felt to be inappropriate to pool them; therefore, only the
results for the subgroups are given. The pooled relative risk for
death in trauma patients was 0.84 (95% CI 0.69 to 1.04), for
patients with burns 1.49 (95% CI 0.56 to 3.95) and for patients
undergoing surgery 0.51 (95% CI 0.09 to 2.73). Only one trial
gave data on disability (Cooper 2004) and the relative risk for a
poor outcome was 1.00 (95% CI 0.82 to 1.22).
D I S C U S S I O N
This review does not give us enough data to be able to say whether
hypertonic crystalloid is better than isotonic crystalloid for the
resuscitation of patientswith traumaor burns, or those undergoing
surgery. However, the confidence intervals are wide and do not
exclude clinically significant differences between hypertonic and
isotonic crystalloid. A previous review (Perel 2007) found there
was a trend towards a favourable effect on mortality for colloids in
hypertonic crystalloid compared to isotonic crystalloids. However,
those results are compatible with the play of chance.
We chose not to pool the results of the burns, surgery and trauma
patients, as we felt these groups were too clinically heterogeneous.
Bleeding and fluid management in patients undergoing elective
surgery would tend to be more controlled and, therefore, different
to that in trauma patients.
Most of the trials are small and quality was judged to be adequate
in only five of them. There was variation in the type of partici-
pants, and length of follow-up, and little standardisation in terms
of fluid regimes. Also some of the trials were old. Although older
trials will not necessarily be of poorer quality, it may be that treat-
ment protocols have subsequently altered, making these trials less
relevant to current clinical practice. Indeed in the 1970s and 1980s
there were few protocols on fluid resuscitation in the critically ill.
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Since the late 1980s, there have been more clear guidelines and
standardisation of fluid resuscitation regimes, although many ar-
eas of contention still exist.
Mortality was selected as the main outcome measure in this sys-
tematic review for several reasons. In the context of critical illness,
death or survival is a clinically relevant outcome that is of imme-
diate importance to patients, and data on death are reported in
many of the studies. Furthermore, one might expect that mor-
tality data would be less prone to measurement error or biased
reporting than would data on pathophysiological outcomes. The
use of a pathophysiological end-point as a surrogate for an ad-
verse outcome assumes a direct relationship between the two, an
assumption that may sometimes be inappropriate. Finally, when
trials collect data on a number of physiological end-points, there
is the potential for bias, due to the selective publication of end-
points showing striking treatment effects.
Hypertonic solutions have been proposed as the fluid of choice in
patients with head injuries (Walsh 1991), as they may maintain
cerebral perfusion pressure without causing brain swelling with
an increase in intracranial pressure. However, we found only one
small trial (Simma 1998) among people with head injuries.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review does not provide any evidence that hypertonic crys-
talloid is better than isotonic crystalloid, but it does not rule out
clinically important differences.
Implications for research
Further trials are needed comparing hypertonic to isotonic crystal-
loid. These trials should be multi-centre prospective randomised
controlled trials, that are large enough to detect a clinically im-
portant difference. Clinically relevant outcomes such as mortality
should be used and trials should specify the type and amount of
fluid used.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bortolani 1996
Methods Randomised controlled trial. Method of allocation concealment is not described.
No mention of blinding.
Participants 40 patients, with burns over 30% of the body surface area admitted within 4 hours of trauma.
Country: Italy
Interventions 1. Hypertonic lactated saline (n=20)
2. Ringer’s lactated saline (n=20)
Outcomes Haemodynamic variables.
Death.
Complications.
Notes Length of follow-up not clear.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Caldwell 1979
Methods Treatments were alternated.
No mention of blinding.
Participants 20 children with thermal burns covering 30% or more of the body surface area.
Country: USA
Interventions 1. Hypertonic lactated Ringer’s (n=17).
2. Lactated Ringer’s (n=20).
i.v. treatment discontinued after 48 hrs.
Outcomes Death.
Haemodynamic variables.
Notes Length of follow-up not clear.
No loss to follow-up reported.
Risk of bias
Item Authors’ judgement Description
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Caldwell 1979 (Continued)
Allocation concealment? No C - Inadequate
Cooper 2004
Methods Double blind randomised controlled trial.
Identical bags of sequentially numbered, computer randomised fluid were packed in groups of 4 in each
ambulance.
Participants 229 patients with traumatic brain injury.
Country: Australia.
Interventions 1. 250 ml of Hypertonic saline (7.5%).
2. 250 ml of ringers lactate.
Outcomes Death.
Disability (glasgow outcome scale).
Cognitive score.
Functional independence score.
Notes Follow up 6 months.
One patient in control group declined to participate and two in intervention were lost to follow-up.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Croft 1992
Methods Randomised controlled trial. Patients were divided consecutively, with a random allocation chart.Method
of allocation concealment was not described.
No mention of blinding.
Participants 28 patients undergoing major intra-abdominal surgery. Patients with an abnormality of a cardiac valve,
liver failure, pacemaker, shock, septicemia or presence of myocardial ischemia less than 24 hours before
the study were excluded.
Country: Canada.
Interventions 1. Hypertonic saline (n=13).
2. Isotonic Ringer’s lactate (n=15).
Preoperatively RL or HS were infused at a rate sufficient to maintain a PAWP and a CVP within 3 mm
Hg of the initial value.
Outcomes Haemodynamic variables.
Death.
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Croft 1992 (Continued)
Notes Follow up 72 hours.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Cross 1989
Methods Randomised double-blind study. Method of allocation concealment not described.
Doctors and nurses directly involved in pt care did not know identity of solutions.
Participants 20 post-op coronary artery bypass patients. Patients with history of significant arrhythmias, congestive
heart failure, renal, hepatic, or pulmonary failure were excluded.
Country: USA
Interventions 1. Hypertonic saline (n=11).
2. Normal saline (n=9).
for 24 hr period following arrival at ITU.
Study solutions were initially infused at 100 ml/hr, subsequent rates were adjusted according to the clinical
status and were infused to maintain hemodynamic stability.
Outcomes Death.
Hemodynamic variables.
Notes Follow-up 24 hours.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Gunn 1989
Methods Randomised controlled trial. Method of allocation concealment not described.
Participants 51 adult patients who sustained at least 20% body surface area burns and who were admitted within 12
hours of injury.
Interventions 1. Hypertonic sodium lactate
2. Ringer’s lactate.
Intravenous fluid was administered to maintain the urine output at a target rate of 0.5-1.0 cc/kg/hour,
and maintain a minimal or zero base deficit in serial blood gas analyses.
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Gunn 1989 (Continued)
Outcomes Hemodynamic variables.
Enteral intake.
Notes Follow-up was for 72 hours. High drop-out rate due to need for surgery, excision and grafting. These
patients were not followed up after surgery.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
Jarvela 2002
Methods Randomised controlled trial. Patients were randomly allocated according to a list of random digits to 2
groups.
Blinding not specified.
Participants 72 patients undergoing elective coronary artery bypass graft surgery. Patients were excluded if they had a
left ventricular ejection fraction less than 0.4, a serum creatinine more than 130 umol/L, hepatic or renal
disease, or continuous medication with diuretics.
Country: Finland.
Interventions 1. Hypertonic saline (7.5%) (n=36).
2. Normal saline (0.9%) (n=36).
Both groups received 4ml/kg during 30 minutes, when volume loading was needed during the postopera-
tive warming period in ICU. The infusion was stopped if systemic arterial pressure exceeded 170 mmHg.
Outcomes Hemodynamic variables.
MAP.
Cardiac index.
Notes Follow-up first post-op morning.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Jelenko 1978
Methods Randomised controlled trial, method of allocation concealment not described.
Blinding not mentioned.
No loss to follow up.
Participants 12 patients with burns covering more than 20% of body surface.
Country: USA.
Interventions 1. Hypertonic saline (240MeQ Na+, 120 MeQ Chloride, 120 MeQ lactate) (n=5).
2. Ringer’s lactate (n=7).
Allocated fluid was used, guided by haemodynamic variables, to the end of resuscitation.
Outcomes Death.
Hemodynamic variables.
Notes Follow-up to the end of resuscitation.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
McGough 1990
Methods Randomised controlled trial. Method of allocation concealement not described.
Participants 50 patients undergoing total hip arthroplasty, hysterectomy, or radical prostatectomy.
Interventions 1. Hypertonic saline at 4 ml/kg/hr.
2. Ringers lactate at 8 ml/kg/hr.
Outcomes Complications.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Shackford 1983
Methods Patients were assigned by random number to one of two groups. Allocation was done by list of random
numbers read by someone entering the patient into the trial (open list).
No mention of blinding.
Participants 58 patients undergoing aortic reconstruction.
Country: USA.
Interventions 1. Group one received a hypertonic solution (HSL) (n=30).
2. Group two received ringers lactate (n=28).
Fluidwas given tomaintain the cardiac filling pressure within 3 torr of the preoperative level and the cardiac
output at or above the preoperative level. All pts received 5% dextrose in 0.25N saline as a maintenance
solutuion.
Outcomes Hemodynamic variables.
Death.
Notes Follow-up three days.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Shackford 1987
Methods Patients were assigned by random number to one of two groups.
Allocation was done by list of random numbers read by someone entering the patient into the trial (open
list).
No mention of blinding.
Participants 52 patients undergoing aortic reconstruction.
Country: USA
Interventions 1. Hypertonic lactated saline (n=26).
2. Ringer’s lactate (n=26).
During and immediately after the operation fluid was given to maintain the CO equal to preoperative
levels and the cardiac filling pressures within 3 torr of the preoperative value. Post-op all of the patients
received 5% dextrose in normal saline as a maintenance solution, this was continued until the first day
post-op. During this same period, additional fluid (eitherHSL or RL) was given to maintain cardiac filling
pressures and CO at pre-op levels.
Outcomes Hemodynamic variables.
Serum compositional changes.
Notes Follow-up three days.
Risk of bias
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Shackford 1987 (Continued)
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Simma 1998
Methods Randomized controlled trial. Randomization was done by an independent investigator. Staff were not
blinded to the type of fluid.
Participants 32 head-injured children under the age of 16 with Glasgow coma scores of <8. The patients entered the
study at the time when ICP was first measured.
Country: Switzerland.
Interventions 1. Hypertonic saline (n=15).
2. Ringer’s lactate (n=17).
Over 72 hours.
Outcomes Hemodynamic variables.
Complications.
Length of hospital stay.
Death.
Notes Follow-up until discharge from hospital.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Vassar 1990
Methods Randomised controlled trial, allocation concealment unclear.
Double blind study (solutions prepared in identical containers).
No loss to follow up.
Participants 59 injured patients were entered into the trial. Participants were emergency department admissions with
trauma and a systolic blood pressure below 80mm Hg and were 18 years or older.
Pregnant women and people with preexisting cardiac, hepatic or renal disease were excluded.
Country: USA
Interventions 1. 7.5% saline (n=32).
2. Ringer’s lactate (n=27).
Allocated fluids were given as the initial resuscitation fluid in the emergency department.
Outcomes Haemodynamic variables.
Death.
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Vassar 1990 (Continued)
Notes Follow-up until discharge from hospital.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Vassar 1993a
Methods Randomised controlled double blind trial. Allocation concealed by random sequence of identical con-
tainers.
36 people excluded post randomisation as deemed not to have met eligibility criteria.
No loss to follow up.
Participants 169 pre-hosptial trauma patients, who were undergoing ambulance transport to an emergency centre, had
systolic blood pressure 90 mmHg or less, and were 18 years or older.
Exclusions: asystolic, undergoing CPR, lack sinus complex on ECG, more than 2 hours after trauma,
pregnant, preexisting seizures, bleeding disorder, hepatic, cardiac or renal disease.
Country: USA
Interventions 1. 7.5% saline (n=85).
2. 0.9% saline (n=84).
Participants received 250mL of the allocated fluid in the pre-hospital setting. Additional isotonic crystal-
loids were given as needed.
Outcomes Deaths reported.
Haemodynamic variables.
Trauma scores and neurological outcome scores.
Notes Follow-up until discharge from hospital.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Vassar 1993b
Methods Randomised controlled trial, allocation concealed by sequential use of coded identical containers. Only
the manufacturer could know the treatment assignment.
Double blind study.
39/233 patients excluded as deemed not to meet eligibility criteria, unclear from which groups.
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Vassar 1993b (Continued)
Participants 95 pre-hospital trauma patients undergoing helicoptor transport to an emergency centre, had a systolic
blood pressure of 100mmHg or less and were 18 years or older.
Exclusions: asystolic, undergoing CPR, lack sinus complex on ECG, more than 2 hours after trauma,
pregnant, preexisting seizures, bleeding disorder, hepatic, cardiac or renal disease.
Country: USA
Interventions 1. 7.5% saline. (n=50)
2. Ringer’s lactate. (n=45)
Participants received 250mL of the allocated fluid in the pre-hospital setting. Additional isotonic crystal-
loids were given as needed.
Outcomes Deaths reported.
Haemodynamic variables.
Trauma scores and neurological outcome scores.
Notes Follow-up until discharge from hospital.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Younes 1988a
Methods Random assignment. Method of allocation concealment not mentioned.
Participants 33 patients admitted to the emergency ward in hypovolemic shock (mean arterial pressure < 60 mmHg)
Interventions 1. Hypertonic 7.5% saline (n=18).
2. Isotonic NaCl (n=15).
Both fluids received at infusion rate of 10ml/minute, over 15 minutes. No other fluid was given after the
infusion unless MAP fell below 80mmHg, until typed-crossmatched blood was available. Patients were
excluded from the study as soon as given fluid or blood.
Outcomes MAP
Notes Length of follow-up not recorded.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Younes 1988b
Methods Random assignment. Method of allocation concealment not mentioned.
Participants 31 patients admitted for abdominal aorta reconstructive surgery.
Interventions 1. Hypertonic 7.5% NaCl, (n=18)
2. Isotonic 0.9% saline (n=13)
Both groups received fluid as the volume of 4ml/kg of body weight, infused during 15 minutes. The
infusion was started 2 minutes before the release of the aortic clamp.
Outcomes MAP.
Haemodynamic variables.
Notes Length of follow up not recorded.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Younes 1992
Methods Randomised ’in a double blind fashion’.
Blinding by use of similar bottles.
No loss to follow up.
Participants 70 emergency department admissions, who had a systolic blood pressure of less than 80mm Hg and were
19 years and older.
Exclusions: pregnant, preexisting cardiac or metabolic disease.
Interventions 1. 7.5% saline (n=35).
2. 0.9% saline (n=35).
Allocated fluid was for initial bolus of 250mL, followed by isotonic crystalloids as needed.
Outcomes Deaths reported.
Fluid balance.
Notes Follow-up until discharge from hospital.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
MAP = mean arterial pressure.
ICU = Intensive care unit.
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PCWP = Pulmonary capillary wedge pressure.
Characteristics of excluded studies [ordered by study ID]
Fisher 1992 Cross-over study.
Holcroft 1987 The study was not randomised. Fluid was administered depending on the attending surgeon.
Shackford 1998 Study compared hypertonic fluid versus hypotonic.
Shao 2005 The patients were ’assigned’ and not randomised.
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D A T A A N D A N A L Y S E S
Comparison 1. Hypertonic versus isotonic crystalloid
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death 14 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Trauma 6 651 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.69, 1.04]
1.2 Burns 3 89 Risk Ratio (M-H, Fixed, 95% CI) 1.49 [0.56, 3.95]
1.3 Surgery 5 230 Risk Ratio (M-H, Fixed, 95% CI) 0.51 [0.09, 2.73]
2 Poor outcome (GOS) 1 226 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.82, 1.22]
2.1 Trauma 1 226 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.82, 1.22]
F E E D B A C K
Lactated Ringer’s not isotonic
Summary
Lactated Ringer’s solution is not a truly isotonic fluid. In one report (Tommasino C, Moore S, Todd MM. Crit Care Med 1988;16
p867) the measured osmolality was stated to be approximately 254 mosm/l while the calculated osmolality was 273 mosm/l.
The treatment of traumatized patients will include the infusion of many literes of crystalloids during the first hours. In comparison, the
250 ml of lactated Ringer’s or saline used at intervention in the studies concerned probably does not matter very much. The problem
addressed by the review, rather than one of “isotonic versus hypotonic”, may be more precisely formulated as something like “early
supplementation or not” of hypertonic fluid to the continued use of many liters of a weakly hypotonic fluid.
The hypothesis that 250 ml of hypertonic fluid is beneficial, may easily lead to the idea that many litres of a hypotonic fluid is
detrimental. Or is the hypertonic fluid of benefit only when it is added to adjust for the hypotonic one? Will a test with really isotonic
crystalloid do better than the hypotonic one and show the supplementation with hypertonic fluid not only to be unnecessary, but even
harmful?
The reports often conceal the true nature of the fluids used behind designations like “conventional isotonic solutions” or “standard of
care”, and the amount of fluid given after arrival in hospital may not be stated.
Implications for research is that studies with the continued use of truly isotonic solutions have to be done to decide whether hypertonic
or weakly hypotonic solutions are beneficial or detrimental. The nature and amount of fluids used in future studies should be clearly
stated.
I certify that I have no affiliations with or involvement in any organisation or entity with a direct financial interest in the subject matter
of my criticisms.
Reply
We agree that lactated Ringer’s is not a truly isotonic fluid and have, therefore, changed the title of the review to reflect this. The title
is now ’Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients’.
We also agree that the nature and amount of fluids used in future studies should be clearly stated, and have included a statement to
this effect in the conclusions.
Contributors
Comment by Per Størset (anesthesiologist), December 2002.
Reply from Frances Bunn, May 2004.
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WH A T ’ S N E W
Last assessed as up-to-date: 14 October 2007.
10 July 2008 Amended Converted to new review format.
H I S T O R Y
Protocol first published: Issue 2, 2000
Review first published: Issue 4, 2000
20 February 2008 New search has been performed This review was originally published in the Cochrane Library in 2000. It has
subsequently been updated in 2001, 2004, and, most recently, 2008. No new
studies were added in the most recent update.
C O N T R I B U T I O N S O F A U T H O R S
FB screened citations for eligibility, obtained references, contacted authors, extracted data, entered data and wrote up the review. IR
helped to write the review. RT commented on the protocol and review. DT screened citations for eligibility.
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• NHS Research and Development, UK.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Plasma Substitutes; Critical Illness; Hypertonic Solutions [∗therapeutic use]; Hypovolemia [mortality; ∗therapy]; Isotonic Solutions
[∗therapeutic use]; Randomized Controlled Trials as Topic; Rehydration Solutions [∗therapeutic use]
MeSH check words
Humans
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Papers
Human albumin administration in critically ill patients:
systematic review of randomised controlled trials
Cochrane Injuries Group Albumin Reviewers
Abstract
Objective: To quantify effect on mortality of
administering human albumin or plasma protein
fraction during management of critically ill patients.
Design: Systematic review of randomised controlled
trials comparing administration of albumin or plasma
protein fraction with no administration or with
administration of crystalloid solution in critically ill
patients with hypovolaemia, burns, or
hypoalbuminaemia.
Subjects: 30 randomised controlled trials including
1419 randomised patients.
Main outcome measure: Mortality from all causes at
end of follow up for each trial.
Results: For each patient category the risk of death in
the albumin treated group was higher than in the
comparison group. For hypovolaemia the relative risk
of death after albumin administration was 1.46 (95%
confidence interval 0.97 to 2.22), for burns the relative
risk was 2.40 (1.11 to 5.19), and for
hypoalbuminaemia it was 1.69 (1.07 to 2.67). Pooled
relative risk of death with albumin administration was
1.68 (1.26 to 2.23). Pooled difference in the risk of
death with albumin was 6% (95% confidence interval
3% to 9%) with a fixed effects model. These data
suggest that for every 17 critically ill patients treated
with albumin there is one additional death.
Conclusions: There is no evidence that albumin
administration reduces mortality in critically ill
patients with hypovolaemia, burns, or
hypoalbuminaemia and a strong suggestion that it
may increase mortality. These data suggest that use of
human albumin in critically ill patients should be
urgently reviewed and that it should not be used
outside the context of rigorously conducted,
randomised controlled trials.
Introduction
In patients with acute and chronic illness serum
albumin concentration is inversely related to risk of
death. A systematic review of cohort studies meeting
specified criteria estimated that for each 2.5 g/l decre›
ment in serum albumin concentration the risk of death
increases by between 24% and 56%.1 The association
persists after adjustment for other known risk factors
and pre›existing illness, and some commentators have
suggested the possibility of the albumin molecule hav›
ing a direct protective effect.1 Partly as a result of the
association between serum albumin and mortality,
human albumin solutions are now used in the
management of a diverse range of medical and
surgical problems. Licensed indications for human
albumin solution are the emergency treatment of
shock and other conditions in which restoration of
blood volume is urgent, the acute management of
burns, and clinical situations associated with hypopro›
teinaemia.2
Compared with other colloidal solutions and with
crystalloid solutions, human albumin solutions are
expensive.3 Volume for volume, human albumin
solution is twice as expensive as hydroxyethyl starch
and over 30 times more expensive than crystalloid
solutions such as sodium chloride or Ringer’s lactate.
Because of the high cost and limited availability of
human albumin, it is imperative that its use should be
restricted to the indications for which it has been
shown to be effective. To quantify the effect on
mortality of human albumin solution in the manage›
ment of critically ill patients with hypovolaemia from
injury or surgery, burns, and hypoproteinaemia, we
conducted a systematic review of randomised control›
led trials.
Methods
Identification of trials
Our aim was to identify all relevant randomised
controlled trials that were available for review by
March 1998. A randomised controlled trial was
defined as a trial in which the subjects followed were
assigned prospectively to one of two (or more)
interventions by random allocation or some quasi›
random method of allocation. This definition was
agreed at an international meeting held in Oxford in
November 1992 in association with the official opening
of the UK Cochrane Centre. We sought to identify all
randomised controlled trials of administration of
human albumin or plasma protein fraction (supple›
mental albumin or plasma protein fraction compared
with no albumin or plasma protein fraction or with a
crystalloid solution) in critically ill patients with
hypovolaemia from trauma or surgery, with burns, or
with hypoalbuminaemia. Studies that compared differ›
ent levels of albumin supplementation were also
included.
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Trials were identified by computerised searches of
the Cochrane Controlled Trials Register, Medline,
Embase, and BIDS Index to Scientific and Technical
Proceedings (search strategies are available from IR);
by hand searching 29 international journals and the
proceedings of several international meetings on fluid
resuscitation; by checking the reference lists of all
included trials; and by contacting the authors of identi›
fied trials and asking them about any other published
or unpublished trials that may have been conducted.
There were no language restrictions. To identify
unpublished trials we searched the register of the
Medical Editors’ Trial Amnesty,4 and contacted the
Medical Directors of Bio Products Laboratory
(Zenalb), Centeon (Albuminar), and Alpha Therapeu›
tic UK (Albutein).
Outcome measures and data extraction
The outcome measure was mortality from all causes at
the end of the follow up period scheduled for each
trial. For all trials we collected data on the type of par›
ticipants, details about the interventions, the quality of
concealment of allocation, and mortality at the end of
follow up. We rated quality of allocation concealment
using the method proposed by Schulz et al.5 We sought
mortality data in simple categorical form, and we did
Summary of randomised trials comparing albumin with no albumin or crystalloid that met criteria for inclusion
Trial Critical illness
No of
patients Intervention Control
Length of
follow up
Total No
of deaths
Allocation
concealment*
Hypovolaemia
Skillman et al31 Surgery 16 25% concentrated salt›poor albumin
1 g/kg and 5% albumin in saline
Ringer’s lactate with 5% dextrose 1 day Not known 2
Shah et al27 Trauma 20 5% salt›poor albumin in Ringer’s
lactate
Ringer’s lactate Unspecified 5 3
Lowe et al20 Trauma 171 50 g albumin/200 ml Ringer’s lactate Ringer’s lactate 5 days 6 3
Boutros et al9 Surgery 24 Albumin in 5% dextrose 5% dextrose in lactated Ringer’s (n=9)
5% dextrose in 0.45% NaCl (n=8)
4 days 2 2
Virgilio et al33 Surgery 29 5% albumin in Ringer’s lactate Ringer’s lactate 21⁄2 weeks 2 2
Lucas et al21 Trauma 52 150 g salt›poor albumin during
operation, 150 g/day for 5 days
postoperatively
No albumin To positive fluid
balance or oral
intake
7 1
Zetterstrom et al37 Surgery 30 20% albumin 100 ml at end of
operation, 200 ml on day of operation,
100 ml/day for next 3 days
No albumin Unspecified 1 3
Zetterstrom38 Surgery 18 5% albumin to keep pulmonary
arterial occlusion pressure equal to
preoperative level
Balanced electrolyte solution of Ringer’s
type to keep pulmonary arterial pressure
equal to preoperative level
Unspecified 2 3
Grundman et al17 Surgery 17 Human albumin and crystalloid Crystalloid only 5 days 1 2
Rackow et al30 Trauma and sepsis 17 5% albumin 0.9% NaCl To discharge 12 2
Gallagher et al12 Surgery 10 5% albumin Ringer’s lactate 1 day 0 3
Nielsen et al23 Surgery 26 80 g albumin in units of 100 ml 20%
albumin on day of operation, 20 g
daily for next 3 days
No albumin 4 days 0 2
Prien et al26 Surgery 12 20% albumin to maintain central
venous pressure at preoperative level
Ringer’s lactate Unspecified 0 2
Boldt et al8 Surgery 30 5% albumin No albumin 1 day 0 3
McNulty et al22 Surgery 28 5% albumin Isotonic crystalloid Unspecified Not known 2
Woods et al36 Surgery 69 Albumin supplementation No supplementation To discharge 1 1
Pockaj et al25 Vascular leak
syndrome
107 5% albumin in 0.9% NaCl 0.9% NaCl Unspecified 0 2
Tłllłfsrud et al32 Surgery 20 4% albumin when fluid required Ringer’s acetate 48 hours 1 3
So et al28 Hypotensive preterm
infant
63 5% albumin 10 ml/kg over 30 minutes 0.9% NaCl 10 ml/kg over 30 minutes To discharge 12 3
Woittiez et al34 Surgery 31 20% albumin 0.9% NaCl Unspecified 12 3
Burns
Jelenko et al18 Burns 14 Hypertonic crystalloid with 12.5 g/l
albumin
Ringer’s lactate 5 days 3 2
Goodwin et al14 Burns 79 2.5% albumin in Ringer’s lactate Ringer’s lactate To discharge 14 2
Greenhalgh et al15 Burns 70 25% albumin to maintain serum
levels between 2.5 and 3.5 g/dl
No albumin unless levels dropped
below 1.5 g/dl
To discharge 10 3
Hypoproteinaemia
Bland et al7 Hypoproteinaemia 27 25% albumin 8 ml/kg 5% glucose 8 ml/kg Unspecified 5 2
Nilsson et al24 Hypoalbuminaemia
(postoperative)
59 20›25 g albumin/day for 3 days
starting day after operation
No supplemental albumin To discharge 1 3
Brown et al10 Hypoalbuminaemia 67 TPN with added albumin No supplemental albumin To discharge 10 1
Foley et al11 Hypoalbuminaemia 40 TPN with added albumin (25›50 g/day
25% albumin)
No supplemental albumin To discharge 13 1
Kanarek et al19 Hypoalbuminaemia 24 TPN with added albumin No supplemental albumin Unspecified 5 3
Wojtysiak et al35 Hypoalbuminaemia 30 TPN with added albumin No supplemental albumin 5 days 0 1
Greenough et al16 Hypoalbuminaemic sick
preterm infants
40 20% salt›poor albumin 5 ml/kg with
maintenance fluids
5 ml/kg maintenance fluid placebo 24 hours after
infusion
10 3
Golub et al13 Hypoalbuminaemia 219 37.5 g/day albumin until serum
albumin >3.0 g/dl
No supplemental albumin To discharge 18 3
Rubin et al29 Hypoalbuminaemia 36 TPN with added albumin No supplemental albumin To discharge 3 3
TPN=Total parenteral nutrition. *Allocation concealment: 1=inadequate, 2=unclear, 3=adequate.
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not extract data on time to death. If a report did not
include the numbers of deaths in each group, we
sought these data from the authors. Two reviewers
independently extracted the data, and any disagree›
ments were resolved by discussion.
Data analysis and statistical methods
We used the Mantel›Haenszel method to calculate
relative risks, risk differences, and 95% confidence
intervals for death for each trial on an intention to treat
basis using RevMan (Review Manager) statistical
software. When there are no events in one group the
software adds 0.5 to each cell of the 2 × 2 table. We
tested heterogeneity between trials using ÷2 tests, with
P<0.05 indicating significant heterogeneity. As long as
statistical heterogeneity did not exist, we used a fixed
effects model to calculate summary relative risks and
95% confidence intervals.
To examine the extent to which the results of the
meta›analyses may have been biased as a result of the
selective inclusion of randomised trials with positive
findings (publication and other selection bias), we pre›
pared a funnel plot and used the regression approach
to assessing funnel plot asymmetry proposed by Egger
et al.6 We used the log odds ratio in the funnel plot
because this is the measure that is used in the
regression test of funnel plot asymmetry as described
by Egger et al. Using simple unweighted linear
regression, we regressed the standard normal deviate
(defined as the log odds ratio divided by its standard
error) against the estimate’s precision (defined as the
inverse of the standard error). The larger the deviation
of the intercept of the regression line from zero, the
greater the asymmetry and the more likely it is that the
meta›analysis will yield biased estimates of effect. As
suggested by Egger et al, we considered P < 0.1 to indi›
cate significant asymmetry.
Results
We identified a total of 32 randomised controlled trials
that met the study’s inclusion criteria.7–38 The table
shows details of these trials. Mortality data were
available either from the published report or on
contact with the authors in 30 of these trials. The two
trials for which mortality data could not be obtained
included a total of 42 randomised patients, comprising
3% of the total number of randomised patients in all
trials meeting our inclusion criteria.22 31 One of the
trials was an unpublished trial registered in the Medical
Editors’ Trial Amnesty, and we obtained further details,
including data on mortality, directly from the trialist. In
six trials there were no deaths in either the intervention
or comparison groups.8 12 23 25 26 35
The trial by Lucas et al was reported in five
publications.21 39–42 An early report gave the mortality
data for 52 randomised patients, 27 allocated to receive
albumin and 25 allocated to receive no albumin.21 Sub›
sequent publications indicated that recruitment to the
trial continued until 94 patients were randomised.
Mortality data for all the 94 patients were not
published, nor were they available on contact with the
author. Consequently, we present the outcome data for
the 52 patients.
Of the 24 trials in which one or more deaths
occurred in either the intervention or control groups,
13 included a method of allocation concealment that
would be expected to reduce the risk of foreknowledge
of treatment allocation (pharmacy controlled ran›
domisation or serially numbered sealed opaque
envelopes). In seven trials this was unclear, and in four
trials concealment was inadequate (table).
In each of the patient categories the risk of death in
the albumin treated group was higher than in the com›
parison group (fig 1). For hypovolaemia the relative
risk of death after albumin administration was 1.46
(95% confidence interval 0.97 to 2.22), for burns the
relative risk was 2.40 (1.11 to 5.19), and for
hypoalbuminaemia the it was 1.69 (1.07 to 2.67). There
was no significant heterogeneity either between or
within the groups of trials, or overall (÷2 = 15.32,
df = 23, P > 0.2). The pooled relative risk of death with
albumin administration was 1.68 (1.26 to 2.23).
There was no significant heterogeneity in the risk
difference for mortality (÷2 = 36.69, df = 29, P > 0.1).
The pooled difference in the risk of death with albumin
was 6% (95% confidence interval 3% to 9%).
Type of injury 
Hypovolaemia
Subtotal
χ2 =9.45 (df=12)
Lowe et al20
Shah et al27
Lucas et al21
Virgilio et al33
Boutros et al9
Zetterstrom et al37
Zetterstrom et al38
Grundmann et al17
Rackow et al30
Woods et al36
Tølløfsrud et al32
So et al28
Woittiez et al34
3/57
2/9
7/27
1/15
0/7
0/15
2/9
1/14
6/9
1/37
0/10
7/32
8/15
38/256
3/84
3/11
0/25
1/14
2/17
1/15
0/9
0/6
6/8
0/32
1/10
5/31
4/16
26/278
4.0
4.5
0.9
1.7
2.5
2.5
0.8
1.1
10.5
0.9
2.5
8.4
6.4
46.6
1.47 (0.31 to 7.05)
0.81 (0.17 to 3.87)
13.93 (0.84 to 231.94)
0.93 (0.06 to 13.54)
0.45 (0.02 to 8.34)
0.33 (0.01 to 7.58)
5.00 (0.27 to 91.52)
1.40 (0.06 to 30.23)
0.89 (0.48 to 1.64)
2.61 (0.11 to 61.81)
0.33 (0.02 to 7.32)
1.36 (0.48 to 3.82)
2.13 (0.81 to 5.64)
1.46 (0.97 to 2.22)
Hypoalbuminaemia
Subtotal
χ2 =0.99 (df=7)
Total
χ2 =15.32 (df=23)
Bland et al7
Nilsson et al24
Brown et al10
Foley et al11
Kanarek et al19
Greenough et al16
Golub et al13
Rubin et al29
4/14
1/29
6/34
7/18
3/12
6/20
12/116
2/16
41/259
1/13
0/30
4/33
6/22
2/12
4/20
6/103
1/15
24/248
1.7
0.8
6.7
8.9
3.3
6.6
10.5
1.7
10.2
98/596 58/608
0.01 0.1 1 10 100
Favours
intervention
Favours
control
100.0
3.71 (0.47 to 29.06)
3.10 (0.13 to 73.15)
1.46 (0.45 to 4.70)
1.43 (0.58 to 3.49)
1.50 (0.30 to 7.43)
1.50 (0.50 to 4.52)
1.78 (0.69 to 4.56)
1.88 (0.19 to 18.60)
1.69 (1.07 to 2.67)
1.68 (1.26 to 2.23)
Burns
Subtotal
χ2 =2.45 (df=2)
Jelenko et al18
Goodwin et al14
Greenhalgh et al15
1/7
11/40
7/34
19/81
2/7
3/39
3/36
8/82
3.3
5.0
4.8
13.1
0.50 (0.06 to 4.33)
3.57 (1.08 to 11.85)
2.47 (0.69 to 8.79)
2.40 (1.11 to 5.19)
Intervention
No of deaths
Control Relative risk
(95% CI)
Relative risk
(95% CI)
Weight
(%)
Fig 1 Fixed effects model of relative risks (95% confidence interval) of death associated with
intervention (fluid resuscitation with albumin or plasma protein fraction) compared with
control (no albumin or plasma protein fraction or resuscitation with a crystalloid solution) in
critically ill patients
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Figure 2 shows a funnel plot for the 24 trials in
which deaths occurred. There was no clear evidence of
asymmetry, and the regression approach to funnel plot
asymmetry yielded an intercept of − 0.39 and P = 0.33,
indicating no statistical evidence of selection bias.
We repeated the analyses for the 13 trials with
deaths in which allocation concealment was
adequate.13 15 16 19 20 24 27–29 32 34 37 38 For hypovolaemia the
relative risk of death with albumin administration was
1.39 (0.80 to 2.40), for burns the relative risk was 2.47
(0.69 to 8.79), and for hypoalbuminaemia it was 1.71
(0.92 to 3.18). There was no substantial heterogeneity
between the trials in the various categories (÷2 = 4.42,
df = 12, P > 0.2), and the pooled relative risk of death
with albumin administration was 1.61 (1.09 to 2.38).
Thus, restricting the analyses to the adequately
concealed trials had almost no effect on the relative
risks in each group or overall.
Discussion
We found no evidence that albumin reduced mortality
and a strong suggestion that it might increase the risk
of death in patients with hypovolaemia, burns, or
hypoproteinaemia. Overall, the risk of death in patients
treated with albumin was 6% (95% confidence interval
3% to 9%) higher than in patients not given albumin.
Limitations of study
Mortality was selected as the outcome measure in this
systematic review for several reasons. In the context of
critical illness, death or survival is a clinically relevant
outcome that is of immediate importance to patients,
and data on death are reported in nearly all studies.
Furthermore, one might expect that mortality data
would be less prone to measurement error or biased
reporting than would data on pathophysiological out›
comes. The use of a pathophysiological end point as a
surrogate for an adverse outcome assumes a direct
relationship between the two, an assumption that may
sometimes be inappropriate. Finally, when trials collect
data on a number of physiological end points, there is
the potential for bias due to the selective publication of
end points showing striking treatment effects. Because
we obtained mortality data for all but two of the
included trials, the likelihood of bias due to selective
publication of trial outcomes is minimal. We examined
mortality from all causes because the attribution of
cause of death in critically ill patients, many of whom
may have multiorgan failure, can be problematic and
may be prone to bias. Length of follow up was not
specified in many of the trials, but when these data
were available, follow up was for the first week or until
hospital discharge.
Although publication bias is a potent threat to the
validity of systematic reviews, it is unlikely to have had
an important impact in this study. There was no
evidence of funnel plot asymmetry on visual inspec›
tion, and there was no statistical evidence of asymmetry
from linear regression analysis.
In some of the trials included in this review alloca›
tion concealment was inadequate or unclear. As a
result, it is possible that more severely ill patients were
preferentially allocated to albumin treated groups,
which could account for the increased mortality in
these groups. Nevertheless, when we repeated the
analyses for only those trials in which the method of
allocation concealment would be expected to reduce
the risk of foreknowledge of allocation, the point
estimates were almost identical.
Implications of results
To what extent are the results of this review of 30 rela›
tively small randomised trials of albumin administra›
tion generalisable to clinical practice? We believe that
this is a matter for judgment by the responsible
clinician faced with an individual patient.43 However,
the advantage of an overview such as ours is that, since
it includes many studies, the results are based on a wide
range of patients. Because the results were consistent
across the studies, they might reasonably be taken to
apply to this wide variety of patients.43 Moreover, the
evidence that we have brought together is, as far as we
can ensure, the totality of the available randomised evi›
dence for the use of albumin in hypovolaemia, burns,
and hypoalbuminaemia, the indications for which
albumin is currently licensed.
Is there a plausible mechanism by which human
albumin might increase mortality? Albumin is used in
hypovolaemia and hypoalbuminaemia because it is
believed to be effective in replacing volume and
supporting colloid oncotic pressure.44 However, albumin
is also believed to have anticoagulant properties, inhibit›
ing platelet aggregation and enhancing the inhibition of
factor Xa by antithrombin III.44 Such anticoagulant
activity might be detrimental in critically ill patients, par›
ticularly those with haemorrhagic hypovolaemia. Fur›
thermore, albumin has been shown to distribute across
the capillary membrane, a process that is accelerated in
critically ill patients.45 It has been suggested that
increased leakage of albumin into the extravascular
spaces might reduce the oncotic pressure difference
across the capillary wall, making oedema more likely.45
Conclusions
Because this review was based on relatively small trials
in which there were only a small number of deaths the
results must be interpreted with caution. Nevertheless,
we believe that a reasonable conclusion from these
results is that the use of human albumin in the
management of critically ill patients should be
reviewed. A strong argument could be made that
human albumin should not be used outside the
context of a properly concealed and otherwise
rigorously conducted randomised controlled trial with
Log odds ratio
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0
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2
Fig 2 Funnel plot for the 24 trials in which deaths occurred and that
were used in systematic review
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mortality as the end point. Until such data become
available, there is also a case for a review of the licensed
indications for albumin use.
This review will also be published in the Cochrane Library, where
it will be regularly updated to take account of new data and
comments on this version.
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Why albumin may not work
Starling’s principle is often represented as the leakage
of fluids from the arterial end of capillaries, where the
hydrostatic pressure is greater than the oncotic
pressure (derived from the plasma proteins), and the
reabsorption of fluid into the venous end, where the
oncotic pressure exceeds the hydrostatic pressure. A
small excess of fluid in the interstitial space—when
filtration from the capillaries is greater than
reabsorption—is dealt with by lymphatic drainage from
the interstitial space. The rationale for giving albumin
solutions rather than crystalloid solutions in cases of
hypovolaemic shock is that fluid reabsorption from the
interstitial space is enhanced, and fluid therefore
remains in the vascular system for longer.
But in recent years the assumed reabsorption of
fluid at the venous end of capillaries has been
challenged. There is now good evidence to show that,
except in the gut and the renal circulation, there is no
sustained reabsorption of fluid at the venous end of
capillaries. Instead, there is a small constant level of fil›
tration from the capillaries, restrained by the osmotic
pressure of the plasma proteins. In some rare
circumstances—for example, in hypovolaemic shock—
there is a transient reabsorption of fluid, but this lasts
for only a few minutes and it amounts to an “internal
transfusion” of about 500 ml of fluid over 15 minutes.
The production of life threatening pulmonary
oedema begins when the loss of protein and fluid from
the blood vessels exceeds the volume of fluid that can be
drained from the interstitial space by the lymphatics. In
some disease states or when tissue is damaged, as in
severe burns, the capillary walls become very much
more permeable under the influence of direct cellular
damage and from inflammatory mediators. The
filtration of fluids, together with proteins, out into the
interstitial space is greatly increased and cannot be
matched by lymphatic drainage. The filtration rate may
be further increased by a fall in the hydrostatic pressure
in the interstitial space as a result of tissue damage, so
that even more fluid is sucked out of the capillaries.
Conventionally, colloids such as albumin are admin›
istered to these patients in an attempt to maintain their
intravascular volume, but because of the increased
permeability of the vessels, the albumin solution
becomes much less effective in maintaining plasma vol›
ume than in healthy individuals who have normal vessel
permeability. Thus the rationale for administering albu›
min solutions becomes much less clear. In disease states
such as the nephrotic syndrome, for example, there is
new evidence to show that protein is lost not only from
the renal circulation owing to greater permeability of the
renal vessels, but also from the rest of the systemic circu›
lation. This being the case, it is difficult to see how the
administration of albumin could ever replace the deficit
without causing further problems.
Abi Berger—Science editor, BMJ
A memorable patient
“I got no counselling”
Examining war pensioners can provide an opportunity to listen,
unstressed by the constraints imposed by active disease or the
length of the appointment. Occasionally, you are exposed to tales
of immense courage or distress recounted with characteristic
British understatement.
The gentle former bank messenger described how his warship
was ordered alongside a burning merchant ship which was
packed full of ammunition. The inevitable happened and the
pensioner found himself floating in the water. He was taken
ashore to a hospital and after four weeks of convalescence his bed
was required and he was sent back to his ship on “light duties.”
What had these “light” duties consisted of? “Well by then,” he
recounted, “our ship had been beached and we had to go below
decks to bring out the bodies and sew them into canvas
hammocks. When the padre found out what we were doing it was
stopped, but, you know doc, I got no counselling,” he added with
a wry smile.
Close to tears, he described his visit to bereaved parents whose
only son he had taught to wash and iron his own clothes.
Amazingly, my patient had no subsequent experience of
flashbacks or nightmares. But what he did have was a strong
feeling of the shared experience of working with fellow survivors
and their relatives to lay to rest shipmates with whom he had
sailed and fought. The existence of a common enemy allowed
comfort to be obtained from even this gruesome task, spared
from the modern distraction of searching through a sequence of
events for someone to blame and the possibility of eventual
financial compensation.
Jim Ford, senior medical officer, Department of Health, Leeds
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A B S T R A C T
Background
Treatment of haemorrhagic shock involves maintaining blood pressure and tissue perfusion until bleeding is controlled. Different
resuscitation strategies have been used to maintain the blood pressure in trauma patients until bleeding is controlled. However, while
maintaining blood pressure may prevent shock, it may worsen bleeding.
Objectives
To assess the effects of early versus delayed, and larger versus smaller volume of fluid administration in trauma patients with bleeding.
Search strategy
We searched the CENTRAL (The Cochrane Library 2008, Issue 4), the Cochrane Injuries Group’s Specialised Register (searched
October 2008), MEDLINE (to October 2008), EMBASE (to October 2008), the National Research Register (in Current controlled
trials.gov; searched October 2008) and the Science Citation Index (to October 2008). We checked reference lists of identified articles
and contacted authors and experts in the field.
Selection criteria
Randomised trials of the timing and volume of intravenous fluid administration in trauma patients with bleeding. Trials in which
different types of intravenous fluid were compared were excluded.
Data collection and analysis
Two authors independently extracted data and assessed trial quality.
Main results
We did not combine the results quantitatively because the interventions and patient populations were so diverse.
Early versus delayed fluid administration
Three trials reported mortality and two coagulation data.
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In the first trial (n=598) relative risk (RR) for death with early fluid administration was 1.26 (95% confidence interval of 1.00−1.58).
The weighted mean differences (WMD) for prothrombin time and partial thromboplastin time were 2.7 (95% CI 0.9−4.5) and 4.3
(95% CI 1.74−6.9) seconds respectively.
In the second trial (n=50) RR for death with early blood transfusionwas 5.4 (95%CI 0.3−107.1). TheWMD for partial thromboplastin
time was 7.0 (95% CI 6.0−8.0) seconds. In the third trial (n=1309) RR for death with early fluid administration was 1.06 (95% CI
0.77−1.47).
Larger versus smaller volume of fluid administration
Three trials reported mortality and one coagulation data.
In the first trial (n=36) RR for death with a larger volume of fluid resuscitation was 0.80 (95% CI 0.28−22.29). Prothrombin time
and partial thromboplastin time were 14.8 and 47.3 seconds in those who received a larger volume of fluid, as compared to 13.9 and
35.1 seconds in the comparison group.
In the second trial (n=110) RR for death with a high systolic blood pressure resuscitation target (100mmHg) maintained with a larger
volume of fluid, as compared to low systolic blood pressure resuscitation target (70mmHg) maintained with a smaller volume of fluid
was 1.00 (95% CI 0.26−3.81). In the third trial (n=25) there were no deaths.
Authors’ conclusions
We found no evidence from randomised controlled trials for or against early or larger volume of intravenous fluid administration in
uncontrolled haemorrhage. There is continuing uncertainty about the best fluid administration strategy in bleeding trauma patients.
Further randomised controlled trials are needed to establish the most effective fluid resuscitation strategy.
P L A I N L A N G U A G E S U M M A R Y
No evidence from trials to support or not to support the use of early or larger volume intravenous fluid in uncontrolled bleeding
About one third of injury deaths are due to shock from blood loss. Preventing shock in people with uncontrolled bleeding is, therefore,
very important and is generally done by giving fluids intravenously. The aim is to maintain blood pressure and reduce tissue damage.
The review of trials found that there is uncertainty about the best time to give fluid and what volume of fluid should be given. While
increasing fluids will maintain blood pressure, it may also worsen bleeding by diluting clotting factors in the blood. More research is
needed.
B A C K G R O U N D
In 1990 approximately five million people died worldwide as a
result of injury (Murray 1996). For people younger than 35 years,
injury is now the leading cause of death. Nevertheless, the global
epidemic of injury is only beginning. It is estimated that by 2020,
deaths from injury will have increased from 5.1 million to 8.4
million (Murray 1997). About one third of injury deaths are due
to haemorrhagic shock (Deakin 1994). Acute blood loss following
injury leads to a reduction in tissue perfusion and tissue oxygen
delivery that, if prolonged, causes lactic acidosis and organ fail-
ure. Treatment of haemorrhagic shock involves maintaining blood
pressure and tissue perfusion until the bleeding is controlled. Over
the past 50 years, a number of resuscitation strategies have been
used tomaintain the blood pressure in trauma patients until bleed-
ing is controlled. The evidence for the effectiveness of these ap-
proaches has been the subject of a number of systematic reviews
by the Cochrane Injuries Group and by others.
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Pre-hospital use of medical anti-shock trousers
Medical anti-shock trousers (MAST) were first used in the Viet-
nam War to stabilise patients with haemorrhagic shock during
transportation. After the war, MAST became widely used in the
care of bleeding trauma patients. MAST increases blood pressure
by compressing the blood vessels in the legs, thus increasing sys-
temic vascular resistance, and by shunting blood from the lower
body to the brain, heart and lungs. It was hoped that by increasing
venous return to the heart, MAST would maintain blood flow to
vital organs until definitive care was given. Nevertheless, a system-
atic review of randomised controlled trials of MAST use in pre-
hospital trauma care provided no evidence that MAST increases
survival, and a suggestion that it may increase the risk of death.
The pooled relative risk of death with MAST was 1.13 (95% CI
0.97−1.32) (Dickinson 1999).
Paramedic ambulance crews
In high-income countries, an increasing number of ambulance
crews include a paramedic trained in advance life support.
Paramedics receive extra training in intubation, intravenous can-
nulation, and the administration of intravenous fluids. Only a
small proportion of paramedic-attended trauma patients require
intubation (1%), but a larger proportion (18%) receive intra-
venous fluids (Nicholl 1998). Because of the strong conviction
amongst the public and medical profession that paramedic inter-
vention is beneficial, it has been difficult to conduct randomised
controlled trials comparing paramedic and non-paramedic trauma
care. However, a review and meta-analysis of four cohort studies
gave a significantly increased (p=0.03) risk of death in paramedic
attended patients (RR=1.26) (Nicholl 1998). Because of the po-
tential for confounding by injury severity, the validity of inferences
from cohort studies must be questioned. Nevertheless, the results
are consistent with the hypothesis that efforts by paramedics to
raise the blood pressure of bleeding trauma patients may be coun-
terproductive.
Colloid fluid resuscitation
Intravenous fluid administration, with colloid or crystalloid solu-
tions, is the mainstay of the non-surgical management of bleeding
trauma patients. Colloids are better than crystalloid solutions in
expanding the circulation, because they are retained within the
blood vessels to a greater extent. Crystalloid solutions rapidly leak
out of the blood vessels into the interstitial spaces. After a colloid
infusion, the increase in the circulating volume is about the same
as the volume of colloid infused, whereas only about one quar-
ter of the volume of a crystalloid infusion remains in the blood
vessels (Weil 1999). Although colloids are effective in expanding
the circulation there is no evidence that this improves outcome in
critically ill patients (Alderson 2000).
The systematic reviews of medical anti-shock trousers, paramedic
resuscitation and colloid administration call into question the ben-
efits of raising the blood pressure in bleeding trauma patients. But
by what mechanisms could fluid resuscitation adversely affect out-
come? Stern, using a swinemodel of near-fatal haemorrhage, found
that attempts to restore blood pressure with crystalloid resulted in
increased haemorrhage volume and markedly higher mortality (
Stern 1993). It was postulated that the increased pulse pressure
from crystalloid resuscitation might cause the mechanical disrup-
tion of blood clots and worsen bleeding. It has also been proposed
that fluid administration might also worsen bleeding by diluting
clotting factors. In view of the concerns raised by the previous
systematic reviews and by the results of animal models of haem-
orrhagic hypovolaemia, we have conducted a systematic review of
the effect on mortality of early versus delayed fluid resuscitation,
and of larger versus smaller fluid volumes.
O B J E C T I V E S
To examine the effect on mortality and coagulation times of two
intravenous fluid administration strategies in the management of
haemorrhagic hypovolaemia: early compared to delayed adminis-
tration and larger compared to smaller volume of fluid adminis-
tered.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All unconfounded randomised and quasi-randomised controlled
trials of the timing or volume of intravenous fluid administration
in haemorrhagic hypovolaemia.
Types of participants
Patients of all ages with haemorrhagic hypovolaemia of traumatic
or non-traumatic origin. Because the physiological response to
bleeding and to fluid resuscitation is likely to be similar among
patients with internal bleeding (e.g. bleeding peptic ulcer) and
those with external bleeding (e.g. penetrating trauma), both types
of participants were included.
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Types of interventions
Intravenous fluids including crystalloid solutions, colloids, plasma
and blood. Trials in which the timing or volume of fluid admin-
istration is confounded by the type of intravenous fluid given −
for example, a trial comparing the administration of 1000ml of
colloid with 500ml blood − were excluded.
Types of outcome measures
Mortality from all causes at the end of the follow-up period sched-
uled for each trial. We sought mortality data in simple categorical
form, and we did not extract data on time to death. If a report did
not include the numbers of deaths in each group, we sought these
data from the authors. We also sought data on prothrombin time
and partial thromboplastin time during fluid administration.
Search methods for identification of studies
Searches were not restricted language, date or publication status.
Electronic searches
We searched:
• CENTRAL ((The Cochrane Library 2008, Issue 4),
• MEDLINE (1966 to October 2008),
• National Research Register (October 2008),
• EMBASE (1980 to October 2008),
• Web of Science; Science Citation Index (to October 2008),
• Cochrane Injuries Group Trials Register (searched October
2008),
• Current Controlled Trials (Searched October 2008).
The search strategy can be found in Appendix 1.
Searching other resources
We checked the reference lists of all included studies and contacted
authors and experts in the field. The Science Citation Index was
checked for eligible papers that cited two of the trials (Bickell
1994, Blair 1986) included in this review.
Data collection and analysis
Selection of studies
One reviewer (IK) examined the electronic search results for re-
ports of possibly relevant trials and these reports were then re-
trieved in full. The first reviewer (IK) also contacted experts in
the field for unpublished and ongoing trials. A second reviewer
(FB) examined 10% of the electronic search results to check for
agreement on eligibility criteria. Two reviewers (FB, IK) applied
the selection criteria independently to the trial reports, resolving
disagreements by discussion with a third (IR).
Data extraction and management
Two reviewers (IK, FB) independently extracted information on
the following: method of allocation concealment, number of ran-
domised patients, type of participants and the interventions, loss
to follow-up and length of follow-up. The outcome data sought
were numbers of deaths, prothrombin time and partial thrombo-
plastin time. The reviewers were not blinded to the authors or
journal when doing this. Results were compared and any differ-
ences resolved by discussion.
Where there was insufficient information in the published report
we attempted to contact the authors for clarification.
Assessment of risk of bias in included studies
Since there is evidence that the quality of allocation concealment
particularly affects the results of studies, two reviewers (IK, FB)
scored this quality on the scale used by Higgins 2008 as shown
below, assigning ’No’ to poorest quality and ’Yes’ to best quality:
• Yes = trials deemed to have taken adequate measures to
conceal allocation (i.e. central randomisation; serially numbered,
opaque, sealed envelopes; or other description that contained
elements convincing of concealment)
• Unclear = trials in which the authors either did not report
an allocation concealment approach at all or reported an
approach that did not fall into one of the other categories
• No = trials in which concealment was inadequate (such as
alternation or reference to case record numbers or to dates of
birth).
Where the method used to conceal allocation was not clearly re-
ported, the author(s) were contacted, if possible, for clarification.
We then compared the scores allocated and resolved differences
by discussion.
Data synthesis
The following comparisons were made:
• early versus delayed intravenous fluids administration
• larger versus smaller volume of intravenous fluids
administration.
The relative risk of death and 95% confidence interval (95% CI)
was calculated, such that a relative risk of more than 1 indicated a
higher risk of death in the first group named. The relative risk was
chosen as it is more readily applied to the clinical situation. The
weighted mean difference was calculated for coagulation times.
Because of differences in the types of patients and in the nature of
the trial interventions we did not pool the data in our analysis.
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R E S U L T S
Description of studies
See: Characteristics of included studies.
Our original search strategy found 4,487 potentially eligible re-
ports of which six unpublished trials met the inclusion criteria. A
further 655 abstracts were retrieved from a search carried out in
August 2007, and another search in October 2008 retrieved 261
abstracts. All search results were scanned by two individuals for
potentially relevant studies. No new trials that met the inclusion
criteria were indentified from these search results.
A. Early versus delayed intravenous fluids
administration
Bickell 1994
This trial compared early versus delayed administration of Ringer’s
acetate solution, an isotonic crystalloid, in patients with penetrat-
ing torso injuries during the prehospital phase. Participants were
adults over 16 years of age, with gunshot or stab wounds to the
torso, and who had a systolic blood pressure of <90mmHg. Partic-
ipants with head injury, a Revised Trauma Score of zero or minor
injuries were excluded. During the trial, 22 patients (8%) in the
delayed resuscitation group were inadvertently given fluid prior to
surgery in violation of the protocol. Follow-up was until hospital
discharge.
Blair 1986
This trial compared early versus delayed blood transfusion in pa-
tients with acute gastrointestinal haemorrhage during the first 24
hours after admission. Patients with oesophageal varices were ex-
cluded because of abnormal coagulation related to liver diseases.
Follow-up was until hospital discharge.
Turner 2000
This trial compared early versus no/delayed fluid administration in
trauma patients. Participants were all trauma patients with mod-
erate to severe injuries, over the age of 16 years of age. Patients
who were pregnant or without vital signs were excluded. Fluids
given were crystalloids. Protocol compliance was poor with 31%
of patients in the early fluid group receiving fluids and 80% of
the delayed/no fluid group not given fluids. Follow-up was for six
months.
B. Larger versus smaller volume of intravenous fluids
administration
Dunham 1991
This trial compared fluid resuscitation using the rapid infusion
system and conventional fluid administration method in trauma
patients during the first 24 hours of admission. Participants were
between 14 and 60 years of age and had a systolic blood pressure
of <90mmHg. Patients with a Glasgow Coma Score of <5, cardiac
arrest, quadriplegia and myocardial infarct on admission were ex-
cluded. Fluids given included red blood cells, platelets, fresh frozen
plasma and crystalloids. Follow-up was until hospital discharge.
Dutton 2002
This trial compared the maintenance of target systolic blood pres-
sures of 70 and 100mmHg respectively with fluid restriction
(Plasma, Plasmalyte-A and red blood cells in the first 24 hours)
in patients with blunt and penetrating trauma injuries. All partic-
ipants suffered haemorrhagic shock with a systolic blood pressure
(SBP) of <90mmHg. Patients with head or spinal cord injury were
excluded. Length of follow-up period was until death or hospital
discharge.
Fortune 1987
This trial compared the maintenance of haematocrit at 30% and
40% respectively with blood transfusion in patients following
acute injuries and haemorrhage during the first 72 hours of ad-
mission. All participants had sustained Class III/IV haemorrhage
with a systolic blood pressure of <90mmHg, heart rate > 100 beats
per minute. Follow-up was for three days.
Risk of bias in included studies
A. Early versus delayed intravenous fluids
administration
Bickell 1994
Randomisationwas by alternate day allocationwhich allowed fore-
knowledge of treatment allocation. Data were analysed as ran-
domised, on an intention-to-treat basis. Blinding of outcome as-
sessment was not stated. There was no loss to follow-up.
Blair 1986
Contact with the author of this trial established the adequacy of
the randomisation method used. Allocation was by opening sealed
envelopes at the time of patient presentation. Blinding of outcome
assessment was not stated. Data were analysed as randomised, on
an intention-to-treat basis. There was no loss to follow-up.
Turner 2000
Paramedics rather than trauma patients were randomised, using
computer-generated random numbers, stratified by base stations.
The paramedics crossed over to alternate fluid protocol halfway
through the trial and they were not blinded. Data were analysed as
randomised, on an intention-to-treat basis. There was no blinding
in outcome assessment.
B. Larger versus smaller volume of intravenous fluids
administration
Dunham 1991
Methodof randomisation and allocation concealmentwas unclear.
Blinding of outcome assessment was not stated. Data on eight
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patients who died during the first 12 hours were excluded from
the analysis except for the outcome of death.
Dutton 2002
Randomisation was by selecting the next numbered envelope from
a supply maintained in the Trauma Resuscitation Unit. The en-
velopes were made up in batches of 20 (10 to each group), thor-
oughly mixed, and then numbered for selection. Allocation was
blinded to all Unit personnel prior to enrolment . Only the pa-
tients were blinded to the allocation in this trial after randomisa-
tion. Data were analysed as randomised, on an intention-to-treat
basis. Blinding of outcome assessment was not stated. There was
no loss to follow-up.
Fortune 1987
Contact with the co-author of this trial established the adequacy of
the randomisation method used. Sequences of random allocations
were generated by a statistician not involved with the study, in sets
of sealed opaque envelopes, differentiated by sex and age groups.
Both patients and physicians had no prior knowledge of which arm
the patient would be assigned to. Blinding of outcome assessment
was not stated. There was no loss to follow-up.
The characteristics of each trial are listed in Characteristics of
included studies.
Effects of interventions
A. Early versus delayed fluid administration
One trial (Bickell 1994) reported mortality and coagulation time
on a total of 598 hypotensive trauma patients with penetrating
torso injuries. Mortality was 116/309 (38%) in the early and
86/289 (30%) in the delayed administration group. The relative
risk for death with early fluid administration was 1.26 (95% CI
1.00−1.58). Prothrombin time and partial thromboplastin time
were 14.1 and 31.8 seconds in the early, as compared to 11.4 and
27.5 seconds in the delayed administration group. The weighted
mean difference (WMD) for prothrombin time and partial throm-
boplastin time was 2.7 (95% CI 0.90−4.5) and 4.3 seconds (95%
CI 1.7−6.9) respectively.
One trial (Blair 1986) reported mortality and coagulation time on
a total of 50 hypotensive patients with acute upper gastrointestinal
haemorrhage. Mortality was 2/24 (8%) in the early as compared
to 0/26 (0%) in the delayed transfused group. The relative risk for
death with early blood transfusion was 5.4 (95% CI 0.3−107.1).
Activated partial thromboplastin time was 48 in the early, as com-
pared to 41 seconds in the delayed administration group. The
WMD for partial thromboplastin time was 7.0 seconds (95% CI
6.0−8.0).
In one trial (Turner 2000) on a total of 1309 trauma patients,
mortality was 73/699 (10.4%) in the early as compared to 60/610
(9.8%) in the delayed/no fluid administration group. The relative
risk for death with early fluid administration was 1.06 (95% CI
0.77−1.47). There were no data on coagulation times.
B. Larger versus smaller volume of fluid
administration
One trial (Dunham 1991) reported mortality and coagulation
time on a total of 36 hypotensive trauma patients. Mortality was
5/20 (25%) in the group who received a larger volume of fluids
administered conventionally, as compared to 5/16 (31%) in the
group who received a smaller volume of fluids administered using
the Rapid Infusion System. The relative risk for death is 0.80 (95%
CI 0.28−2.29). Prothrombin time and partial thromboplastin
time were 14.8 and 47.3 seconds in the group who received a
larger volume of fluid as compared to 13.9 and 35.1 seconds in
the comparison group.
In one trial (Dutton 2002) on a total of 110 hypotensive patients
with blunt and penetrating injuries, mortality was 4/55 (7.3%)
in the group administered a larger volume and 4/55 (7.3%) in
the group administered a smaller volume (1000ml less than in the
intervention group). The relative risk for death is 1.00 (95% CI
0.26−3.81). There were no data on coagulation times.
In one trial (Fortune 1987) on a total of 25 hypotensive patients
with acute injury and haemorrhage, there were no data on mor-
tality in both the groups administered with larger or smaller vol-
ume of blood. Contact with the co-author established that there
were no deaths in either group. There were no data on coagulation
times.
D I S C U S S I O N
This review found insufficient evidence for or against the use of
early or larger volume fluid resuscitation in the treatment of un-
controlled haemorrhage. While vigorous fluid resuscitation may
be life-saving in some patients, results from clinical trials are in-
conclusive.
Every year, tens of thousands of patients receive intravenous fluids
in the management of bleeding. The Advanced Trauma Life Sup-
port (ATLS) protocol of the American College of Surgeons rec-
ommends the liberal use of isotonic crystalloid to correct hypoten-
sion in bleeding trauma patients. Nevertheless, we could find no
reliable evidence to support or not to support this recommenda-
tion. While we cannot exclude the possibility that we overlooked a
large high-quality randomised controlled trial showing that early
or larger volume fluid resuscitation is beneficial, we believe that
this is unlikely. To identify eligible trials we screened over 4,000
potentially relevant reports, we searched the reference lists of in-
cluded trials, and contacted authors and experts in the field.
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Six published trials were reviewed. Due to their heterogeneity, in
terms of types of patients and types of fluids used, we did not
attempt to perform a meta-analysis of the studies.
Death was chosen as the primary end-point in this review for two
reasons. First, death is a clinically relevant outcome that matters
to patients. Second, death is not prone to measurement error and
to reporting bias, as are pathophysiological end points. Mortal-
ity data were available for all six included trials, three on the ef-
fect of early fluid resuscitation (Bickell 1994; Blair 1986; Turner
2000) and three on the effect of larger volume fluid resuscitation
(Dunham 1991, Dutton 2002, Fortune 1987).Three trials exam-
ined the effect of fluid administration on coagulation. Clotting
times were significantly elevated in the immediate resuscitation
groups (Bickell 1994, Blair 1986) and the group who received
a larger volume (Dunham 1991). Method of randomisation was
inadequate in two trials (Bickell 1994, Turner 2000) and unclear
in another (Dunham 1991). Allocation concealment was inade-
quate in two trials (Bickell 1994; Turner 2000). Because inade-
quate randomisation and poorly concealed allocation can bias the
results of randomised controlled trials, and because this bias can
be large and can operate in either direction, the impact of early or
larger volume fluid resuscitation on mortality remains difficult to
estimate.
Interpretation of results also needs to be cautious due to the het-
erogeneous nature of traumatic injuries encountered in these tri-
als. Haemorrhagic shock can be caused by a variety of underly-
ing anatomic injuries. Some of these injuries, such as posterior
pelvic fractures, may be more amenable to hypotensive manage-
ment maintained by smaller volume of fluid, than liver injuries
where haemostasis can be difficult to achieve (Dutton 2002).
The use of medical anti-shock trousers, early and larger volume
fluid administration and colloid resuscitation are based on the idea
that raising the blood pressure in bleeding trauma patients will
maintain tissue perfusion and so prevent haemorrhagic shock and
its consequences. However, while maintaining blood pressure may
prevent shock, it may worsen bleeding. In view of the lack of ev-
idence for or against the effectiveness of currently recommended
resuscitation protocols and the potential for harm, the balance of
risks and benefits of contemporary resuscitation practice warrants
careful consideration. Further randomised controlled trials are re-
quired to identify the most effective strategies for the fluid man-
agement of bleeding trauma patients.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We found no evidence for or against the use of early or larger
volume intravenous fluid administration in uncontrolled haemor-
rhage. There is uncertainty about the effectiveness of fluid resus-
citation in patients with bleeding following trauma.
Implications for research
Large, well concealed, randomised controlled trials are urgently
needed to establish the optimal fluid resuscitation strategy in
haemorrhaging trauma patients, with a focus on specific types of
injuries likely to benefit from the appropriate resuscitation strat-
egy in terms of timing and volume of fluids given.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bickell 1994
Methods Quasi-randomised controlled trial.
(Allocation by alternation - odd and even numbered days of the month.)
Participants 598 trauma patients >16 years of age with penetrating injuries and hypotension.
Mean age = 31 years.
Exclusion: pregnancy, Revised Trauma Score = 0, minor injuries not requiring surgery.
Interventions 1) 870ml of Ringer’s solution pre-hospital (n=309).
2) 92ml of Ringer’s solution with IV cannulation pre-hospital (n=289).
Outcomes • Haemodynamic variables,
• amount of fluids given,
• intraoperative blood loss,
• post-op
• complications,
• process of care,
• death.
Notes Patients in both groups were treated with a standard paramedical protocol as appropriate until after IV
cannulation.
22/289(8%) in delayed fluids group were inadvertently given fluids in violation of the protocol. Results
were analysed as randomised on an intention-to-treat basis.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No
Blair 1986
Methods Randomised controlled trial.
(Allocation by opening sealed envelopes.)
Participants 50 patients with acute severe upper gastrointestinal haemorrhage.
Mean age = 62
Exclusion: patients with oesophageal varices due to abnormal coagulation.
Interventions 1) >/= 2 units of blood in first 24 hr (n=24).
2) No blood transfusion during first 24 hr
(n=26).
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Blair 1986 (Continued)
Outcomes • Coagulation times,
• Haematocrit,
• re-bleeding rate,
• volume of blood given,
• death.
Notes 5/26 patients in the no-blood group received blood in the first 24 hours when their Hgb < 8g/dl.
Results were analysed as randomised on an intention-to-treat basis.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes
Dunham 1991
Methods Randomised controlled trial.
(Allocation unclear.)
Participants 36 trauma patients >14 <60 years of age with hypotension.
Mean age = 35.
Exclusion: Glasgow Coma Score <5,
cardiac arrest,
quadriplegia,
myocardial infarct.
Interventions 1. 23,661ml of IV fluids (red blood cells, fresh frozen plasma, platelets and Plasmalyte-A)in first 24 hours via
conventional fluid administration (CFA) (n=20).
2. 20,224 ml of IV fluids (red blood cells, fresh frozen plasma, platelets and Plasmalyte-A, given via the RIS
(Rapid Infusion System). (n=16).
Outcomes • Blood loss,
• temperature,
• Haematocrit,
• coagulation times,
• serum Lactate,
• base excess,
• ionised calcium,
• costs,
• death.
Notes Data from 3/20 patients in CFA group and 5/16 patients in RIS group who died in the first 12 hours were excluded
from subsequent analyses except for death.
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Dutton 2002
Methods Randomised controlled trial.
(Allocation by drawing the next numbered envelope from a batch of 20, thoroughlymixed but sequentially
numbered envelopes.)
Participants 110 trauma patients >16, <55 years of age with blunt and penetrating injuries and in shock.
Mean age = 31
Exclusion: pregnancy, no pulse, head or spinal injury, known end-organ ischaemic disease.
Interventions 1. Bolus of fluids (plasma, Plasmalyte-A and packed red blood cells) to maintain systolic blood
pressure of >100mmHg (n=55).
2. 1000ml less of fluids (plasma, Plasmalyte-A and packed red blood cells) to maintain a lower blood
pressure of 70mmHg (n=55).
Outcomes • Duration of bleeding,
• average ISS,
• death.
Notes All patients maintained at a haematocrit of at least 25%.
Results analysed as randomised on an intention-to-treat basis.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes
Fortune 1987
Methods Randomised controlled trial.
(Random allocations generated by a statistician blinded to the study, in sets of sealed opaque envelopes.)
Participants 25 patients with acute injury and haemorrhage, hypotensive, urine output < 20ml/hr.
Mean age = 46.
Exclusion: history of myocardial infarction in previous year as a higher haematocrit could be harmful.
Interventions 1. >/= 5 units of blood to maintain Haematocrit at 40% (n=13).
2. < 5 units of blood transfusion to maintain Haematocrit at 30% (n=12).
Outcomes • Cardiopulmonary status,
• death not reported, but later obtained from the author.
Notes Study was designed to test the hypothesis that sufficient oxygen can be provided at lower haematocrit of
30%.
Allocation concealment was later reported to be adequate when co-author was contacted.
Risk of bias
Item Authors’ judgement Description
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Fortune 1987 (Continued)
Allocation concealment? Yes
Turner 2000
Methods Randomised controlled trial (of paramedics using computer-generated random numbers, stratified by base
stations).
Participants 1309 trauma patients > 16 years of age.
Exclusion: pregnancy,
no vital signs.
Interventions 1. >/= 1 unit of fluids of Hartmann’s solution and Haemacell pre-hospital (n=699)
2. Delayed/no fluids pre-hospital (n=610).
Outcomes • Post-op complications,
• process of care,
• costs,
• death.
Notes Protocol compliance was poor with 31% of the fluid group receiving fluids and 80% of the no fluid group
not given fluids.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No
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D A T A A N D A N A L Y S E S
This review has no analyses.
WH A T ’ S N E W
Last assessed as up-to-date: 21 October 2008.
6 November 2008 New search has been performed Search updated. No new trials were found for inclusion in the review.
H I S T O R Y
Protocol first published: Issue 3, 2000
Review first published: Issue 1, 2001
20 August 2008 Amended Converted to new review format.
12 April 2003 New search has been performed Data have now become available from a trial (Dutton 2002) which was ongoing
in 2000. These data did not affect the results or the overall conclusion of the
review. Types of injuries may be an important consideration in the research
design of future trials in fluids resuscitation.
C O N T R I B U T I O N S O F A U T H O R S
IK screened citations, extracted data, contacted authors, entered data into RevMan and helped to write the review. IR developed the
protocol, and helped to write the review. FB screened citations, extracted data, and commented on the review.
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SYSTEMATIC REVIEW
Traffic calming for the prevention of road traffic injuries:
systematic review and meta-analysis
F Bunn, T Collier, C Frost, K Ker, I Roberts, R Wentz
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Injury Prevention 2003;9:200–204
Objective: To assess whether area-wide traffic calming schemes can reduce road crash related deaths
and injuries.
Design: Systematic review and meta-analysis.
Data sources: Cochrane Injuries Group Specialised Register, Cochrane Central Register of Controlled
Trials, Medline, EMBASE, Sociological Abstracts Science (and social science) citation index, National
Technical Information service, Psychlit, Transport Research Information Service, International Road
Research Documentation, and Transdoc, and web sites of road safety organisation were searched;
experts were contacted, conference proceedings were handsearched, and relevant reference lists were
checked.
Inclusion criteria: Randomised controlled trials, and controlled before/after studies of area-wide traf-
fic calming schemes designed to discourage and slow down through traffic on residential roads.
Methods: Data were collected on road user deaths, injuries, and traffic crashes. For each study rate
ratios were calculated, the ratio of event rates before and after intervention in the traffic calmed area
divided by the corresponding ratio of event rates in the control area, which were pooled to give an
overall estimate using a random effects model.
Findings: Sixteen controlled before/after studies met our inclusion criteria. Eight studies reported the
number of road user deaths: pooled rate ratio 0.63 (95% confidence interval (CI) 0.14 to 2.59). Six-
teen studies reported the number of injuries (fatal and non-fatal): pooled rate ratio 0.89 (95% CI 0.80
to 1.00). All studies were in high income countries.
Conclusion: Area-wide traffic calming in towns and cities has the potential to reduce road traffic inju-
ries. However, further rigorous evaluations of this intervention are needed, especially in low and mid-
dle income countries.
The worldwide epidemic of road traffic injuries is only justbeginning. At present, over a million people die each yearand some 10million people sustain permanent disabilities
in road traffic crashes. For people under 44 years, road traffic
crashes are a leading cause of death and disablement, second
only to HIV and AIDS.1 Many developing countries are still at
comparatively low levels of motorisation and the incidence of
road traffic injuries in these countries is likely to increase. It is
estimated that by 2020 road traffic crashes will have moved
from ninth to third in the world disease burden ranking, as
measured in disability adjusted life years.2
Most of the road deaths in developing countries involve
vulnerable road users such as pedestrians and cyclists. In
Ethiopia, pedestrian injuries account for 84% of all road traffic
fatalities compared with 32% in Britain and 15% in the USA.3
In the heavily motorised countries drivers and passengers
account for the majority of road deaths but pedestrians
account for a large proportion of road deaths involving
children. The identification of effective strategies for the
prevention of road traffic injuries is of global health
importance.
In urban areas, road traffic crashes are scattered widely, and
in such situations localised interventions for high risk sites are
not appropriate. In high income countries area-wide traffic
calming schemes, including the treatment of both main roads
and residential roads, have been proposed as a strategy for
reducing such scattered crashes. Traffic calming has been
defined as the combination of mainly physical measures that
reduce the negative effects of motor vehicle use, alter driver
behaviour, and improve conditions for non-motorised street
users.4 It has been estimated that area-wide traffic calming
schemes can reduce the number of road traffic injuries by
about 15%.5 However, this estimate was based on a review that
included uncontrolled before/after studies in which the effect
of traffic calming could be confounded by other factors that
influence road traffic injury rates. In particular, in high income
countries there is evidence that pedestrian injury rates have
fallen because of a reduction in walking.6 In this case, the
inclusion of uncontrolled studies could exaggerate the appar-
ent effect of traffic calming.We conducted a systematic review
of controlled studies to assess the effect of area-wide traffic
calming on road user deaths, injuries (fatal and non-fatal),
and numbers of road traffic crashes.
METHODS
Inclusion criteria
We included randomised controlled trials and controlled
before/after studies of area-wide traffic calming schemes. Eli-
gible schemes included those that involved a number of
specific changes to the road layout, road hierarchy or road
environment, for example road narrowing, road closures,
creation of one way streets, changes at junctions, mini-
roundabouts, road surface treatment, or speed humps. We
excluded studies describing the enforcement of legal interven-
tions, financial incentives or disincentives, and interventions
investigating alteration to road signage or traffic lights alone,
or studies solely describing interventions to separate different
road users (cycle lanes, bus lanes, pedestrian walkways). The
outcomes of interest were all road user deaths, all road user
injuries (fatal and non-fatal), and the number of traffic
crashes.
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Identification of studies
We searched the following electronic databases; Cochrane
Injuries Group Specialized Register, Cochrane Central Register
of Controlled Trials, Medline, EMBASE, Sociological Abstracts
Science (and Social Science) Citation Index, National Techni-
cal Information Service, Psychlit, Transport Research Infor-
mation Service, International Road Research Documentation,
and TRANSDOC (the last three combined in the TRANSPORT
database). One reviewer examined titles, abstracts, and
keywords of citations, as given on electronic databases, for eli-
gibility. Where possible the full text of all of potentially
relevant citations was obtained.We also searched the web sites
of road safety organisations, contacted experts, hand searched
conference proceedings, and checked reference lists of
relevant papers. There were no language restrictions. Further
details of the search strategy can be seen in box 1.
Data extraction and analysis
One reviewer decided whether studies met the inclusion crite-
ria, and this was checked by a second reviewer. Using a data
collection form two reviewers independently extracted data
on road user deaths, injuries (fatal and non-fatal), traffic
crashes, characteristics of the intervention and control area,
and types of measures implemented. To assess study quality
we collected information on how the intervention and control
areas were matched, duration of the before and after periods,
Box 1: Strategy for identification of studies
Search strategy for electronic databases; searches run in 2000
• Terms describing the intervention, outcomes, and study methodology were combined.
• A: the intervention—area traffic control* or TRAFFIC RESTRAINT* or traffic calming or traffic engineering or road design or road
layout or roundabout* or humps or bumps or traffic distribution or traffic redistribution or traffic flow or crosswalk* or speed cush-
ion* or chicane* or road narrowing or refuges or road hierarchy or traffic hierarchy or four way* stop* or access only or shel-
tered parking or left turn lane* or wooner* or junction layout or road layout or lateral clearance.
• B: the outcome—accident* or injur* or fatalit* or death or safety.
• C: the study methodology—evaluation or assess* or stud* or evaluation or assess* or (controlled near2 stud*) or comparison or
comparative or intervention near2 stud* or controls.
Web sites searched; searches conducted in 2001
• AAA Foundation for Traffic Safety (USA): www.aaafoundation.org
• ARRB, Australian Road Research Board: www.arrb.org.au
• Australian Transport Safety Bureau: www.atsb.gov.au
• CROW, Information and Technology Centres for Transport and Infrastructure (Netherlands): www.crow.nl
• Danish Council for Road Safety Research: www.trm.dk/eng/veje/rft
• Danish Transport Research Institute: www.dtf.dk
• DVR, Deutscher Verkenrssichereitsrat Road Safety Institute (Germany): www.dvr.de/
• FINNRA, Finnish National Road administration: www.tieh.fi
• INRETS, Institut National de Recherche sur les Transports et leur Sécurité (France): www.inrets.fr
• ITE, Institute of Transportation Engineers (USA): www.ite.org
• LET, Laboratoire d’economie des transports (France): www.lsh-lyon.cnrs.fr
• NHTSA, National Highway Traffic Safety Administration (USA): www.nhtsa.dot.gov
• Swedish National Roads Administration: www.vv.se/for_lang/english/
• SWOV, Institute for Road Safety Research (Netherlands): www.swov.nl
• TOI, Institute of Transport Economics (Norway): www.toi.no
• TC, Transport Canada: www.tc.gov
• TRB, Transportation Research Board: www.nas.edu/trb/
• TRL, Transport Research Laboratory (UK): www.trl.co.uk
• US Department of Transport, Federal Highway Administration (USA): www.fhwa.dot.gov
• VTI, Swedish National Road and Transport Research Institute: www.vti.se
• VTT, Finland www.vtt.fi/indexe.htm
Conference proceedings handsearched
• Australian Road Research Board (ARRB). Proceedings of the 12th ARRB conference; Hobart, Tasmania 27–31 August 1984.
• Australian Road Research Board (ARRB). Proceedings of the 15th ARRB conference; Darwin 26–31 August 1990.
• Institution of Professional Engineers New Zealand (IPENZ). Annual conference, Christchurch February 1992 volumes 1 and 2.
• Institution of Professional Engineers New Zealand (IPENZ). Proceedings of the technical session of the group at the annual confer-
ence of IPENZ; Auckland 8–12 February 1982.
• Institute of Transportation Engineers (ITE). Proceedings of the 45th to 71st ITE annual meeting, 1975–2001.
• Institute of Transportation Engineers (ITE). Transportation and traffic theory 9th international symposium; Netherlands 1984.
• Institute of Transportation Engineers (ITE). Residential street design and traffic control 1989.
• Israel Institute of Technology. International conference on pedestrian safety; Haifa 20–23 December 1976.
• Landor Publishing Ltd. The third national traffic calming conference; London 18 October 1996.
• Organisation for Economic Co-operation and Development (OECD). Proceedings of the symposium on techniques of improving
urban conditions by restraint of road traffic; 25–27 October 1971.
• PTRC Transport, Highways and Planning Summer 13th–18th Annual Meetings, 1985–90.
• Swedish Road and Traffic Research Institute. Proceedings of the conference on strategic highway research program and traffic
safety on two continents; Gothenburg, Sweden 18–20 September 1991.
• Swedish Road and Traffic Research Institute. Proceedings of the conference on strategic highway research program and traffic
safety on two continents; Gothenburg, Sweden 27–29 September 1989.
• Swedish Road and Traffic Research Institute. Proceedings of the conference on road safety and traffic environment in Europe;
Gothenburg, Sweden 26–28 September 1990.
• The Technion Israel Institute of Technology. The second international conference on new ways for improved road safety and qual-
ity of life; Tel-Aviv Hilton Hotel, Israel 7–10 October 1991.
• Transportation Research Institute. International conference on new ways and means for improved safety; Tel Aviv, Israel 20–23
February 1989.
• Transport Research Laboratory. Safety 91 Papers on vehicle safety, traffic safety and road user safety research; TRL Laboratory,
Berks 1–2 May 1991.
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and, because of the potential for contamination, we also noted
the proximity of the intervention and control areas.
For each study we calculated a rate ratio: the ratio of event
rates before and after intervention in the traffic calmed area
divided by the corresponding ratio of event rates in the control
area. This gives the reduction in the incident rate in the inter-
vention area compared to that in the control area. For
example, a rate ratio of 0.8 corresponds to a 20% reduction in
events compared with that predicted from the rates in the
control area. For the calculation of 95% confidence intervals,
standard errors of the logarithms of the rate ratios were con-
structed assuming that the number of events in each area in
each period followed a Poisson distribution,7 provided there
was at least one event in each period. For studies with no
events in one or more periods exact confidence intervals were
calculated where the rate ratio was defined. Rate ratios were
combined on a logarithmic scale using a random effects meta-
analysis model. The assumption of random effects means that
the effect estimates and confidence intervals allow for
variation in study specific rate ratios over and above that due
to variability within studies.8 In this meta-analysis such addi-
tional variability reflects both underlying heterogeneity in rate
ratios across studies and any variability arising through
overdispersion9 if the assumption that events follow Poisson
distributions is violated.
For studies with no events in one or more periods 1/2 was
added to all counts in the pooled analysis. In the analysis of
road user deaths, where the majority of studies had no events
in at least one period, no test of heterogeneity was carried out,
and a pooled estimate of the rate ratio was obtained from the
column totals. Analyses were carried out in Stata version 7.0
(Stata corporation, College Station, Texas 77845, USA).
RESULTS
The searches identified 12 986 published and unpublished
reports which were screened for eligibility. We obtained the
full text of 586 reports and of these 12 reports, describing 16
controlled before/after studies, met our inclusion criteria (see
table 1).10–21 We found no randomised controlled trials. Seven
studies were done in Germany,10–12 16 six in the UK,13 17–21 two in
Australia,14 and one in the Netherlands15; all were done in the
1970s and 1980s. In most studies attempts had been made to
match the intervention and control sites. However, in three
Table 1 Table of included studies
Study ID Methods Participating areas Interventions
Charlottenburg16 CBA (I) Residential area with small businesses. Area of
about 60 hectares with 15000 inhabitants
Different levels of road surface, road
narrowing, chicanes, staggered lanes, speed
restrictions
(Germany 1977–84) 2 years before data
2 years after data (C) Similar area in the same city
GST Borgentreich10–12 CBA (I) Whole town centre: mixture of residential,
commercial, and farm properties
Road narrowing, redesigning major roads,
traffic free zones, speed restrictions(Germany 1983–90) 3 years before data
3 years after data (C) Similar area in different town
GST Buxtehude10–12 CBA (I) Mixture of shopping and residential areas. Area
of about 268 hectares population of about 11000
Road narrowing, speed restrictions, and a wide
range of traffic restraint measures(Germany 1981–87) 2 years before data
2 years after data (C) Similar area in the same city
GST Esslingen10–12 CBA (I) Mixture of residential, industrial, and commercial
properties
Reconstruction of major roads, speed
restrictions, and renewal of residential roads(Germany 1983–90) 2 years before data
2 years after data (C) Similar area in another town
GST Ingolstadt10–12 CBA (I) Most of the old part of the town, 5500
inhabitants
A wide range of traffic restraint measures
(Germany 1982–90) 2 years before data
2 years after data (C) Similar area in another town
GST Mainz10–12 CBA (I) Rural suburb of 200 hectares with 11000
inhabitants
Reconstruction of public spaces including road
narrowing and narrowing of road entrances(Germany 1983–90) 2 years before data
2 years after data (C) Similar area in the same city
GST Moabit10–12 CBA (I) Residential area of about 120 hectares near the
city centre
Rebuilding of major traffic roads, increasing
level of vegetation in streets(Germany 1982–88) 2 years before data
2 years after data (C) Similar area in the same city
Rijswijk/Eindhoven15 CBA (I) Road districts in Rijswijk and Eindhoven Road humps, road closures and narrowing,
raised cross roads. Public spaces reclassified(Netherlands 1972–86) 6 years before data (C) Residential zones bordering on main traffic
arteries within the boundaries of Rijswijk and
Eindhoven5 years after data
Swindon13 CBA (I) 2.8 km section of an all purpose road in Swindon Roundabouts, pedestrian crossings, changes to
intersections(UK 1975–81) 2 years before data
3 years after data (C) 3 routes of similar layout and function
Sydney-Canterbury14 CBA (I) Predominantly residential area in city Speed humps, roundabouts, slow points, speed
limits(Australia 1981–87) 3 years before data (C) Similar area in the same city
2.5 years after data
Sydney-Willoughby14 CBA (I) Predominantly residential area in city Entry thresholds, slow points, speed humps, T-
intersection treatments, roundabouts, and road
closures
(Australia 1980–87) 2 years after data (C) Similar area in the same city
2 years before data
USP Bradford17 CBA (I) Mainly residential area, population
approximately 33000
Junction redesign, closure of through roads, and
installation of central refuges(UK 1981–88) 5 years before data
2 years after data (C) Similar area in same city
USP Bristol18 CBA (I) Mainly residential area of approximately 10
square km, population was approximately 32000 in
about 12000 households
Junction redesign, mini-roundabouts, right turn
bans, improvement of pedestrian crossings,
improved road signs and markings, road
closures
(UK 1981–88) 5 years before data
2 years after data (C) Similar area in same city
USP Nelson19 CBA (I) An area of 7 square km, population of
approximately 30000 people
Junction redesign, road closures, and mini-
roundabouts(UK 1980–87) 5 years before data
2 years after (C) Similar area in same city
USP Reading20 CBA (I) Approximately 8 square km, with a population of
about 36000 people
Road closures, right turn bans, mini-
roundabouts(UK 1979–86) 5 years before data
2 years after data (C) Similar area in same city
USP Sheffield21 CBA (I) Mostly residential area covering approximately 9
square km, population approximately 50000
Road closures, traffic islands, central refuges,
turning restrictions(UK 1979–87) 5 years before data
5 years after data (C) Similar area in same city
CBA, controlled before after study; I, intervention area; C, control area; GST, German six towns project; USP, UK Urban Safety Project.
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differences in the land use characteristics or type of district are
reported,14 15 and in one the control area was much larger than
the intervention area.15 Outcome data was collected from
police or local authority records in all studies.
Eight studies reported the number of road user deaths.10 14
The pooled rate ratio was 0.63 (95% confidence interval (CI)
0.14 to 2.59). This result should be interpreted with caution
since many of the studies include at least one period in which
no road user deaths were observed. Sixteen studies reported
the number of road traffic injuries (fatal and non-fatal).10–21
The pooled rate ratio was 0.89 (95% CI 0.80 to 1.00) (fig 1),
with statistically significant heterogeneity between the
studies (p = 0.05). Nine studies reported the total number of
road traffic crashes.10 19 20 The pooled rate ratio was 0.95 (95%
CI 0.81 to 1.11) (fig 2), again with statistically significant
heterogeneity between the studies (p = 0.001). Thirteen trials
reported the number of pedestrian crashes.10 14 17–21 The pooled
rate ratio was 1.00 (95% CI 0.84 to 1.18) There was no signifi-
cant heterogeneity (p = 0.21).
DISCUSSION
This systematic review of controlled before/after studies shows
that area-wide traffic calming has the potential to prevent
road traffic injuries. Although the effect of traffic calming on
road user deaths is in the same direction as for injuries (fatal
and non-fatal), because the number of road user deaths in the
included studies is low the estimated rate ratio is imprecise.
Indeed, the imprecision in the rate ratio may be understated
by the confidence interval because the way that the confidence
interval was calculated ignores the likely heterogeneity
between studies. Although we found no reliable evidence that
traffic calming reduces the number of road traffic crashes,
because traffic calming may reduce vehicle speeds,22 this is not
inconsistent with a reduction in the occurrence of injury. Our
estimates of the effectiveness of traffic calming provide a basis
for future cost effectiveness analyses that would be important
in informing decisions about resource allocation.
Several methodological issues may have a bearing on the
validity of these results. Publication and other selection biases
are a potential threat to validity in all systematic reviews, but
this is a particular problem in road safety where a large
proportion of the available research is published in the grey
literature. In this review only two of the included studies were
published in journals. There are also problems identifying
published controlled studies in the road safety databases.23
Search strategies for identifying controlled studies in medical
databases can achieve high sensitivity because terms describ-
ing the study methodology are included among the indexing
(descriptor) terms. Road safety databases, however, have a
very limited range of indexing terms describing the study
methodology. Despite our considerable efforts to identity all
eligible studies, published and unpublished, irrespective of
Figure 1 Number of road traffic
injuries (fatal and non-fatal).
Figure 2 Number of road traffic
crashes.
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language of publication,we cannot exclude the possibility that
some studies were missed resulting in reduced precision and
the potential for bias.
Although we found no randomised controlled trials of traf-
fic calming schemes, the inclusion of studies with well
matched intervention and control areas, with adequate before
and after periods, may avoid the problem of confounding by
changes in the background rate of injury. All but one15 of the
included studies had attempted to match the intervention and
control areas and all had collected at least two years before
and two years after data, with a number collecting up to five
years before or after data.
Because there was significant heterogeneity between the
studies reporting the number of road traffic injuries and
crashes, these results should be interpreted with caution. The
observed heterogeneity may be due to differences in study
design, in the types of traffic calming schemes involved, or in
the way outcomes were defined and data collected.
The included studies were all conducted in the 1970s and
1980s, and, apart from two Australian studies,were all done in
Europe. As a result it may make it more difficult to generalise
from this systematic review and make inferences about the
effectiveness of present day area-wide traffic calming
schemes. In addition road traffic crashes are a major cause of
death and injury in low and middle income countries where
most of the casualties are pedestrians, cyclists, and riders of
motorised two wheelers. Although traffic calming appears to
be a promising intervention for preventing road traffic injuries
because none of the included studies were conducted in low
and middle income countries further rigorous evaluation is
required in these settings.
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Key points
• Injuries as a result of road traffic crashes are a global
problem and are likely to increase.
• A previous meta-analysis, including uncontrolled before
after studies, found area-wide traffic calming can reduce
road traffic injuries by about 15%.
• This systematic review, of 16 controlled before after studies,
found an 11% reduction in road traffic injuries (fatal and
non-fatal).
• Traffic calming has the potential to prevent road traffic inju-
ries but further rigorous evaluations, particularly in low and
middle income countries, is required.
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Papers
Safety education of pedestrians for injury prevention:
a systematic review of randomised controlled trials
Olivier Duperrex, Frances Bunn, Ian Roberts
Abstract
Objectives To quantify the effectiveness of safety
education of pedestrians.
Design Systematic review of randomised controlled
trials of safety education programmes for pedestrians
of all ages.
Main outcome measures Effect of safety education
on pedestrians’ injuries, behaviour, attitude, and
knowledge and on pedestrian›motor vehicle
collisions. Quality of trials: methods of randomisation;
and numbers lost to follow up
Results We identified 15 randomised controlled trials
of safety education programmes for pedestrians.
Fourteen trials targeted children, and one targeted
institutionalised adults. None assessed the effect of
safety education on the occurrence of pedestrian
injury, but six trials assessed its effect on behaviour.
The effect of pedestrian education on behaviour
varied considerably across studies and outcomes.
Conclusions Pedestrian safety education can change
observed road crossing behaviour, but whether this
reduces the risk of pedestrian injury in road traffic
crashes is unknown. There is a lack of good evidence
of effectiveness of safety education for adult
pedestrians, specially elderly people. None of the trials
was conducted in low or middle income countries.
Introduction
Each year about one million people die and about 10
million are seriously injured on the world’s roads.1 The
World Health Organization has indicated that, for
people aged 3›35 years, road traffic crashes are now the
leading cause of death and disablement. The global
economic burden of road traffic crashes is estimated at
$500bn (£300bn, &500bn).2 Most of the casualties are
in low and middle income countries, and most are vul›
nerable road users: pedestrians, cyclists, and riders of
two wheeled motor vehicles. Children as pedestrians
are particularly vulnerable, and pedestrian injuries
account for most of the 280 000 childhood road deaths
each year.1 3 4 Elderly pedestrians constitute another
particularly vulnerable group.4
In the prevention of pedestrian injuries, edu›
cational measures to teach pedestrians how to cope
with the traffic environment are considered to be an
essential component of any strategy, and pedestrian
education has been recommended in high, middle, and
low income countries.2 Because the resources available
for road safety are limited, a key question for road
safety policy concerns the relative effectiveness of
different prevention strategies. The aim of this system›
atic review of randomised controlled trials was to
quantify the effectiveness of safety education pro›
grammes for pedestrians in improving their knowl›
edge, attitudes, and behaviour and, most importantly,
in preventing pedestrian›motor vehicle collisions.
Methods
Identification of trials
We aimed to identify all randomised controlled trials of
road safety education programmes for pedestrians of
all ages. We also included community based interven›
tions such as media awareness campaigns and parental
education programmes. We excluded studies where
safety education of pedestrians was confounded by
another intervention and studies that tried to modify
the behaviour of drivers towards pedestrians.
We identified trials by computerised searches of the
Cochrane Injuries Group specialised register,
Cochrane Controlled Trials Register, Transport,
Medline, Embase, ERIC, PsychLit, Spectr, and the
World Health Organization’s database on the internet;
by checking the reference lists of relevant reviews,
books, and articles; by contacting authors of relevant
papers; by use of the citation analysis facility of the Sci›
ence Citation Index and Social Sciences Citation
Index; and by contacting relevant professionals,
organisations, and voluntary agencies. No method›
ological filters were used, and we made no language
restrictions and repeated searches with key words
translated into French, German, Italian, Spanish,
Dutch, and Danish.
Outcome measures and data extraction
Two reviewers independently extracted data on pedes›
trians’ injuries, behaviour, attitude, and knowledge;
pedestrian›motor vehicle collisions; methods of
randomisation; and numbers lost to follow up. We
assessed trial quality using the method proposed by
Schulz.5 Disagreements were resolved by discussion
with a third reviewer. When the method used to
conceal allocation of intervention was not clearly
reported we contacted the study author, if possible, for
clarification.
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Data analysis and statistical methods
Wherever possible we performed an intention to treat
analysis. Meta›analysis was not considered appropriate
because of the differences across studies in the types of
interventions and the types of outcomes. We calculated
effect estimates with RevMan version 4.1 and report
these as relative risks (95% confidence intervals) for
dichotomous outcomes (relative probability of present›
ing the measured outcome in trained pedestrians com›
pared with non›trained ones) and as standardised
mean difference (95% CI) for continuous outcomes. If
the variance for the change score was not presented
and could not be obtained from the authors, we
ascribed a value using a correlation factor between
pretest and post›test scores of r=0.50.6 7 We report the
post›test data or the change between pretest and post›
test when available, grouped by age categories and by
type of outcomes. Outcomes are expressed as
“positive” expected behaviour, attitude, or knowledge,
so that a relative risk of > 1 and a standardised mean
Table 1 Characteristics of included randomised controlled trials of safety education of pedestrians
Study and country Participants
Allocation
concealment* Interventions Outcomes Loss to follow up
Ampofo Boateng
et al (1993),10 UK
26 children aged 5 C Direct education:
1—Trained using a tabletop model of traffic environment
2—Trained in a real traffic environment
3—No training
Child’s perception about safest place
to cross road in real traffic situation
(attitude)
37.5% for
intervention group
Bouck (1992),11 UK 40 children aged 8›11 C Indirect education provided by teachers
1—Trained in classroom and in semi›real environment
2—No training
Child’s knowledge 20% for both
groups
Cross et al (1988),12
Australia
138 children aged 7›8 C Direct education
1—Trained in classroom during teaching unit on speed
2—No training
Child’s response and documentation
of verbal explanation in a play
situation (tabletop model) (attitude)
Not stated
Downing et al
(1981),13 UK
1560 children aged 3
and their parents
A Indirect education provided by parents
1—Road safety booklet after an interview
2—Interview but no booklet
3—Road safety booklet with a letter
4—No intervention
Child’s knowledge 44% overall
Limbourg et al
(1981),14 Germany
658 parents volunteered
to teach their children
aged 3›6
C Indirect education provided by parents
1—Behavioural road safety training by parent with psychologist’s
supervision
2—Behavioural road safety training by parent without
psychologist’s supervision
3—Parents shown a film and given a booklet on road safety
problems in childhood
4—No training
Child’s behaviours in real traffic
situations with and without
distraction
15% overall
Luria et al (2000),15
USA
246 children aged 5 C Direct education
1—Trained with Safety City programme
2—No training
Child’s knowledge 26% for both
groups
Matson (1980),16
USA
30 “mentally retarded”
institutionalised adults
aged 21›55
B Direct education
1—Individual training in classroom using tabletop model
2—Independence training in a semi›real traffic situation
3—Training in how to cook and to make the bed
Steps performed correctly on a set of
target behaviours
Not stated
Miller et al (1982),17
USA
550 children (2nd
grade)
A Indirect education provided by teachers
1—Beltman programme
2—Beltman programme with booster course at 4 months
3—Normal safety teaching
Child’s safety knowledge and
behaviour
6% for knowledge
test and 65% and
77% for reported
behaviour
Nishioka et al
(1991),18 Japan
79 children aged 4›5 A Direct education
1—Caution advising how to behave safely (“A motorcycle is
running. If you come around here, stop and look at the right
and left side, as it is dangerous”)
2—Simple caution (“A motorcycle is running. Be careful as it is
dangerous”)
3—No caution (“A motorcycle is running”)
Child’s behaviour 10%
Renaud et al
(1989),19 Canada
136 children aged 5 C Direct education
1—Simulation game, targeted attitude
2—Simulation game, targeted behaviour
3—Simulation game, targeted attitude and behaviour
4—No simulation game
Child’s behaviour, attitude, and
knowledge
None
Singh (1979),20 UK 4024 children aged
5›13
B Indirect education provided by teachers
1—Traffic education materials used by class teachers
2—No road safety education
Child’s knowledge 7 classes in
intervention, none
in control group
Thomson et al
(1992),21 UK
30 children aged 5 C Direct education
1—Trained in a real traffic environment
2—Trained using tabletop model of traffic environment
3—No training
Child’s perception about safest place
to cross road in real traffic situation
(attitude)
None
Thomson et al
(1997),22 UK
201 children aged 5:
104 in year 1, 97 in
year 2
C Indirect education provided by 10 parent volunteers
1—Trained in a real traffic environment
2—No training
Child’s behaviour when crossing
between parked cars, and when
crossing near junction. Child’s
perception about safest place to cross
road in real traffic situation (attitude)
None
Thomson et al
(1998),23 UK
60 children aged 5 C Direct education
1—Trained using tabletop model of traffic environment and real
traffic environment
2—No training
Child’s perception about safest place
to cross road in real traffic situation
(attitude)
None
*Score of quality on scale used by Schulz et al5 assigning A to best quality and C to poorest quality: A=trials deemed to have taken adequate measures to conceal allocation (that is, central
randomisation, numbered or coded bottles or containers, drugs prepared by the pharmacy, serially numbered, opaque, sealed envelopes, or other description that contained elements convincing
of concealment); B=trials in which authors either did not report allocation concealment approach or reported an approach that did not fall into one of the other categories; C=trials in which
concealment was inadequate (such as alternation or reference to case record numbers or to dates of birth).
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difference of > 0 represent a beneficial effect of the
intervention programme.
In the included studies, training was provided
either directly to the target population (direct
education) or by training “intermediate” educators
such as parents or teachers (indirect education). The
way safety education is provided and the age of the tar›
get group are potential effect modifiers, but we did not
explore their influence because we did not perform a
meta›analysis.
For cluster randomised trials, we calculated an
“effective sample size” if the intra›cluster coefficient was
available.8 We excluded studies in which there were less
than five randomised clusters because, in order to ana›
lyse at the individual level, one would have to assume
that there is no clustering of individual responses
within the community, which is almost always
untenable.9
Results
We identified 13 899 studies, of which 674 (5%) were
potentially relevant based on the title or abstract of the
report. After a full text review, we identified 15 trials
that met our inclusion criteria,10–23 two of which are
reported in the same document.22 Table 1 shows the
basic characteristics of these trials.
The methodological quality of the included trials
was generally poor. The method of allocation conceal›
ment was adequate in only three trials,13 17 18 outcome
assessment was blinded in eight,10 11 14–16 21–23 and in
most of the studies large numbers of participants were
lost to follow up. The participants were children in 14
of the studies and institutionalised adults in one.16 No
trial focused on the other vulnerable pedestrian group,
elderly people. All trials were conducted in high
income countries. Eight studies involved the direct
education of study participants,10 12 15 16 18 19 21 23 and
seven involved the use of parents13 14 22 or teachers11 17 20
as educators. Outcomes were measured before and
after the intervention in 12 studies10 12–17 20–23 and only
after the intervention in three studies.11 18 19 None of the
trials assessed the effect of safety education on the
occurrence of pedestrian injury, but five assessed the
effect on observed behaviour,14 16 18 19 22 one assessed
reported behaviour,17 six assessed attitude,10 12 19 21–23
and five assessed knowledge.11 13 15 17 20
Each research group used different tools to
measure outcomes, and the delay for the post›test
measurement varied from less than one month to eight
months. Six trials measured the effect of safety
education at different times after the
intervention.14 17 21–23 The effect of the intervention was
lower in the later follow up period for 18 of the 24
behavioural outcomes,14 22 for two of the four attitude
outcomes,21–23 and for the two knowledge outcomes.17
In some studies, the post›test conditions varied and
influenced the results. For example, Limbourg and
Gerber14 reported that 5›6 year old children given
safety education were, at five months after intervention,
more likely to stop and look at the line of vision when
crossing roads than controls (relative probability 1.79
(95% confidence interval 1.18 to 2.72) for children
without distraction). However, when the children were
distracted by racing with another child the relative
probability increased to 2.80 (1.39 to 5.64).
Table 2 shows the most pertinent outcomes and
only the longest period to post›test measurements.
(More detailed results are available in the Cochrane
Library.) Overall, the effect of safety education on
Table 2 Selected outcomes of randomised controlled trials of safety education of pedestrians
Population
Injuries,
deaths,
collisions Behaviour Attitude Knowledge
Children and adolescents:
<5 years old No RCT found Trained children more likely to stop and look at
line of vision than controls (RR 1.71 (95% CI
0.62 to 4.70))14
No RCT found Trained children knew slightly more often that
they had to “walk or stay on pavement” than
controls (RR 1.05 (0.79 to 1.39))13*†
5›9 years old No RCT found Trained children more likely to stop and look at
line of vision than controls (RR 1.79 (1.18 to
2.72))14
Trained children more likely to stop at line of
vision when crossing between parked cars than
controls (RR 1.73 (1.39 to 2.14))22*
Trained children more likely to “always cross in
crosswalks” according to their parents than
controls (RR 1.63 (0.89 to 3.00))17*
Trained children more likely to exhibit “safe
behaviour” than controls (RR 2.13 (1.01 to
4.47))18*
Trained children had better “post›test transfer
score” than controls (SMD 0.83 (0.31 to 1.35))19
Trained children had greater proportion of routes
categorised as “safe” at post›test than controls
(SMD 1.28 (0.30 to 2.26))10
Change between pretest and post›test in
proportion of routes categorised as “safe” greater
in trained children than controls:
(SMD 0.80 (−0.12 to 1.72))21‡
(SMD 0.17 (−0.21 to 0.55))22‡
(SMD 0.92 (0.39 to 1.46))23‡
Trained children had better “post›test attitude
score” than controls (SMD 0.85 (0.35 to 1.35))19
Trained children more likely to apply “concept of
speed” than controls (RR 1.27 (1.07 to 1.50))12
Change between pretest and post›test scores of
“crossing the street” test slightly greater in trained
children than controls (SMD 0.16 (−0.13 to
0.45))15
Change between pretest and post›test in score of
“traffic safety knowledge” test was greater in
trained children than controls (SMD 0.81 (0.60 to
1.02))17‡
Change between pretest and post›test scores of
“cognitive” test greater in trained children than
controls (5›7 year olds, SMD 0.47 (0.36 to 0.57);
7›9 year olds, 0.96 (0.85 to 1.08))20‡
10›14 years
old
No RCT found No RCT found No RCT found Change between pretest and post›test scores of
“cognitive” test greater in trained children than
controls (SMD 0.57 (0.46 to 0.68))20‡
Trained children had better post›test score of
“conspicuity, mass, speed and control” test than
controls (SMD 2.39 (1.46 to 3.33))11
15›20 years
old
No RCT found No RCT found No RCT found No RCT found
Adults No RCT found Trained institutionalised adults had higher
“post›test mean proportion of steps correctly
performed” than controls (RR 5.17 (3.48 to
7.67))16*
No RCT found No RCT found
Elderly people No RCT found No RCT found No RCT found No RCT found
RCT=randomised controlled trial (only most relevant outcomes are reported here with longest period to post›test measurements). RR=relative risk. SMD=standardised mean difference
*Intervention groups pooled. †Control groups pooled. ‡Variance of change between pretest and post›test measurements ascribed.
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pedestrian behaviour varied considerably. The relative
probability of trained pedestrians behaving correctly
compared with controls ranged between 1.63 and 2.13
for the selected outcomes in table 2 but varied overall
between 0.49 (control group performed better than
trained group) and 9.29 for all the studies and
outcomes (data not shown). Safety education improved
pedestrians’ attitude and intentions (with standardised
mean differences ranging from 0.17 to 1.28) and their
knowledge about road safety when outcomes were
measured before and after intervention (standardised
mean differences from 0.16 to 2.39), but for
dichotomous outcomes the range of effect was wide
(relative probability ranging from 0.72 to 1.66) (data
not shown).
Discussion
Despite a thorough search in several databases in many
languages and by contact with various interested
parties, we could not identify good evidence of
effectiveness of safety education for adult pedestrians
and only limited evidence for child pedestrians. None
of the included trials assessed the effect of safety
education on the occurrence of pedestrian injury, but
six trials assessed the effect on observed behaviour.
Some of these trials showed evidence of behavioural
change after safety education, but for various reasons it
is difficult to predict what effect this might have on
pedestrian injury risk.
Firstly, we cannot be sure that the observed behav›
iour is causally related to the occurrence of pedestrian
injury. For example, Nishioka et al18 considered that
slowing down or stopping before crossing a road to be
the safe response. However, even if this behavioural
change, observed in a simulated traffic environment,
was repeated in a real traffic situation it is difficult to
estimate what effect it would have on injury risk. Once
a child has established that a road is clear, it may be
safer to run across before another vehicle approaches
because it reduces the time of exposure to risk.
Secondly, assuming that the measured behaviours are
causally related to risk of pedestrian injury, we have no
reliable information about the size of this effect, and so
we cannot predict how much a given behavioural
change will reduce the risk of injury. Finally, there is
uncertainty about the extent to which the observed
behavioural changes persist over time, although the
apparent declines may have been due to chance alone.
Limitations of review
Certain methodological issues could have an impor›
tant bearing on the validity of our findings. In particu›
lar, publication and other selection biases may have
resulted in the over›representation of studies showing
promising intervention effects. This is especially likely
in the context of road safety, where a large proportion
of the available research information is published in
the grey literature of road safety research organisa›
tions. Most of the statistical methods that can be used
to assess the possibility of publication bias require the
use of meta›analysis and so could not be used in this
systematic review.
Although we made considerable efforts to identify
all eligible trials, published and unpublished irrespec›
tive of language, we cannot exclude the possibility of
selection bias. The validity of the inferences from any
systematic review depends on the quality of the
included studies, and in this case many of the studies
were of poor quality. It has been shown that inadequate
allocation concealment, lack of blinding of outcome
assessment, and large losses to follow up can result in
the overestimation of intervention effects in ran›
domised controlled trials,5 and many of these method›
ological weaknesses were present in the included trials.
Several included studies were conducted more
than 10 years ago, and so their relevance to the current
situation is open to question. Walking habits and the
pedestrian environment have dramatically changed
during the past two decades. All the included trials
compared groups that were in the same surroundings,
allowing the effect of the intervention to be isolated.
Another limitation of this study is that we could not
identify any randomised controlled trial conducted in
low and middle income countries.
Implications of results
The Global Road Safety Partnership strongly recom›
mends road safety education of children worldwide.24
Our review indicates that there is no reliable evidence
supporting the effectiveness of pedestrian education
for preventing injuries in children and inconsistent
evidence that it might improve their behaviour,
attitudes, and knowledge. While the value of safety
education of pedestrians remains in doubt, environ›
mental modification and the enforcement of appropri›
ate speed limits may be more effective strategies to
protect children from road traffic.
Conclusions
Pedestrian safety education can improve children’s
knowledge of the road crossing task and can change
observed road crossing behaviour, but whether this
reduces the risk of pedestrian›motor vehicle collision is
What is already known on this topic
Road traffic crashes are a leading cause of death
and disablement, and pedestrians are particularly
vulnerable road users
Several organisations strongly recommend road
safety education
As resources are limited, a key question concerns
the relative effectiveness of different prevention
strategies, including road safety education of
pedestrians
What this study adds
This systematic review showed safety education for
pedestrians could improve children’s knowledge
and change their observed road crossing
behaviour
However, effects on pedestrian injury were
unknown
There is a lack of good evidence of effectiveness of
safety education for adult pedestrians, especially
elderly people, and in low and middle income
countries
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unknown. No trial focused on the other vulnerable
road users, elderly pedestrians. None of the trials was
conducted in low and middle income countries.
Large scale, randomised controlled trials with
injury outcomes (or end points that are likely to predict
injury outcomes, such as near misses) are needed to
establish the effectiveness of safety education of pedes›
trians. Although some existing trials showed evidence
of behavioural change after safety education, these
changes cannot be assumed to decrease pedestrian
injury risk.
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A systematic review of older people’s
perceptions of facilitators and barriers to
participation in falls-prevention interventions
FRANCES BUNN*, ANGELA DICKINSON*, ELAINE
BARNETT-PAGE*, ELIZABETH MCINNES#
and KHIM HORTON**
ABSTRACT
The prevention of falls is currently high on the health policy agenda in the United
Kingdom, which has led to the establishment of many falls-prevention services.
If these are to be eﬀective, however, the acceptability of services to older people
needs to be considered. This paper reports a systematic review of studies of older
people’s perceptions of these interventions. The papers for review were identiﬁed
by searching electronic databases, checking reference lists, and contacting experts.
Two authors independently screened the studies and extracted data on the factors
relating to participation in, or adherence to, falls-prevention strategies. Twenty-
four studies were identiﬁed, of which 12 were qualitative. Only one study speciﬁ-
cally examined interventions that promote participation in falls-prevention
programmes ; the others explored older people’s attitudes and views. The factors
that facilitated participation included social support, low intensity exercise, greater
education, involvement in decision-making, and a perception of the programmes
as relevant and life-enhancing. Barriers to participation included fatalism, denial
and under-estimation of the risk of falling, poor self-eﬃcacy, no previous history
of exercise, fear of falling, poor health and functional ability, low health ex-
pectations and the stigma associated with programmes that targeted older people.
KEY WORDS – health attitudes, health-related behaviour, adherence, older
people, falls prevention, systematic review.
Background
Falls are the leading cause of serious accidental injury (resulting in
admission to hospital for four or more days) amongst people aged 65
or more years in the United Kingdom (Cryer 2001). Hip fractures are
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an especially grave complication of falls in older adults, and result in
more hospital admissions than any other type of injury ( Jensen et al.
1982), which during 2000 cost the National Health Service (NHS) in
England around £1.7 billion (Easterbrook et al. 2001). There is a 10–20
per cent reduction in expected survival in the ﬁrst year following a hip
fracture (Cummings et al. 1985; Magaziner et al. 1989; Lu-Yao et al.
1994), and roughly one-half of survivors never recover normal function
(Magaziner et al. 1989). Falling can also have serious psycho-social
consequences, such as increased anxiety and depression, and can raise
the fear of falling and reduce activity (Chandler et al. 1996; Lachman
et al. 1998; Yardley and Smith 2002). The prevention and management
of falls in older people is a key target of the Department of Health
(DOH 2001), and national guidelines on the topic have recently been
produced by the UK National Institute for Health and Clinical
Excellence (NICE 2004).
Older people are at particular risk of falls and fall-related injuries.
Physiological changes with age, such as osteoporosis, postural insta-
bility, gait disturbances, diminished muscle strength, poor vision and
cognitive impairment, as well as multiple medications, are all risk
factors for falling. Environmental hazards, such as steps, stairs, beds,
baths, showers, lighting, loose rugs, and the absence of grab rails and
banisters, have also been identiﬁed as contributing to falls (Parker,
Twemlow and Pryor 1996; Lilley, Arie and Chilvers 1995; Cryer
2001). Apart from the injury sustained in the fall, there are other
potential consequences, such as loss of mobility, increased dependency
and disability, hypothermia, pressure-related injuries and infections
(DOH 2001).
In recent years, much attention in health-promotion research and in
health care has focused on falls and falls prevention among older
adults. In particular, several trials and systematic reviews have in-
vestigated the eﬀectiveness of various falls-prevention strategies, and
shown that eﬀective interventions include multi-disciplinary, multi-
factorial risk-factor screening and intervention programmes, muscle
strength and balance training, individually-tailored home exercise pro-
grammes, home modiﬁcation, T’ai Chi programmes, medication review,
and the follow up of patients who have fallen (Cryer 2001 ; Easterbrook
et al. 2001; Gillespie et al. 2003; Parker, Gillespie and Gillespie 2005).
Previous reviews have concentrated on quantitative evaluations of
eﬀectiveness, however, and have neglected the patients’ views about
the acceptability of the programmes. As a result, service or guideline
developers have little information by which to improve acceptability or
adherence.
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Aims and objectives
The aim was to undertake a systematic review of the research evidence on
the barriers and facilitators which inﬂuence older people’s participation in,
and adherence to, falls-prevention programmes and interventions, and to
identify the measures that promote acceptance. The exercise was expected
to identify examples of good practice. Five review questions were to be
asked of each published report :
1. What inﬂuences whether older people participate in falls-prevention
programmes?
2. What factors prevent older people from taking part in falls-prevention
programmes?
3. What do older people perceive to be the beneﬁts of falls-prevention
programmes?
4. What interventions are eﬀective in promoting participation in falls-
prevention programmes?
5. What are the key components of successful interventions for promoting
participation in falls-prevention programmes?
The search strategy and coding
The studies of interest were those that evaluated interventions to pro-
mote adherence to, or participation in, a falls-prevention programme
or strategy, and that identiﬁed the factors that inﬂuenced whether
older people participated and were compliant. Further details of
the inclusion criteria are provided in Table 1. We searched for all po-
tentially relevant literature, both published and unpublished, with no
date restrictions, and included relevant evidence regardless of country
of origin. In order to ﬁnd all potential studies we used a broad, topic-
oriented approach. Methodological search ﬁlters were not used, as
many non-randomised studies are not key-worded by study design
(Peersman et al. 1998). The search terms were both free-text and
‘medical subject heading’ (MeSH) terms and they were combined
with the appropriate Boolean operators. Details of the search terms
and the databases that were searched are given in Table 2. In addition,
lists of references in the selected papers were checked for otherwise
unfound contributions. To identify unpublished or grey literature, we
contacted ﬁeld researchers and experts, including the guideline de-
velopment group of NICE. The searches were conducted in January
2005.
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All citations identiﬁed by the above searches were downloaded into an
Endnote database. Two authors independently screened the titles and ab-
stracts against the inclusion criteria and extracted data from the full papers
T A B L E 2. The search strategy
Search terms and sequence
#1. (fall or falls or falling or faller* or fallen or slip or trips or tripped). #2. accidental falls.
#3. femoral neck fractures. #4. (#1 or #2 or #3).
#5. (old or older or senior* or elder* or aged or geriatric* or middleage*) #6. (#4 and #5)
#7. (impact* or psycholog* or psychosocial or emotion or experience* or subjective* or status
or perception* or consequence* or sequelae or eﬀect* or meaning* or rating* or view*)
#8. (#6 and #7)
Abstract databases searched
AMED (Allied and Complementary Medicine Database) 1985–2005
CINAHL (Cumulative Index to Nursing and Allied Health Literature) 1982–2005
CCTR (Cochrane Controlled Trials Register) Cochrane Library Issue 1, 2005
DARE (Database of Reviews of Eﬀectiveness ) ; Cochrane Library Issue 1, 2005
HTA (Health Technology Assessment Database ) 1988–2005
HMIC (Health Management and Information Consortium ) 1983–2005. Includes the database of
The King’s Fund (London), the Department of Health Library and Information Service, and
The Nuﬃeld Institute for Health (Leeds).
MEDLINE 1966–2005
UK National Research Register (Issue 1 2005).
NHS Economic Evaluations Database 1968–2005
PsychInfo 1872–2005
SIGLE (System for Information on Grey Literature) 1976–2005
ZETOC (British Library Electronic Table of Contents) 1993–2005
T A B L E 1. Inclusion criteria for the systematic review
Attribute Intervention studies Other studies of facilitators and barriers
Type of study Randomised-control trials, controlled
trials, controlled before/after studies
Any type, including non-intervention
and qualitative.
Excluding editorials/policy documents/
single case studies.
Participants Older people (mainly aged 65+ years) Older people (mainly aged 65+ years)
Intervention Main focus: intervention to promote
participation in falls-prevention pro-
grammes
Examining barriers and facilitators
to participation in programmes/inter-
ventions.
Setting All settings (including A&E/care home/
hospital)
All settings (including A&E/care home/
hospital)
Outcomes Rates of compliance/adherence with
programme/strategy
Measures of/self reports of barriers/
beneﬁts of participation.
Predictors of compliance/adherence Participant views/experiences of falls
prevention-strategies.
Participants’ views and experiences of
programme/strategy
Note : A&E Accident and emergency hospital departments (=casualty wards).
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onto a specially designed form. Disagreements were resolved by dis-
cussion. Two reviewers independently assessed the quality of the selected
studies using design assessment checklists. The quality criteria were in-
formed by several sources (Higgins 2006; Thomas et al. 2003; Spencer et al.
2003) and are similar to established tools (Mays and Pope 1995; Giacomini
and Cook 2000). The core quality-assessment principles are summarised
in Table 3.
The papers were categorised by study design using the following
categories : randomised-controlled trial, controlled trial, before/after study
(with or without control), cohort study (with or without concurrent
controls), case control, survey, process evaluation and qualitative study.
Process evaluations were categorised in terms of the intervention’s
implementation, its acceptability, and the explanations given about why
an intervention was successful or unsuccessful. Non-intervention studies
(cohort, case-control and cross-sectional survey designs) were diﬀer-
entiated by whether they aimed to identify or analyse the factors that
inﬂuence adherence with falls and fracture prevention, and whether they
T A B L E 3. Core principles of quality assessment for main study designs
Study type Scoring strategy and criteria
Randomised-controlled
trials
Quality scoring:
Allocation to treatment groups concealed
Study blinded, if possible
All randomised participants included in the analysis (intention to treat)
Withdrawals/drop-outs, reasons given for each group
Cross-sectional
studies/surveys
Quality scoring:
Selected subjects are representative (all eligible or a random sample)
80 per cent or more agreed to participate
Exposure/outcome status ascertained in a standardised way
Qualitative studies Assessed on seven criteria, scored as ‘yes ’, ‘no’, ‘partly ’ or ‘unclear’ :
Scope and purpose, e.g. clearly stated question, clear outline of
theoretical framework
Design, e.g. discussion of why particular approach/methods chosen
Sample, e.g. adequate description of sample used and how sample
identiﬁed and recruited
Data collection, e.g. systematic documentation of tools/guides/
researcher role, recording methods explicit
Analysis, e.g. documentation of analytic tools/methods used, evidence
of rigorous/systematic analysis
Reliability and validity, e.g. presentation of original data, how
categories/concepts/themes developed and were they checked by
more than one author, interpretation, how theories developed,
triangulation with other sources
Generalisability, e.g. suﬃcient evidence for generalisability or limits
made clear by author(s)
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sought older people’s views about such programmes. Data were also
extracted on the type, location and duration of the intervention, the
characteristics of the participants and providers, the country, the main
aims of the study, and the outcome measures.
The reviewed studies
The electronic searches yielded 6,191 records from all data bases,
including duplicates. Of those, 134 appeared potentially relevant and
a hard copy was obtained for screening. After full text review, 24 studies
met the inclusion criteria. One study (Yardley and Todd 2005) was in two
parts using both quantitative and qualitative methods. The remaining
studies were excluded because they did not meet the inclusion criteria
or because the quality was poor. Details of the studies’ aims, settings and
methods, of the interventions (where appropriate), and of the participants
are summarised in Table 4 (further details are available on request from
the authors).
Seven studies took place in the UK (Table 4, rows 1, 2, 5, 7, 8/9, 19, 20) ;
seven in the USA (6, 10, 11, 14, 16–18) ; ﬁve in Australia (3, 4, 12, 23, 24) ;
and ﬁve in Canada (13, 15, 21, 22, 25). Thirteen studies focused on
people living in the community (1, 3–5, 8/9, 10–15, 19, 20) ; one on a com-
bination of community dwellers and nursing/residential home residents
(6) ; and three on people living in a continuing-care retirement village
(16–18). Two studies were conducted in hospital (2, 7). Of the studies in
English-speaking countries, only a few examined the health-promotion
needs of non-English speaking groups (5, 21, 25). In the majority of the
studies, the participants were aged 60 or more years, but in one (13) they
were aged 55 or more years. The participants were variously those at high
risk of falling or the ‘healthy and active ’. Sample sizes ranged from eight
to 89 in the qualitative studies, and from 19 to 1,500 in the quantitative
studies.
Only one study (18) evaluated an intervention (more exercise) explicitly
to promote adherence to, or participation in, a falls-prevention pro-
gramme or strategy. Two studies were process evaluations. One (1) looked
at the implementation of and adherence to a nurse-led falls-prevention
programme, and the other (13) examined the acceptability to older people
of line-dancing and T’ai Chi classes. The other studies all identiﬁed factors
involved in older people participating or complying with falls-prevention
programmes. Five of these examined older people’s general views on falls
and falls prevention (2, 4, 5, 6, 8), two examined speciﬁc adherence factors,
such as self-eﬃcacy (3, 12), and the rest aimed to identify the factors that
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inﬂuence adherence to falls and fractures prevention interventions. The
following sections of the paper present the ﬁndings about three groups of
studies concerned respectively with falls and falls prevention in general
(N=8), exercise interventions (11), and home modiﬁcations or assistive
devices, e.g. canes (5).
The methodologies and quality of the studies
The qualitative studies employed methodologies that ranged from
phenomenology to discourse analysis, although some did not make the
method clear (Tables 5 and 6). In general, the studies had clearly deﬁned
aims, and gave adequate descriptions of the sampling and data collection,
but there was limited evidence of sample validation, triangulation or
assessments of generalisability. All examined people’s views or knowledge
of falls prevention or strategies to reduce falls, in most cases using semi-
structured interviews and focus groups, and with the ﬁndings reported
as themes and categories. Five examined perceptions, motivations and
barriers to physical activity (Gavin and Myers 2003; Grossman and
Stewart 2003; Resnick and Spellbring 2000; Sharon et al. 1997; Stead et al.
1997), and two these same reactions to home modiﬁcation or assistive
devices (Aminzadeh and Edwards 1998; Clemson, Cusick and Fozzard
1999), and the remainder examined more general reactions.
The quantitative studies used various methods to measure or review
predictors of increased exercise adherence, behaviour change, falls
history, fear of falling, ability and conﬁdence, self-eﬃcacy, participation
rates, and activity levels. Overall the quality was low to fair. Some
had small sample sizes (e.g. Hinman 1998; Resnick 2002) and some
reached conclusions and recommendations that were questionably
supported by the data. For example, although Cheal and Clemson (2001)
was treated as a qualitative study, it also had a quantitative component,
but the uncontrolled ‘before and after ’ design and very small sample
were inadequate to assess the eﬃcacy of the intervention. In both the
randomised-controlled trials, the allocation to the samples was not
fully described and neither reported a sample size calculation or an
intention-to-treat analysis. Only Resnick (2002) gave details of numbers
lost to follow-up.
Of the surveys, two stated that they used a random sample (Bruce,
Devine and Prince 2002; Edwards et al. 2003), and three a convenience
sample (Aminzadeh and Edwards 2000; Hinman 1998; Yardley and
Smith 2002). Only three studies gave the response rates (Bruce, Devine
and Prince 2002; Edwards et al. 2003; Yardley and Smith 2002), none of
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T A B L E 4. Summary characteristics of included studies
Study Authors Aim Method/intervention Participants Setting
A. Falls prevention: general
1 Allen (1999) Explored recruitment to and
attendance at
falls-prevention programme.
Part of RCT of a nurse-led falls-
prevention programme (included
medication review and exercise).
Recently fallen aged
65+, N=202
Community, UK
2 Ballinger (2000) Explored perspectives on falls and
falling among those with hip
fracture.
Qualitative study with: semi-
structured interviews/discourse
analysis.
Age: 65+ (M=81)
N=8 (7 f, 1 m).
Hospital, UK
3 Cheal (2001) Evaluation of Steady As You Go
programme (enhance self-eﬃcacy)
Before/after study. Qualitative
semi-structured interviews.
Age: 65+, N=8 Community, Australia
4 Commonwealth
DHAC
(2000)
Explored information needs/
perceptions of falls and their
prevention.
Qualitative study. 7 discussion
groups, 10 in-depth interviews.
Thematic analysis.
Age: 65+, and carers.
N=59
Rural/metro
community dwellers,
Australia
5 Health Education
Board for Scotland
(2003)
Explored constructions of the risks of
falling.
Qualitative study, 2 phases. Second
phase used to validate and explore
data from ﬁrst phase. Individual and
group interviews.
Age: 60+. Phase 1
N=39 (14 m, 25 f ),
Phase 2 N=50 (40 f,
10 m)
Community (rural and
urban), UK
6 Hinman (1998) Described beliefs held by older adults
regarding stability, cause and
control of their falls.
Survey. 8 brief closed questions (no
mention of validation). Convenience
sample, no information on response
rate.
Age: 64–91 (M=79).
N=25 (15 f, 10 m)
Community and
residential care, USA
7 Simpson (2003) Examined the precautions older
people are prepared to take to
prevent falls.
Qualitative, semi-structured inter-
views. Recorded by hand-taken
notes.
Age: 65+ (M=83).
N=32 (26 f, 6 m).
Hospital, UK
8 Yardley (2005) Part 1 Identiﬁed negative aspects of falls
prevention communications and
improving messages.
Qualitative study including focus
groups and 21 individual interviews.
Age: 61–94. N=66
(41 f, 24 m)
Community, UK
4
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9 Yardley (2005) Part 2 To determine which beliefs and feel-
ings have greatest impact on
intentions to undertake falls-
prevention activities. Inﬂuence of
diﬀerent messages.
Questionnaires/ structured
interviews on attitudes to balance
training (BT), beliefs/feelings about
falling. Randomised to one of four
groups: (a) leaﬂet on positive beneﬁts
of BT, (b) leaﬂet describing need to
do BT, (c) both leaﬂets ; (d) no leaﬂet.
Age: 60–95
(M=74.7), N=715,
73% f
Community, UK
B. Falls prevention: exercise
10 Boyette (1997) Assess initiation to and adherence
with a strength-training pro-
gramme.
Follow-up subset for 6-months of a
previous 4-month strength-training
and ﬂexibility intervention.
Initiation deﬁned: completing pro-
gramme/attending 75% of sessions.
Adherence deﬁned: continuing ex-
ercises 6 months after intervention.
Age: M=71.3. N=46
(33 f, 13 m). Healthy
older adults.
Community, USA
11 Sharon (1997) To understand older adults’ attitudes
and concerns about a strength-
training intervention and to identify
factors that determined their
adherence.
Qualitative study, 3 focus groups (1
10 f, 1 7 m, 1 of 7 m/f ). Participants
drawn from Boyette (1997).
Excluded if depressed, cognitive
impairment or cardiovascular
disease.
Aged: 61–82, N=23 Community, USA
12 Bruce (2002) Examined whether fear of falling
reduced recreational physical
activity levels in healthy older
women.
Cross-sectional analysis of data from
RCT of calcium supplements to
prevent fractures. Measured fear of
falling and physical activity (vali-
dated scales). 27% response rate.
Age: 70–85 (M=75.2).
Ambulatory f,
N=1500
Community, Australia
13 Gavin (2003) Explored participation and
adherence to T’ai Chi and
line-dancing classes.
Process evaluation with qualitative
and survey elements. People
enrolling for T’ai Chi/line-dancing
classes. 75% reported good health.
Age: 55+, N=328.
Mostly f (85%), white
(97%)
Community, Canada
14 Grossman (2003) Explored perceptions, motivations
and barriers to physical activity
In-depth interviews using open-ended
questions. Details of data analysis
not given.
Age: 75+ (M=80),
N=33. Sedentary/
inactive.
Community, USA
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TABLE 4 (Cont.)
Study Authors Aim Method/intervention Participants Setting
15 Rejeski (1997) Examined predictors of exercise
compliance.
RCT. Compared health education,
aerobic exercise and resistance
exercise on self-reported disability.
Knee osteoarthritis and self-
reported diﬃculties with ADLs.
Age: M=68.6.
N=439 (308 f,
131 m)
Unclear, Canada
16 Resnick (2000) Explored factors inﬂuencing adher-
ence to an exercise programme.
Qualitative study. Open-ended
interviews with members of a
walking group.
Age: M=81. N=23
(91% f ).
Continuing care
retirement village,
USA
17 Resnick (2001) Tested model of exercise behaviour,
explored factors inﬂuencing adher-
ence to an exercise programme.
Survey. Assessed self-eﬃcacy/
motivation, fear of falling and health
status using validated scores.
Association between above factors
and exercise adherence (session
attendance).
Age: 65+ (M=85).
N=201(77% f ). No
cognitive impair-
ment.
Continuing care
retirement village,
USA
18 Resnick (2002) Assessed eﬀect of intervention on
self-eﬃcacy, exercise activity, falls
and fall-related injuries.
RCT, WALC intervention (walk,
address pain, fear and fatigue, learn
about exercise and verbal encour-
agement). Control : routine care,
assessment and treatment when
necessary. Outcomes: exercise
self-eﬃcacy, health status, exercise
behaviour and activity.
Age: M=88. N=20
(3 lost to follow up).
Sedentary women.
Community care
retirement
community,
USA
19 Stead (1997) Investigated factors inﬂuencing
participation in physical activity.
Qualitative study. Focus groups. Age:65–75+. N=6
groups of 6–8 (3
groups aged 65–74, 3
aged 75+)
Community, UK
20 Yardley (2002) Identiﬁed commonly-feared conse-
quences of falling and whether these
lead to activity avoidance.
Survey (random sub-sample of large
RCT of Vit D). 75% response rate.
Measured fear of falling at baseline
and at six months (validated scales).
Age: 75+ (M=81).
N=224 (106 m,
118 f), Healthy
people
Community, UK
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C. Falls prevention: home modiﬁcation/assistive devices
21 Aminzadeh (2000) Explored factors associated with
cane use.
Questionnaires. Convenience
sample. Used cognitive mediator
instrument – designed for this study
(not clear if validated).
Age: 65+ (M=77).
N=106. 48% used
canes
Community, Canada
22 Aminzadeh (1998) Views on the use of assistive
devices.
Qualitative study. 4 focus groups.
Taped and transcribed categories
established.
Age: M=72.2. N=30
(Italian and British
Canadian) 70% f
Community, Canada
23 Clemson (1999) Examined compliance with
home-hazard advice.
Qualitative study. Semi-structured
in-depth ethnographic interviews
Age: 65+, N=9
(received home
safety advice)
Community, Australia
24 Cumming (2001) Examined adherence/predictors of
adherence, to home modiﬁcation
recommendations by an OT.
Compliance study (part of RCT of
OT falls-prevention intervention).
12 month follow-up.
Age: 65+ (M=76.4).
N=178, 56% f
Community (recruited
at hospital),
Australia.
25 Edwards (2003) Identiﬁed predictors of bathroom
safety-device use (e.g. grab-bar/
rails).
Descriptive comparative study,
face-to-face interviews. Measured
grab-bar use and falls history
(validated scales) and used logistic
regression to identify predictors of
grab-bar use. 62.5% response rate.
Age: 60+ (M=73.9),
76% f. N=550
(French/English-
speaking, no cogni-
tive impairment)
32% fell previous
year
Community, Canada
Notes : DHAC: Department of Health and Aged Care, Commonwealth of Australia. f : female. m: male. M=average or arithmetic mean. RCT: randomised
controlled trial. Vit : Vitamin. WALC: Women against lung cancer. Full citations of the included studies are in the List of References.
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which were over 80 per cent. Four reported that they used validated out-
come measures (Bruce, Devine and Prince 2002; Edwards et al. 2003;
Resnick 2001; Yardley and Smith 2002).
T A B L E 5. Methodological approaches used in included studies
Methodology Studies
Qualitative (n=12) Aminzadeh 1998, Ballinger 2000, Cheal 2001, Clemson 1999,
Commonwealth of Australia 2000, Grossman 2003, Health Education
Board for Scotland 2003, Resnick 2000, Sharon 1997, Simpson 2003,
Stead 1997, Yardley and Todd 2005 (n.b. Cheal 2001, Resnick 2000,
Yardley 2005 had quantitative components).
Randomised controlled
trials (n=2)
Rejeski 1997, Resnick 2002.
Cross sectional/survey
(n=6)
Aminzadeh 2000, Bruce 2002, Edwards 2003, Hinman 1998, Resnick
2001, Yardley 2002.
Evaluation of compliance
(on intervention group of
an RCT/controlled trial)
(n=2)
Boyette 1997, Cumming 2001.
Process evaluation (n=2) Allen 1999, Gavin 2000 (included a qualitative element).
T A B L E 6. Quality assessment of the qualitative studies
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Aminzadeh 1998 + y + + + + + 6.5
Ballinger 2000 + + y + + y + 6.0
Butler 1998 y + + + + x ? 4.5
Cameron 1994 + + + + y y y 5.5
Cheal 2001 + x + + y y y 4.5
Clemson 1999 + y + + + + ? 5.5
C. of Australia 20001 y + + y x x y 3.5
Gavin 2003 y y + y x y y 3.5
Grossman 2003 y x + y y y + 4.0
HEBS 20032 + + + + + + + 7.0
Resnick 2000 + + + + + + + 7.0
Sharon 1997 + x y + y + y 4.5
Simpson 2003 + x + + + + y 5.5
Stead 1997 + + y + y y y 5.0
Yardley 2005 + + + y x x + 4.5
Notes+ yes,x no,y partly, ? not clear. 1. Health Education Board for Scotland. 2. Department of
Health and Age Care, Commonwealth of Australia. 3. Aggregate of scores for each attribute (1 for
‘yes ’, 0.5 for ‘partly’).
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Reactions to three types of intervention
General studies of falls and falls prevention
Four of the eight studies of older people’s perspectives on falls and falling
in this category used qualitative methods (Ballinger and Payne 2000;
Commonwealth of Australia 2000; Health Education Board for Scotland
2003; Simpson, Darwin and Marsh 2003) and one used quantitative
methods (Hinman 1998). One study (Cheal and Clemson 2001) used
quantitative and qualitative methods to examine falls and self-eﬃcacy, and
one (Yardley and Todd 2005) used mixed methods to study issues around
the communication of the risk of falling and prevention strategies. One
study (Allen and Simpson 1999) was a process evaluation that explored
recruitment to, and attendance at, a falls-prevention programme.
It emerged that the term ‘falls prevention’ is unfamiliar to many older
people (Commonwealth of Australia 2000) and that some are unaware of
the beneﬁts of falls-prevention interventions (Simpson, Darwin and Marsh
2003). Although many people accepted that environmental and personal
changes might prevent falling, they tended to advocate change for others
rather than themselves (Health Education Board for Scotland 2003;
Hinman 1998). Other issues around falls and falls prevention that were
noted included stigma, denial, identity, the attribution of falls to external
factors, and low health expectations.
Studies of exercise interventions
Eleven studies looked at factors that aﬀect participation in, and adherence
to, physical activity routines. Some examined exercise in general whereas
others focused on speciﬁc exercise programmes such as strength training
(Boyette, Sharon and Brandon 1997; Sharon et al. 1997), walking (Resnick
and Spellbring 2000), and T’ai Chi and line dancing (Gavin and Myers
2003). One study examined whether fear of falling deterred physical ac-
tivity (Bruce, Devine and Prince 2002), and a randomised controlled trial
assessed the eﬀect of an intervention to promote exercise (Resnick 2002).
Many of the studies did not treat exercise as a falls-prevention intervention
but as a challenge that promotes general health; those that did showed
that many people are unaware of the beneﬁts of exercise in preventing falls
(Simpson, Darwin and Marsh 2003; Yardley and Todd 2005).
The factors shown to increase participation in exercise programmes
were high exercise self-eﬃcacy, past exercise history, good general health,
and unimpaired functional abilities (Rejeski et al. 1997; Resnick and
Spellbring 2000; Resnick 2001). Among the programme characteristics
shown to improve adherence were: frequent bouts of activity of moderate
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duration (Rejeski et al. 1997), accessibility, transport, convenience, having a
social dimension, strong leadership (Boyette, Sharon and Brandon 1997;
Gavin and Myers 2003; Sharon et al. 1997), and exercise tailored to
individual needs and capabilities (Gavin and Myers 2003). In addition, an
intervention to help people learn about exercise and overcome barriers
appeared to increase overall activity and exercise at six months, but the
sample size was small and the follow-up was limited (Resnick 2002). The
factors shown to be associated with the avoidance of exercise included
greater age (Yardley and Smith 2002), fear of falling (Bruce, Devine and
Prince 2002), fear of exertion (Grossman and Stewart 2003), and dis-
comfort such as pain or shortness of breath (Simpson, Darwin and Marsh
2003; Resnick and Spellbring 2000).
Studies of home modiﬁcations and assistive devices
Two studies explored factors in adherence to prescribed home modiﬁ-
cations (Clemson, Cusick and Fozzard 1999; Cumming et al. 2001) and one
examined the use of bathroom-safety devices such as grab-bars (Edwards
et al. 2003). Three of the general studies (reviewed above) also looked at
home modiﬁcations (Commonwealth of Australia 2000; Hinman 1998;
Simpson, Darwin and Marsh 2003). The other two studies (Aminzadeh
and Edwards 1998, 2000) examined the factors that aﬀect the use of
assistive devices such as canes. Shared ﬁndings were that many see ‘home-
health checks ’ as intrusive and unnecessary, that people dislike changes to
their home, and that many have a perception of low risk (Clemson, Cusick
and Fozzard 1999; Simpson, Darwin and Marsh 2003). The tendency to
reject home-safety advice may be related to older people’s wish to main-
tain their independence and control over their lives and homes (Clemson,
Cusick and Fozzard 1999). Barriers to the use of canes and walking aids
included stigma, embarrassment, fear of dependence, and denial of
the need. Home modiﬁcations and walking aids were more acceptable
than eyesight and footwear checks, medication reviews, and balance and
exercise programmes (Commonwealth of Australia 2000).
Cross-cutting themes
Barriers and facilitators
The most common barriers and facilitators relating to participation and
adherence to falls-prevention programmes that were identiﬁed by two
reviewers in the quantitative and qualitative studies are shown in Table 7.
Among the barriers to participation and concordance, one that emerged
462 Frances Bunn et al.
376
strongly was fatalistic attitudes. Falls were often attributed to chance or
bad luck and therefore not regarded as preventable. Several of the studies
present similar quotations from their respondents that demonstrate this
attitude, for example, ‘ I don’t know how you can be told how to prevent
falling. You don’t do it on purpose … it just happens ’ (Yardley and Todd
T A B L E 7. Facilitators and barriers for older people participating in falls-prevention
interventions
Facilitators Barriers
A. General
Information that falls can be
preventable
Fatalism/attributing falls to external causes/lack of
knowledge about eﬀectiveness of falls prevention
Communicating life-enhancing
aspects of strategies, e.g. maintaining
independence and control
Perception that physical deterioration inevitable with age
Accessible, appealing information
format, from a variety of sources
and in diﬀerent languages
Lack of relevant information in appropriate formats/
language
Choice of interventions for diﬀerent
people and lifestyles
Provision of ‘one size ﬁts all ’ advice. Advice seen as
common sense/patronising
High self-eﬃcacy Low self-eﬃcacy. Fear of loss of independence/risk-
taking ability
Personalised modiﬁcations No perception of need for help (no previous falls)
Emphasis on social aspects of
interventions
Provoking fear of falling by using scare tactics
Social stigma: association with old age/frailty
Diﬀering agenda of older people and health professionals
B. Exercise
Previous exercise ‘habit ’ No previous exercise ‘habit ’
Making exercise fun/enjoyable/
sociable
Physical discomfort/unpleasant sensations associated
with exercise
Good leadership/facilitation Underlying beliefs about personality type (e.g. too lazy,
no willpower)
Motivation/information about
physical and psychological
beneﬁts of exercise
Self perception: too old to exercise
Programmes tailored to needs or
lifestyle
Poor knowledge of suitable exercises
Convenient scheduling/
reasonable pricing/good access
and transport
Commitment and high cost. Poor access/awareness
C. Home modiﬁcations/assistive devices
Facilitate feeling of ownership of
interventions, shared decision-
making
Dislike of interventions seen as intrusive/didactic
Referral from health-care
professional (especially doctor)
Stigma of devices associated with old age
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2005: 16). This idea extended to people’s rational for not exercising.
Some respondents were reported as fatalistically believing that they
were basically a lazy person or lacked willpower and therefore could not
exercise (Resnick and Spellbring 2000).
A widespread ﬁnding was the attribution of falls to external causes, and
a complementary resistance to admitting ‘ intrinsic ’ risk factors, such as
poor eyesight or dizziness (Commonwealth of Australia 2000). Instead,
falls were often attributed to external causes, such as the incompetence of
others or inevitable physical deterioration, over which the individual had
no control (Allen and Simpson 1999; Ballinger and Payne 2000). One of
many participants’ quotations that illustrated this well is found in the
Health Education Board for Scotland (2003: 17) study: ‘You couldn’t have
prevented it ; it was just the corner of the pavement or something. You
know something that anybody of any age could do’. In contrast, Hinman
(1998) reported that 68 per cent of the participants related their falls to
intrinsic rather than environmental factors, but this study had a small
sample and used a brief questionnaire with closed questions that may have
been leading.
Some people felt falls-prevention interventions were not appropriate for
them because they had low health expectations and saw physical decline
as an inevitable consequence of ageing. A characteristic expression was,
‘ I did a lot of exercise in years gone by … but in recent years, no[t so]. At
my age I guess I don’t believe it makes a diﬀerence’ (Resnick and
Spellbring 2000: 39). The opposite views were also reported. Evidently
many older people reject the idea that they need falls-prevention advice or
help because they see themselves as ﬁt, healthy and able to manage (Allen
and Simpson 1999). They may wish to distance themselves from the
identity of an ‘older’ person, and see falls prevention as more relevant
for ‘older ’ or ‘ frailer ’ people (Yardley and Todd 2005: 13). They may,
therefore, be alienated by information that is explicitly targeted at older
people or that encourages participation by stereotyping older people
(Aminzadeh and Edwards 1998; Ballinger and Payne 2000; Health
Education Board for Scotland 2003; Stead et al. 1997; Yardley and Todd
2005), and dislike advice that they see as common sense and ﬁnd patron-
ising (Yardley and Todd 2005: 14). Although some ﬁt and active older
people may understandably deny the impact of ageing, some of those at
high risk and of those with a history of falls also saw falls-prevention advice
as relevant to others not themselves (Yardley and Todd 2005).
Related to the issue of identity is the perception of stigma. People often
felt stigmatised by interventions aimed at ‘older people ’, for example
canes, walking frames and grab-bars (Aminzadeh and Edwards 2000:
300). Pride also played a part in people being reluctant to accept advice or
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help (Yardley and Todd 2005: 14). Activities that allowed older people to
defy stereotypes (e.g. intense exercise programmes) may facilitate partici-
pation (Sharon et al. 1997). A contradiction was found, however, between
people not wanting to be seen as ‘old’ and distancing themselves from
other ‘old ’ people, and the fact that many valued programmes or inter-
ventions that involved contact with people of a similar age and outlook
(Stead et al. 1997; Sharon et al. 1997).
Independence and risk negotiation
The studies conﬁrm that many older people see independence as very
important. Some disliked interventions that they saw as didactic or
intrusive (Simpson, Darwin and Marsh 2003). They wanted to maintain
their independence and make their own decisions and risk assessments
(Clemson, Cusick and Fozzard 1999). A Scottish participant put this well :
‘ I think if you’ve been independent all your life, it’s an embarrassment to
be dependent ’ (Health Education Board for Scotland 2003: 27). A fear of
falling can lead to a loss of conﬁdence, adversely aﬀect participation in
daily activities, and be a barrier to participation in interventions such as
exercise (Bruce, Devine and Prince 2002; Cheal and Clemson 2001;
Grossman and Stewart 2003; Yardley and Smith 2002). Commonly feared
consequences of falling included physical damage, loss of independence,
damage to identity, and embarrassment and stigma associated with
falling, particularly in a public place (Health Education Board for
Scotland 2003; Yardley and Smith 2002). Fear of falling could be made
worse by hazard-reduction advice that was frightening and oppressive
(Yardley and Todd 2005).
Social interaction and support
For some participants who disliked group activities, the social aspect of
falls-prevention interventions was a barrier (Allen and Simpson 1999), but
it seems the majority of people preferred interventions with a strong social
and recreational component (Allen and Simpson 1999; Boyette, Sharon
and Brandon 1997; Stead et al. 1997; Sharon et al. 1997). Social support was
important at several levels. Family and friends had a role in encouraging
participation in, and adherence to, falls-prevention programmes
(Cameron and Quine 1994; Grossman and Stewart 2003; Sharon et al.
1997). In addition, the desire to remain healthy and active so as not to be a
‘burden’ and to keep up with family and grandchildren was an incentive
for some to exercise (Grossman and Stewart 2003). Support from pro-
gramme leaders was also important with strong leadership a facilitator to
exercise adherence (Boyette, Sharon and Brandon 1997; Sharon et al. 1997).
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Previous experience
Previous experience of falls-prevention programmes was an important
factor in acceptance of and participation in the interventions, and simi-
larly participation in and adherence to exercisewasmore likely among those
with a history of taking exercise (Resnick and Spellbring 2000; Resnick
2001 ; Stead et al. 1997). One study found that a ‘habit ’ of exercise was the
strongest predictor of future exercise behaviour (Rejeski et al. 1997). There
was mixed evidence about whether having fallen previously might aﬀect
attitudes towards falls prevention. Some studies found that those who had
fallen before were more likely to be receptive to falls-prevention inter-
ventions (Commonwealth of Australia 2000; Edwards et al. 2003), but this
was not corroborated by another study (Cumming et al. 2001).
The role of the healthcare professional
Health-care professionals, particularly physicians, emerged as important
social referents for older people (Aminzadeh and Edwards 2000;
Commonwealth of Australia 2000; Grossman and Stewart 2003), although
one study (Stead et al. 1997) found that they were not perceived as a
credible source of information or advice on exercise. Home visits were
sometimes seen as an intrusion but this reaction depended on the per-
ceived authority of the person making the visits and recommendations :
(Simpson, Darwin and Marsh 2003). Therapists and patients may not
share the same agenda and perspectives about falls (Ballinger and Payne
2000) ; that is, concordance is not present, and professionals need to take
into account older people’s views and understand and empathise with
their risk-taking behaviour (Clemson, Cusick and Fozzard 1999, Simpson,
Darwin and Marsh 2003).
Discussion
The systematic review found 24 studies that examined some aspect of
older people’s attitudes towards falls prevention. Twelve used qualitative
methods and the rest quantitative designs. The majority were exploratory
studies and collected older people’s views on falls and falls prevention.
The studies identiﬁed a number of factors that aﬀected participation in
falls-prevention interventions and programmes. These included denial,
fatalism, self-eﬃcacy, past exercise habits, a fear of falling, general health
and functional ability, health expectations, under-estimation of personal
risk of falling, stigma, embarrassment, and the inconvenience of some
assistive devices.
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Of particular interest were those aspects of falls-prevention programmes
that improved participation and adherence, and the studies provided
evidence that social support and interaction, low intensity exercise (e.g.
walking), education, and the perception that a programme was relevant
and beneﬁcial had these eﬀects. Social support was very important in
reinforcing engagement with falls-prevention interventions, both at the
individual level (i.e. from health-care professionals, family, friends) and at
the societal level (i.e. wider cultural norms that support the idea of older
people remaining active).
Many of the themes identiﬁed by the review, e.g. identity, stigma, in-
dependence, denial of the ageing process and health expectations, concern
the ways in which older people view themselves and believe they are seen
by others. The social identity of older people is sometimes stigmatised,
incorporating references to disability, disenfranchisement and other
negative attributes. The way dependency is emphasised as a concomitant
of old age is culturally constructed and historically located (Chater 1999;
McCormack 2003). Discrimination towards older people has been
described throughout the British National Health Service and social-care
services (Grimley Evans 1997; Department of Health 2001), and is
pervasive in society, which adds to older people’s disempowerment
(Bytheway 1995; Tones 1998). Those working with older people to prevent
falls therefore need to be aware of, and to challenge, the factors that
sustain their marginalised position (Ryles 1999).
One of the aims of the review was to assess the eﬀectiveness of inter-
ventions used to promote the acceptance of falls-prevention strategies and
to identify examples of good practice, but only one very small study that
evaluated the promotion of adherence to a falls-prevention intervention
was found (Resnick 2002). The majority of the reviewed studies were
exploratory. The facilitators of participation were identiﬁed more often
by inference or by the investigators’ ‘ subjective synthesis ’ than by a stat-
istically signiﬁcant eﬀect from a controlled study. Many of the studies
examined only beliefs and attitudes, not actual behaviour. The presented
evidence allows us to speculate about the key factors in successful inter-
ventions but these need further evaluation.
Several paradoxes that are challenges for those designing falls-
prevention programmes emerged from the review. On the one hand, some
people reject interventions that stereotype them as ‘old ’ and wishing to
avoid contact with other older people, but on the other hand, many people
valued interventions that involved contact with people of a similar age and
outlook. Another evident challenge is how health practitioners make
people aware of their potential risk of falling without causing distress or
denial of the problem.
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Limitations and strengths of the review
A number of the review’s methodological features could inﬂuence the
validity of its results. Publication and other selection biases threaten
the validity of all systematic reviews, but this is a particular problem
when searching for studies that used non-randomised designs. These
are more diﬃcult to identify than randomised-controlled trials, because
of the diversity of designs, the absence of standardised terminology,
and the limitations of key-wording or cataloguing (Peersman et al.
1998). Despite our eﬀorts to identify all eligible published and unpub-
lished studies, we cannot exclude the possibility that some were missed.
The included studies use several diﬀerent methodologies. Although
methods for conducting syntheses and meta-analyses of trials are
well established (Egger, Davey-Smith and Altman 2001; Green and
Higgins 2005), several approaches have been proposed for reviewing
qualitative and non-randomised studies and they are still being developed
(Campbell 2003; Dixon-Woods, Fitzpatrick and Roberts 2001; Harden
et al. 2004).
There are also issues around quality assessment, both in terms of which
quality criteria should be used and how that information should be applied
to the review ﬁndings (Dixon-Woods Fitzpatrick and Roberts 2001 ;
Sandelowski, Docherty and Emden 1997). In addition, there is no con-
sensus on whether studies should be weighted by design and quality.
Therefore, although we critically appraised the qualitative studies in the
review, we did not use this information to exclude studies or weight
the results. More work is needed on the tools and procedures for quality
assessments of qualitative studies in systematic reviews. Despite these issues,
a narrative synthesis provides a valuable overview of evidence from dis-
parate studies, and usefully identiﬁes the contributions of such studies to
the evidence base. In particular, it collates the evidence about patient
perspectives on falls prevention, which have been neglected in the devel-
opment and implementation of the interventions.
The generalisability of the review ﬁndings must be considered. The
studies in this review sampled older people from both community and
extended-care settings. Although a few attempted to assess the eﬃcacy
of an intervention or reported associations with very few respondents,
the majority had acceptable sample sizes. In addition, although some of
the studies acknowledged the problems of generalisation, there was im-
pressive consistency in the prominent themes. On the other hand, few
participants were from non-English speaking backgrounds, there were
few data on gender or social-class diﬀerences, and those with cognitive
impairments were usually excluded.
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Conclusions
Much research has been done on which interventions are eﬀective in
preventing falls and there have been systematic reviews (Cryer 2001;
Easterbrook et al. 2001; Gillespie et al. 2003; Parker, Gillespie and Gillespie
2005), but the little evidence of the factors that inﬂuence participation and
long-term adherence has not previously been collated. Gender and eth-
nicity may aﬀect attitudes towards and participation in falls-prevention
strategies but there is no research on these factors (Horton 2002).
Currently, the health-care and other professionals that are developing or
providing falls-prevention services have little knowledge of either older
people’s views or the barriers to their participation that older people per-
ceive. Further research that raises understanding of the factors that inﬂu-
ence older people’s ambivalence towards falls-prevention interventions
and that promote their continuing involvement will improve service de-
sign and eﬀectiveness.
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GLOSSARY OF TERMS 
 
Adolescents 
This term includes people aged 12-18 
 
Young people 
This term includes people aged 18-25 
 
MSM 
Men who have sex with men is a broad term and includes gay and bisexual men and those who 
have sex with men but do not identify themselves as either gay or bisexual. 
 
Relative risk (RR) 
This is the ratio of risk in two groups.  In an intervention study it is the ratio of the risk in the 
intervention group to the risk in the control group.  A risk ratio of one indicates no difference 
between the groups.  For a desirable outcome (e.g number of STIs) a risk ratio that is greater than 
one indicates that the intervention was effective in reducing the risk of that outcome. 
 
Odds Ratio (OR) 
The ratio of the odds of an event in one group to the odds of an event in another group.  An odds 
ratio of one indicates no difference between comparison groups.  For a desirable outcome (e.g 
number of STIs) a odds ratio that is greater than one indicates that the intervention was effective in 
reducing the risk of that outcome.  
 
95% Confidence Interval 
This is a measure of the precision of an estimated value. For example, the confidence interval of 
an odds ratio tells us the boundaries within which we can be 95% certain the true value for the 
population falls.  Moreover, if we collected 100 samples, we are saying 95 of these would give rise 
to an odds ration within the boundaries of the confidence interval.  Wide intervals indicate lower 
precision and narrow intervals greater precision. 
Effect Size 
This is a measure of the magnitude of the differences between two variables, also known as a 
treatment effect. For example, an odds ratio or a relative risk represents the size of the difference 
in two possible outcomes. There are many different methods of calculating effect size dependant 
on the properties of the data, whether it is continuous or discrete and the manner in which it is 
distributed. 
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EXECUTIVE SUMMARY  
 
Background 
 
Over the last ten years there has been a large increase in sexually transmitted infections 
(STIs) and the UK continues to have the highest rate of teenage pregnancy in Western 
Europe.  Government policy has set targets to decrease under 18 conceptions and 
improve sexual health.  The National Institute for Health and Clinical Excellence (NICE) 
has been asked by the Department of Health to develop public health intervention 
guidance to reduce the rate of sexually transmitted diseases (STIs), including HIV, and 
under 18 conceptions.  The rapid review presented here is intended to assist with this 
guidance development by assessing the effectiveness of one to one interventions, with 
special reference to vulnerable and high-risk groups. 
 
Objectives 
 
The objectives of the review were to: 
 
 To review the evidence of effectiveness of one to one interventions for the 
prevention of STI (including HIV) 
 To review the evidence of effectiveness of one to one interventions for the 
prevention of conceptions in the under 18’s 
 
Methods 
 
Selection criteria 
We included randomised controlled trials and controlled before/after studies of one to one 
interventions to prevent under 18 conceptions and STIs.  This included one to one 
interventions to provide information or education, advice, therapy, promotion of 
contraception or condom use, and activities to increase self confidence, self-esteem and 
to develop skills.  Our primary outcomes were conceptions and STIs (including HIV).  In 
addition we looked at secondary outcomes such as condom use, knowledge, number of 
sexual partners and general sexual risk behaviours.  We also included qualitative studies 
that looked at the process of the interventions (e.g. how and why they do/do not work) 
and/or those focusing specifically on the user perspective of potential barriers and 
facilitators. 
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Data sources 
We searched the following electronic databases: AMED, CINAHL, Cochrane Database of 
systematic Reviews, Cochrane Central Register of Controlled Trials, DARE, EMBASE, 
HMIC, HTA, IBSS, Psychinfo, PubMed and SIGLE from 1990-November 2005; and we 
handsearched reference lists from included studies. 
 
Data extraction and quality assessment 
Two reviewers independently screened electronic records, extracted data and assessed 
study quality using specially designed forms.  Study quality was assessed using the NICE 
quality assessment checklists and each study was assigned a quality rating of ++ (best 
quality), + and – (poorest quality). 
 
Data synthesis 
Owing to the wide scope of the research question, and the heterogeneity in interventions, 
participants, follow up, and outcomes, an overall meta-analysis was not considered to be 
appropriate.  If data were available we calculated relative risks (RR) with 95% confidence 
intervals.  Data are presented in tables with an indication of whether the intervention had 
a positive effect (+), a negative effect (-) or no statistically significant effect (0).  In 
addition, where possible, forest plots, without a pooled summary statistic, are presented 
to give a visual representation of the data.  Results are presented in two sections, one for 
the prevention of STIs and one for the prevention of under 18 conceptions. 
 
Main results  
We found 62 studies that met our inclusion criteria.  Of these, 56 were quantitative and six 
were qualitative studies.   
 
Additional studies included.  
Prevention of STIs 
In the initial rapid review we included a systematic review of psychosocial interventions to 
reduce sexual risk behaviours among drug users (Van Empelen 2003). However, this was 
a relatively poor quality systematic review that provided little data from the original 
studies. Therefore, in this update we have included the original studies instead of the 
systematic review.  This is an additional three studies (Gibson 1999, Kotranski 1998, 
O’Neill 1996).   
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Prevention of under 18 conceptions 
This update of the review includes an additional five studies (Nor 2003, Olds 1997, Olds 
2002, Olds 2004, Shlay 2003).   These were initially excluded as they did not focus solely 
on under 18’s but included older women as well.  However, as literature in this area was 
scarce and as all the studies included at least 40% of under 20’s we have included them 
in this update.   Of these additional studies one looked at contraceptive care in an STI 
clinic (Shlay 2003) and the rest evaluated home visiting programmes for pregnant women 
or mothers.  
 
The effectiveness of one to one interventions for the reduction of STIs (including 
HIV) 
Forty-four studies evaluated one to one interventions for the prevention of STIs/HIV 
infection.  Of those, 43 were RCTs, and one was an uncontrolled before/after study.  Six 
studies were graded as having a low risk of bias (++), 11 as having a medium risk of bias 
(+) and the rest as having a high risk of bias (-).  Five qualitative studies that explored 
barriers and facilitators to the effectiveness of one to one interventions were also 
included; of these three were graded as having a low risk of bias (++) and two as a 
medium risk of bias (+). 
 
The quantitative studies included a variety of populations, settings, providers and types of 
intervention.  Many of the populations included were groups at particular risk for STIs/HIV 
infection. For example: adolescents, MSM, black and minority groups, people with a 
history of a previous STI, drug users, prisoners and people with HIV.  All interventions 
included safer sex counselling and education of some sort.  In 27 studies this was based 
on some form of theoretical model, and 25 reported that they involved skills development.  
This included areas such as the development of social skills, self-esteem, self-efficacy or 
negotiation skills for condom use.  Of the qualitative studies one was concerned with the 
prevention of STI, three with the prevention of HIV and one with the promotion of sexual 
health. 
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The main results are presented below: 
STIs (including HIV) 
(Forest Plot Figures 1, 2 & 3. Effect of one to one interventions on STIs)  
Evidence Statement 1.1 
In summary the evidence on the effectiveness of one to one interventions for the 
prevention of STIs is mixed but on balance marginally supports the interventions.  There 
is evidence from Project RESPECT a large (++) US study (Kamb 1998) that both a two 
session and a four session one to one counselling intervention can reduce STIs in the 
long and very long term in heterosexuals, and from one (+) study that STIs in men can be 
reduced in the long term after one 90 minute session (Kalichman).  However, the effect 
appears to decrease over time, with one study finding a reduction in effect after six 
months (Kamb 1998).  
 
Evidence Statement 1.2 
In addition  EXPLORE a large (++) US study of ten session one to one counselling for 
MSM found a 15.7% reduction in HIV infection but this was not statistically significant 
(EXPLORE 2004). The other studies found no statistically significant effect on STIs but 
may have been underpowered for this outcome.   
 
Evidence Statement 1.3  
Interventions with adolescents appeared to be particularly effective.  A subgroup analysis 
of Project RESPECT (Bolu 2004) found a significant reduction in sexually transmitted 
infections with both the four and two session interventions versus a didactic control.  
Although this was the only study to show a statistically significant difference the general 
trend in this group of studies was towards a reduction in STIs. 
 
Condom use 
(Forest Plot Figures 4&5 Effect of one to one interventions on consistent condom use.)  
Evidence Statement 1.4 
Twenty-five studies reported condom use, of which only eight showed a statistically 
significant increase in condom use in the intervention group compared to the control. 
However, overall there is weak evidence (that is it is mixed or conflicting but on balance 
marginally supports) that one to one STI/HIV prevention interventions can increase short 
and long-term condom use compared to control.    Project RESPECT, a large good quality 
(++) US study found an increase in condom use in both the four and two session 
counselling intervention groups compared to a didactic control (Kamb 1998). However, 
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several studies found the effect of an intervention appears to decrease, or disappear over 
time.  Greater uniformity is needed in the way in which condom use is measured in 
studies.   
 
Unprotected sex 
(Forest Plot Figures 6&7 Effect of one to one interventions on unprotected sex.)  
 
Evidence Statement 1.5  
Fifteen studies reported unprotected sex.  Only six studies found a statistically significant 
difference between intervention and control and in general the evidence is conflicting on 
whether or not one to one STI/HIV interventions reduce unprotected sex.  However, 
EXPLORE a large high quality (++) US RCT found that there was a 13.9% reduction in 
unprotected sex at very long term follow up after a 10 session + boosters HIV prevention 
counselling intervention (EXPLORE 2004).  At present there seems to be support for 
multi-session interventions but conflicting evidence on shorter interventions. 
 
Number of sexual partners/initiation of intercourse  
Evidence Statement 1.6  
Ten studies reported number of partners, initiation of intercourse, or abstinence as an 
outcome.   No high quality studies reported this outcome; three were graded as (+) and 
seven as (-).  Only two studies, one (+) and one (-) found a statistically significant effect 
(Downs 2004, Metzler 2000) and in one the effect was not maintained after 6 months 
(Downs 2004). In summary there is weak evidence that one-to-one interventions for the 
prevention of STIs/HIV are ineffective in reducing the number of sexual partners or in 
promoting abstinence.  However, it should be noted that the interventions included in this 
review appeared to be designed to promote safer sexual behaviour rather than 
abstinence. 
 
Risk taking behaviour/perception of risk 
Evidence Statement 1.7 
Seven studies measured overall risk taking behaviour (e.g. sexual risk taking scores). 
One (+) study set in a UK STI clinic found a significant effect on risk perception (James 
1998).  The remaining six (-) RCTs did not find any significant effect on risk taking 
behaviour or risk perception (Baker 1994, O’Neill 1996, Deas 2000, Ashworth 1994, 
Proude 2004, Gibson 1999, O’Neill 1996).  However, three of the studies involved HIV 
prevention for drug users where much of the focus was on safer injecting and drug use 
behaviour rather than safer sexual behaviour (Baker 1994, Gibson 1999, O’Neil 1996).  In 
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summary, there is little evidence that one to one interventions can reduce risk taking 
behaviour or perception of risk but the quality of studies is poor.   
 
How does the content of the intervention (what?) influence effectiveness? 
(Forest Plot Figures 9 & 10  Studies with face to face counselling effect on STIs.)  
 
Evidence Statement 1.8 
Nineteen studies compared a theory based/ skills training intervention with a more 
didactic control.  Of those ten measured STIs (Boekeloo 1999, Boyer 1997, El-Bassel 
2003, Kalichman 2005, Kamb 1998, Maher 2003, Metzler 2000, Orr 1996, Scholes 2003, 
Shrier 2001).  In general the effects on STIs were mixed.  However, Project RESPECT 
(Kamb 1998) a large (++) US study found that two and four session theory based 
interventions are more likely to be effective than a didactic control. These interventions 
were, however, both longer than the control.  Further large scale evaluations of theory 
based interventions are needed to establish which components of interventions are the 
most effective.   
 
Qualitative studies supported the idea of skills based interventions and found participants 
wanted practical and psychological strategies to increase self-efficacy for contraception 
and condom and safe sex negotiation (Choi 2004, Seal 2005). 
 
Does the way that the intervention is carried out e.g. Type/mode of communication, 
influence effectiveness? 
Evidence Statement 1.9  
There was a range of types of one to one communication used.  The majority of studies 
evaluated face to face communication between a health care professional, trained 
counsellor, or health educator and an individual client.  Other types of communication 
evaluated in a few studies included computer assisted interventions, leaflets, personal 
diaries, and video.  Three poor quality studies (-) compared a face to face intervention 
with a video intervention and found no statistically significant differences (Ashworth 1994, 
DeLamater 2000, Robert 1990), and one (+) study found no difference between face to 
face and telephone counselling (Rotheram-Borus 2004).  Therefore, there is insufficient 
evidence to say whether or not face-to-face delivery is superior to other methods of 
delivery such as telephone, computer assisted or video based interventions.  However, 
the majority of effective interventions involved face-to-face communication. 
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Does the effectiveness depend on the job title/position or other factors such as 
age, gender, sexuality, ethnicity, of the deliverer (leader)?  What are the significant 
features of an effective deliverer (leader)? 
Evidence Statement 1.10 
Evidence from Project RESPECT a large (++) US study, which found a decrease in STIs 
and an increase in safe sexual behaviour, suggests that clinic staff do not need extensive 
experience of counselling to deliver a one to one counselling intervention, but that 
enthusiasm and motivation are key (Kamb 1998). In a large HIV prevention trial, which 
reduced HIV and unsafe sex, counsellors had 40 hours of training.  Both of these studies 
highlight the importance of training and quality control (Kamb 1998, EXPLORE 2004).  
Although qualitative studies reported the importance of peers we found only one 
evaluation of a one to one peer led intervention.  Further research is needed to evaluate 
different types of leaders for one to one interventions, in particular evaluating the effect of 
peer-led programmes. 
 
Setting (where?).  Does the site/setting of delivery of the intervention influence 
effectiveness? 
Evidence Statement 1.11  
The majority of interventions were delivered in a clinic setting of some sort, for example 
STI/GUM clinics, family planning clinics, primary care clinics and HIV clinics.  None of the 
studies compared one setting with another so there is insufficient evidence to say whether 
the site/setting of delivery of one to one interventions influences effectiveness.  However, 
the authors of Project RESPECT, a (++) trial which showed a counselling intervention to 
be effective in reducing STIs and increasing condom use, suggest that STI clinics may be 
appropriate places to deliver interventions as it is possible those seeking treatment for a 
STI may be particularly amenable to behaviour change (Kamb 1998). 
 
Does the intensity (or length) of the intervention influence effectiveness/duration of 
effect? 
Evidence Statement 1.12 
Evidence is mixed on whether the intensity or length of one to one interventions for the 
prevention of STIs influences effectiveness.  A (++) 10 session HIV prevention 
intervention for MSM found a significant reduction in unprotected sex and a reduction in 
HIV (EXPLORE  2004).  However, longer interventions may not necessarily be better than 
shorter ones.  A (++) study (Kamb 1998) found that both a brief two session and an 
enhanced four session intervention were effective in reducing STIs and increasing 
condom use, although the four session intervention was marginally more effective than 
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the two session intervention.   Two studies evaluated the addition of booster sessions to 
an intervention.  Both, Project RESPECT 2 a (++) study (Metcalf 2005) and a (-) study 
(Patterson 2003), found no evidence that a counselling intervention with additional 
booster sessions was more effective, in reducing STIs, than a counselling intervention 
without booster sessions.  
 
Does the effectiveness vary with age, gender, sexuality, socio-economic status, 
ethnicity? 
Evidence Statement 1.13 
Age 
A subgroup analysis of Project RESPECT (Bolu 2004) found a significant reduction in 
sexually transmitted infections in adolescents with both the four and two session 
interventions versus a didactic control.   The intervention was more effective with 
adolescents than with other age groups. Although this was the only study with 
adolescents to show a statistically significant difference the general trend in this group of 
studies was towards a reduction in STIs. 
 
Ethnicity 
Evidence Statement 1.14 
In 15 studies all or the majority of participants were black, and in the majority of the rest 
the populations were multiethnic.  One important exception is a (++) HIV prevention study 
which found a 10 session counselling intervention reduced HIV and unsafe sex in MSM 
(EXPLORE 2004).  The majority of participants in this study were white and they reported 
difficulty in recruiting and retaining black and Hispanic participants.  In subgroup analyses 
of Project RESPECT (Bolu 2004) they found that a four session intervention was more 
effective than a two session intervention for white participants but that conversly the two 
session intervention was more effective than the four session intervention for black 
participants. 
 
Sexuality 
Evidence Statement 1.15 
Project RESPECT a large (++) US study of a STI prevention intervention included 
heterosexuals only.  They found significant reductions in STIs and an increase in condom 
use after a four and two session counselling intervention (Kamb 1998).  EXPLORE a 
large high quality (++) US RCT with MSM found a non significant reduction in HIV and a 
13.9% reduction in unprotected sex at very long term follow up after a 10 session + 
boosters HIV prevention counselling intervention (EXPLORE 2004).  
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THE EFFECTIVENESS OF ONE TO ONE INTERVENTIONS FOR PREVENTING 
UNDER 18 CONCEPTIONS? 
 
The effectiveness of one to one interventions for the prevention of under 18 
conceptions 
(Forest Plot Figure 11. Effect of one to one interventions on pregnancies (includes repeat 
pregnancies)  
 
We found only twelve studies that evaluated the effectiveness of one to one interventions 
to prevent conceptions in the under 18s.  On the quality assessment score three out of 
eleven RCTs scored (++), three (+), and five (-), and a controlled study scored (-).  In 
addition, we included three qualitative studies that looked at barriers and facilitators to the 
prevention of under 18 conceptions.  Of these two were graded as (++), and one was 
graded as (+). 
 
Two studies evaluated the advanced provision of emergency contraception, six  looked at 
health care programmes for pregnant women/ mothers, two looked at contraceptive care 
and advice in clinics, and two looked at sexual/reproductive health education.   
 
Of the qualitative studies two included information on the prevention of pregnancy in 
teenagers and one looked at sexual health promotion. 
 
Pregnancy 
 
Eleven studies reported data on pregnancy or repeat pregnancies.   
 
Advanced Emergency contraception 
Evidence Statement 1.16 
Of the two studies (++) of advanced provision of emergency contraception, one (Gold 
2004) found a trend towards a reduction in pregnancies but this was not statistically 
significant (Gold 2004), and the other found a non significant reduction in the pharmacy 
access group but not advanced provision group (Harper 2005). 
 
Support for pregnant women/mothers 
(Forest Plot Figure 12. Effect of one to one home visiting or support for pregnant women/mothers 
on repeat pregnancies).  
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Evidence Statement 1.17 
Six studies evaluated interventions to support pregnant women or mothers.  Although only 
two of the studies focused solely on adolescents (O’Sullivan 1992, Quinlivan 2003) all 
included at least 40% of adolescents and focused on disadvantaged, low-income women.  
There is good evidence that multi-session support and home visiting for disadvantaged 
low-income pregnant women or mothers can prevent repeat pregnancies with two (+) 
(Olds 2002, Olds 2004) and one (-) (O’Sullivan 1992) studies showing a significant 
reduction in repeat pregnancies in the intervention group compared to control.  In addition 
one (-) study (Olds 1997) found a reduction in repeat pregnancies in poor unmarried 
women, although not in the sample as a whole. 
 
Clinic based contraception care 
(Forest Plot Figure 13: Effect of one to one interventions on contraception use).  
 
Evidence Statement 1.18 
One (-) RCT and one (2+) non randomised controlled study evaluated contraception 
advice and support in a clinic based setting (Shlay 2003, Winter 1991).  One (Winter 
1991) found a significant reduction in pregnancies and the other (Shlay 2003) showed a 
trend towards a reduction in the intervention group compared to control but this was not 
significant. 
 
In summary although only four studies showed a statistically significant reduction in 
pregnancy (O’Sullivan 1992, Olds 2002, Olds 2004, Winter 1991) the general trend was 
towards a reduction. Therefore, there appears to be evidence that one to one 
interventions with adolescents can reduce pregnancies.  Multi-session nurse home 
visiting appears particularly effective, especially with low-income disadvantaged women 
(Olds 1997, Olds 2002, Olds 2004).  However, more research, is needed in this area with 
a focus on the under 18s and studies powered to detect a change in pregnancies. 
 
Contraception use  
Evidence Statement 1.19 
Seven studies reported contraception use. This was measured in various different ways, 
including oral contraception, emergency contraception and condom use.  Four studies 
showed a statistically significant effect on contraception use. Two increased oral 
contraceptive use. These were a  (++) RCT (Quinlivan 2003) and a (+) RCT (Danielson 
1990) that found one to one interventions with teenagers can improve contraception use 
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in the long term.   Of the two (++) studies of advanced provision of emergency 
contraception one found an increase in the use of EC (Harper 2005) and one an increase 
in condom use (Gold 2004).  In the other studies the general trend was towards an 
increase in contraception use although one (-) study found the effect on contraception use 
was no longer significant at 12 months (Winter 1991).  Therefore, there is some evidence 
that one to one interventions with under 18s can increase contraception use.  However, 
further research in this area is needed. 
 
How does the content of the intervention influence effectiveness? 
Evidence Statement  1.20 
There are few studies evaluating interventions to prevent under 18 conceptions and in 
general there is insufficient evidence to say whether or not the content of one to one 
interventions influences effectiveness.  However, there is good evidence that multi-
session support and home visiting for disadvantaged low-income pregnant women or 
mothers can prevent repeat pregnancies with two (+) (Olds 2002, Olds 2004) and two (-) 
(Olds 1997, O’Sullivan 1992) studies showing a significant reduction in repeat 
pregnancies in the intervention group compared to control. 
 
Does the way the intervention is carried out e.g type/mode of communication, 
influence effectiveness? 
Evidence Statement 1.21 
There is insufficient evidence to say whether or not the type/mode of communication of 
one to one interventions to prevent under 18 conceptions influence effectiveness. 
 
Does the effectiveness depend on the job title/position or other factors such as 
age, gender, sexuality, ethnicity, of the deliverer (leader)? What are the significant 
features of an effective deliverer (leader)? 
Evidence Statement 1.22 
In general there is insufficient evidence to say whether or not the type of leader influences 
the effectiveness of one to one interventions for preventing under 18 conceptions. 
However, one (+) US study of home visiting for mothers (Olds 2002) found that nurses 
were more effective than paraprofessionals in reducing repeat pregnancies. 
 
Setting (where?). Does the site/setting of delivery of the intervention influence 
effectiveness? 
Evidence Statement 1.23 
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Most intervention were delivered in clinics or via home visiting.  There is good evidence 
that multi-session support and home visiting for disadvantaged low-income pregnant 
women or mothers can prevent repeat pregnancies with two (+) (Olds 2002, Olds 2004) 
and one (-) (O’Sullivan 1992) studies showing a significant reduction in repeat 
pregnancies in the intervention group compared to control, and one (++) study an 
increase in reliable contraception use (Quinlivan 2003).  In addition one (-) study (Olds 
1997) found a reduction in repeat pregnancies in poor unmarried women, although not in 
the sample as a whole. 
 
Does the intensity (or length) of the intervention influence effectiveness/duration of 
effect? 
Evidence Statement 1.24 
There is insufficient evidence that the length of clinic based one to one interventions, for 
the prevention of under 18 conceptions, influences the effectiveness/duration of effect.  
There is good evidence from one (++) study (Quinlivan 2003) two (+) (Olds 2002, Olds 
2004) and two (-) studies (Olds 1997, O’Sullivan 1992) that multi-session one to one 
interventions may increase effective contraception use and prevent repeat pregnancies. 
 
Does the effectiveness vary with age, gender, sexuality, socio-economic status, 
ethnicity? 
 
Gender 
Evidence Statement 1.25 
In summary, there is insufficient evidence to say whether or not gender influences the 
effectiveness of one to one interventions to prevent under 18 conceptions. Most studies 
included in the review were aimed at females and there would appear to be a need for 
further research that evaluates interventions that include, or are specifically targeted at, 
males. 
 
Socio-economic status 
Evidence Statement 1.26 
There is good evidence from one (++) study (Quinlivan 2003) two (+) (Olds 2002, Olds 
2004) and two (-) studies (Olds 1997, O’Sullivan 1992) that multi-session home visiting or 
support can be effective in increasing effective contraception use and preventing 
pregnancies in low-income disadvantaged women. 
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Conclusions 
There is evidence that one to one interventions can reduce STIs and may increase 
condom use and prevent unsafe sexual behaviours.  However, effectiveness decreases 
over time.   A brief US STI prevention intervention, Project RESPECT, delivered in the 
context of routine health services with existing staff has been shown to be effective (Kamb 
1998) in reducing STIs and increasing condom use. Components of Project RESPECT 
included: 
 Client centred intervention tailored to individual’s personal risk 
 Behavioural goal setting and risk reduction strategies 
 Standardised training and structured protocols for clinic staff 
 Quality control through observation and feedback 
 
For MSM a multi-session intervention was shown to be more effective than the brief 
Project RESPECT model (EXPLORE 2004).  However, this involved over 10 sessions. 
 
One to one interventions can also improve contraception use and prevent pregnancies in 
the under 18’s. Multi-session interventions involving home visiting appear to be 
particularly effective in preventing repeat pregnancies in high-risk groups. 
 
Limitations of the review 
 Lack of research, in particular there was little UK based research 
 In many US studies treatment as usual or control groups received interventions 
which are more structured and detailed than usual care currently provided in GUM 
clinics in the UK which makes generalisability to the UK difficult 
 Lack of objective primary outcome measures such as incidence of STIs/HIV and 
conceptions.   
 A number of poor quality and underpowered studies 
 
 
Barriers to implementation 
 The provision of resources for multi-session interventions 
 Recruitment and retention of participants, particularly for multi-session 
interventions 
 Difficulty generalising current research to a UK setting 
 
Recommendations for future research 
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There were a number of gaps in the evidence base identified by this review, in particular 
for the prevention of under 18 conceptions.  Overall the effectiveness of many STI and 
under 18 conception prevention programmes remains in doubt.  For this reason further 
high-quality large scale research is needed with evaluation an integral part of 
programmes.  Areas for future research identified by the review include the following: 
 
Prevention of STIs (including HIV) 
 Evaluations aimed specifically at vulnerable groups – e.g young people in or 
leaving care, young people from some ethnic backgrounds, sex workers, refugees 
and asylum seekers 
 Evaluations of interventions in the UK as most of the included studies were from 
the USA 
 Replication, and evaluation, in the UK of successful US interventions (e.g. Project 
RESPECT) to evaluate applicability in the UK setting 
 Studies large enough to detect a reduction in STIs/HIV infections 
 Evaluations of peer-led interventions 
 
 
Prevention of under 18 conceptions 
 Evaluations aimed specifically at vulnerable groups – e.g.  young people in or 
leaving care, young people from some ethnic backgrounds, refugees and asylum 
seekers 
 Evaluations of interventions in the UK as most of the included studies were from 
the USA 
 Studies large enough to detect a reduction in conceptions 
 The development and evaluation of one to one interventions in different settings 
(e.g school based, clinic based) 
 
402
The effects of telephone consultation
and triage on healthcare use and
patient satisfaction: 
a systematic review
ABSTRACT
Background
In recent years there has been a growth in the use of the
telephone consultation for healthcare problems. This has
developed, in part, as a response to increased demand
for GP and accident and emergency department care.
Aim
To assess the effects of telephone consultation and
triage on safety, service use, and patient satisfaction.
Design of study 
We looked at randomised controlled trials, controlled
studies, controlled before/after studies, and interrupted
time series of telephone consultation or triage in a
general healthcare setting.
Setting 
All healthcare settings were included but the majority of
studies were in primary care. 
Method
We searched the Cochrane Central Register of Controlled
Trials, EPOC specialised register, PubMed, EMBASE,
CINAHL, SIGLE, and the National Research Register and
checked reference lists of identified studies and review
articles. Two reviewers independently screened studies
for inclusion, extracted data, and assessed study quality. 
Results 
Nine studies met our inclusion criteria: five randomised
controlled trials; one controlled trial; and three interrupted
time series. Six studies compared telephone consultation
with normal care; four by a doctor, one by a nurse, and
one by a clinic clerk. Three of five studies found a
significant decrease in visits to GPs but two found an
increase in return consultations. In general at least 50%
(range = 25.5–72.2%) of calls were handled by telephone
consultation alone. Of seven studies reporting accident
and emergency department visits, six showed no
difference between the groups and one — of nurse
telephone consultation — found an increase. Two studies
reported deaths and found no difference between nurse
telephone consultation and normal care. 
Conclusions 
Although telephone consultation appears to have the
potential to reduce GP workload, questions remain about
its effect on service use. Further rigorous evaluation is
needed with emphasis on service use, safety, cost, and
patient satisfaction. 
Keywords
consultation; hotlines; review, systematic; telephone;
triage.
INTRODUCTION
In recent years there has been an increase in the use
of telephone consultation and triage (the process
where calls from people with a healthcare problem
are received, assessed, and managed by giving
advice or by referral to a more appropriate service).1
One impetus for the development of telephone
consultation has been to reduce the workload of
GPs and accident and emergency (A&E)
departments. A&E attendances in the UK have
increased,2 as has demand for the service of GPs,
although it has been estimated that more than half of
out-of-hours calls can be handled by telephone
advice alone.3–5
Although some telephone consultation is done by
doctors,3 much is now done by qualified nurses
using computer-based clinical decision support
systems. This reflects changes in the role of the
nurse in recent years and the move towards nurses
undertaking some tasks previously carried out by
doctors. One of the largest telephone consultation
systems in operation is NHS Direct; this is a 24-hour
nurse-led telephone advice system, based in
England, that aims to help callers self-manage
problems and reduce unnecessary demands on
other NHS services.6,7
Frances Bunn, Geraldine Byrne and Sally Kendall
F Bunn, BSc(Hons), MSc, research fellow in evidence-based
practice; S Kendall, BSc(Hons), PhD, RGN, RHV, professor of
nursing, Centre for Research in Primary and Community
Care; G Byrne, BA(Hons), PhD, RNT/PGCE, principal
lecturer, School of Nursing and Midwifery, University of
Hertfordshire, Hatfield.
Address for correspondence
Frances Bunn, Centre for Research in Primary and
Community Care, University of Hertfordshire, College Lane,
Hatfield AL10 9AB. E-mail: f.bunn@herts.ac.uk 
Submitted: : 10 November 2004; Editor’s response:
4 February 2005; final acceptance: 22 April 2005.
©British Journal of General Practice 2005; 55: 956–961.
British Journal of General Practice, December 2005
F Bunn, G Byrne and S Kendall
956
403
British Journal of General Practice, December 2005
To date relatively little information exists on whether
telephone consultation reduces pressure on other
services. In Denmark, demand for home visits fell by
28% after the introduction of telephone consultation
by doctors.3 In the UK there was a small decrease in
the use of GP cooperatives, although no significant
decrease in the use of A&E departments or ambulance
services after the introduction of NHS Direct.8
Caller satisfaction with NHS Direct has been
found to be high.9,10 However, it has been argued that
older people, minority ethnic groups, and other
disadvantaged groups underuse the service, and
that it may in fact have increased, not decreased,
the workload of other healthcare services.11
Concerns about telephone consultation include the
quality and safety of advice given;12–17 although other
research has found it safe and effective.18–20 In an
attempt to clarify the situation we conducted a
systematic review of telephone consultation and
triage services to assess their effect on safety,
satisfaction, and service usage. 
METHOD
Inclusion criteria
We included randomised controlled trials, controlled
trials, controlled before/after studies and interrupted
time series of telephone consultation or triage. This
included telephone consultation, by any healthcare
worker, compared with a face-to-face consultation
or normal care (not including telephone
consultation), or telephone consultation by one type
of healthcare worker versus another (for example,
nurse-led versus doctor-led telephone consultation).
Disease-specific phone lines were excluded. The
outcomes of interest were: mortality; adverse
events; service use; calls handled by telephone
alone; patient satisfaction; and cost.
Identification of studies
We searched for published and unpublished studies
using the following databases: Cochrane Central
Register of Controlled Trials (Cochrane Library Issue
1 2003), specialised register of the Cochrane
Effective Practice and Organisation of Care Group
(EPOC) (March 2003), PubMed (1966–February
2003), EMBASE (February 2003), CINAHL
(1983–February 2003), SIGLE (System for
Information on Grey Literature) (1980–February
2003), and the National Research Register (Issue 2
2003). For details of the search terms used see Box
1. We checked reference lists of identified studies
and review articles and contacted experts in the
field. There were no language restrictions. 
Data extraction and analysis
Two reviewers independently screened titles and
abstracts of citations identified by the electronic
search, applied the selection criteria to potentially
relevant papers, and extracted data from included
studies using a standardised checklist. We
extracted information on participants, outcomes,
and the intervention, which included the
comparison, setting, service provider, use of
algorithms or computer-based clinical decision
support systems, and hours covered. We assessed
methodological quality using the criteria of the
Cochrane EPOC Group.21
Due to heterogeneity in study design,
interventions, outcomes, and participating health
professionals we did not pool studies in a meta-
analysis. Instead a narrative and tabular summary of
findings is presented and where possible we have
reported post-intervention differences and 95%
How this fits in
In recent years there has been a growth in the use
of telephone consultation for the management of
healthcare problems. Previous research suggests
that more than half of calls can be handled by
telephone advice alone, but there have been
doubts about safety, and the quality of advice
given. In this review we found that telephone
consultation can reduce GP visits and that, in
general, 50% of calls can be handled by
telephone. There was no apparent increase in
adverse effects or use of other services and
patients were satisfied. However, there was limited
data on patient satisfaction and adverse effects.
Systematic Reviews
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P 1. Triage (MeSH) all fields
P 2. Helpline* (free text)
P 3. Hotlines (MeSH) all fields
P 4. Family practice/organisation and administration
(MeSH)
P 5. Emergency medicine/organisation and
administration (MeSH)
P 6. #1 OR #2 OR #3 OR #4 OR #5
P 7. Telephone* (free text)
P 8. #6 AND #7
P 9. Telephone consultation
P 10. Telephone triage 
P 11. NHS direct
P #8 OR #9 OR #10 OR #11
Box 1. Search terms and strategy.
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confidence intervals (CIs) or P-values. For
interrupted time series, where possible, we have
calculated a change in the level of outcome at the
first point after the introduction of the intervention,
and estimated a change in the slopes of the
regression line (calculated as post-intervention
minus pre-intervention slope). 
RESULTS
We identified 11 studies that met the inclusion
criteria (Figure 1). However, two22,23 did not present
relevant data and were excluded, leaving nine
studies. Five were randomised controlled trials,19,24–27
one a controlled trial,28 and three were interrupted
time series,29–31 one of which31 was a population-
based study. Two of the randomised controlled
trials19,27 were parallel trials using the same
methodology; six were set in general
practice,19,25,27,29–31 all except one of them31 in the UK.
Four studies concerned out-of-hours care.19,24,27,31 In
all studies, where a nurse delivered telephone
consultation, algorithms or protocols were used.
More information about individual studies can be
found in Supplementary Table 1.
In the controlled studies, allocation concealment
was adequate in three,19,25,27 inadequate in one,28
and unclear in two.24,26 Four studies reported
adequate follow up of patients19,25–27 and all five
randomised controlled trials and the one controlled
study had blinded assessment of the primary
outcome. In all three interrupted time series the
intervention was independent of other changes;
they had blinded assessment of the primary
outcome and complete data sets. In two of the
interrupted time series the data were analysed
appropriately. However, in the third31 the
researchers did not look for serial correlation and
the analysis was redone using time series
regression techniques. In one31 a change from
manual to electronic recording after the start of the
intervention may have led to detection bias. 
When interpreting the data, it should be noted
that for many of the outcomes equivalence was
regarded as desirable. Researchers were normally
concerned about determining whether telephone
consultation or triage was as safe and effective as
existing services. Numerical data from individual
studies are presented in Supplementary Tables 2
and 3.
Telephone consultation versus normal care 
Six studies compared telephone consultation with
standard management that did not include
telephone consultation (Supplementary Table 2). In
four of these the telephone consultation was by a
doctor,24,25,29,31 in one a nurse30 and in one a clinic
clerk.26
Routine GP appointments. Of three routine GP
appointments, one29 found a significant reduction of
39% in GP visits (P<0.001). However, one
telephone consultation by a doctor25 found that
although same-day appointments had decreased,
there was an increase of visits in the 2-week follow-
up period (mean difference 0.2 [95% CI = 0.0 to
0.3]). The other telephone consultation (by a nurse)30
also found that although there was a significant
reduction in immediate visits (range difference [RD]
-0.23 [95% CI = -0.26 to -0.20]) there was an
increase in return consultations (RD = 0.32 [95%
CI = 0.22 to 0.41]).
Calls handled by telephone advice alone. Calls
handled by telephone advice alone ranged from
25.5% in the study of telephone consultation by
nurses30 to 52%29 and 72%25 by doctors.
Visits to A&E. With regard to visits to A&E, in the
three studies of telephone consultation by a doctor,
two24,25 found no significant difference between
telephone consultation and face-to-face
appointments (RD = -0.04 to 0). The other study31
found a significant increase in contacts with A&E
but, given the constant rise in contact rates, the
authors performed a regression model that showed
the increase was not statistically significant. The
study of nurse telephone consultation30 found a
significant rise in the number of visits to A&E (mean
difference = 0.023 [95% CI = 0.015 to 0.032]).
958
Studies to be excluded
from meta-analysis
because no relevant data
(n = 2) 
Potentially appropriate
studies to be included in
the analysis (n = 11)
Studies included in the
analysis (n = 9)
Studies excluded 
(n = 3375)
Studies retrieved for more
detailed evaluation 
(n = 62)
Studies excluded (n = 51)
40 = not right study type
11 = not right intervention
Potentially relevant studies
identified and screened for
retrieval (n = 3437)
Figure 1. Flow chart
showing how studies were
identified.
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Hospital admissions. When hospital admissions
(n = 2) were compared, the trial of telephone
consultation by doctors24 found no significant
difference between the intervention and control
groups (adjusted risk difference at 2-year follow up
= 0.03). However, the trial using clinic clerks to run a
specialised telephone service26 found a significant
reduction in hospitalisations at 12 months (mean
difference = 0.17; P<0.05).
Home visits by GPs. One study reported the number
of home visits by a GP30 and found a non-significant
reduction in the number of visits (RD = -0.02 [95%
CI = -0.04 to 0.00]).
Out-of-hours contacts. One trial of telephone
consultation by a doctor25 found no difference in out-
of-hours contacts between the two groups (mean
difference = 0). However, the other, an interrupted
time series of nurse telephone consultation,30 found
a significant increase in the number of out-of-hours
contacts in the intervention group (mean difference
= 0.04 [95% CI = 0.01 to 0.07]).
Patient satisfaction. Two randomised controlled trials
compared satisfaction in intervention and control
groups. One25 found no significant difference in
satisfaction between telephone and face-to-face
consultations (difference = -8.4% [95% CI = -23.1 to
6.4%]) and the other26 found that patients in the
intervention group were more satisfied (P<0.05).
Satisfaction was high in the two other studies. In one
of these24 78% of those interviewed were satisfied
with length of time before the doctor responded,
length of consultation, and care provided; in the
other,29 98% were satisfied or very satisfied with the
outcome of the telephone consultation and 84%
happy to receive the service again in the future.
However, the data regarding satisfaction needs to be
interpreted cautiously. In one study25 there was a
response rate of less than 50%, and in two24,29 there
was no comparison group — one because it was an
interrupted time series29 and the other because the
researchers only collected data on a subset of
intervention patients.
Cost. The study30 that carried out an economic
evaluation found little difference in cost between the
intervention and control groups (mean difference =
1.48 [95% CI = -0.19 to 3.15]). In the other,29 the
researchers looked at cost of phone calls only, and
found that telephone bills increased by 26%.
Telephone consultations compared by type of
healthcare worker 
Three studies compared telephone consultation by
one type of healthcare worker with another
(Supplementary Table 3). Two randomised controlled
trials compared nurse telephone consultation with
telephone consultation by a doctor in an out-of-hours
deputising service17,25 and one controlled trial
compared telephone consultation by a health assistant
with telephone advice from a doctor or a nurse. 26
Routine GP appointments. Two trials19,27 reported
less GP appointments in surgery in the intervention
group during the trial period. However, this was only
significant in one19 (relative risk = 0.62 [95%
CI = 0.58 to 0.66]). 
Calls handled by telephone advice alone. In one
study,19 both doctors and nurses handled 50% of
calls by telephone advice alone. In the other,27 59%
of calls in the nurse consultation group and 62% of
calls in the GP group were managed by telephone
advice alone.
Visits to A&E. All three studies found a slight
increase in number of visits to A&E in the
intervention group (range = 0.3–2% increase), but
results were not significant.
Hospital admissions. Two studies19,27 found no
significant difference between the intervention and
control groups regarding the number of hospital
admissions at 24 hours and 3 days after contact
with out-of-hours services (RD at 3 days = -0.01
[95% CI = -0.02 to 0.00] and -0.02 [95% CI = -0.08
to 0.05]).
Out-of-hours contacts. Two studies27 found a
significant reduction in the number of home visits by
the deputising service (RD = -0.06 [95% CI = -0.07
to -0.04] and -0.12 [95% CI = -0.24 to -0.11]). 
Cost. In the trial with an economic evaluation,19 the
cost of providing nurse telephone consultation was
£81 237 a year. However, there was a reduction in
overall costs of over £100 000.
Death. Neither randomised controlled trial19,27 found a
significant difference in deaths between nurse
telephone triage and triage by a doctor for patients
who had been in contact with the out-of-hours service
within the previous 7 days (RD = 0 [95% CI = 0.00 to
0.00] and RD = 0 [95% CI = -0.03 to 0.04]). However,
one27 was underpowered to detect mortality.
DISCUSSION 
Summary of main findings
This systematic review found that telephone
consultation and triage reduce immediate GP or
British Journal of General Practice, December 2005 959
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home visits and that, in general, at least 50% of
calls can be handled by telephone advice alone.
However, it is unclear if, in some instances, triage is
just delaying visits as two studies25,30 showed an
increase in return consultations. We found no
evidence of an increase in adverse effects or use of
other services and patients were satisfied.
However, data on some important outcomes, in
particular patient satisfaction, cost, and adverse
events, were reported by few of the included
studies. Initially, we felt there might be a distinction
between telephone consultation and triage
systems; in reality, we found that these terms were
used interchangeably. The majority of studies in this
review (five out of nine) were set in UK general
practice.
One of the aims of this review was to compare
telephone consultation by different groups of
healthcare professionals. Only three of the included
studies directly compared one group of healthcare
worker with another.19,27,28 The two studies
comparing nurse telephone consultation with a GP
deputising service19,27 were good quality randomised
controlled trials and found nurses could reduce GP
workload without an increase in adverse events.
Two of the older studies26,28 used unqualified staff to
deliver telephone consultation and are, therefore,
perhaps less relevant to present-day systems
where the emphasis seems to be on consultation by
qualified staff. In the other included studies the type
of healthcare professional delivering the
intervention did not appear to affect outcome,
although one study — of nurse telephone
consultation — found a small but significant
increase in out-of-hours contacts and visits to
A&E.30 Although other uncontrolled studies have
found high levels of satisfaction with nurse
telephone consultation,11,12 we have no way of
assessing this important outcome as none of the
studies of nurse telephone consultation in this
review reported it adequately.
Comparison with existing literature
This review supports previous estimates that at least
50% of calls can be handled by telephone advice
alone.5–7 In addition, findings from an observational
study of the impact of NHS Direct,8 showing that
there was no decrease in the use of A&E
departments but an impact on the use of GP
cooperatives, are similar to the results of this review.
Previous studies have highlighted the potential for
errors or mismanagement with telephone
consultation;15–16 however, few studies in this review
reported adverse outcomes. The two that did19,27
found no increase in adverse events, although one27
was underpowered to detect mortality. 
Strengths and limitations of the study
We used systematic and rigourous methods to
synthesise the current evidence on telephone
consultation and highlight areas for further
research.
However, there are a number of methodological
issues that could have an important bearing on the
validity of these results. Publication and other
selection biases are a potential threat to validity in all
systematic reviews, but this is a particular problem
when searching for non-randomised studies. Non-
randomised studies are more difficult to identify than
those that are randomised because there is a variety
of study designs, no standardised terminology, and
they may not be keyworded according to study
design.32 Despite our efforts to identify all eligible
studies, published and unpublished, we cannot
exclude the possibility that some studies were
missed. In addition, no studies met all of the
methodological criteria on the EPOC checklist
(which may adversely affect the validity of the
results) and the diversity of study types,
interventions, and outcomes measured makes
meaningful comparison between studies
problematic. 
Another limitation of this review concerns the
identification of the most appropriate outcome
measures. We chose service use as one of our major
outcomes, as did the majority of studies included in
the review. However, it could be argued that
reducing service use should not be the aim of
telephone consultation. Preventing patients from
consulting GPs for minor illnesses is not necessarily
desirable and may also discourage those with
severe or treatable problems from attending — on
the other hand, telephone consultation may have the
potential to increase access for those who are
unable or reluctant to present in person. In addition,
although 50% of calls may be dealt with by
telephone advice alone this does not necessarily
equate to a 50% drop in workload. Indeed, a new
service such as telephone consultation may attract
patients who would previously have dealt with their
problem without recourse to a healthcare
professional. This may be a particular issue with a
telephone advice and information service such as
NHS Direct. Patient satisfaction and safety may,
therefore, be the most important outcomes.
However, there was a lack of data on both these
outcomes and over half the studies in the review
were randomised controlled trials, which are
generally too small to detect rare adverse events.33
Implications for clinical practice and future
research
The increase in the use of telephone consultation is,
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at least partially, a response to increased workloads
for GPs and attempts to manage requests for same-
day appointments. In addition the current
government agenda is promoting the use of
alternative technologies to improve access to health
care. The largest telephone consultation service
within the UK is now NHS Direct, which is presently
staffed by qualified nurses. However, we found no
controlled studies of this service that met our
inclusion criteria. Therefore, although telephone
consultation appears to have the potential to reduce
GP workload, further rigorous evaluation is needed
with emphasis on service use, safety, cost and
patient satisfaction.
Supplementary information
Additional information is available online at
http://www.rcgp.org.uk/journal/supp/index.asp
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